,Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
0,prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.613794947081577,2.0008197326043438,0.0,0.04362789663485255,0.043,14/23,18.70%,CDH4;CDH20;GRID2;TENM3;TENM4;CDH8;PTPRD;SDK1;TENM2;CDHR3;CADM1;ADGRL3;CDH2;CLDN16
1,prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.7844618347682051,1.9308343512139592,0.0,0.07067719254846114,0.128,6/7,16.50%,GRID2;TENM3;TENM4;PTPRD;TENM2;CADM1
2,prerank,regulation of TOR signaling (GO:0032006),-0.647887323943662,-1.9060742429783675,0.005434782608695652,1.0,0.536,6/6,35.70%,GAS6;UBR2;RICTOR;WDR59;SLC38A9;MIOS
3,prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.6028225806451613,-1.8928382500606507,0.0,0.6855639147178362,0.59,8/8,40.30%,ANKIB1;WAC;PRICKLE1;FHIT;MDM2;CSNK1E;FBXO22;XPO1
4,prerank,translation (GO:0006412),-0.9077231695085256,-1.8676548612099622,0.0,0.5629180861785711,0.663,3/3,9.60%,PPA2;AGO2;MRPS21
5,prerank,chemical synaptic transmission (GO:0007268),0.5463615388213624,1.867435892914374,0.0,0.12215811057758716,0.288,20/29,32.30%,GRID2;CACNB2;DLGAP2;CACNA1A;CHRM3;ASIC2;RIMBP2;PTPRN2;GRIK3;CDH8;GRID1;HCRTR1;HCRTR2;RIT2;DLG2;LIN7A;HTR7;KCNMB1;PRKAR2B;NOVA1
6,prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.889558232931727,1.8620470048605084,0.0,0.10339811502460054,0.319,4/4,11.40%,GRID2;GRIK3;CDH8;GRID1
7,prerank,adherens junction organization (GO:0034332),0.7451682234655972,1.8270761354107534,0.0035335689045936395,0.1301856435584,0.437,6/7,18.10%,CDH4;CDH20;CDH8;CDHR3;CADM1;CDH2
8,prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.699497487437186,-1.8092902031048848,0.004629629629629629,0.6594991504977947,0.812,5/5,30.50%,GAS6;MAP2K5;BTRC;FZD6;CD200
9,prerank,histone ubiquitination (GO:0016574),-0.8986960882647944,-1.796817533646762,0.006369426751592357,0.5814260892991587,0.835,3/3,10.50%,UBR2;WAC;USP22
10,prerank,cellular protein catabolic process (GO:0044257),-0.7700803212851405,-1.7856773288314676,0.020491803278688523,0.5307917488841013,0.852,4/4,23.40%,AP2A2;YME1L1;MDM2;CAPN2
11,prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.7700803212851405,-1.7758721834873767,0.012605042016806723,0.4842330947457547,0.878,4/4,23.40%,YME1L1;ATE1;MDM2;CAPN2
12,prerank,regulation of trans-synaptic signaling (GO:0099177),0.7084397723851035,1.775697770450779,0.006009615384615385,0.2251199466358392,0.667,5/7,20.10%,GRID2;CACNA1A;GRIK3;GRID1;LRP8
13,prerank,positive regulation of synaptic transmission (GO:0050806),0.8167025309913352,1.7756858096282706,0.002509410288582183,0.19308460539253317,0.667,4/5,13.40%,SHANK2;ADCY8;SLC24A2;CACNG4
14,prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.7045226130653267,-1.7755337175027368,0.02564102564102564,0.37702984522943783,0.879,5/5,30.00%,ANKIB1;PRICKLE1;MDM2;CSNK1E;FBXO22
15,prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.7045226130653267,-1.7755337175027368,0.02564102564102564,0.37702984522943783,0.879,5/5,30.00%,ANKIB1;PRICKLE1;MDM2;CSNK1E;FBXO22
16,prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.4249492900608519,-1.7499784906395675,0.05172413793103448,0.41048972860028177,0.925,14/14,58.20%,PIP4K2A;CSNK2A1;MTMR2;PLD1;FAR1;PLA2G4A;MTMR1;PTEN;LPCAT1;SLC44A2;LPIN1;DDHD2;INPP5F;CHKA
17,prerank,positive regulation of macroautophagy (GO:0016239),-0.663316582914573,-1.7491967108103759,0.028925619834710745,0.3763685827122274,0.928,5/5,34.10%,PIP4K2A;WAC;RAB3GAP2;OPTN;SESN3
18,prerank,cell-cell junction organization (GO:0045216),0.6455370648373513,1.7454479694802723,0.004429678848283499,0.25598668350499737,0.783,7/10,18.10%,CDH4;CDH20;CDH8;SDK1;CDHR3;CADM1;CDH2
19,prerank,regulation of dendrite development (GO:0050773),0.7041097718782962,1.739428679032293,0.006045949214026602,0.24635218966480077,0.815,6/7,25.70%,DCC;ALK;HECW2;CAMK1D;LRP8;BCL11A
20,prerank,neuron differentiation (GO:0030182),0.6863630886860911,1.7349771871569284,0.00576036866359447,0.23646319976090083,0.831,5/8,14.70%,TENM3;ALK;TENM4;PTPRD;TENM2
21,prerank,neuron development (GO:0048666),0.5976877602873739,1.729701432758796,0.004296455424274973,0.22845153146977337,0.845,7/13,14.70%,TENM3;CNTNAP2;ALK;TENM4;MAP2;SH3GL2;TENM2
22,prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.8515546639919759,-1.7271333316998831,0.006557377049180328,0.41238902149693596,0.95,3/3,15.20%,WAC;CSNK2A1;FHIT
23,prerank,neural crest cell development (GO:0014032),0.744740368347951,1.7261820867451425,0.0012254901960784314,0.21901204110695985,0.857,5/6,20.30%,NRG1;SEMA3A;CDH2;SEMA3E;SEMA6A
24,prerank,synapse assembly (GO:0007416),0.6540142082392066,1.7213256021106964,0.004667444574095682,0.2158574085810551,0.872,6/9,18.10%,SHANK2;GRID2;LRRTM3;SDK1;ADGRL3;CDH2
25,prerank,modulation of chemical synaptic transmission (GO:0050804),0.5741602777676184,1.7174034088639345,0.004296455424274973,0.21109669414606513,0.885,7/14,20.10%,GRID2;DLGAP2;CACNA1A;GRIK3;GRID1;CDH2;LRP8
26,prerank,neuropeptide signaling pathway (GO:0007218),0.8232931726907631,1.7101489002175314,0.00796812749003984,0.21610351466463634,0.905,4/4,18.00%,SORCS3;HCRTR1;HCRTR2;SORCS2
27,prerank,positive regulation of autophagy (GO:0010508),-0.6462311557788946,-1.710105078325673,0.021645021645021644,0.4323300426622987,0.964,5/5,35.80%,DHRSX;WAC;OPTN;SESN3;ULK1
28,prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.7399598393574297,-1.700661124553917,0.026515151515151516,0.43149740899822886,0.974,4/4,26.40%,TNKS2;DCP2;NEK7;SMG6
29,prerank,cellular response to interleukin-1 (GO:0071347),-0.715863453815261,-1.6932280459045583,0.016194331983805668,0.42762377515733235,0.982,4/4,28.80%,BTRC;RBMX;PELI2;PLCB1
30,prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.7399598393574297,-1.6841399711337086,0.03237410071942446,0.43188708155301353,0.986,4/4,26.40%,UPF3A;PPP2R2A;UPF2;SMG6
31,prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.6855846949335292,1.6833148576962151,0.00954653937947494,0.281018189199244,0.96,6/7,26.90%,DPP6;KCNIP1;KCNMA1;NOS1AP;STK39;KCNMB1
32,prerank,positive regulation of neuron projection development (GO:0010976),0.6247455841950202,1.6627810760765867,0.006795016987542469,0.335318880841755,0.982,7/10,20.10%,LRRC7;TENM3;ALK;CAMK1D;RIT2;MAGI2;LRP8
33,prerank,negative regulation of synaptic transmission (GO:0050805),0.703676346423249,1.6624873314766342,0.010830324909747292,0.3174656611796104,0.983,3/6,8.80%,SHANK2;SLC24A2;GRIK3
34,prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.6227649123052148,1.6405167780638115,0.017064846416382253,0.3847521242176786,0.997,6/9,25.20%,CDH4;TENM3;SDK1;CADM1;CDH2;ROBO2
35,prerank,protein localization to membrane (GO:0072657),0.5473475424490755,1.6386540111546268,0.011615628299894404,0.3751562831630971,0.997,9/16,24.80%,CACNB2;LRRC7;DPP6;SPTBN4;WNK3;MAGI2;ANK1;DLG2;LIN7A
36,prerank,cell junction assembly (GO:0034329),0.5985386489756289,1.6324984384871624,0.013318534961154272,0.3837177384979651,0.997,7/11,18.10%,SHANK2;CDH20;CDH8;SDK1;CDHR3;ADGRL3;CDH2
37,prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.734673366834171,1.6267868183678782,0.01139240506329114,0.3913025710904139,0.997,5/5,26.90%,WNK2;KCNMA1;WNK3;NOS1AP;KCNMB1
38,prerank,negative regulation of GTPase activity (GO:0034260),-0.939879759519038,-1.6228987425545998,0.00819672131147541,0.6985071560473507,1.0,2/2,6.30%,ARFGEF1;BCAS3
39,prerank,membrane depolarization (GO:0051899),0.8665997993981946,1.6196462328575487,0.004219409282700422,0.40467719426432364,0.997,3/3,13.60%,CACNA1A;CACNG4;SCN3A
40,prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.8635907723169508,1.6190803401684024,0.005649717514124294,0.37526971569434775,0.999,3/3,13.90%,CACNB2;PDE4B;NOS1AP
41,prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.8635907723169508,1.6190803401684024,0.005649717514124294,0.37526971569434775,0.999,3/3,13.90%,CACNB2;PDE4B;NOS1AP
42,prerank,positive regulation of long-term synaptic depression (GO:1900454),0.9879759519038077,1.6164814390611792,0.0,0.35833045769425564,0.999,2/2,1.40%,ADCY8;GRID2
43,prerank,regulation of long-term synaptic depression (GO:1900452),0.9879759519038077,1.6164814390611792,0.0,0.35833045769425564,0.999,2/2,1.40%,ADCY8;GRID2
44,prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.9338677354709418,-1.6023414993892742,0.01876675603217158,0.7072037305935451,1.0,2/2,6.90%,CES1;SREBF2
45,prerank,regulation of cholesterol storage (GO:0010885),-0.9338677354709418,-1.6023414993892742,0.01876675603217158,0.7072037305935451,1.0,2/2,6.90%,CES1;SREBF2
46,prerank,regulation of cholesterol metabolic process (GO:0090181),-0.9338677354709418,-1.6023414993892742,0.01876675603217158,0.7072037305935451,1.0,2/2,6.90%,CES1;SREBF2
47,prerank,regulation of cation transmembrane transport (GO:1904062),0.779731562457328,1.6017180688412909,0.011795543905635648,0.41162920474983383,0.999,3/4,13.70%,DPP6;KCNIP1;WNK3
48,prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.7733199598796389,-1.6009361206718211,0.0391566265060241,0.6231824213823071,1.0,3/3,23.00%,INSR;ARNT;ZBTB20
49,prerank,positive regulation of glycolytic process (GO:0045821),-0.7733199598796389,-1.6009361206718211,0.0391566265060241,0.6231824213823071,1.0,3/3,23.00%,INSR;ARNT;ZBTB20
50,prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.7733199598796389,-1.6009361206718211,0.0391566265060241,0.6231824213823071,1.0,3/3,23.00%,INSR;ARNT;ZBTB20
51,prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.8644150532299851,1.6008871775204796,0.006887052341597796,0.40143682544979503,0.999,2/3,3.70%,HS3ST5;HS3ST4
52,prerank,cellular response to laminar fluid shear stress (GO:0071499),-0.9338677354709418,-1.5987565690023644,0.013812154696132596,0.5640993158033315,1.0,2/2,6.90%,MAP2K5;SREBF2
53,prerank,cellular response to fluid shear stress (GO:0071498),-0.9338677354709418,-1.5987565690023644,0.013812154696132596,0.5640993158033315,1.0,2/2,6.90%,MAP2K5;SREBF2
54,prerank,response to laminar fluid shear stress (GO:0034616),-0.9338677354709418,-1.5987565690023644,0.013812154696132596,0.5640993158033315,1.0,2/2,6.90%,MAP2K5;SREBF2
55,prerank,anterograde trans-synaptic signaling (GO:0098916),0.5062118288687668,1.5981290874248917,0.015544041450777202,0.3998060447617888,1.0,13/19,36.30%,CACNB2;CACNA1A;CHRM3;ASIC2;HCRTR1;HCRTR2;RIT2;DLG2;HTR7;KCNMB1;PRKAR2B;NOVA1;PRKAR1B
56,prerank,regulation of cell cycle phase transition (GO:1901987),-0.940881763527054,-1.596486256729953,0.005128205128205128,0.552546061140105,1.0,2/2,6.20%,ANAPC16;BTRC
57,prerank,ion homeostasis (GO:0050801),0.786765338407589,1.594836280965756,0.02027027027027027,0.40089814952916447,1.0,3/4,13.70%,WNK2;UNC80;WNK3
58,prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.9348697394789578,-1.5942023455188385,0.007444168734491315,0.5435066200235568,1.0,2/2,6.80%,CCND1;WAC
59,prerank,regulation of sodium ion transport (GO:0002028),0.7737826361373304,1.5880044888170297,0.014725568942436412,0.4193458889671233,1.0,3/4,13.70%,WNK2;SPTBN4;WNK3
60,prerank,potassium ion transport (GO:0006813),0.6665722422195729,1.5868196157722103,0.019583843329253364,0.41163581503720276,1.0,5/6,26.90%,KCNQ5;KCNMA1;SLC24A2;SLC9C1;KCNMB1
61,prerank,protein modification by small protein removal (GO:0070646),-0.3489650344637293,-1.5849371733586264,0.036585365853658534,0.5467538913134291,1.0,12/13,47.40%,ASXL1;USP24;WDR20;USP22;MDM2;MBD5;PTEN;USP31;KAT2B;KAT2A;DDB2;USP33
62,prerank,protein deubiquitination (GO:0016579),-0.3489650344637293,-1.5849371733586264,0.036585365853658534,0.5467538913134291,1.0,12/13,47.40%,ASXL1;USP24;WDR20;USP22;MDM2;MBD5;PTEN;USP31;KAT2B;KAT2A;DDB2;USP33
63,prerank,central nervous system neuron differentiation (GO:0021953),0.7626611567996266,1.583521025165093,0.01335113484646195,0.41621013389649336,1.0,3/4,11.20%,GRID2;MDGA2;MAP2
64,prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5156092648539778,-1.5816576951273253,0.02631578947368421,0.5438990859299886,1.0,7/7,48.90%,UPF3A;PPP2R2A;UPF2;DCP2;SMG6;CNOT6;SAMD4A
65,prerank,regulation of actin filament-based process (GO:0032970),-0.6636546184738955,-1.5809922636016058,0.036885245901639344,0.5297436018733148,1.0,4/4,34.00%,RICTOR;EFNA5;CDK10;RHOBTB1
66,prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.6414904330312186,1.5793485174586523,0.023837902264600714,0.40220204167968127,1.0,7/7,36.30%,ADCY8;CALCR;ADCY9;HTR7;DPEP1;PRKAR2B;PRKAR1B
67,prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.6414904330312186,1.5793485174586523,0.023837902264600714,0.40220204167968127,1.0,7/7,36.30%,ADCY8;CALCR;ADCY9;HTR7;DPEP1;PRKAR2B;PRKAR1B
68,prerank,negative regulation of immune response (GO:0050777),0.6414904330312186,1.5793485174586523,0.023837902264600714,0.40220204167968127,1.0,7/7,36.30%,ADCY8;CALCR;ADCY9;HTR7;DPEP1;PRKAR2B;PRKAR1B
69,prerank,modification-dependent protein catabolic process (GO:0019941),-0.43434343434343436,-1.5786422135819824,0.061224489795918366,0.5242342289217653,1.0,10/10,57.10%,ANKIB1;ANAPC16;BTRC;MDM2;FBXO22;MIB1;FBXW4;HACE1;USP33;ZNRF3
70,prerank,peptidyl-lysine dimethylation (GO:0018027),-0.9108216432865731,-1.5778230905264716,0.016129032258064516,0.5120602995403779,1.0,2/2,9.20%,ASH1L;KMT2A
71,prerank,positive regulation of cellular catabolic process (GO:0031331),-0.4475172212506524,-1.5753674062173164,0.04411764705882353,0.5066435963409266,1.0,8/9,35.80%,INSR;DHRSX;ZC3HAV1;FAF1;ARNT;ZBTB20;OPTN;ULK1
72,prerank,Fc receptor signaling pathway (GO:0038093),-0.6787148594377509,-1.5731819537560559,0.054901960784313725,0.48721941414458503,1.0,4/4,32.50%,MAP2K4;BTRC;PPP3CB;PPP3CA
73,prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.6787148594377509,-1.5731819537560559,0.054901960784313725,0.48721941414458503,1.0,4/4,32.50%,MAP2K4;BTRC;PPP3CB;PPP3CA
74,prerank,histone H4-K16 acetylation (GO:0043984),-0.9108216432865731,-1.5684118359043027,0.012437810945273632,0.4940182055659032,1.0,2/2,9.20%,KANSL1;KMT2A
75,prerank,peptide biosynthetic process (GO:0043043),-0.906813627254509,-1.5654346328230768,0.016713091922005572,0.49191996873244725,1.0,2/2,9.60%,AGO2;MRPS21
76,prerank,negative regulation of inflammatory response (GO:0050728),0.5919293293542136,1.5633713786748222,0.03908045977011494,0.4663133288739924,1.0,8/9,36.30%,ADCY8;CALCR;RORA;ADCY9;HTR7;DPEP1;PRKAR2B;PRKAR1B
77,prerank,negative chemotaxis (GO:0050919),0.660887438836879,1.5632271131323892,0.029797377830750895,0.4550501485416749,1.0,4/6,20.30%,SLIT2;SEMA3A;SEMA3E;SEMA6A
78,prerank,negative regulation of chemotaxis (GO:0050922),0.6336519091881391,1.5626179988386568,0.030267753201396973,0.4463351965228591,1.0,5/7,25.20%,SLIT2;SEMA3A;SEMA3E;SEMA6A;ROBO2
79,prerank,mRNA splice site selection (GO:0006376),-0.6676706827309237,-1.5612865296707845,0.07083333333333333,0.4952305201807889,1.0,4/4,33.60%,PSIP1;LUC7L3;CELF2;SRSF1
80,prerank,regulation of potassium ion transport (GO:0043266),0.8314827709349789,1.5611428219763812,0.011363636363636364,0.44193995196065766,1.0,2/3,5.50%,DPP6;KCNIP1
81,prerank,protein monoubiquitination (GO:0006513),-0.9348697394789578,-1.558161787180884,0.010610079575596816,0.49423997043447987,1.0,2/2,6.80%,UBE2D3;WAC
82,prerank,presynapse assembly (GO:0099054),0.7551802317969185,1.5578553499019767,0.014492753623188406,0.448120824006557,1.0,3/4,14.00%,LRRTM3;PTPRD;PCLO
83,prerank,synapse organization (GO:0050808),0.5350128053703543,1.5456594785404305,0.028446389496717725,0.49654633983946134,1.0,7/13,19.10%,SHANK2;CACNB2;PTPRD;SDK1;ADGRL3;CDH2;SEMA3E
84,prerank,peptidyl-lysine trimethylation (GO:0018023),-0.8947895791583166,-1.5402804459025956,0.03439153439153439,0.5547493948449368,1.0,2/2,10.80%,KMT2A;SETD5
85,prerank,response to amino acid starvation (GO:1990928),-0.646586345381526,-1.5402339283534394,0.036585365853658534,0.5296712762854948,1.0,4/4,35.70%,WDR59;SESN3;SLC38A9;MIOS
86,prerank,cellular response to amino acid starvation (GO:0034198),-0.646586345381526,-1.5402339283534394,0.036585365853658534,0.5296712762854948,1.0,4/4,35.70%,WDR59;SESN3;SLC38A9;MIOS
87,prerank,axon development (GO:0061564),0.6663345678286324,1.5344361637722388,0.03178484107579462,0.5420369539638294,1.0,5/6,28.30%,DCC;SPTBN4;MAPK8IP3;ADGRB1;PARD3
88,prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.4248234106962664,-1.5326399492731484,0.04132231404958678,0.5484241914494937,1.0,9/9,58.00%,INSR;PIP4K2A;FGFR1;PTEN;UNC5B;ROR2;PTK2;EGFR;IGF1R
89,prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.8907815631262525,-1.5279763092495509,0.03430079155672823,0.5545812269791037,1.0,2/2,11.20%,YME1L1;MICU1
90,prerank,negative regulation of cytokine production (GO:0001818),-0.5879396984924624,-1.5272638039916848,0.06372549019607843,0.5453094313467568,1.0,5/5,41.60%,GAS6;MAP2K5;LGR4;CD200;BPI
91,prerank,positive regulation of cell projection organization (GO:0031346),0.5158464406853452,1.5166887240554825,0.030687830687830688,0.628009029426491,1.0,9/15,25.20%,LRRC7;TENM3;TIAM1;SLIT2;PTPRD;CAMK1D;RIT2;MAGI2;ROBO2
92,prerank,axon extension (GO:0048675),0.682883779439205,1.5125306114379884,0.025477707006369428,0.6391676543513007,1.0,3/5,15.30%,AUTS2;SLIT2;SEMA3A
93,prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.622025601554653,1.508794423545415,0.033214709371293,0.648013502995544,1.0,5/7,26.40%,ADCY8;CALCR;ADGRL3;ADGRB1;ADCY9
94,prerank,negative regulation of axon extension (GO:0030517),0.6506376752446352,1.5075635471906077,0.04590570719602978,0.6412028325004808,1.0,4/6,20.30%,MAP2;SEMA3A;SEMA3E;SEMA6A
95,prerank,regulation of collagen biosynthetic process (GO:0032965),-0.7442326980942828,-1.5071926606902109,0.05128205128205128,0.6175480135118558,1.0,3/3,25.90%,SUCO;EMILIN1;CREB3L1
96,prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.473313192346425,-1.5058174457625761,0.07878787878787878,0.6104622613813996,1.0,7/7,53.10%,ANKIB1;PRICKLE1;MDM2;CSNK1E;FBXO22;PTEN;PTK2
97,prerank,mitotic sister chromatid segregation (GO:0000070),-0.8927855711422845,-1.5037909270045378,0.041237113402061855,0.6063512777812077,1.0,2/2,11.00%,CSNK2A1;POGZ
98,prerank,histone H3-K36 methylation (GO:0010452),-0.8947895791583166,-1.503293355838303,0.03439153439153439,0.5960784565269139,1.0,2/2,10.80%,ASH1L;SETD5
99,prerank,long-term synaptic potentiation (GO:0060291),0.9158316633266533,1.5023592994986068,0.0093603744149766,0.6454311028160087,1.0,2/2,8.60%,SHANK2;SLC24A2
100,prerank,long-term synaptic depression (GO:0060292),0.9158316633266533,1.5023592994986068,0.0093603744149766,0.6454311028160087,1.0,2/2,8.60%,SHANK2;SLC24A2
101,prerank,regulation of telomerase activity (GO:0051972),-0.7301905717151455,-1.5017222612332553,0.05993690851735016,0.5915862183216042,1.0,3/3,27.30%,NEK7;SMG6;NVL
102,prerank,axon guidance (GO:0007411),0.4512860141645484,1.5004902342971604,0.030364372469635626,0.6445807865561058,1.0,13/27,25.20%,DCC;SHC3;LAMA2;SLIT2;NRXN3;SPTBN4;SEMA3A;SEMA3E;KIF5C;SEMA6A;ENAH;LAMA3;ROBO2
103,prerank,organelle fission (GO:0048285),-0.8687374749498997,-1.5001048621063309,0.04040404040404041,0.5868517690472885,1.0,2/2,13.40%,TMCC1;MFF
104,prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7270301091918012,1.4941724338647353,0.03590425531914894,0.6695875335835216,1.0,3/4,18.10%,GRIK3;CACNG4;CDH2
105,prerank,negative regulation of protein polymerization (GO:0032272),0.7222178452757053,1.4928347931097001,0.027704485488126648,0.6657781660050707,1.0,3/4,21.70%,SLIT2;MAP2;KANK1
106,prerank,axonogenesis (GO:0007409),0.43755265407926974,1.4902739261992821,0.030181086519114688,0.6675714524341846,1.0,16/32,28.30%,DCC;SHC3;AUTS2;LAMA2;SLIT2;NRXN3;SPTBN4;SEMA3A;SEMA3E;KIF5C;SEMA6A;ADGRB1;ENAH;LAMA3;ROBO2;PARD3
107,prerank,neuron projection extension (GO:1990138),0.6802717444256495,1.4868384460894835,0.03367875647668394,0.6752487870797196,1.0,3/5,15.30%,AUTS2;SH3GL2;SEMA3A
108,prerank,protein poly-ADP-ribosylation (GO:0070212),-0.8837675350701402,-1.4854958398920624,0.035422343324250684,0.624738784176437,1.0,2/2,11.90%,TNKS2;ZC3HAV1
109,prerank,protein ADP-ribosylation (GO:0006471),-0.8837675350701402,-1.4854958398920624,0.035422343324250684,0.624738784176437,1.0,2/2,11.90%,TNKS2;ZC3HAV1
110,prerank,regulation of telomere capping (GO:1904353),-0.7392176529588766,-1.4811958093712028,0.08108108108108109,0.6312478902759058,1.0,3/3,26.40%,TNKS2;NEK7;SMG6
111,prerank,regulation of protein metabolic process (GO:0051246),-0.6375502008032128,-1.4800083533599806,0.07228915662650602,0.6250438930220972,1.0,4/4,36.60%,MAP2K5;FAF1;MDM2;LTBP4
112,prerank,positive regulation of cell junction assembly (GO:1901890),0.6111925024345646,1.4793649868402305,0.049160671462829736,0.706912158009509,1.0,3/7,10.10%,GRID2;CNTNAP2;PTPRD
113,prerank,cellular response to insulin stimulus (GO:0032869),-0.41977800201816345,-1.4779443762304758,0.07142857142857142,0.6222309270781202,1.0,9/9,58.50%,INSR;FOXC2;HDAC5;KAT2B;LPIN1;GOT1;ATP6V0A4;IGF1R;IRS1
114,prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6032927947132269,1.4766003366123324,0.06422018348623854,0.7105683178935389,1.0,5/7,28.30%,LRRC7;ANK1;DLG2;LIN7A;PARD3
115,prerank,regulation of hydrolase activity (GO:0051336),-0.4526209677419355,-1.4763604854222678,0.07246376811594203,0.617622927020897,1.0,8/8,55.20%,RAB3GAP2;ARHGAP12;ITGB1BP1;EFNA5;RABGAP1;NF1;PTK2;WRN
116,prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.8987975951903808,1.4729871197485274,0.015822784810126583,0.7197549857590521,1.0,2/2,10.30%,FBN2;GREM2
117,prerank,positive regulation of histone methylation (GO:0031062),0.7846388057191895,1.467456088717038,0.03818953323903819,0.7413932495599298,1.0,2/3,11.50%,AUTS2;TET1
118,prerank,glutamate receptor signaling pathway (GO:0007215),0.7936673713137388,1.4663779965989567,0.03288490284005979,0.7359299030689045,1.0,2/3,8.80%,GRID2;GRIK3
119,prerank,regulation of cytoskeleton organization (GO:0051493),-0.473313192346425,-1.4654624476232418,0.08904109589041095,0.6524071100007136,1.0,7/7,53.10%,RICTOR;CAPN2;EFNA5;KATNBL1;CDK10;RHOBTB1;PTK2
120,prerank,regulation of secretion (GO:0051046),0.8896029300797305,1.459173295942254,0.021374045801526718,0.7693529247559162,1.0,1/2,0.50%,NRG1
121,prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.8507014028056111,-1.4578858356438136,0.05289672544080604,0.6603790562666634,1.0,2/2,15.20%,WAC;FHIT
122,prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.8507014028056111,-1.4578858356438136,0.05289672544080604,0.6603790562666634,1.0,2/2,15.20%,WAC;FHIT
123,prerank,regulation of neuron projection development (GO:0010975),0.4596552217613907,1.457718963939528,0.052904564315352696,0.765880688667315,1.0,12/19,34.40%,DCC;LRRC7;TENM3;CAMK1D;SEMA3A;RIT2;CDH2;MAGI2;KANK1;MBOAT1;TRPV4;CRMP1
124,prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.7151454363089268,-1.4571043897602327,0.052083333333333336,0.6530912018191134,1.0,3/3,28.80%,BTRC;PELI2;PLCB1
125,prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.6262570978235557,1.4520502502291142,0.05093167701863354,0.7887231205285551,1.0,4/6,22.10%,WNK2;WNK3;HECW2;STK39
126,prerank,positive regulation of cellular component organization (GO:0051130),0.600921015701106,1.4497355483350072,0.050119331742243436,0.7904420509996394,1.0,2/7,2.60%,NRG1;FRMPD4
127,prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.7030640032940552,1.4382218615580116,0.04945054945054945,0.8530663308774185,1.0,3/4,20.10%,ADCY8;CAMK1D;LRP8
128,prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.697338197305592,1.438110782949787,0.06040268456375839,0.8162779460380912,1.0,3/4,20.30%,SEMA3A;SEMA3E;SEMA6A
129,prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.697338197305592,1.438110782949787,0.06040268456375839,0.8162779460380912,1.0,3/4,20.30%,SEMA3A;SEMA3E;SEMA6A
130,prerank,neural crest cell migration (GO:0001755),0.697338197305592,1.438110782949787,0.06040268456375839,0.8162779460380912,1.0,3/4,20.30%,SEMA3A;SEMA3E;SEMA6A
131,prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.6980942828485457,-1.4375572359340787,0.08305647840531562,0.7235245160964432,1.0,3/3,30.50%,MAP2K5;FAF1;CD200
132,prerank,neuronal ion channel clustering (GO:0045161),0.8687374749498997,1.4342339947990357,0.028846153846153848,0.82943586674782,1.0,2/2,13.30%,CNTNAP2;SPTBN4
133,prerank,organelle transport along microtubule (GO:0072384),-0.843687374749499,-1.433390526792074,0.06315789473684211,0.7300745120782148,1.0,2/2,15.90%,ARHGAP21;LRPPRC
134,prerank,anterograde axonal protein transport (GO:0099641),0.7743229689067201,1.4311384596259105,0.0546218487394958,0.8155144578469814,1.0,3/3,22.80%,MAPK8IP3;KIF5C;DLG2
135,prerank,axo-dendritic protein transport (GO:0099640),0.7743229689067201,1.4311384596259105,0.0546218487394958,0.8155144578469814,1.0,3/3,22.80%,MAPK8IP3;KIF5C;DLG2
136,prerank,protein localization to presynapse (GO:1905383),0.7743229689067201,1.4311384596259105,0.0546218487394958,0.8155144578469814,1.0,3/3,22.80%,MAPK8IP3;KIF5C;DLG2
137,prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.616119844017912,1.4303431404800897,0.07560975609756097,0.8091839305167803,1.0,5/6,28.30%,DCC;MAP2;SPTBN4;ADGRB1;PARD3
138,prerank,positive regulation of calcium ion transport (GO:0051928),0.7617733704657161,1.430299466727601,0.05006954102920723,0.7986027522392686,1.0,2/3,13.70%,CACNB2;WNK3
139,prerank,organelle assembly (GO:0070925),-0.31808943089430897,-1.428894031365315,0.034482758620689655,0.7373077066895465,1.0,16/16,68.80%,EXOC4;GBF1;POGZ;FARP2;CDC14A;NEK7;UBXN2A;CCDC57;ULK1;TTBK2;ARL13B;PTPDC1;IFT172;FNBP1L;CDC14B;DZIP1L
140,prerank,dendrite extension (GO:0097484),0.8787575150300602,1.4287897320349077,0.02073365231259968,0.7971572932062566,1.0,2/2,12.30%,AUTS2;SH3GL2
141,prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6948979454492299,1.42519952173161,0.07529722589167767,0.8089645328390382,1.0,3/4,16.10%,CDH20;CDH8;CDHR3
142,prerank,regulation of neuron death (GO:1901214),0.6182913882087835,1.4249813359678722,0.046019900497512436,0.7998976539379149,1.0,5/6,32.20%,GRID2;DCC;PPARGC1A;TRIM2;RRAS2
143,prerank,positive regulation of histone modification (GO:0031058),0.8797595190380761,1.4223949814095818,0.03785488958990536,0.8060645435694707,1.0,2/2,12.20%,TET1;PPARGC1A
144,prerank,eye morphogenesis (GO:0048592),0.6816828588347995,1.4180648892523886,0.0728476821192053,0.8223803290484093,1.0,2/4,10.20%,TENM3;FBN2
145,prerank,neuron projection morphogenesis (GO:0048812),0.5167290613083005,1.41714789263736,0.09080962800875274,0.8183502711282469,1.0,7/11,29.90%,DCC;CNTNAP2;MAP2;SPTBN4;ADGRB1;PARD3;DOCK10
146,prerank,negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.8216432865731462,-1.4164382209500053,0.06753246753246753,0.7794459203795407,1.0,2/2,18.10%,EMILIN1;SNX25
147,prerank,regulation of ion transmembrane transport (GO:0034765),0.8647294589178358,1.4163120475795992,0.04179566563467492,0.8133209441550623,1.0,2/2,13.70%,CHRM3;WNK3
148,prerank,glycerophospholipid metabolic process (GO:0006650),-0.695085255767302,-1.4143975101941202,0.07540983606557378,0.7770758399856017,1.0,3/3,30.80%,FAR1;PLCB1;PLA2G4A
149,prerank,negative regulation of ion transport (GO:0043271),0.8647294589178356,1.413379699138939,0.04153354632587859,0.8024416702481809,1.0,2/2,13.70%,WNK2;WNK3
150,prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.8647294589178356,1.413379699138939,0.04153354632587859,0.8024416702481809,1.0,2/2,13.70%,WNK2;WNK3
151,prerank,positive regulation of potassium ion import across plasma membrane (GO:1903288),0.8647294589178356,1.413379699138939,0.04153354632587859,0.8024416702481809,1.0,2/2,13.70%,WNK2;WNK3
152,prerank,ncRNA processing (GO:0034470),-0.5863453815261044,-1.4099013590016312,0.09663865546218488,0.7851757655742739,1.0,4/4,41.70%,AGO2;ESF1;NVL;RCL1
153,prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.5277757765321667,1.4093640596970403,0.08565072302558398,0.8177407637487892,1.0,7/10,35.10%,ADCY8;CALCR;ADGRL3;ADGRB1;GNAO1;ADCY9;GRK5
154,prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.6784042932057652,1.4093155876705978,0.07368421052631578,0.8085466769134965,1.0,2/4,4.90%,ADCY8;CHRM3
155,prerank,regulation of neutrophil chemotaxis (GO:0090022),0.8577154308617236,1.4081510094756666,0.038461538461538464,0.797051925225596,1.0,2/2,14.40%,SLIT2;CAMK1D
156,prerank,regulation of leukocyte chemotaxis (GO:0002688),0.8577154308617236,1.4081510094756666,0.038461538461538464,0.797051925225596,1.0,2/2,14.40%,SLIT2;CAMK1D
157,prerank,axon extension involved in axon guidance (GO:0048846),0.8486973947895793,1.406229981995152,0.03322259136212625,0.782224215291129,1.0,2/2,15.30%,SLIT2;SEMA3A
158,prerank,neuron projection extension involved in neuron projection guidance (GO:1902284),0.8486973947895793,1.406229981995152,0.03322259136212625,0.782224215291129,1.0,2/2,15.30%,SLIT2;SEMA3A
159,prerank,motor neuron axon guidance (GO:0008045),0.8486973947895793,1.406229981995152,0.03322259136212625,0.782224215291129,1.0,2/2,15.30%,SLIT2;SEMA3A
160,prerank,regulation of lamellipodium assembly (GO:0010591),0.7482048857931107,1.4060828559792564,0.06837606837606838,0.7745848517757409,1.0,2/3,9.80%,AUTS2;SLIT2
161,prerank,negative regulation of coagulation (GO:0050819),0.8697615665002466,1.4055672886507886,0.04265402843601896,0.7615574246205475,1.0,1/2,1.60%,HS3ST5
162,prerank,regulation of coagulation (GO:0050818),0.8697615665002466,1.4055672886507886,0.04265402843601896,0.7615574246205475,1.0,1/2,1.60%,HS3ST5
163,prerank,regulation of developmental growth (GO:0048638),-0.6860581745235708,-1.4054585748903619,0.10679611650485436,0.793078902277981,1.0,3/3,31.70%,INSR;PLCB1;MBD5
164,prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7534486324779874,1.405243821682185,0.06358381502890173,0.7553779947460091,1.0,2/3,13.90%,CACNB2;NOS1AP
165,prerank,extracellular structure organization (GO:0043062),0.43516002969797096,1.4049550631817005,0.06907216494845361,0.7418901334150164,1.0,15/22,39.50%,LAMA2;MMP16;FBN2;ADAMTSL1;COL22A1;MMP17;COL8A1;LAMA3;ADAMTS3;ADAMTS10;SMOC2;PXDN;COL5A3;DDR2;ST7
166,prerank,external encapsulating structure organization (GO:0045229),0.43516002969797096,1.4049550631817005,0.06907216494845361,0.7418901334150164,1.0,15/22,39.50%,LAMA2;MMP16;FBN2;ADAMTSL1;COL22A1;MMP17;COL8A1;LAMA3;ADAMTS3;ADAMTS10;SMOC2;PXDN;COL5A3;DDR2;ST7
167,prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.5301845639568346,1.4044066619798365,0.08813559322033898,0.737347067738506,1.0,5/9,17.50%,ADCY8;CACNA1A;HCRTR1;HCRTR2;CALCR
168,prerank,histone deacetylation (GO:0016575),-0.44108761329305135,-1.4042786738468471,0.10869565217391304,0.786962933598096,1.0,7/7,56.30%,SMARCAD1;PER2;RCOR3;HDAC5;MTA3;PRDM5;TBL1X
169,prerank,protein autoubiquitination (GO:0051865),-0.5773092369477911,-1.4020996051561523,0.11764705882352941,0.784822173811599,1.0,4/4,42.60%,UBE2D3;SH3RF1;MDM2;DDB2
170,prerank,regulation of actin filament polymerization (GO:0030833),0.6359598673964407,1.400706525412579,0.06415094339622641,0.7515191641139339,1.0,3/5,23.50%,SLIT2;KANK1;BAIAP2L1
171,prerank,plasma membrane bounded cell projection organization (GO:0120036),0.5961212482949867,1.3999007453779426,0.08946078431372549,0.7485499993021462,1.0,3/6,12.30%,CNTNAP2;MAP2;SH3GL2
172,prerank,inorganic cation transmembrane transport (GO:0098662),0.45449344278510023,1.3988675806842434,0.07476635514018691,0.7470564565753673,1.0,13/17,45.80%,KCNQ5;CACNA1A;ASIC2;SLC24A2;SCN3A;SLC9C1;SCARA5;SCNN1B;TRPV4;CACNA1C;SLC6A16;TRPC1;ATP6V0A4
173,prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.8467464749420205,1.3961330554698115,0.03503184713375796,0.7546257399503692,1.0,1/2,1.20%,ADCY8
174,prerank,regulation of neuron differentiation (GO:0045664),0.6328062719156242,1.3944632541877942,0.08408796895213454,0.7561434558900328,1.0,3/5,11.80%,ALK;TIAM1;BRINP1
175,prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.521608040201005,-1.3942172005456643,0.07582938388625593,0.8069863572758698,1.0,5/5,48.20%,KMT2A;TNRC6A;TESC;KAT2B;TNRC6B
176,prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.6688451315310311,1.389224368098117,0.08115183246073299,0.7781203164428395,1.0,3/4,22.10%,CHRM3;WNK3;STK39
177,prerank,negative regulation of sodium ion transport (GO:0010766),0.7508142197106464,1.3881968257946604,0.08442503639010189,0.7762607772294946,1.0,2/3,13.70%,WNK2;WNK3
178,prerank,modulation by host of symbiont process (GO:0051851),0.8549546837800547,1.3881282163439388,0.04567699836867863,0.7692915245302162,1.0,1/2,1.50%,HMGA2
179,prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.7965931863727455,-1.3866823806717736,0.08378378378378379,0.8274047246594576,1.0,2/2,20.60%,EMILIN1;ARNT
180,prerank,cilium assembly (GO:0060271),-0.31841302136317395,-1.3850447760841842,0.09302325581395349,0.8237920271070983,1.0,17/17,68.80%,EXOC4;GBF1;TNPO1;CSNK1E;CDC14A;CCDC57;TTBK2;ARL13B;PTPDC1;IFT172;TBC1D32;CEP70;FNBP1L;CDC14B;NINL;PRKAR2B;DZIP1L
181,prerank,semaphorin-plexin signaling pathway (GO:0071526),0.6224884151426573,1.3846846896105647,0.0970625798212005,0.7817140507321432,1.0,3/5,20.30%,SEMA3A;SEMA3E;SEMA6A
182,prerank,regulation of cell adhesion (GO:0030155),-0.44511581067472306,-1.3846280318802906,0.12048192771084337,0.8145956636627051,1.0,7/7,55.90%,TESC;ITGB1BP1;EFNA5;PPP3CA;EPHA2;PTK2;PRKCA
183,prerank,cellular response to glucose stimulus (GO:0071333),0.6351006121451903,1.383451770023938,0.08375634517766498,0.781658402134324,1.0,2/5,7.90%,ADCY8;PTPRN2
184,prerank,regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.7965931863727455,-1.3794314529071632,0.08042895442359249,0.8272708977214506,1.0,2/2,20.60%,CHD6;ARNT
185,prerank,positive regulation of cation transmembrane transport (GO:1904064),0.7331995987963891,1.378752985972932,0.055873925501432664,0.8016085661145377,1.0,3/3,26.90%,KCNMA1;NOS1AP;KCNMB1
186,prerank,proteoglycan metabolic process (GO:0006029),0.8517034068136273,1.3785417502958501,0.03459119496855346,0.7956697141367554,1.0,2/2,15.00%,HS3ST4;CHST9
187,prerank,regulation of potassium ion import (GO:1903286),0.7380831867865016,1.3782964985559425,0.08972503617945007,0.789845729383192,1.0,2/3,13.70%,WNK2;WNK3
188,prerank,heterochromatin organization (GO:0070828),0.8386773547094188,1.378203886895382,0.04975922953451043,0.7835726049536071,1.0,2/2,16.30%,HMGA2;MECOM
189,prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.6699769954963454,1.3769544894185655,0.07983761840324763,0.7836960150910541,1.0,3/4,22.10%,WNK2;WNK3;STK39
190,prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.5684436861213498,1.3765636429105754,0.10211267605633803,0.7792095419323737,1.0,4/7,22.80%,LRRC7;DLGAP2;CACNG4;DLG2
191,prerank,regulation of catabolic process (GO:0009894),-0.7995991983967935,-1.3763474579593125,0.09343434343434344,0.8303267137312331,1.0,2/2,20.30%,FAF1;MDM2
192,prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.6760280842527583,-1.374583934583934,0.1289308176100629,0.82724359423596,1.0,3/3,32.70%,USP22;RICTOR;FGFR1
193,prerank,regulation of autophagosome assembly (GO:2000785),-0.8086172344689379,-1.3738607421515305,0.10026385224274406,0.8001276458245303,1.0,2/2,19.40%,PIP4K2A;RAB3GAP2
194,prerank,positive regulation of vacuole organization (GO:0044090),-0.8086172344689379,-1.3738607421515305,0.10026385224274406,0.8001276458245303,1.0,2/2,19.40%,PIP4K2A;RAB3GAP2
195,prerank,positive regulation of autophagosome assembly (GO:2000786),-0.8086172344689379,-1.3738607421515305,0.10026385224274406,0.8001276458245303,1.0,2/2,19.40%,PIP4K2A;RAB3GAP2
196,prerank,protein-DNA complex assembly (GO:0065004),-0.4380664652567976,-1.3736064397804175,0.13559322033898305,0.7916706559206894,1.0,7/7,56.60%,MNAT1;ORC3;CHD1L;ORC4;NAP1L4;DDB2;KAT6B
197,prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.8336673346693388,1.3718015495788112,0.05055292259083728,0.8002949609491666,1.0,2/2,16.80%,HECW2;USP44
198,prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.7297093350194943,1.370082517652136,0.08811188811188811,0.8030240919224688,1.0,2/3,13.70%,WNK2;WNK3
199,prerank,cellular response to starvation (GO:0009267),-0.4521651560926485,-1.3686593396243159,0.10559006211180125,0.8027976244406476,1.0,7/7,55.20%,SREBF2;WDR59;SESN3;SLC38A9;MIOS;USP33;WRN
200,prerank,"wound healing, spreading of cells (GO:0044319)",0.8240263827416908,1.3678516081868874,0.06132075471698113,0.8092490071358095,1.0,1/2,4.20%,TMEFF2
201,prerank,protein destabilization (GO:0031648),-0.7995991983967935,-1.3673514847243886,0.0925,0.7987584434359536,1.0,2/2,20.30%,BTRC;MDM2
202,prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.8036072144288576,-1.3658237518064202,0.12857142857142856,0.7955321276332197,1.0,2/2,19.90%,ARHGEF3;ROBO1
203,prerank,sodium ion transmembrane transport (GO:0035725),0.562873269810638,1.3655021382242025,0.10311750599520383,0.8155015173691659,1.0,5/7,28.10%,ASIC2;SLC24A2;SCN3A;SLC9C1;SCNN1B
204,prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.6249010006039629,1.3649275630344742,0.09762202753441802,0.8117281796747425,1.0,4/5,30.30%,WNK3;SPRED2;PARD3;SPRED3
205,prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.4657947686116701,-1.3637186702787207,0.14204545454545456,0.7945537855262056,1.0,6/6,53.80%,CCND1;MNAT1;CCNY;PTEN;CCND2;EGFR
206,prerank,cellular response to hormone stimulus (GO:0032870),0.6102002687459723,1.3611609744556468,0.09665427509293681,0.8272140054612277,1.0,4/5,32.60%,SLIT2;ROBO2;WT1;NCOA2
207,prerank,positive regulation of ion transport (GO:0043270),0.6628499593320245,1.3604728263747223,0.09866666666666667,0.8249638636408483,1.0,2/4,13.70%,CACNB2;WNK3
208,prerank,regulation of dephosphorylation (GO:0035303),-0.6599799398194583,-1.3600044716466122,0.12320916905444126,0.8018910125370913,1.0,3/3,34.30%,MTMR2;SMG6;MTMR1
209,prerank,negative regulation of phosphorylation (GO:0042326),0.7211547520330965,1.3568507526958522,0.0782608695652174,0.8394507960539801,1.0,2/3,12.30%,SLIT2;SH3GL2
210,prerank,protein localization to plasma membrane (GO:0072659),0.48122608155441404,1.3563496721883768,0.11584699453551912,0.8358466538213825,1.0,5/12,21.00%,CACNB2;DPP6;SPTBN4;WNK3;ANK1
211,prerank,positive regulation of insulin secretion (GO:0032024),0.7209144759812156,1.356200106385368,0.06843575418994413,0.8300277702355917,1.0,1/3,1.20%,ADCY8
212,prerank,mesonephric tubule development (GO:0072164),0.7241725175526581,1.3561192110878086,0.08333333333333333,0.823945985150633,1.0,3/3,27.80%,SLIT2;ROBO2;WT1
213,prerank,regulation of DNA recombination (GO:0000018),-0.6800401203610833,-1.3558443795522508,0.12773722627737227,0.8099215133313032,1.0,3/3,32.30%,SPIDR;SMARCAD1;ZRANB3
214,prerank,protein localization to cell periphery (GO:1990778),0.471875294684024,1.3545246048174184,0.10162162162162162,0.827454997652163,1.0,6/13,24.80%,CACNB2;DPP6;SPTBN4;WNK3;ANK1;LIN7A
215,prerank,organelle fusion (GO:0048284),-0.7785571142284569,-1.3538849703086238,0.112,0.8001809343790307,1.0,2/2,22.40%,MFF;CHCHD3
216,prerank,mitochondrial fusion (GO:0008053),-0.7785571142284569,-1.3538849703086238,0.112,0.8001809343790307,1.0,2/2,22.40%,MFF;CHCHD3
217,prerank,Golgi to plasma membrane transport (GO:0006893),-0.6639919759277834,-1.3537026775913872,0.1266233766233766,0.792392551488249,1.0,3/3,33.90%,EXOC4;GGA2;OPTN
218,prerank,heart trabecula morphogenesis (GO:0061384),0.8193504486396661,1.3509081542460462,0.08179012345679013,0.82981612202486,1.0,1/2,0.50%,NRG1
219,prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.8193504486396661,1.3509081542460462,0.08179012345679013,0.82981612202486,1.0,1/2,0.50%,NRG1
220,prerank,ventricular trabecula myocardium morphogenesis (GO:0003222),0.8193504486396661,1.3509081542460462,0.08179012345679013,0.82981612202486,1.0,1/2,0.50%,NRG1
221,prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.8076152304609218,-1.3490999346370596,0.10817941952506596,0.804181730181836,1.0,2/2,19.50%,TNKS2;DCP2
222,prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.6120603015075377,1.3478740743071536,0.11689961880559085,0.8436561291724857,1.0,5/5,39.10%,ADCY8;CACNA1A;CALCR;TRPV4;CACNA1C
223,prerank,mRNA 3'-end processing (GO:0031124),-0.6670010030090271,-1.3453783974734292,0.15181518151815182,0.8076057128174039,1.0,3/3,33.60%,THOC2;CSTF3;SRSF1
224,prerank,RNA 3'-end processing (GO:0031123),-0.6670010030090271,-1.3453783974734292,0.15181518151815182,0.8076057128174039,1.0,3/3,33.60%,THOC2;CSTF3;SRSF1
225,prerank,calcium ion transport (GO:0006816),0.514889434388246,1.3451040003150467,0.11818181818181818,0.8561391899176752,1.0,3/9,8.60%,CACNB2;CACNA1A;SLC24A2
226,prerank,regulation of phosphatase activity (GO:0010921),-0.995995995995996,-1.3447074850567,0.004008016032064128,0.8027543274901159,1.0,1/1,0.60%,PPP6R3
227,prerank,plasma membrane invagination (GO:0099024),-0.7675350701402806,-1.344363609090227,0.11396011396011396,0.7975655376178131,1.0,2/2,23.50%,ELMO1;ARHGAP12
228,prerank,cytoskeleton organization (GO:0007010),0.4823872665601006,1.3439292203980844,0.11686879823594266,0.8575988523811917,1.0,5/11,21.00%,CECR2;PCLO;WASF3;SEMA6A;ANK1
229,prerank,activation of adenylate cyclase activity (GO:0007190),0.6078581381363212,1.3430155106626032,0.12040557667934093,0.8576982054973606,1.0,4/5,31.10%,ADCY8;CALCR;ADCY9;CAP2
230,prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.998998998998999,-1.3419378945401828,0.0,0.7981928406815814,1.0,1/1,0.30%,ARID1B
231,prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.998998998998999,-1.3419378945401828,0.0,0.7981928406815814,1.0,1/1,0.30%,ARID1B
232,prerank,cellular response to drug (GO:0035690),0.6565993623834272,1.3412737256486567,0.09283819628647215,0.8642100276991584,1.0,3/4,28.20%,PDE4B;DPEP1;ACER2
233,prerank,negative regulation of DNA binding (GO:0043392),0.8075190646995415,1.339573987166641,0.0778816199376947,0.8713751319438396,1.0,1/2,1.50%,HMGA2
234,prerank,activation of protein kinase B activity (GO:0032148),0.6068999558921961,1.3392374615856166,0.11847133757961784,0.8671942677578252,1.0,1/5,0.50%,NRG1
235,prerank,regulation of protein targeting to membrane (GO:0090313),-0.6509528585757272,-1.3389440399054846,0.13636363636363635,0.8043167329591352,1.0,3/3,35.20%,MFF;ITGB1BP1;TCAF1
236,prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.6509528585757272,-1.3389440399054846,0.13636363636363635,0.8043167329591352,1.0,3/3,35.20%,MFF;ITGB1BP1;TCAF1
237,prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.571285140562249,-1.338854981132472,0.13382899628252787,0.7975841622207506,1.0,4/4,43.20%,PPP2R2A;PPP2R2D;PPP3CA;PPP5C
238,prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.6529588766298897,-1.3383271931699574,0.14984709480122324,0.7867105869617094,1.0,3/3,35.00%,BCAS3;ITGB1BP1;PTEN
239,prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.6529588766298897,-1.3383271931699574,0.14984709480122324,0.7867105869617094,1.0,3/3,35.00%,BCAS3;ITGB1BP1;PTEN
240,prerank,amyloid fibril formation (GO:1990000),-0.7995991983967935,-1.337604268595024,0.12041884816753927,0.7864227177495848,1.0,2/2,20.30%,GGA2;MDM2
241,prerank,cerebellar granule cell differentiation (GO:0021707),0.986986986986987,1.337086159651409,0.016563146997929608,0.8551005856889774,1.0,1/1,1.40%,GRID2
242,prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.986986986986987,1.337086159651409,0.016563146997929608,0.8551005856889774,1.0,1/1,1.40%,GRID2
243,prerank,regulation of postsynaptic membrane potential (GO:0060078),0.986986986986987,1.337086159651409,0.016563146997929608,0.8551005856889774,1.0,1/1,1.40%,GRID2
244,prerank,excitatory postsynaptic potential (GO:0060079),0.986986986986987,1.337086159651409,0.016563146997929608,0.8551005856889774,1.0,1/1,1.40%,GRID2
245,prerank,cell differentiation in hindbrain (GO:0021533),0.986986986986987,1.337086159651409,0.016563146997929608,0.8551005856889774,1.0,1/1,1.40%,GRID2
246,prerank,ribosome biogenesis (GO:0042254),-0.5863453815261044,-1.3368109229456573,0.13178294573643412,0.784493362064637,1.0,4/4,41.70%,ESF1;NVL;XPO1;RCL1
247,prerank,negative regulation of neuron projection development (GO:0010977),0.522573656296431,1.3366575529945195,0.12738095238095237,0.8523109017939751,1.0,6/8,34.40%,DCC;SEMA3A;KANK1;BCL11A;TRPV4;CRMP1
248,prerank,stem cell development (GO:0048864),0.8206412825651301,1.3342048413473202,0.060842433697347896,0.8563042845852253,1.0,2/2,18.10%,NRG1;CDH2
249,prerank,neural crest cell differentiation (GO:0014033),0.8206412825651301,1.3342048413473202,0.060842433697347896,0.8563042845852253,1.0,2/2,18.10%,NRG1;CDH2
250,prerank,mesenchymal cell development (GO:0014031),0.8206412825651301,1.3342048413473202,0.060842433697347896,0.8563042845852253,1.0,2/2,18.10%,NRG1;CDH2
251,prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.8046092184368736,1.3341942668283657,0.08293460925039872,0.8506125030473006,1.0,2/2,19.70%,SH3GL2;MAGI2
252,prerank,chromatin remodeling (GO:0006338),0.49221917129892223,1.333173549104077,0.14448236632536973,0.8536406392854489,1.0,2/10,1.80%,HMGA2;CECR2
253,prerank,cardiocyte differentiation (GO:0035051),0.995995995995996,1.3320670269629402,0.012915129151291513,0.8134533193969886,1.0,1/1,0.50%,NRG1
254,prerank,cardiac endothelial cell differentiation (GO:0003348),0.995995995995996,1.3320670269629402,0.012915129151291513,0.8134533193969886,1.0,1/1,0.50%,NRG1
255,prerank,myoblast differentiation (GO:0045445),0.995995995995996,1.3320670269629402,0.012915129151291513,0.8134533193969886,1.0,1/1,0.50%,NRG1
256,prerank,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),0.995995995995996,1.3320670269629402,0.012915129151291513,0.8134533193969886,1.0,1/1,0.50%,NRG1
257,prerank,striated muscle cell differentiation (GO:0051146),0.995995995995996,1.3320670269629402,0.012915129151291513,0.8134533193969886,1.0,1/1,0.50%,NRG1
258,prerank,endocardial cell differentiation (GO:0060956),0.995995995995996,1.3320670269629402,0.012915129151291513,0.8134533193969886,1.0,1/1,0.50%,NRG1
259,prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.995995995995996,1.3320670269629402,0.012915129151291513,0.8134533193969886,1.0,1/1,0.50%,NRG1
260,prerank,negative regulation of secretion (GO:0051048),0.995995995995996,1.3320670269629402,0.012915129151291513,0.8134533193969886,1.0,1/1,0.50%,NRG1
261,prerank,cardiac muscle cell myoblast differentiation (GO:0060379),0.995995995995996,1.3320670269629402,0.012915129151291513,0.8134533193969886,1.0,1/1,0.50%,NRG1
262,prerank,protein autophosphorylation (GO:0046777),0.427906495563116,1.3320017098404393,0.11715481171548117,0.8087889535902615,1.0,14/18,47.10%,WNK2;ALK;WNK3;STK33;STK39;GRK5;DDR2;MAP3K13;IGF1R;UHMK1;FLT4;VRK1;EGFR;PTK2
263,prerank,lymphocyte chemotaxis (GO:0048247),-0.7705410821643286,-1.331739592843227,0.11956521739130435,0.822799062127205,1.0,2/2,23.20%,GAS6;SLC12A2
264,prerank,regulation of cell cycle process (GO:0010564),0.7122533508889167,1.330527102454841,0.11581920903954802,0.8164767567063007,1.0,1/3,1.50%,HMGA2
265,prerank,positive regulation of neuron migration (GO:2001224),0.7985971943887775,1.3302696336602895,0.09060402684563758,0.8081631572640087,1.0,2/2,20.30%,SEMA3A;SEMA6A
266,prerank,regulation of neuron migration (GO:2001222),0.7985971943887775,1.3302696336602895,0.09060402684563758,0.8081631572640087,1.0,2/2,20.30%,SEMA3A;SEMA6A
267,prerank,ERBB signaling pathway (GO:0038127),0.5454257150366901,1.3295193731483594,0.12646370023419204,0.8095874319516657,1.0,3/7,12.50%,NRG1;SHC3;NRG2
268,prerank,positive regulation of nervous system development (GO:0051962),0.6417739625861492,1.3263971414686724,0.12283044058744993,0.8277844692057743,1.0,2/4,10.10%,GRID2;PTPRD
269,prerank,positive regulation of synapse assembly (GO:0051965),0.6417739625861492,1.3263971414686724,0.12283044058744993,0.8277844692057743,1.0,2/4,10.10%,GRID2;PTPRD
270,prerank,calcium ion import (GO:0070509),0.60048062626329,1.3259197624395365,0.12452830188679245,0.8266954364784621,1.0,2/5,3.50%,CACNB2;CACNA1A
271,prerank,G protein-coupled opioid receptor signaling pathway (GO:0038003),0.988988988988989,1.3243212411590237,0.02127659574468085,0.7942383361863469,1.0,1/1,1.20%,ADCY8
272,prerank,response to forskolin (GO:1904321),0.988988988988989,1.3243212411590237,0.02127659574468085,0.7942383361863469,1.0,1/1,1.20%,ADCY8
273,prerank,regulation of long-term synaptic potentiation (GO:1900271),0.988988988988989,1.3243212411590237,0.02127659574468085,0.7942383361863469,1.0,1/1,1.20%,ADCY8
274,prerank,regulation of response to stress (GO:0080134),0.988988988988989,1.3243212411590237,0.02127659574468085,0.7942383361863469,1.0,1/1,1.20%,ADCY8
275,prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.988988988988989,1.3243212411590237,0.02127659574468085,0.7942383361863469,1.0,1/1,1.20%,ADCY8
276,prerank,positive regulation of synaptic plasticity (GO:0031915),0.988988988988989,1.3243212411590237,0.02127659574468085,0.7942383361863469,1.0,1/1,1.20%,ADCY8
277,prerank,cellular response to ketone (GO:1901655),0.988988988988989,1.3243212411590237,0.02127659574468085,0.7942383361863469,1.0,1/1,1.20%,ADCY8
278,prerank,neuroinflammatory response (GO:0150076),0.988988988988989,1.3243212411590237,0.02127659574468085,0.7942383361863469,1.0,1/1,1.20%,ADCY8
279,prerank,cellular response to forskolin (GO:1904322),0.988988988988989,1.3243212411590237,0.02127659574468085,0.7942383361863469,1.0,1/1,1.20%,ADCY8
280,prerank,response to morphine (GO:0043278),0.988988988988989,1.3243212411590237,0.02127659574468085,0.7942383361863469,1.0,1/1,1.20%,ADCY8
281,prerank,positive regulation of voltage-gated calcium channel activity (GO:1901387),0.9769769769769769,1.322557611165204,0.03592814371257485,0.8055255392845988,1.0,1/1,2.40%,CACNB2
282,prerank,positive regulation of cholesterol metabolic process (GO:0090205),-0.992992992992993,-1.321294800388184,0.020876826722338204,0.859103186207497,1.0,1/1,0.90%,CES1
283,prerank,regulation of bile acid metabolic process (GO:1904251),-0.992992992992993,-1.321294800388184,0.020876826722338204,0.859103186207497,1.0,1/1,0.90%,CES1
284,prerank,regulation of bile acid biosynthetic process (GO:0070857),-0.992992992992993,-1.321294800388184,0.020876826722338204,0.859103186207497,1.0,1/1,0.90%,CES1
285,prerank,negative regulation of cholesterol storage (GO:0010887),-0.992992992992993,-1.321294800388184,0.020876826722338204,0.859103186207497,1.0,1/1,0.90%,CES1
286,prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.992992992992993,-1.321294800388184,0.020876826722338204,0.859103186207497,1.0,1/1,0.90%,CES1
287,prerank,regulation of steroid biosynthetic process (GO:0050810),-0.992992992992993,-1.321294800388184,0.020876826722338204,0.859103186207497,1.0,1/1,0.90%,CES1
288,prerank,positive regulation of steroid metabolic process (GO:0045940),-0.992992992992993,-1.321294800388184,0.020876826722338204,0.859103186207497,1.0,1/1,0.90%,CES1
289,prerank,regulation of anion transport (GO:0044070),-0.992992992992993,-1.321294800388184,0.020876826722338204,0.859103186207497,1.0,1/1,0.90%,CES1
290,prerank,negative regulation of lipid storage (GO:0010888),-0.992992992992993,-1.321294800388184,0.020876826722338204,0.859103186207497,1.0,1/1,0.90%,CES1
291,prerank,angiotensin maturation (GO:0002003),-0.992992992992993,-1.321294800388184,0.020876826722338204,0.859103186207497,1.0,1/1,0.90%,CES1
292,prerank,positive regulation of cholesterol efflux (GO:0010875),-0.992992992992993,-1.321294800388184,0.020876826722338204,0.859103186207497,1.0,1/1,0.90%,CES1
293,prerank,regulation of angiotensin levels in blood (GO:0002002),-0.992992992992993,-1.321294800388184,0.020876826722338204,0.859103186207497,1.0,1/1,0.90%,CES1
294,prerank,histone H4-K5 acetylation (GO:0043981),-0.985985985985986,-1.3203787920440049,0.025390625,0.8565052849812375,1.0,1/1,1.60%,KANSL1
295,prerank,histone H4-K8 acetylation (GO:0043982),-0.985985985985986,-1.3203787920440049,0.025390625,0.8565052849812375,1.0,1/1,1.60%,KANSL1
296,prerank,endosome organization (GO:0007032),-0.9879879879879879,-1.3188163340684167,0.024390243902439025,0.8705114525231785,1.0,1/1,1.40%,TMCC1
297,prerank,negative regulation of double-strand break repair (GO:2000780),0.8074916538742459,1.3185834465822104,0.08507223113964688,0.8386372430634532,1.0,1/2,1.50%,HMGA2
298,prerank,regulation of nervous system process (GO:0031644),0.8075592815699383,1.318565755978199,0.09752321981424149,0.8294202371479834,1.0,1/2,3.30%,DLGAP2
299,prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.8075592815699383,1.318565755978199,0.09752321981424149,0.8294202371479834,1.0,1/2,3.30%,DLGAP2
300,prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.809065423290948,1.3167767596327316,0.08641975308641975,0.8430664494969553,1.0,1/2,1.60%,HS3ST5
301,prerank,regulation of stem cell differentiation (GO:2000736),-0.7454909819639278,-1.3166460496832615,0.1517412935323383,0.8905485749055139,1.0,2/2,25.70%,KMT2A;BMPR1A
302,prerank,T cell activation (GO:0042110),-0.6268806419257773,-1.3157495305712137,0.1639871382636656,0.8964088904002877,1.0,3/3,37.60%,PPP3CB;PPP3CA;CHD7
303,prerank,positive regulation of potassium ion transport (GO:0043268),0.6325697414379694,1.315511227686059,0.1126005361930295,0.8504531317353924,1.0,3/4,26.90%,KCNMA1;NOS1AP;KCNMB1
304,prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
305,prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
306,prerank,platelet degranulation (GO:0002576),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
307,prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
308,prerank,positive regulation of protein export from nucleus (GO:0046827),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
309,prerank,mononuclear cell differentiation (GO:1903131),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
310,prerank,negative regulation of biomineralization (GO:0110150),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
311,prerank,membrane fusion involved in viral entry into host cell (GO:0039663),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
312,prerank,positive regulation of natural killer cell activation (GO:0032816),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
313,prerank,negative regulation of interleukin-1 production (GO:0032692),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
314,prerank,B cell chemotaxis (GO:0035754),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
315,prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
316,prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
317,prerank,receptor-mediated virion attachment to host cell (GO:0046813),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
318,prerank,negative regulation of interferon-gamma production (GO:0032689),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
319,prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
320,prerank,fusion of virus membrane with host plasma membrane (GO:0019064),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
321,prerank,negative regulation of biomineral tissue development (GO:0070168),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
322,prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
323,prerank,positive regulation of dendritic cell chemotaxis (GO:2000510),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
324,prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
325,prerank,response to interferon-alpha (GO:0035455),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
326,prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
327,prerank,negative regulation of dendritic cell apoptotic process (GO:2000669),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
328,prerank,hematopoietic stem cell migration (GO:0035701),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
329,prerank,regulation of glomerular filtration (GO:0003093),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
330,prerank,cellular response to vitamin (GO:0071295),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
331,prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
332,prerank,regulation of fibroblast apoptotic process (GO:2000269),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
333,prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
334,prerank,dendritic cell differentiation (GO:0097028),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
335,prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
336,prerank,regulation of dendritic cell chemotaxis (GO:2000508),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
337,prerank,cellular response to interferon-alpha (GO:0035457),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
338,prerank,regulation of natural killer cell differentiation (GO:0032823),-0.997997997997998,-1.3152104140827297,0.010309278350515464,0.7038286924534247,1.0,1/1,0.40%,GAS6
339,prerank,positive regulation of protein glycosylation (GO:0060050),-0.9829829829829829,-1.315105639660623,0.024844720496894408,0.7001874597598944,1.0,1/1,1.90%,ARFGEF1
340,prerank,negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
341,prerank,mesodermal cell differentiation (GO:0048333),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
342,prerank,positive regulation of stem cell proliferation (GO:2000648),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
343,prerank,mesoderm formation (GO:0001707),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
344,prerank,positive regulation of cell aging (GO:0090343),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
345,prerank,positive regulation of response to stimulus (GO:0048584),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
346,prerank,stem cell differentiation (GO:0048863),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
347,prerank,regulation of stem cell proliferation (GO:0072091),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
348,prerank,negative regulation by host of viral transcription (GO:0043922),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
349,prerank,chromatin organization involved in negative regulation of transcription (GO:0097549),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
350,prerank,mesenchyme development (GO:0060485),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
351,prerank,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
352,prerank,regulation of DNA binding (GO:0051101),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
353,prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
354,prerank,positive regulation of cellular senescence (GO:2000774),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
355,prerank,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
356,prerank,heterochromatin assembly (GO:0031507),0.985985985985986,1.314193596881661,0.04225352112676056,0.788194425366692,1.0,1/1,1.50%,HMGA2
357,prerank,positive regulation of dendrite development (GO:1900006),0.8006012024048097,1.3133890649859077,0.09523809523809523,0.791194108902174,1.0,2/2,20.10%,ALK;LRP8
358,prerank,homologous chromosome segregation (GO:0045143),0.8016032064128258,1.3124095986411022,0.1001669449081803,0.7961630740971479,1.0,2/2,20.00%,RNF212;FMN2
359,prerank,cell-cell junction assembly (GO:0007043),0.5174730034369917,1.3121607293785853,0.1518987341772152,0.7945948814105696,1.0,7/8,44.30%,CDH20;CDH8;CDHR3;CDH2;TRPV4;CDH11;PRKCA
360,prerank,negative regulation of proteolysis (GO:0045861),-0.984984984984985,-1.3114434668381638,0.03285420944558522,0.735430706873614,1.0,1/1,1.70%,DNAJC1
361,prerank,cellular response to glucagon stimulus (GO:0071377),0.639558232931727,1.3101252135103614,0.13096862210095497,0.796482857251219,1.0,4/4,36.30%,ADCY8;ADCY9;PRKAR2B;PRKAR1B
362,prerank,activation of protein kinase A activity (GO:0034199),0.639558232931727,1.3101252135103614,0.13096862210095497,0.796482857251219,1.0,4/4,36.30%,ADCY8;ADCY9;PRKAR2B;PRKAR1B
363,prerank,response to glucagon (GO:0033762),0.639558232931727,1.3101252135103614,0.13096862210095497,0.796482857251219,1.0,4/4,36.30%,ADCY8;ADCY9;PRKAR2B;PRKAR1B
364,prerank,renal water homeostasis (GO:0003091),0.639558232931727,1.3101252135103614,0.13096862210095497,0.796482857251219,1.0,4/4,36.30%,ADCY8;ADCY9;PRKAR2B;PRKAR1B
365,prerank,cognition (GO:0050890),-0.5833333333333333,-1.3093474888053178,0.1565217391304348,0.7530643951269015,1.0,4/4,42.00%,SETD5;TUSC3;CHD7;NF1
366,prerank,Golgi organization (GO:0007030),-0.30465587044534415,-1.3082463363361152,0.1625,0.7589386989703172,1.0,12/12,70.00%,ARHGAP21;ARFGEF1;GBF1;BCAS3;STX6;UBXN2A;OPTN;FBXW8;HACE1;SEC23IP;VRK1;COG7
367,prerank,transport along microtubule (GO:0010970),-0.983983983983984,-1.3079930280253584,0.024793388429752067,0.7483705754890206,1.0,1/1,1.80%,ARHGAP21
368,prerank,Golgi localization (GO:0051645),-0.983983983983984,-1.3079930280253584,0.024793388429752067,0.7483705754890206,1.0,1/1,1.80%,ARHGAP21
369,prerank,establishment of Golgi localization (GO:0051683),-0.983983983983984,-1.3079930280253584,0.024793388429752067,0.7483705754890206,1.0,1/1,1.80%,ARHGAP21
370,prerank,nuclear membrane reassembly (GO:0031468),-0.41389728096676737,-1.3079879133124983,0.11801242236024845,0.7439619082474627,1.0,7/7,59.00%,PPP2R2A;AHCTF1;REEP3;UBXN2A;SPAST;VRK1;NUP93
371,prerank,negative regulation of lamellipodium organization (GO:1902744),0.7845691382765532,1.306325667521639,0.0985691573926868,0.8282362460962003,1.0,2/2,21.70%,SLIT2;KANK1
372,prerank,negative regulation of transport (GO:0051051),0.6904794694788352,1.306247464592873,0.13540197461212977,0.8250458825462607,1.0,1/3,0.50%,NRG1
373,prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.6974013380707598,1.3061820688871562,0.11965811965811966,0.8216334284221087,1.0,1/3,1.20%,ADCY8
374,prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.968968968968969,-1.3057844616884586,0.07128712871287128,0.7474947586846994,1.0,1/1,3.30%,UQCRC2
375,prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.968968968968969,-1.3057844616884586,0.07128712871287128,0.7474947586846994,1.0,1/1,3.30%,UQCRC2
376,prerank,aerobic electron transport chain (GO:0019646),-0.968968968968969,-1.3057844616884586,0.07128712871287128,0.7474947586846994,1.0,1/1,3.30%,UQCRC2
377,prerank,aerobic respiration (GO:0009060),-0.968968968968969,-1.3057844616884586,0.07128712871287128,0.7474947586846994,1.0,1/1,3.30%,UQCRC2
378,prerank,receptor clustering (GO:0043113),0.5913000954570644,1.304027702160732,0.1503184713375796,0.836971832009219,1.0,3/5,22.80%,LRRC7;MAGI2;DLG2
379,prerank,cellular response to osmotic stress (GO:0071470),0.7011033099297893,1.3037990956577588,0.11965811965811966,0.8346538491039576,1.0,3/3,30.10%,WNK3;STK39;TRPV4
380,prerank,neuron projection maintenance (GO:1990535),-0.98998998998999,-1.3020403617961134,0.02631578947368421,0.7666539074295161,1.0,1/1,1.20%,INSR
381,prerank,neuron projection organization (GO:0106027),-0.98998998998999,-1.3020403617961134,0.02631578947368421,0.7666539074295161,1.0,1/1,1.20%,INSR
382,prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.98998998998999,-1.3020403617961134,0.02631578947368421,0.7666539074295161,1.0,1/1,1.20%,INSR
383,prerank,positive regulation of nuclear division (GO:0051785),-0.98998998998999,-1.3020403617961134,0.02631578947368421,0.7666539074295161,1.0,1/1,1.20%,INSR
384,prerank,regulation of lipid biosynthetic process (GO:0046890),-0.7725450901803607,-1.3017399186023773,0.1368421052631579,0.7656248963588358,1.0,2/2,23.00%,ADIPOR2;ZBTB20
385,prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.986986986986987,-1.3016839636694622,0.024844720496894408,0.7572947996839917,1.0,1/1,1.50%,AP2A2
386,prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.986986986986987,-1.3016839636694622,0.024844720496894408,0.7572947996839917,1.0,1/1,1.50%,AP2A2
387,prerank,anterograde axonal transport (GO:0008089),0.6433451973532904,1.301537280031172,0.14378238341968913,0.849800790804757,1.0,3/4,22.80%,MAPK8IP3;KIF5C;DLG2
388,prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.6379137412236711,-1.3012316926270182,0.16346153846153846,0.7540798957024569,1.0,3/3,36.50%,MAP2K5;ITGB1BP1;HDAC5
389,prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.6379137412236711,-1.3012316926270182,0.16346153846153846,0.7540798957024569,1.0,3/3,36.50%,MAP2K5;ITGB1BP1;HDAC5
390,prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.804546050087783,1.3011369656565428,0.085667215815486,0.8497349600403923,1.0,1/2,2.40%,CACNB2
391,prerank,chondrocyte differentiation (GO:0002062),0.7960321860683882,1.3002841070584445,0.11954765751211632,0.8536991570007403,1.0,1/2,1.50%,HMGA2
392,prerank,regulation of synapse structural plasticity (GO:0051823),0.974974974974975,1.3002178036956378,0.042884990253411304,0.8503834909614213,1.0,1/1,2.60%,FRMPD4
393,prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.993993993993994,-1.2999415857385759,0.017928286852589643,0.7540663151289022,1.0,1/1,0.80%,UBE2D3
394,prerank,protein K11-linked ubiquitination (GO:0070979),-0.993993993993994,-1.2999415857385759,0.017928286852589643,0.7540663151289022,1.0,1/1,0.80%,UBE2D3
395,prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.993993993993994,-1.2999415857385759,0.017928286852589643,0.7540663151289022,1.0,1/1,0.80%,UBE2D3
396,prerank,histone H3 deacetylation (GO:0070932),-0.7765531062124248,-1.2997061512660915,0.17784256559766765,0.75258382918858,1.0,2/2,22.60%,SMARCAD1;PER2
397,prerank,"fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.6920762286860581,1.2995827995134548,0.1277533039647577,0.8321812108251244,1.0,3/3,31.00%,ELOVL2;ELOVL7;ELOVL6
398,prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.6920762286860581,1.2995827995134548,0.1277533039647577,0.8321812108251244,1.0,3/3,31.00%,ELOVL2;ELOVL7;ELOVL6
399,prerank,"fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.6920762286860581,1.2995827995134548,0.1277533039647577,0.8321812108251244,1.0,3/3,31.00%,ELOVL2;ELOVL7;ELOVL6
400,prerank,"fatty acid elongation, saturated fatty acid (GO:0019367)",0.6920762286860581,1.2995827995134548,0.1277533039647577,0.8321812108251244,1.0,3/3,31.00%,ELOVL2;ELOVL7;ELOVL6
401,prerank,fatty acid elongation (GO:0030497),0.6920762286860581,1.2995827995134548,0.1277533039647577,0.8321812108251244,1.0,3/3,31.00%,ELOVL2;ELOVL7;ELOVL6
402,prerank,"fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.6920762286860581,1.2995827995134548,0.1277533039647577,0.8321812108251244,1.0,3/3,31.00%,ELOVL2;ELOVL7;ELOVL6
403,prerank,activation of protein kinase activity (GO:0032147),0.46906500978559734,1.2990934029656873,0.1543550165380375,0.8324956250689923,1.0,6/11,36.30%,NRG1;ADCY8;TOM1L1;ADCY9;PRKAR2B;PRKAR1B
404,prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.7755511022044087,-1.2985343927067827,0.13746630727762804,0.7594462991801512,1.0,2/2,22.70%,SPIDR;TP53BP1
405,prerank,regulation of axonogenesis (GO:0050770),0.5288617727937548,1.2980766576918499,0.1481042654028436,0.8377661657154837,1.0,4/7,25.20%,TIAM1;SLIT2;CDH2;ROBO2
406,prerank,protein sulfation (GO:0006477),0.9849849849849849,1.297394989734795,0.03807615230460922,0.8212269255021769,1.0,1/1,1.60%,HS3ST5
407,prerank,regulation of viral entry into host cell (GO:0046596),0.9849849849849849,1.297394989734795,0.03807615230460922,0.8212269255021769,1.0,1/1,1.60%,HS3ST5
408,prerank,modulation by symbiont of entry into host (GO:0052372),0.9849849849849849,1.297394989734795,0.03807615230460922,0.8212269255021769,1.0,1/1,1.60%,HS3ST5
409,prerank,sulfation (GO:0051923),0.9849849849849849,1.297394989734795,0.03807615230460922,0.8212269255021769,1.0,1/1,1.60%,HS3ST5
410,prerank,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.9849849849849849,1.297394989734795,0.03807615230460922,0.8212269255021769,1.0,1/1,1.60%,HS3ST5
411,prerank,regulation of viral life cycle (GO:1903900),0.9849849849849849,1.297394989734795,0.03807615230460922,0.8212269255021769,1.0,1/1,1.60%,HS3ST5
412,prerank,negative regulation of catabolic process (GO:0009895),0.634213711196053,1.297165206305814,0.14933333333333335,0.8195079411924611,1.0,3/4,21.10%,ALK;FMN2;ADGRB1
413,prerank,negative regulation of actin filament polymerization (GO:0030837),0.6904723718353835,1.2968704474581572,0.12445730824891461,0.8187336822285859,1.0,2/3,21.70%,SLIT2;KANK1
414,prerank,endomembrane system organization (GO:0010256),-0.3049645390070922,-1.295817093132424,0.23529411764705882,0.78073712980687,1.0,13/13,70.00%,TMCC1;ARHGAP21;ARFGEF1;GBF1;BCAS3;REEP3;UBXN2A;OPTN;FBXW8;HACE1;SEC23IP;NUP93;COG7
415,prerank,apical protein localization (GO:0045176),0.9619619619619619,1.294863192025037,0.05976095617529881,0.8319005267635107,1.0,1/1,3.90%,SHROOM3
416,prerank,mammary gland development (GO:0030879),0.7944912542922418,1.294664390601498,0.09822866344605476,0.8302180977723704,1.0,1/2,0.50%,NRG1
417,prerank,response to hydroxyurea (GO:0072710),-0.9769769769769769,-1.2940657526472625,0.04474708171206226,0.7686137472603785,1.0,1/1,2.50%,SPIDR
418,prerank,cellular response to alkaloid (GO:0071312),-0.9769769769769769,-1.2940657526472625,0.04474708171206226,0.7686137472603785,1.0,1/1,2.50%,SPIDR
419,prerank,cellular response to hydroxyurea (GO:0072711),-0.9769769769769769,-1.2940657526472625,0.04474708171206226,0.7686137472603785,1.0,1/1,2.50%,SPIDR
420,prerank,regulation of establishment of protein localization (GO:0070201),-0.9769769769769769,-1.2940657526472625,0.04474708171206226,0.7686137472603785,1.0,1/1,2.50%,SPIDR
421,prerank,cellular response to nitrogen compound (GO:1901699),-0.9769769769769769,-1.2940657526472625,0.04474708171206226,0.7686137472603785,1.0,1/1,2.50%,SPIDR
422,prerank,cellular response to radiation (GO:0071478),-0.9769769769769769,-1.2940657526472625,0.04474708171206226,0.7686137472603785,1.0,1/1,2.50%,SPIDR
423,prerank,response to ionizing radiation (GO:0010212),-0.9769769769769769,-1.2940657526472625,0.04474708171206226,0.7686137472603785,1.0,1/1,2.50%,SPIDR
424,prerank,regulation of striated muscle cell differentiation (GO:0051153),0.793924158690426,1.2936047062991083,0.09294871794871795,0.835650988759309,1.0,1/2,0.50%,NRG1
425,prerank,excitatory synapse assembly (GO:1904861),0.7787028128949086,1.293529214141409,0.10945273631840796,0.8290158003034466,1.0,1/2,1.40%,GRID2
426,prerank,prepulse inhibition (GO:0060134),0.7787028128949086,1.293529214141409,0.10945273631840796,0.8290158003034466,1.0,1/2,1.40%,GRID2
427,prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.7625250501002003,-1.29268579173255,0.15425531914893617,0.7741095090896766,1.0,2/2,24.00%,AGO2;TNRC6A
428,prerank,miRNA mediated inhibition of translation (GO:0035278),-0.7625250501002003,-1.29268579173255,0.15425531914893617,0.7741095090896766,1.0,2/2,24.00%,AGO2;TNRC6A
429,prerank,negative regulation of transposition (GO:0010529),-0.9779779779779779,-1.2914484386127671,0.041749502982107355,0.7766444348072529,1.0,1/1,2.40%,UBR2
430,prerank,regulation of transposition (GO:0010528),-0.9779779779779779,-1.2914484386127671,0.041749502982107355,0.7766444348072529,1.0,1/1,2.40%,UBR2
431,prerank,"wound healing, spreading of epidermal cells (GO:0035313)",-0.978978978978979,-1.2892529364711824,0.03792415169660679,0.7877059900468828,1.0,1/1,2.30%,COL5A1
432,prerank,macromolecule biosynthetic process (GO:0009059),-0.978978978978979,-1.2892529364711824,0.03792415169660679,0.7877059900468828,1.0,1/1,2.30%,COL5A1
433,prerank,positive regulation of organelle assembly (GO:1902117),-0.6158475426278837,-1.2878719877980813,0.17218543046357615,0.7959027293916539,1.0,3/3,38.70%,PIP4K2A;RAB3GAP2;CNOT6
434,prerank,Golgi transport vesicle coating (GO:0048200),-0.9679679679679679,-1.2878229545672004,0.06796116504854369,0.7625632944082649,1.0,1/1,3.40%,GBF1
435,prerank,regulation of protein localization to cell surface (GO:2000008),-0.9679679679679679,-1.2878229545672004,0.06796116504854369,0.7625632944082649,1.0,1/1,3.40%,GBF1
436,prerank,protein localization to endoplasmic reticulum exit site (GO:0070973),-0.9679679679679679,-1.2878229545672004,0.06796116504854369,0.7625632944082649,1.0,1/1,3.40%,GBF1
437,prerank,establishment of monopolar cell polarity (GO:0061162),-0.9679679679679679,-1.2878229545672004,0.06796116504854369,0.7625632944082649,1.0,1/1,3.40%,GBF1
438,prerank,cellular response to virus (GO:0098586),-0.9679679679679679,-1.2878229545672004,0.06796116504854369,0.7625632944082649,1.0,1/1,3.40%,GBF1
439,prerank,COPI-coated vesicle budding (GO:0035964),-0.9679679679679679,-1.2878229545672004,0.06796116504854369,0.7625632944082649,1.0,1/1,3.40%,GBF1
440,prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.9679679679679679,-1.2878229545672004,0.06796116504854369,0.7625632944082649,1.0,1/1,3.40%,GBF1
441,prerank,Golgi to endosome transport (GO:0006895),-0.9679679679679679,-1.2878229545672004,0.06796116504854369,0.7625632944082649,1.0,1/1,3.40%,GBF1
442,prerank,COPI coating of Golgi vesicle (GO:0048205),-0.9679679679679679,-1.2878229545672004,0.06796116504854369,0.7625632944082649,1.0,1/1,3.40%,GBF1
443,prerank,regulation of cation channel activity (GO:2001257),0.5072004813683693,1.2874973821652953,0.17325581395348838,0.8742065102379765,1.0,4/8,22.80%,CACNB2;LRRC7;CACNG4;DLG2
444,prerank,response to leptin (GO:0044321),-0.95995995995996,-1.2869524788203315,0.06299212598425197,0.7585315302175576,1.0,1/1,4.20%,CCND1
445,prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.95995995995996,-1.2869524788203315,0.06299212598425197,0.7585315302175576,1.0,1/1,4.20%,CCND1
446,prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.95995995995996,-1.2869524788203315,0.06299212598425197,0.7585315302175576,1.0,1/1,4.20%,CCND1
447,prerank,extracellular matrix organization (GO:0030198),0.37786137592040725,1.2863744225778857,0.12893401015228426,0.8804257432088278,1.0,17/30,39.50%,COL25A1;LAMA2;MMP16;FBN2;ADAMTSL1;FLRT2;COL22A1;MMP17;COL8A1;LAMA3;ADAMTS3;ADAMTS10;SMOC2;PXDN;COL5A3;DDR2;ST7
448,prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.958958958958959,1.2841349597606706,0.07662082514734773,0.8796216693223289,1.0,1/1,4.20%,TMEFF2
449,prerank,epiboly involved in wound healing (GO:0090505),0.958958958958959,1.2841349597606706,0.07662082514734773,0.8796216693223289,1.0,1/1,4.20%,TMEFF2
450,prerank,regulation of integrin biosynthetic process (GO:0045113),0.958958958958959,1.2841349597606706,0.07662082514734773,0.8796216693223289,1.0,1/1,4.20%,TMEFF2
451,prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.958958958958959,1.2841349597606706,0.07662082514734773,0.8796216693223289,1.0,1/1,4.20%,TMEFF2
452,prerank,negative regulation of stress fiber assembly (GO:0051497),0.958958958958959,1.2841349597606706,0.07662082514734773,0.8796216693223289,1.0,1/1,4.20%,TMEFF2
453,prerank,autophagosome-lysosome fusion (GO:0061909),-0.9729729729729729,-1.2838413164131024,0.07378640776699029,0.773473640314928,1.0,1/1,2.90%,PIP4K2A
454,prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.9729729729729729,-1.2838413164131024,0.07378640776699029,0.773473640314928,1.0,1/1,2.90%,PIP4K2A
455,prerank,negative regulation of lipid kinase activity (GO:0090219),-0.9729729729729729,-1.2838413164131024,0.07378640776699029,0.773473640314928,1.0,1/1,2.90%,PIP4K2A
456,prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.97997997997998,-1.2834333984564288,0.05058365758754864,0.762496071614518,1.0,1/1,2.20%,UAP1
457,prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.97997997997998,-1.2834333984564288,0.05058365758754864,0.762496071614518,1.0,1/1,2.20%,UAP1
458,prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.97997997997998,-1.2834333984564288,0.05058365758754864,0.762496071614518,1.0,1/1,2.20%,UAP1
459,prerank,amino sugar biosynthetic process (GO:0046349),-0.97997997997998,-1.2834333984564288,0.05058365758754864,0.762496071614518,1.0,1/1,2.20%,UAP1
460,prerank,positive regulation of programmed cell death (GO:0043068),0.4409582959879496,1.2833017323843494,0.16575790621592149,0.8796856178674365,1.0,4/13,9.80%,HMGA2;KCNMA1;TIAM1;SLIT2
461,prerank,positive regulation of apoptotic process (GO:0043065),0.4409582959879496,1.2833017323843494,0.16575790621592149,0.8796856178674365,1.0,4/13,9.80%,HMGA2;KCNMA1;TIAM1;SLIT2
462,prerank,negative regulation of vascular permeability (GO:0043116),0.6867045659815412,1.282103407046941,0.14942528735632185,0.8862935680228272,1.0,2/3,12.30%,SLIT2;SH3GL2
463,prerank,regulation of proteolysis (GO:0030162),-0.6369107321965898,-1.2818601963764802,0.16393442622950818,0.7721286887416485,1.0,3/3,36.60%,DNAJC1;BTRC;LTBP4
464,prerank,regulation of cell death (GO:0010941),0.5460965621336403,1.2815066309231333,0.17245657568238212,0.8868963744808809,1.0,4/6,32.20%,DCC;CALCR;ACER2;RRAS2
465,prerank,positive regulation by host of viral process (GO:0044794),-0.9519519519519519,-1.280473036494879,0.09072978303747535,0.7622937742369705,1.0,1/1,5.00%,NUCKS1
466,prerank,modulation by host of viral genome replication (GO:0044827),-0.9519519519519519,-1.280473036494879,0.09072978303747535,0.7622937742369705,1.0,1/1,5.00%,NUCKS1
467,prerank,response to X-ray (GO:0010165),-0.9519519519519519,-1.280473036494879,0.09072978303747535,0.7622937742369705,1.0,1/1,5.00%,NUCKS1
468,prerank,positive regulation by host of viral transcription (GO:0043923),-0.9519519519519519,-1.280473036494879,0.09072978303747535,0.7622937742369705,1.0,1/1,5.00%,NUCKS1
469,prerank,positive regulation by host of viral genome replication (GO:0044829),-0.9519519519519519,-1.280473036494879,0.09072978303747535,0.7622937742369705,1.0,1/1,5.00%,NUCKS1
470,prerank,cellular response to X-ray (GO:0071481),-0.9519519519519519,-1.280473036494879,0.09072978303747535,0.7622937742369705,1.0,1/1,5.00%,NUCKS1
471,prerank,viral mRNA export from host cell nucleus (GO:0046784),-0.963963963963964,-1.2804507761003607,0.07249466950959488,0.7557026957922074,1.0,1/1,3.80%,THOC2
472,prerank,translocation of molecules into host (GO:0044417),-0.963963963963964,-1.2804507761003607,0.07249466950959488,0.7557026957922074,1.0,1/1,3.80%,THOC2
473,prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.7595190380761523,-1.280416384418168,0.18527918781725888,0.7526091480812395,1.0,2/2,24.30%,CAMK2D;DLG1
474,prerank,positive regulation of telomere capping (GO:1904355),-0.7505010020040079,-1.278162972382872,0.19452054794520549,0.7573064042772818,1.0,2/2,25.20%,TNKS2;NEK7
475,prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.7505010020040079,-1.278162972382872,0.19452054794520549,0.7573064042772818,1.0,2/2,25.20%,TNKS2;NEK7
476,prerank,positive regulation of telomere maintenance (GO:0032206),-0.7505010020040079,-1.278162972382872,0.19452054794520549,0.7573064042772818,1.0,2/2,25.20%,TNKS2;NEK7
477,prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.7505010020040079,-1.278162972382872,0.19452054794520549,0.7573064042772818,1.0,2/2,25.20%,TNKS2;NEK7
478,prerank,positive regulation of ion transmembrane transport (GO:0034767),0.7805611222444889,1.2776384776746614,0.115625,0.9137490516905911,1.0,2/2,22.10%,WNK3;STK39
479,prerank,steroid biosynthetic process (GO:0006694),0.948948948948949,1.277352874585145,0.11885245901639344,0.9010940673279755,1.0,1/1,5.20%,OSBPL6
480,prerank,regulation of sterol transport (GO:0032371),0.948948948948949,1.277352874585145,0.11885245901639344,0.9010940673279755,1.0,1/1,5.20%,OSBPL6
481,prerank,bile acid metabolic process (GO:0008206),0.948948948948949,1.277352874585145,0.11885245901639344,0.9010940673279755,1.0,1/1,5.20%,OSBPL6
482,prerank,bile acid biosynthetic process (GO:0006699),0.948948948948949,1.277352874585145,0.11885245901639344,0.9010940673279755,1.0,1/1,5.20%,OSBPL6
483,prerank,acyl-CoA biosynthetic process (GO:0071616),-0.960960960960961,-1.2772588972404506,0.07171314741035857,0.7602870501473052,1.0,1/1,4.10%,ACACA
484,prerank,spinal cord motor neuron differentiation (GO:0021522),0.954954954954955,1.276448740368189,0.09981167608286252,0.9014319827000696,1.0,1/1,4.60%,MDGA2
485,prerank,cell differentiation in spinal cord (GO:0021515),0.954954954954955,1.276448740368189,0.09981167608286252,0.9014319827000696,1.0,1/1,4.60%,MDGA2
486,prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.954954954954955,-1.2755783375678964,0.09563409563409564,0.7551507736122727,1.0,1/1,4.70%,MAP2K5
487,prerank,regulation of response to cytokine stimulus (GO:0060759),-0.954954954954955,-1.2755783375678964,0.09563409563409564,0.7551507736122727,1.0,1/1,4.70%,MAP2K5
488,prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.954954954954955,-1.2755783375678964,0.09563409563409564,0.7551507736122727,1.0,1/1,4.70%,MAP2K5
489,prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.954954954954955,-1.2755783375678964,0.09563409563409564,0.7551507736122727,1.0,1/1,4.70%,MAP2K5
490,prerank,negative regulation of chemokine production (GO:0032682),-0.954954954954955,-1.2755783375678964,0.09563409563409564,0.7551507736122727,1.0,1/1,4.70%,MAP2K5
491,prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.954954954954955,-1.2755783375678964,0.09563409563409564,0.7551507736122727,1.0,1/1,4.70%,MAP2K5
492,prerank,cellular response to acetylcholine (GO:1905145),0.9519519519519518,1.274318495875382,0.10546875,0.9036803017730539,1.0,1/1,4.90%,CHRM3
493,prerank,regulation of smooth muscle contraction (GO:0006940),0.9519519519519518,1.274318495875382,0.10546875,0.9036803017730539,1.0,1/1,4.90%,CHRM3
494,prerank,adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.9519519519519518,1.274318495875382,0.10546875,0.9036803017730539,1.0,1/1,4.90%,CHRM3
495,prerank,regulation of vascular associated smooth muscle contraction (GO:0003056),0.9519519519519518,1.274318495875382,0.10546875,0.9036803017730539,1.0,1/1,4.90%,CHRM3
496,prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.7434869739478958,-1.2743046334165478,0.18298969072164947,0.7609160590069632,1.0,2/2,25.90%,CHD6;CREB3L1
497,prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.9469469469469469,-1.2728754365541326,0.08450704225352113,0.7684271215146278,1.0,1/1,5.50%,ANAPC16
498,prerank,regulation of protein-containing complex assembly (GO:0043254),0.5755675353596503,1.2727059837453585,0.1620603015075377,0.9129332592948463,1.0,1/5,0.50%,NRG1
499,prerank,"phototransduction, visible light (GO:0007603)",0.9469469469469469,1.2721389116586548,0.11155378486055777,0.9095826882196015,1.0,1/1,5.40%,GNGT1
500,prerank,rhodopsin mediated signaling pathway (GO:0016056),0.9469469469469469,1.2721389116586548,0.11155378486055777,0.9095826882196015,1.0,1/1,5.40%,GNGT1
501,prerank,aorta morphogenesis (GO:0035909),-0.7394789579158316,-1.2717303732879786,0.18181818181818182,0.7738059507293175,1.0,2/2,26.30%,BMPR1A;ADAMTS9
502,prerank,regulation of focal adhesion disassembly (GO:0120182),-0.948948948948949,-1.2716682289103964,0.10655737704918032,0.7526049129210127,1.0,1/1,5.30%,MAP4K4
503,prerank,microvillus organization (GO:0032528),-0.948948948948949,-1.2716682289103964,0.10655737704918032,0.7526049129210127,1.0,1/1,5.30%,MAP4K4
504,prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.948948948948949,-1.2716682289103964,0.10655737704918032,0.7526049129210127,1.0,1/1,5.30%,MAP4K4
505,prerank,microvillus assembly (GO:0030033),-0.948948948948949,-1.2716682289103964,0.10655737704918032,0.7526049129210127,1.0,1/1,5.30%,MAP4K4
506,prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.948948948948949,-1.2716682289103964,0.10655737704918032,0.7526049129210127,1.0,1/1,5.30%,MAP4K4
507,prerank,positive regulation of keratinocyte migration (GO:0051549),-0.948948948948949,-1.2716682289103964,0.10655737704918032,0.7526049129210127,1.0,1/1,5.30%,MAP4K4
508,prerank,positive regulation of focal adhesion disassembly (GO:0120183),-0.948948948948949,-1.2716682289103964,0.10655737704918032,0.7526049129210127,1.0,1/1,5.30%,MAP4K4
509,prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.6184738955823292,1.2693664361483317,0.14733969986357434,0.9272270431725702,1.0,4/4,38.40%,ELOVL2;ELOVL7;ELOVL6;HSD17B12
510,prerank,positive regulation of telomerase activity (GO:0051973),-0.7294589178356713,-1.2684962285347452,0.15263157894736842,0.7712784219412155,1.0,2/2,27.30%,NEK7;NVL
511,prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.950950950950951,-1.266209838019225,0.09607843137254903,0.777637777850746,1.0,1/1,5.10%,TAF15
512,prerank,RNA stabilization (GO:0043489),-0.950950950950951,-1.266209838019225,0.09607843137254903,0.777637777850746,1.0,1/1,5.10%,TAF15
513,prerank,mRNA stabilization (GO:0048255),-0.950950950950951,-1.266209838019225,0.09607843137254903,0.777637777850746,1.0,1/1,5.10%,TAF15
514,prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.9569569569569569,-1.2661718200752548,0.073558648111332,0.7688103044695659,1.0,1/1,4.50%,PPA2
515,prerank,tRNA aminoacylation (GO:0043039),-0.9569569569569569,-1.2661718200752548,0.073558648111332,0.7688103044695659,1.0,1/1,4.50%,PPA2
516,prerank,oxoacid metabolic process (GO:0043436),-0.9569569569569569,-1.2661718200752548,0.073558648111332,0.7688103044695659,1.0,1/1,4.50%,PPA2
517,prerank,cellular protein-containing complex assembly (GO:0034622),0.5438861093003545,1.2654744422646598,0.16182048040455121,0.9542908688601832,1.0,3/6,21.20%,NRG1;TIAM1;HIP1
518,prerank,endoplasmic reticulum organization (GO:0007029),-0.75250501002004,-1.2643762824222664,0.1796875,0.7782120048794656,1.0,2/2,25.00%,TMCC1;REEP3
519,prerank,mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
520,prerank,miRNA metabolic process (GO:0010586),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
521,prerank,negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
522,prerank,negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
523,prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
524,prerank,production of siRNA involved in RNA interference (GO:0030422),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
525,prerank,pre-miRNA processing (GO:0031054),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
526,prerank,miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
527,prerank,ncRNA metabolic process (GO:0034660),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
528,prerank,RNA secondary structure unwinding (GO:0010501),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
529,prerank,negative regulation of translational initiation (GO:0045947),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
530,prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
531,prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
532,prerank,RNA interference (GO:0016246),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
533,prerank,positive regulation of trophoblast cell migration (GO:1901165),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
534,prerank,small RNA loading onto RISC (GO:0070922),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
535,prerank,regulation of trophoblast cell migration (GO:1901163),-0.9419419419419419,-1.263727287327422,0.10309278350515463,0.7346273892864538,1.0,1/1,6.00%,AGO2
536,prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.93993993993994,-1.2634715191901071,0.10285714285714286,0.7289455902174135,1.0,1/1,6.20%,BTRC
537,prerank,NIK/NF-kappaB signaling (GO:0038061),-0.93993993993994,-1.2634715191901071,0.10285714285714286,0.7289455902174135,1.0,1/1,6.20%,BTRC
538,prerank,positive regulation of proteolysis (GO:0045862),-0.93993993993994,-1.2634715191901071,0.10285714285714286,0.7289455902174135,1.0,1/1,6.20%,BTRC
539,prerank,meiosis I (GO:0007127),-0.9429429429429429,-1.2622858030427881,0.10019646365422397,0.7308222171085494,1.0,1/1,5.90%,FOXJ3
540,prerank,male meiosis I (GO:0007141),-0.9429429429429429,-1.2622858030427881,0.10019646365422397,0.7308222171085494,1.0,1/1,5.90%,FOXJ3
541,prerank,cellular senescence (GO:0090398),0.7733675278976426,1.2622322249926365,0.1477832512315271,0.9751667491336775,1.0,1/2,1.50%,HMGA2
542,prerank,endocytic recycling (GO:0032456),-0.7484969939879759,-1.2607513721044086,0.15521628498727735,0.7376740288669336,1.0,2/2,25.40%,VPS53;STX6
543,prerank,protein transport (GO:0015031),-0.24541751527494907,-1.2602598940306746,0.15151515151515152,0.7376117623859942,1.0,18/18,76.00%,VPS45;GGA2;RAB28;RAB3GAP2;STX6;TBC1D5;SIL1;OPTN;RABGAP1;SLC10A7;WLS;OLFM2;SEC23IP;ATP6V0A4;TBC1D16;SGSM3;COG7;GRTP1
544,prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.3171225937183384,-1.2593007911979797,0.08695652173913043,0.741970814687825,1.0,13/13,68.80%,EXOC4;GBF1;MAP4K4;CDC14A;CCDC57;TTBK2;ARL13B;PTPDC1;IFT172;FNBP1L;CDC14B;CD2AP;DZIP1L
545,prerank,regulation of homophilic cell adhesion (GO:1903385),0.9419419419419418,1.2586670425022133,0.11530815109343936,0.9989726661934608,1.0,1/1,5.90%,TENM3
546,prerank,response to estrogen (GO:0043627),-0.938938938938939,-1.2577480633173912,0.11332007952286283,0.7470920717249011,1.0,1/1,6.30%,BCAS3
547,prerank,cellular response to estrogen stimulus (GO:0071391),-0.938938938938939,-1.2577480633173912,0.11332007952286283,0.7470920717249011,1.0,1/1,6.30%,BCAS3
548,prerank,intracellular protein transport (GO:0006886),-0.2459183673469388,-1.2565214977485188,0.16129032258064516,0.7531101853059581,1.0,20/20,76.00%,TNPO1;PRICKLE1;VPS45;GGA2;RAB28;RAB3GAP2;STX6;TBC1D5;SIL1;AP1M2;RABGAP1;XPO1;WLS;SEC23IP;IPO8;TBC1D16;NUP93;SGSM3;COG7;GRTP1
549,prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.7704803834764753,1.2553983368481763,0.1486697965571205,1.0,1.0,1/2,1.80%,CECR2
550,prerank,positive regulation of metabolic process (GO:0009893),0.4481231767466062,1.2535183004827122,0.18331503841931943,1.0,1.0,4/12,14.40%,ESRRG;EBF2;PPARGC1A;CAMK1D
551,prerank,regulation of apoptotic process (GO:0042981),0.35191943703312933,1.252925159087136,0.1358148893360161,1.0,1.0,26/41,47.10%,GRID2;HMGA2;KCNMA1;ALK;TIAM1;SLIT2;WNK3;FMN2;LRP8;HIP1;OBSCN;TRIM2;WT1;DPEP1;ACER2;BCL2;GRK5;CASP9;PIDD1;IGF1R;CSRNP3;FLT4;WRN;EGFR;PRAME;PTK2
552,prerank,inorganic ion transmembrane transport (GO:0098660),0.933933933933934,1.2527378049265903,0.12845849802371542,1.0,1.0,1/1,6.70%,ASIC2
553,prerank,sensory perception of taste (GO:0050909),0.933933933933934,1.2527378049265903,0.12845849802371542,1.0,1.0,1/1,6.70%,ASIC2
554,prerank,sensory perception of sour taste (GO:0050915),0.933933933933934,1.2527378049265903,0.12845849802371542,1.0,1.0,1/1,6.70%,ASIC2
555,prerank,histone H2B ubiquitination (GO:0033523),-0.933933933933934,-1.2516681307119795,0.1350844277673546,0.782297750390968,1.0,1/1,6.80%,WAC
556,prerank,vasodilation (GO:0042311),0.9379379379379379,1.249311977573033,0.12393162393162394,1.0,1.0,1/1,6.30%,KCNMA1
557,prerank,negative regulation of smooth muscle contraction (GO:0045986),0.9379379379379379,1.249311977573033,0.12393162393162394,1.0,1.0,1/1,6.30%,KCNMA1
558,prerank,negative regulation of cell volume (GO:0045794),0.9379379379379379,1.249311977573033,0.12393162393162394,1.0,1.0,1/1,6.30%,KCNMA1
559,prerank,negative regulation of epithelial cell migration (GO:0010633),0.5442309477817262,1.2487412422834412,0.1943419434194342,1.0,1.0,3/6,21.10%,SLIT2;MCC;ADGRB1
560,prerank,positive regulation of transporter activity (GO:0032411),0.6597907343576224,1.2449549518979148,0.1625,1.0,1.0,2/3,22.10%,WNK3;STK39
561,prerank,cellular glucose homeostasis (GO:0001678),0.5389215851968414,1.2445969019898109,0.19518072289156627,1.0,1.0,2/6,12.20%,ADCY8;PPARGC1A
562,prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.9379379379379379,-1.2444685171926444,0.156312625250501,0.824327794659393,1.0,1/1,6.40%,YME1L1
563,prerank,mitochondrial protein catabolic process (GO:0035694),-0.9379379379379379,-1.2444685171926444,0.156312625250501,0.824327794659393,1.0,1/1,6.40%,YME1L1
564,prerank,negative regulation of telomere maintenance (GO:0032205),-0.7384769539078155,-1.2437210158585434,0.21298701298701297,0.8235157360237332,1.0,2/2,26.40%,TNKS2;SMG6
565,prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.7384769539078155,-1.2437210158585434,0.21298701298701297,0.8235157360237332,1.0,2/2,26.40%,TNKS2;SMG6
566,prerank,positive regulation of RNA splicing (GO:0033120),-0.9289289289289289,-1.243536269189924,0.12055335968379446,0.802588766129666,1.0,1/1,7.30%,RBMX
567,prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.9289289289289289,-1.243536269189924,0.12055335968379446,0.802588766129666,1.0,1/1,7.30%,RBMX
568,prerank,negative regulation of RNA splicing (GO:0033119),-0.9289289289289289,-1.243536269189924,0.12055335968379446,0.802588766129666,1.0,1/1,7.30%,RBMX
569,prerank,positive regulation of mRNA processing (GO:0050685),-0.9289289289289289,-1.243536269189924,0.12055335968379446,0.802588766129666,1.0,1/1,7.30%,RBMX
570,prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.9289289289289289,-1.243536269189924,0.12055335968379446,0.802588766129666,1.0,1/1,7.30%,RBMX
571,prerank,negative regulation of mRNA processing (GO:0050686),-0.9289289289289289,-1.243536269189924,0.12055335968379446,0.802588766129666,1.0,1/1,7.30%,RBMX
572,prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.9289289289289289,-1.243536269189924,0.12055335968379446,0.802588766129666,1.0,1/1,7.30%,RBMX
573,prerank,membrane protein proteolysis (GO:0033619),-0.9289289289289289,-1.243536269189924,0.12055335968379446,0.802588766129666,1.0,1/1,7.30%,RBMX
574,prerank,regulation of neuron apoptotic process (GO:0043523),0.532161193610609,1.2433538245724414,0.178743961352657,1.0,1.0,4/6,29.80%,GRID2;PPARGC1A;TRIM2;BCL2
575,prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.9319319319319319,-1.243241642413489,0.13709677419354838,0.8018450915289517,1.0,1/1,7.00%,NME3
576,prerank,presynapse organization (GO:0099172),0.9319319319319318,1.2431589866931014,0.1440162271805274,1.0,1.0,1/1,6.90%,LRRTM3
577,prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.9319319319319318,1.2431589866931014,0.1440162271805274,1.0,1.0,1/1,6.90%,LRRTM3
578,prerank,positive regulation of amyloid-beta formation (GO:1902004),0.9319319319319318,1.2431589866931014,0.1440162271805274,1.0,1.0,1/1,6.90%,LRRTM3
579,prerank,regulation of amyloid-beta formation (GO:1902003),0.9319319319319318,1.2431589866931014,0.1440162271805274,1.0,1.0,1/1,6.90%,LRRTM3
580,prerank,adiponectin-activated signaling pathway (GO:0033211),-0.9359359359359359,-1.2428054314711794,0.13549618320610687,0.7910332988118799,1.0,1/1,6.60%,ADIPOR2
581,prerank,vascular wound healing (GO:0061042),-0.9359359359359359,-1.2428054314711794,0.13549618320610687,0.7910332988118799,1.0,1/1,6.60%,ADIPOR2
582,prerank,regulation of fatty acid metabolic process (GO:0019217),-0.9359359359359359,-1.2428054314711794,0.13549618320610687,0.7910332988118799,1.0,1/1,6.60%,ADIPOR2
583,prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.9359359359359359,-1.2428054314711794,0.13549618320610687,0.7910332988118799,1.0,1/1,6.60%,ADIPOR2
584,prerank,angiogenesis involved in wound healing (GO:0060055),-0.9359359359359359,-1.2428054314711794,0.13549618320610687,0.7910332988118799,1.0,1/1,6.60%,ADIPOR2
585,prerank,nervous system development (GO:0007399),0.3565606240935992,1.242100912160622,0.16952573158425832,1.0,1.0,16/39,26.60%,NRG1;SHANK2;CHRM3;ASIC2;IGF2BP2;SDK1;SH3GL2;ADGRL3;CDH2;SEMA6A;ADGRB1;LSAMP;SNTG2;ROBO2;BTBD2;NAV2
586,prerank,positive regulation of collagen metabolic process (GO:0010714),-0.7434869739478958,-1.2414733969986362,0.19487179487179487,0.7932249554440086,1.0,2/2,25.90%,SUCO;CREB3L1
587,prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.7434869739478958,-1.2414733969986362,0.19487179487179487,0.7932249554440086,1.0,2/2,25.90%,SUCO;CREB3L1
588,prerank,response to growth factor (GO:0070848),-0.6068204613841525,-1.2411603867638064,0.20068027210884354,0.7923774916793684,1.0,3/3,39.60%,MAP2K5;BMPR1A;EPHA2
589,prerank,protein kinase B signaling (GO:0043491),-0.6068204613841525,-1.2410536852837304,0.2138157894736842,0.7903938187710309,1.0,3/3,39.60%,GAS6;PTEN;EPHA2
590,prerank,protein localization to axon (GO:0099612),0.9329329329329328,1.2407754708590781,0.14730290456431536,1.0,1.0,1/1,6.80%,CNTNAP2
591,prerank,vocal learning (GO:0042297),0.9329329329329328,1.2407754708590781,0.14730290456431536,1.0,1.0,1/1,6.80%,CNTNAP2
592,prerank,imitative learning (GO:0098596),0.9329329329329328,1.2407754708590781,0.14730290456431536,1.0,1.0,1/1,6.80%,CNTNAP2
593,prerank,positive regulation of gap junction assembly (GO:1903598),0.9329329329329328,1.2407754708590781,0.14730290456431536,1.0,1.0,1/1,6.80%,CNTNAP2
594,prerank,regulation of gap junction assembly (GO:1903596),0.9329329329329328,1.2407754708590781,0.14730290456431536,1.0,1.0,1/1,6.80%,CNTNAP2
595,prerank,positive regulation of exocytosis (GO:0045921),0.7575150300601202,1.239764842409039,0.16639209225700163,1.0,1.0,2/2,24.40%,CADPS2;STXBP5
596,prerank,protein polyglutamylation (GO:0018095),-0.9279279279279279,-1.239390630409886,0.12749003984063745,0.7944675788765754,1.0,1/1,7.40%,TTLL5
597,prerank,peptidyl-glutamic acid modification (GO:0018200),-0.9279279279279279,-1.239390630409886,0.12749003984063745,0.7944675788765754,1.0,1/1,7.40%,TTLL5
598,prerank,positive regulation of neurogenesis (GO:0050769),0.508981742975986,1.2393349584560096,0.20877817319098457,1.0,1.0,3/7,10.10%,TIAM1;SLIT2;PTPRD
599,prerank,regulation of cell killing (GO:0031341),-0.92992992992993,-1.2391360363774158,0.14015151515151514,0.7911534191066708,1.0,1/1,7.20%,CFH
600,prerank,regulation of complement-dependent cytotoxicity (GO:1903659),-0.92992992992993,-1.2391360363774158,0.14015151515151514,0.7911534191066708,1.0,1/1,7.20%,CFH
601,prerank,regulation of histone H3-K4 methylation (GO:0051569),0.754438050227023,1.238860580353977,0.1769352290679305,1.0,1.0,1/2,7.10%,AUTS2
602,prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.754438050227023,1.238860580353977,0.1769352290679305,1.0,1.0,1/2,7.10%,AUTS2
603,prerank,negative regulation of organelle assembly (GO:1902116),-0.59679037111334,-1.2388080188921555,0.2222222222222222,0.7902438069260995,1.0,3/3,40.60%,CDK10;KAT2B;KAT2A
604,prerank,positive regulation of cholesterol storage (GO:0010886),-0.9329329329329329,-1.2380000469742085,0.14931237721021612,0.7751923672705313,1.0,1/1,6.90%,SREBF2
605,prerank,cellular response to sterol depletion (GO:0071501),-0.9329329329329329,-1.2380000469742085,0.14931237721021612,0.7751923672705313,1.0,1/1,6.90%,SREBF2
606,prerank,regulation of sterol biosynthetic process (GO:0106118),-0.9329329329329329,-1.2380000469742085,0.14931237721021612,0.7751923672705313,1.0,1/1,6.90%,SREBF2
607,prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.9329329329329329,-1.2380000469742085,0.14931237721021612,0.7751923672705313,1.0,1/1,6.90%,SREBF2
608,prerank,negative regulation of cholesterol transport (GO:0032375),-0.9329329329329329,-1.2380000469742085,0.14931237721021612,0.7751923672705313,1.0,1/1,6.90%,SREBF2
609,prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.9329329329329329,-1.2380000469742085,0.14931237721021612,0.7751923672705313,1.0,1/1,6.90%,SREBF2
610,prerank,SREBP signaling pathway (GO:0032933),-0.9329329329329329,-1.2380000469742085,0.14931237721021612,0.7751923672705313,1.0,1/1,6.90%,SREBF2
611,prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.9329329329329329,-1.2380000469742085,0.14931237721021612,0.7751923672705313,1.0,1/1,6.90%,SREBF2
612,prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6563010889303178,1.2374613006088824,0.1763888888888889,1.0,1.0,2/3,18.10%,NRG1;CDH2
613,prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.41357576834517473,1.2360130034045473,0.208955223880597,1.0,1.0,12/15,49.30%,SHC3;ALK;PTPRD;SHC4;ANGPTL1;DDR2;IGF1R;FLT4;EGFR;PTK2;SHC2;ROR2
614,prerank,negative regulation of cell projection organization (GO:0031345),0.5022006564498381,1.2357686544647,0.20336943441636582,1.0,1.0,5/7,34.40%,DCC;SEMA3A;KANK1;TRPV4;CRMP1
615,prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.7499302002828057,1.2352454747359365,0.16878980891719744,1.0,1.0,1/2,5.30%,HIF3A
616,prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.7499302002828057,1.2352454747359365,0.16878980891719744,1.0,1.0,1/2,5.30%,HIF3A
617,prerank,positive regulation of lamellipodium assembly (GO:0010592),0.92992992992993,1.2351162091557468,0.1286549707602339,1.0,1.0,1/1,7.10%,AUTS2
618,prerank,regulation of Rac protein signal transduction (GO:0035020),0.92992992992993,1.2351162091557468,0.1286549707602339,1.0,1.0,1/1,7.10%,AUTS2
619,prerank,regulation of histone H4-K16 acetylation (GO:2000618),0.92992992992993,1.2351162091557468,0.1286549707602339,1.0,1.0,1/1,7.10%,AUTS2
620,prerank,positive regulation of lamellipodium organization (GO:1902745),0.92992992992993,1.2351162091557468,0.1286549707602339,1.0,1.0,1/1,7.10%,AUTS2
621,prerank,positive regulation of histone H4 acetylation (GO:0090240),0.92992992992993,1.2351162091557468,0.1286549707602339,1.0,1.0,1/1,7.10%,AUTS2
622,prerank,mitotic spindle organization (GO:0007052),-0.5997993981945837,-1.2349787571360027,0.18518518518518517,0.7900763190794412,1.0,3/3,40.30%,AHCTF1;SPAST;XPO1
623,prerank,positive regulation of reproductive process (GO:2000243),-0.7144288577154309,-1.2346104712668915,0.2017291066282421,0.7900661828633343,1.0,2/2,28.80%,AGO2;PLCB1
624,prerank,actin crosslink formation (GO:0051764),0.7665330661322645,1.2343390213018957,0.18363939899833054,1.0,1.0,2/2,23.50%,GAS2;BAIAP2L1
625,prerank,regulation of stem cell population maintenance (GO:2000036),0.7624014481891439,1.2341197132918678,0.1768595041322314,1.0,1.0,1/2,1.50%,HMGA2
626,prerank,insulin secretion (GO:0030073),0.9219219219219219,1.233980561876608,0.1349206349206349,1.0,1.0,1/1,7.90%,PTPRN2
627,prerank,insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.9219219219219219,1.233980561876608,0.1349206349206349,1.0,1.0,1/1,7.90%,PTPRN2
628,prerank,cardiac conduction system development (GO:0003161),-0.721442885771543,-1.233977112255545,0.1980440097799511,0.7889490638234682,1.0,2/2,28.10%,BMPR1A;NOTCH2
629,prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.721442885771543,-1.233977112255545,0.1980440097799511,0.7889490638234682,1.0,2/2,28.10%,BMPR1A;NOTCH2
630,prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.6108324974924775,-1.2331691401439648,0.1974921630094044,0.7914375373924447,1.0,3/3,39.20%,BTRC;CUL5;FBXW4
631,prerank,medium-chain fatty acid metabolic process (GO:0051791),0.7556084260431235,1.2322964965659264,0.16534181240063592,1.0,1.0,1/2,9.70%,GLYATL2
632,prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.4195171026156942,-1.232280885478999,0.19270833333333334,0.7939256216666701,1.0,6/6,58.40%,CCND1;WAC;MDM2;TFDP2;CNOT6;PIDD1
633,prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.722444889779559,-1.2309333012547659,0.21680216802168023,0.798683185857858,1.0,2/2,28.00%,SETD5;DIP2B
634,prerank,regulation of cellular senescence (GO:2000772),0.6519558676028083,1.2300688545657419,0.1855072463768116,1.0,1.0,3/3,35.00%,HMGA2;AKT3;CDK6
635,prerank,negative regulation of cellular senescence (GO:2000773),0.6519558676028083,1.2300688545657419,0.1855072463768116,1.0,1.0,3/3,35.00%,HMGA2;AKT3;CDK6
636,prerank,negative regulation of cell aging (GO:0090344),0.6519558676028083,1.2300688545657419,0.1855072463768116,1.0,1.0,3/3,35.00%,HMGA2;AKT3;CDK6
637,prerank,base-excision repair (GO:0006284),0.5245916131942108,1.2296072310311355,0.20147420147420148,1.0,1.0,2/6,6.00%,HMGA2;POLE
638,prerank,epithelial tube morphogenesis (GO:0060562),0.9029029029029028,1.2285126835081641,0.18076923076923077,1.0,1.0,1/1,9.80%,SLIT2
639,prerank,negative regulation of monocyte chemotaxis (GO:0090027),0.9029029029029028,1.2285126835081641,0.18076923076923077,1.0,1.0,1/1,9.80%,SLIT2
640,prerank,cellular response to heparin (GO:0071504),0.9029029029029028,1.2285126835081641,0.18076923076923077,1.0,1.0,1/1,9.80%,SLIT2
641,prerank,response to heparin (GO:0071503),0.9029029029029028,1.2285126835081641,0.18076923076923077,1.0,1.0,1/1,9.80%,SLIT2
642,prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.9029029029029028,1.2285126835081641,0.18076923076923077,1.0,1.0,1/1,9.80%,SLIT2
643,prerank,regulation of monocyte chemotaxis (GO:0090025),0.9029029029029028,1.2285126835081641,0.18076923076923077,1.0,1.0,1/1,9.80%,SLIT2
644,prerank,response to ketone (GO:1901654),0.9029029029029028,1.2285126835081641,0.18076923076923077,1.0,1.0,1/1,9.80%,SLIT2
645,prerank,response to alcohol (GO:0097305),0.9029029029029028,1.2285126835081641,0.18076923076923077,1.0,1.0,1/1,9.80%,SLIT2
646,prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.9029029029029028,1.2285126835081641,0.18076923076923077,1.0,1.0,1/1,9.80%,SLIT2
647,prerank,regulation of retinal ganglion cell axon guidance (GO:0090259),0.9029029029029028,1.2285126835081641,0.18076923076923077,1.0,1.0,1/1,9.80%,SLIT2
648,prerank,myeloid leukocyte differentiation (GO:0002573),-0.6068204613841525,-1.2282289778562214,0.21311475409836064,0.8096430336477113,1.0,3/3,39.60%,FARP2;FOXP1;EPHA2
649,prerank,osteoclast differentiation (GO:0030316),-0.6068204613841525,-1.2282289778562214,0.21311475409836064,0.8096430336477113,1.0,3/3,39.60%,FARP2;FOXP1;EPHA2
650,prerank,calcium-ion regulated exocytosis (GO:0017156),-0.9179179179179179,-1.2281083859796276,0.1595959595959596,0.8076461873668482,1.0,1/1,8.40%,PPP3CB
651,prerank,maintenance of apical/basal cell polarity (GO:0035090),0.7535070140280562,1.227492778670362,0.18078175895765472,1.0,1.0,2/2,24.80%,ANK1;LIN7A
652,prerank,maintenance of epithelial cell apical/basal polarity (GO:0045199),0.7535070140280562,1.227492778670362,0.18078175895765472,1.0,1.0,2/2,24.80%,ANK1;LIN7A
653,prerank,cardiac muscle tissue development (GO:0048738),0.6005511750792087,1.2273740514457379,0.21052631578947367,1.0,1.0,1/4,0.50%,NRG1
654,prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.7451056641326408,1.2271952650813789,0.1715210355987055,1.0,1.0,1/2,5.20%,OSBPL6
655,prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.4235412474849095,-1.2257027493244494,0.2046783625730994,0.8179119007606156,1.0,6/6,58.00%,INSR;FGFR1;UNC5B;ROR2;PTK2;IGF1R
656,prerank,retinal ganglion cell axon guidance (GO:0031290),0.7494989979959921,1.2252411734481647,0.18314424635332252,1.0,1.0,2/2,25.20%,SLIT2;ROBO2
657,prerank,regulation of lipid catabolic process (GO:0050994),0.9239239239239239,1.2242962620500242,0.17634854771784234,1.0,1.0,1/1,7.70%,ALK
658,prerank,negative regulation of lipid metabolic process (GO:0045833),0.9239239239239239,1.2242962620500242,0.17634854771784234,1.0,1.0,1/1,7.70%,ALK
659,prerank,negative regulation of lipid catabolic process (GO:0050995),0.9239239239239239,1.2242962620500242,0.17634854771784234,1.0,1.0,1/1,7.70%,ALK
660,prerank,neurotransmitter secretion (GO:0007269),0.5969504962439257,1.2242038491615435,0.2002652519893899,1.0,1.0,3/4,24.80%,PTPRN2;PCLO;LIN7A
661,prerank,signal release from synapse (GO:0099643),0.5969504962439257,1.2242038491615435,0.2002652519893899,1.0,1.0,3/4,24.80%,PTPRN2;PCLO;LIN7A
662,prerank,telomere maintenance via telomerase (GO:0007004),-0.7134268537074148,-1.223863135253832,0.19109947643979058,0.8211122345155272,1.0,2/2,28.90%,PPP6R3;RFC1
663,prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.7134268537074148,-1.223863135253832,0.19109947643979058,0.8211122345155272,1.0,2/2,28.90%,PPP6R3;RFC1
664,prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.7134268537074148,-1.223863135253832,0.19109947643979058,0.8211122345155272,1.0,2/2,28.90%,PPP6R3;RFC1
665,prerank,cilium organization (GO:0044782),-0.31648129423660265,-1.2230556901744767,0.16666666666666666,0.8231508313891243,1.0,11/11,68.80%,EXOC4;GBF1;CDC14A;CCDC57;TTBK2;ARL13B;PTPDC1;IFT172;FNBP1L;CDC14B;DZIP1L
666,prerank,neuromuscular synaptic transmission (GO:0007274),0.7528333436852387,1.2229691424067017,0.18760469011725292,1.0,1.0,1/2,7.00%,RIMBP2
667,prerank,cellular response to lipid (GO:0071396),0.45009480908450716,1.222625954184559,0.21158129175946547,1.0,1.0,4/10,20.60%,ADCY8;BRINP1;PDE4B;RORA
668,prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.7364729458917836,1.2206632498192012,0.19047619047619047,1.0,1.0,2/2,26.50%,CHRM3;HTR7
669,prerank,protein catabolic process (GO:0030163),-0.7394789579158316,-1.220658340734833,0.18356164383561643,0.8334232569783276,1.0,2/2,26.30%,ATE1;ADAMTS9
670,prerank,cellular response to alcohol (GO:0097306),0.5986383690972745,1.220453178835734,0.1952191235059761,1.0,1.0,1/4,1.20%,ADCY8
671,prerank,ATP-dependent chromatin remodeling (GO:0043044),0.6073952483397022,1.2196392935589904,0.2002635046113307,1.0,1.0,1/4,1.80%,CECR2
672,prerank,negative regulation of response to stimulus (GO:0048585),0.4965722740466953,1.2191818364042069,0.22300469483568075,1.0,1.0,5/7,36.90%,HMGA2;SLIT2;AKT3;CDK6;UBASH3B
673,prerank,ether lipid biosynthetic process (GO:0008611),-0.6943887775551102,-1.218978362226745,0.1949367088607595,0.8403915108658209,1.0,2/2,30.80%,FAR1;PLA2G4A
674,prerank,potassium ion transmembrane transport (GO:0071805),0.5236030442892419,1.2188779307501558,0.22194513715710723,1.0,1.0,4/6,33.10%,KCNQ5;SLC24A2;SLC9C1;KCNT2
675,prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.5510388846461868,1.2188358817620013,0.21465295629820053,1.0,1.0,1/5,0.50%,NRG1
676,prerank,cation homeostasis (GO:0055080),0.9179179179179179,1.2187318346597347,0.1709741550695825,1.0,1.0,1/1,8.30%,UNC80
677,prerank,maintenance of blood-brain barrier (GO:0035633),0.6018148715623022,1.2175481457059198,0.2131578947368421,1.0,1.0,2/4,13.70%,LAMA2;WNK3
678,prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.551986128815259,1.2169060220725554,0.21262886597938144,1.0,1.0,4/5,38.40%,ELOVL2;ELOVL7;ELOVL6;HSD17B12
679,prerank,regulation of gastrulation (GO:0010470),0.9229229229229229,1.215382851902797,0.17805383022774326,1.0,1.0,1/1,7.80%,TENM4
680,prerank,positive regulation of gastrulation (GO:2000543),0.9229229229229229,1.215382851902797,0.17805383022774326,1.0,1.0,1/1,7.80%,TENM4
681,prerank,myelin assembly (GO:0032288),0.9229229229229229,1.215382851902797,0.17805383022774326,1.0,1.0,1/1,7.80%,TENM4
682,prerank,cAMP biosynthetic process (GO:0006171),0.7374749498997996,1.215322385761258,0.178743961352657,1.0,1.0,2/2,26.40%,ADCY8;ADCY9
683,prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.7374749498997996,1.215322385761258,0.178743961352657,1.0,1.0,2/2,26.40%,ADCY8;ADCY9
684,prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4868051900051809,1.213755005656313,0.21769499417927823,1.0,1.0,3/8,12.20%,ESRRG;EBF2;PPARGC1A
685,prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.914914914914915,-1.2135973946519847,0.19718309859154928,0.8675109446248511,1.0,1/1,8.70%,CHD6
686,prerank,cellular response to calcium ion (GO:0071277),0.5859919221123558,1.213494258264206,0.20341207349081364,1.0,1.0,3/4,32.50%,ADCY8;DPEP1;CPNE5
687,prerank,cation transport (GO:0006812),0.4929200642380674,1.2121719313115535,0.22062350119904076,1.0,1.0,4/7,28.10%,KCNMA1;SCN3A;KCNMB1;SCNN1B
688,prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.6973947895791582,-1.2109999603557418,0.21012658227848102,0.8781246262819389,1.0,2/2,30.50%,BMPR1A;CD200
689,prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.9129129129129128,1.2109411843966857,0.16913319238900634,1.0,1.0,1/1,8.80%,GRIK3
690,prerank,neural tube closure (GO:0001843),-0.9169169169169169,-1.2099077789884929,0.18309859154929578,0.8757704391207676,1.0,1/1,8.50%,PRICKLE1
691,prerank,primary neural tube formation (GO:0014020),-0.9169169169169169,-1.2099077789884929,0.18309859154929578,0.8757704391207676,1.0,1/1,8.50%,PRICKLE1
692,prerank,tube closure (GO:0060606),-0.9169169169169169,-1.2099077789884929,0.18309859154929578,0.8757704391207676,1.0,1/1,8.50%,PRICKLE1
693,prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.5815010773286015,1.2096933415706297,0.21235521235521235,1.0,1.0,1/4,1.50%,HMGA2
694,prerank,rRNA metabolic process (GO:0016072),-0.5857572718154463,-1.2087326339665438,0.21232876712328766,0.877176196059604,1.0,3/3,41.70%,ESF1;NVL;RCL1
695,prerank,rRNA processing (GO:0006364),-0.5857572718154463,-1.2087326339665438,0.21232876712328766,0.877176196059604,1.0,3/3,41.70%,ESF1;NVL;RCL1
696,prerank,substantia nigra development (GO:0021762),-0.9039039039039038,-1.2083342927978757,0.17782026768642448,0.8772581062073271,1.0,1/1,9.80%,BASP1
697,prerank,protein modification process (GO:0036211),0.6480257131160594,1.2080884135577146,0.21428571428571427,1.0,1.0,1/3,4.90%,CHRM3
698,prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5951742175917398,1.2075860041669073,0.20485175202156333,1.0,1.0,3/4,30.30%,SPRED2;PARD3;SPRED3
699,prerank,protein targeting to mitochondrion (GO:0006626),-0.6923847695390781,-1.2062735827612858,0.21354166666666666,0.8856585321023249,1.0,2/2,31.00%,MFF;IMMP1L
700,prerank,negative regulation of microtubule polymerization (GO:0031115),0.8888888888888888,1.2061901808217443,0.17341040462427745,1.0,1.0,1/1,11.20%,MAP2
701,prerank,regulation of microtubule motor activity (GO:2000574),0.8888888888888888,1.2061901808217443,0.17341040462427745,1.0,1.0,1/1,11.20%,MAP2
702,prerank,regulation of microtubule-based movement (GO:0060632),0.8888888888888888,1.2061901808217443,0.17341040462427745,1.0,1.0,1/1,11.20%,MAP2
703,prerank,regulation of synapse assembly (GO:0051963),0.4904601755883812,1.2061460044883903,0.2313167259786477,1.0,1.0,5/7,40.50%,GRID2;PTPRD;ROBO2;DLG5;GPC4
704,prerank,rRNA transcription (GO:0009303),-0.9119119119119119,-1.2060564995309082,0.18700787401574803,0.8816125067250588,1.0,1/1,9.00%,SPIN1
705,prerank,ncRNA transcription (GO:0098781),-0.9119119119119119,-1.2060564995309082,0.18700787401574803,0.8816125067250588,1.0,1/1,9.00%,SPIN1
706,prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.5190763052208834,-1.2054187048699387,0.2231404958677686,0.8823923452471697,1.0,4/4,48.40%,PELI2;PPP5C;SLC44A2;WLS
707,prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.641869175207437,1.2051586651331418,0.21313868613138687,1.0,1.0,2/3,22.10%,HECW2;STK39
708,prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.641869175207437,1.2051586651331418,0.21313868613138687,1.0,1.0,2/3,22.10%,HECW2;STK39
709,prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.641869175207437,1.2051586651331418,0.21313868613138687,1.0,1.0,2/3,22.10%,HECW2;STK39
710,prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.5837512537612839,-1.2049858579620012,0.25084745762711863,0.8819141093463757,1.0,3/3,41.90%,CWC27;PPIL2;FKBP5
711,prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.7174348697394789,-1.2047234459128742,0.23116883116883116,0.877931532083251,1.0,2/2,28.50%,ACACA;FAR1
712,prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.7174348697394789,-1.2047234459128742,0.23116883116883116,0.877931532083251,1.0,2/2,28.50%,ACACA;FAR1
713,prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.5916144002316289,1.2043030589999186,0.2225201072386059,1.0,1.0,3/4,27.80%,SLIT2;SEMA3E;WT1
714,prerank,apoptotic cell clearance (GO:0043277),0.5912312720107784,1.2040333452270973,0.2049934296977661,1.0,1.0,2/4,21.10%,XKR4;ADGRB1
715,prerank,histone H3-K4 dimethylation (GO:0044648),-0.9099099099099099,-1.2033436889472495,0.16532258064516128,0.8677250997941516,1.0,1/1,9.20%,KMT2A
716,prerank,histone H3-K4 trimethylation (GO:0080182),-0.9099099099099099,-1.2033436889472495,0.16532258064516128,0.8677250997941516,1.0,1/1,9.20%,KMT2A
717,prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.9099099099099099,-1.2033436889472495,0.16532258064516128,0.8677250997941516,1.0,1/1,9.20%,KMT2A
718,prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.9099099099099099,-1.2033436889472495,0.16532258064516128,0.8677250997941516,1.0,1/1,9.20%,KMT2A
719,prerank,histone H3-K4 methylation (GO:0051568),-0.9099099099099099,-1.2033436889472495,0.16532258064516128,0.8677250997941516,1.0,1/1,9.20%,KMT2A
720,prerank,histone H3-K4 monomethylation (GO:0097692),-0.9099099099099099,-1.2033436889472495,0.16532258064516128,0.8677250997941516,1.0,1/1,9.20%,KMT2A
721,prerank,embryonic hemopoiesis (GO:0035162),-0.9099099099099099,-1.2033436889472495,0.16532258064516128,0.8677250997941516,1.0,1/1,9.20%,KMT2A
722,prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5939667737244594,1.2033322225567378,0.22418478260869565,1.0,1.0,3/4,29.50%,SEMA6A;ADAMTS3;SMOC2
723,prerank,cellular component assembly (GO:0022607),0.39713363652164085,1.2032460904559417,0.22661122661122662,1.0,1.0,9/17,37.90%,LRRTM3;PPARGC1A;PCLO;WASF3;BAIAP2L1;LIN7A;PARD3;RHOJ;CD2AP
724,prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.5210843373493975,-1.2016909430427272,0.23809523809523808,0.8714671843605425,1.0,4/4,48.20%,AGO2;TNRC6A;CNOT6;TNRC6B
725,prerank,gene silencing by miRNA (GO:0035195),-0.5210843373493975,-1.2016909430427272,0.23809523809523808,0.8714671843605425,1.0,4/4,48.20%,AGO2;TNRC6A;CNOT6;TNRC6B
726,prerank,cellular metal ion homeostasis (GO:0006875),0.49357285823887637,1.2012165974331048,0.2429245283018868,1.0,1.0,4/7,30.10%,KCNMA1;SLC24A2;CLDN16;TRPV4
727,prerank,positive regulation of cellular component biogenesis (GO:0044089),0.5400089454244253,1.2010642784795678,0.2135678391959799,1.0,1.0,1/5,0.50%,NRG1
728,prerank,negative regulation of cell motility (GO:2000146),0.4219672987724589,1.2005067831374865,0.2348401323042999,1.0,1.0,6/12,28.00%,TMEFF2;SLIT2;MAGI2;LIMCH1;KANK1;DPEP1
729,prerank,mitochondrial gene expression (GO:0140053),-0.9059059059059059,-1.2003154178590039,0.22478991596638656,0.8763269482255436,1.0,1/1,9.60%,MRPS21
730,prerank,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.8998998998998999,1.199843633597191,0.1992110453648915,1.0,1.0,1/1,10.10%,PTPRD
731,prerank,cellular potassium ion homeostasis (GO:0030007),0.7268986956245792,1.1986113130828342,0.2115702479338843,1.0,1.0,1/2,6.30%,KCNMA1
732,prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.7268986956245792,1.1986113130828342,0.2115702479338843,1.0,1.0,1/2,6.30%,KCNMA1
733,prerank,potassium ion homeostasis (GO:0055075),0.7268986956245792,1.1986113130828342,0.2115702479338843,1.0,1.0,1/2,6.30%,KCNMA1
734,prerank,mRNA export from nucleus (GO:0006406),-0.41348088531187127,-1.1984581019062726,0.18857142857142858,0.8782971636628247,1.0,6/6,59.00%,THOC2;NUP58;UPF2;SMG6;SRSF1;NUP93
735,prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.41348088531187127,-1.1984581019062726,0.18857142857142858,0.8782971636628247,1.0,6/6,59.00%,THOC2;NUP58;UPF2;SMG6;SRSF1;NUP93
736,prerank,RNA export from nucleus (GO:0006405),-0.41348088531187127,-1.1984581019062726,0.18857142857142858,0.8782971636628247,1.0,6/6,59.00%,THOC2;NUP58;UPF2;SMG6;SRSF1;NUP93
737,prerank,protein localization to chromosome (GO:0034502),-0.9009009009009009,-1.1982051577061519,0.1748971193415638,0.8725028283332037,1.0,1/1,10.10%,TNKS2
738,prerank,protein auto-ADP-ribosylation (GO:0070213),-0.9009009009009009,-1.1982051577061519,0.1748971193415638,0.8725028283332037,1.0,1/1,10.10%,TNKS2
739,prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.9009009009009009,-1.1982051577061519,0.1748971193415638,0.8725028283332037,1.0,1/1,10.10%,TNKS2
740,prerank,negative regulation of DNA recombination (GO:0045910),-0.6793587174348696,-1.1981991765971938,0.2011173184357542,0.8702000841037969,1.0,2/2,32.30%,TP53BP1;ZRANB3
741,prerank,development of primary male sexual characteristics (GO:0046546),0.7234468937875753,1.1974235367665653,0.22673434856175972,1.0,1.0,2/2,27.80%,MAMLD1;WT1
742,prerank,male gonad development (GO:0008584),0.7234468937875753,1.1974235367665653,0.22673434856175972,1.0,1.0,2/2,27.80%,MAMLD1;WT1
743,prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4336780343990863,1.1973228586217863,0.2480270574971815,1.0,1.0,5/10,30.30%,WNK2;SEMA6A;LMO3;SPRED2;SPRED3
744,prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5474820470114913,1.1968183036281856,0.2462686567164179,1.0,1.0,3/5,28.30%,LRRC7;DLG2;PARD3
745,prerank,embryonic eye morphogenesis (GO:0048048),0.8988988988988988,1.19628588674188,0.18962075848303392,1.0,1.0,1/1,10.20%,FBN2
746,prerank,maintenance of protein location in extracellular region (GO:0071694),0.8988988988988988,1.19628588674188,0.18962075848303392,1.0,1.0,1/1,10.20%,FBN2
747,prerank,regulation of stress fiber assembly (GO:0051492),0.5836027803839956,1.194869975997774,0.25648021828103684,1.0,1.0,2/4,20.80%,TMEFF2;LIMCH1
748,prerank,negative regulation of endothelial cell migration (GO:0010596),0.6400645909120732,1.1944819148773786,0.22320117474302498,1.0,1.0,2/3,21.10%,SLIT2;ADGRB1
749,prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.7334669338677355,1.194421063882303,0.22762951334379905,1.0,1.0,2/2,26.80%,KIF5C;MYO10
750,prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.3816717019133938,-1.1943575163854072,0.18497109826589594,0.8882616147626152,1.0,7/7,62.20%,INSR;FGFR1;PTK2;EGFR;FLT4;IGF1R;DDR2
751,prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.7311720089283882,1.194050964900099,0.22919937205651492,1.0,1.0,1/2,4.90%,CHRM3
752,prerank,acetylcholine receptor signaling pathway (GO:0095500),0.7311720089283882,1.194050964900099,0.22919937205651492,1.0,1.0,1/2,4.90%,CHRM3
753,prerank,medium-chain fatty acid catabolic process (GO:0051793),0.9039039039039038,1.193382088478601,0.2109704641350211,1.0,1.0,1/1,9.70%,GLYATL2
754,prerank,organic acid catabolic process (GO:0016054),0.9039039039039038,1.193382088478601,0.2109704641350211,1.0,1.0,1/1,9.70%,GLYATL2
755,prerank,long-chain fatty acid catabolic process (GO:0042758),0.9039039039039038,1.193382088478601,0.2109704641350211,1.0,1.0,1/1,9.70%,GLYATL2
756,prerank,engulfment of apoptotic cell (GO:0043652),0.6431020395087949,1.1929150578100163,0.21617852161785217,1.0,1.0,2/3,21.10%,XKR4;ADGRB1
757,prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.6282075131675582,1.1919286479673301,0.24964539007092199,1.0,1.0,2/3,17.50%,CACNB2;CALCR
758,prerank,artery morphogenesis (GO:0048844),-0.5827482447342026,-1.1914695287999943,0.2435064935064935,0.9004897450016189,1.0,3/3,42.00%,BMPR1A;ADAMTS9;NF1
759,prerank,regulation of receptor binding (GO:1900120),0.8978978978978979,1.1911987629211516,0.20267686424474188,1.0,1.0,1/1,10.30%,GREM2
760,prerank,sequestering of BMP from receptor via BMP binding (GO:0038098),0.8978978978978979,1.1911987629211516,0.20267686424474188,1.0,1.0,1/1,10.30%,GREM2
761,prerank,positive regulation of translation (GO:0045727),-0.4024144869215292,-1.1904554195589077,0.17613636363636365,0.9034272237581559,1.0,6/6,60.10%,AGO2;UPF3A;PLD1;SAMD4A;UHMK1;CPEB3
762,prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.6258776328986961,1.1881456569341788,0.21861152141802068,1.0,1.0,3/3,37.60%,MEIS1;CDK6;MEIS2
763,prerank,lymphocyte differentiation (GO:0030098),-0.4462311557788945,-1.1880213930797867,0.21428571428571427,0.9124591016203483,1.0,5/5,55.70%,HDAC5;CHD7;TPD52;PBX1;TOX
764,prerank,cellular calcium ion homeostasis (GO:0006874),0.4201857856208565,1.187988479615626,0.2560706401766004,1.0,1.0,6/12,30.10%,ADCY8;SLC24A2;HCRTR1;HCRTR2;BCL2;TRPV4
765,prerank,kinetochore organization (GO:0051383),-0.8918918918918919,-1.1874301567341239,0.23151750972762647,0.9056885814599958,1.0,1/1,11.00%,POGZ
766,prerank,mitotic sister chromatid cohesion (GO:0007064),-0.8918918918918919,-1.1874301567341239,0.23151750972762647,0.9056885814599958,1.0,1/1,11.00%,POGZ
767,prerank,kinetochore assembly (GO:0051382),-0.8918918918918919,-1.1874301567341239,0.23151750972762647,0.9056885814599958,1.0,1/1,11.00%,POGZ
768,prerank,centromere complex assembly (GO:0034508),-0.8918918918918919,-1.1874301567341239,0.23151750972762647,0.9056885814599958,1.0,1/1,11.00%,POGZ
769,prerank,protein localization to cell surface (GO:0034394),-0.8848848848848849,-1.1873616168399839,0.208984375,0.9036401721260562,1.0,1/1,11.70%,GGA2
770,prerank,regulation of NMDA receptor activity (GO:2000310),0.6431288975173445,1.1868292292332179,0.2446351931330472,1.0,1.0,2/3,22.80%,LRRC7;DLG2
771,prerank,endodermal cell differentiation (GO:0035987),0.5433225540958996,1.1867609584337764,0.25725593667546176,1.0,1.0,3/5,23.70%,HMGA2;COL8A1;LAMA3
772,prerank,endoderm formation (GO:0001706),0.5433225540958996,1.1867609584337764,0.25725593667546176,1.0,1.0,3/5,23.70%,HMGA2;COL8A1;LAMA3
773,prerank,histone-serine phosphorylation (GO:0035404),0.710957825689124,1.1867150195892169,0.23390894819466249,1.0,1.0,1/2,1.50%,HMGA2
774,prerank,regulation of chromosome separation (GO:1905818),-0.8998998998998999,-1.1854610894273279,0.22444889779559118,0.9013921281624722,1.0,1/1,10.20%,CSNK2A1
775,prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.8998998998998999,-1.1854610894273279,0.22444889779559118,0.9013921281624722,1.0,1/1,10.20%,CSNK2A1
776,prerank,mitotic chromosome condensation (GO:0007076),-0.8998998998998999,-1.1854610894273279,0.22444889779559118,0.9013921281624722,1.0,1/1,10.20%,CSNK2A1
777,prerank,regulation of chromosome segregation (GO:0051983),-0.8998998998998999,-1.1854610894273279,0.22444889779559118,0.9013921281624722,1.0,1/1,10.20%,CSNK2A1
778,prerank,chromosome condensation (GO:0030261),-0.8998998998998999,-1.1854610894273279,0.22444889779559118,0.9013921281624722,1.0,1/1,10.20%,CSNK2A1
779,prerank,regulation of tumor necrosis factor production (GO:0032680),-0.5867602808425276,-1.1853419255554485,0.25949367088607594,0.8996630727026548,1.0,3/3,41.60%,GAS6;FOXP1;BPI
780,prerank,blood vessel diameter maintenance (GO:0097746),-0.5070281124497992,-1.1853034944976448,0.2490842490842491,0.8975012569074906,1.0,4/4,49.60%,PER2;ITGB1BP1;GCLM;ECE1
781,prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.5767301905717152,-1.1852588693917105,0.2334384858044164,0.895334961881697,1.0,3/3,42.60%,MNAT1;CHD1L;DDB2
782,prerank,regulation of blood circulation (GO:1903522),-0.5070281124497992,-1.1847594646984756,0.24444444444444444,0.8951587757775077,1.0,4/4,49.60%,CAMK2D;PER2;CELF2;ECE1
783,prerank,protein targeting to peroxisome (GO:0006625),-0.6863727454909819,-1.1840502848163423,0.24431818181818182,0.8917749195426972,1.0,2/2,31.60%,ATAD1;ABCD3
784,prerank,peroxisomal membrane transport (GO:0015919),-0.6863727454909819,-1.1840502848163423,0.24431818181818182,0.8917749195426972,1.0,2/2,31.60%,ATAD1;ABCD3
785,prerank,protein import into peroxisome membrane (GO:0045046),-0.6863727454909819,-1.1840502848163423,0.24431818181818182,0.8917749195426972,1.0,2/2,31.60%,ATAD1;ABCD3
786,prerank,mitochondrial protein processing (GO:0034982),-0.6923847695390781,-1.1834555151824233,0.2531017369727047,0.8920908094351436,1.0,2/2,31.00%,YME1L1;IMMP1L
787,prerank,positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.8898898898898899,-1.183171489130971,0.23868312757201646,0.8847362126624063,1.0,1/1,11.20%,MICU1
788,prerank,regulation of cellular response to osmotic stress (GO:0106049),-0.8898898898898899,-1.183171489130971,0.23868312757201646,0.8847362126624063,1.0,1/1,11.20%,MICU1
789,prerank,calcium import into the mitochondrion (GO:0036444),-0.8898898898898899,-1.183171489130971,0.23868312757201646,0.8847362126624063,1.0,1/1,11.20%,MICU1
790,prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.8898898898898899,-1.183171489130971,0.23868312757201646,0.8847362126624063,1.0,1/1,11.20%,MICU1
791,prerank,cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.8778778778778779,1.1823124971913908,0.23137254901960785,1.0,1.0,1/1,12.30%,SH3GL2
792,prerank,regulation of blood-brain barrier permeability (GO:1905603),0.8778778778778779,1.1823124971913908,0.23137254901960785,1.0,1.0,1/1,12.30%,SH3GL2
793,prerank,negative regulation of macrophage migration (GO:1905522),-0.6973947895791582,-1.1820487872680516,0.24296675191815856,0.8832166587422557,1.0,2/2,30.50%,EMILIN1;CD200
794,prerank,negative regulation of cell activation (GO:0050866),-0.6973947895791582,-1.1820487872680516,0.24296675191815856,0.8832166587422557,1.0,2/2,30.50%,EMILIN1;CD200
795,prerank,regulation of macrophage migration (GO:1905521),-0.6973947895791582,-1.1820487872680516,0.24296675191815856,0.8832166587422557,1.0,2/2,30.50%,EMILIN1;CD200
796,prerank,cellular response to hypoxia (GO:0071456),0.505269862946657,1.1819716880146398,0.242274412855377,1.0,1.0,3/6,20.60%,HIF3A;FMN2;RORA
797,prerank,positive regulation of cell cycle (GO:0045787),-0.2975708502024291,-1.1817397466112531,0.23404255319148937,0.882525737666696,1.0,12/12,70.70%,CCND1;USP22;PKN2;MDM2;CCDC57;CCNY;TBX3;CCND2;EGFR;PRKCA;MEIS2;SMOC2
798,prerank,"regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.8878878878878879,-1.18173792954047,0.2459349593495935,0.8716751100789024,1.0,1/1,11.40%,SH3RF1
799,prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.8878878878878879,-1.18173792954047,0.2459349593495935,0.8716751100789024,1.0,1/1,11.40%,SH3RF1
800,prerank,"regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.8878878878878879,-1.18173792954047,0.2459349593495935,0.8716751100789024,1.0,1/1,11.40%,SH3RF1
801,prerank,regulation of alpha-beta T cell proliferation (GO:0046640),-0.8878878878878879,-1.18173792954047,0.2459349593495935,0.8716751100789024,1.0,1/1,11.40%,SH3RF1
802,prerank,"regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",-0.8878878878878879,-1.18173792954047,0.2459349593495935,0.8716751100789024,1.0,1/1,11.40%,SH3RF1
803,prerank,pre-replicative complex assembly (GO:0036388),-0.7014028056112224,-1.1814218500453235,0.2608695652173913,0.8711091133250833,1.0,2/2,30.10%,ORC3;ORC4
804,prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.6278836509528586,1.1810030128078608,0.23941605839416058,1.0,1.0,3/3,37.40%,DCC;BCL2;CASP9
805,prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.6278836509528586,1.1810030128078608,0.23941605839416058,1.0,1.0,3/3,37.40%,DCC;BCL2;CASP9
806,prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.5210843373493975,-1.1806902810999291,0.21370967741935484,0.8701573404242574,1.0,4/4,48.20%,CCND1;TNRC6A;PTEN;TNRC6B
807,prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.5210843373493975,-1.1806902810999291,0.21370967741935484,0.8701573404242574,1.0,4/4,48.20%,CCND1;TNRC6A;PTEN;TNRC6B
808,prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.41348088531187127,-1.1802748807300447,0.20224719101123595,0.8678963277636979,1.0,6/6,59.00%,PPP2R2A;AHCTF1;REEP3;SPAST;VRK1;NUP93
809,prerank,mitotic nuclear membrane organization (GO:0101024),-0.41348088531187127,-1.1802748807300447,0.20224719101123595,0.8678963277636979,1.0,6/6,59.00%,PPP2R2A;AHCTF1;REEP3;SPAST;VRK1;NUP93
810,prerank,actin cytoskeleton reorganization (GO:0031532),0.5375176412620961,1.1793297989000384,0.24097938144329897,1.0,1.0,3/5,30.10%,AUTS2;CDC42BPA;TRPV4
811,prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.8828828828828829,-1.1781162004098837,0.23492723492723494,0.8752705543690324,1.0,1/1,11.90%,ZC3HAV1
812,prerank,protein deacetylation (GO:0006476),-0.44020100502512566,-1.177735437597893,0.19724770642201836,0.875161994942465,1.0,5/5,56.30%,RCOR3;HDAC5;MTA3;PRDM5;TBL1X
813,prerank,regulation of histone methylation (GO:0031060),0.8858858858858859,1.176824880322894,0.22549019607843138,1.0,1.0,1/1,11.50%,TET1
814,prerank,negative regulation of heterochromatin assembly (GO:0031452),0.8858858858858859,1.176824880322894,0.22549019607843138,1.0,1.0,1/1,11.50%,TET1
815,prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.8858858858858859,1.176824880322894,0.22549019607843138,1.0,1.0,1/1,11.50%,TET1
816,prerank,regulation of cardiac muscle cell apoptotic process (GO:0010665),-0.5757271815446339,-1.1767369671493408,0.25901639344262295,0.8771857595702208,1.0,3/3,42.70%,CAMK2D;BMPR1A;HAND2
817,prerank,ERBB2 signaling pathway (GO:0038128),0.5327084262056505,1.1758455193192001,0.26515151515151514,1.0,1.0,2/5,12.50%,NRG1;NRG2
818,prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.40650830468371346,1.1747862508919646,0.272234273318872,1.0,1.0,5/13,20.10%,ADCY8;ALK;PPARGC1A;CAMK1D;LRP8
819,prerank,protein import (GO:0017038),-0.41348088531187127,-1.174261606174327,0.22699386503067484,0.8856177354742378,1.0,6/6,59.00%,TNPO1;PRICKLE1;ATAD1;ABCD3;IPO8;NUP93
820,prerank,negative regulation of interleukin-6 production (GO:0032715),-0.5867602808425276,-1.1739751555420035,0.26557377049180325,0.8828732059417375,1.0,3/3,41.60%,GAS6;CD200;BPI
821,prerank,regulation of interleukin-6 production (GO:0032675),-0.5867602808425276,-1.1739751555420035,0.26557377049180325,0.8828732059417375,1.0,3/3,41.60%,GAS6;CD200;BPI
822,prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.8788788788788788,-1.1737247545834661,0.24151696606786427,0.8758123608436267,1.0,1/1,12.30%,FAF1
823,prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.8788788788788788,-1.1737247545834661,0.24151696606786427,0.8758123608436267,1.0,1/1,12.30%,FAF1
824,prerank,cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.8788788788788788,-1.1737247545834661,0.24151696606786427,0.8758123608436267,1.0,1/1,12.30%,FAF1
825,prerank,regulation of cellular protein catabolic process (GO:1903362),-0.8788788788788788,-1.1737247545834661,0.24151696606786427,0.8758123608436267,1.0,1/1,12.30%,FAF1
826,prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.43760065376971274,-1.1716906363298547,0.2318840579710145,0.8779845490399462,1.0,4/5,11.40%,GAS6;MAP2K5;CSNK2A1;SH3RF1
827,prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.43760065376971274,-1.1716906363298547,0.2318840579710145,0.8779845490399462,1.0,4/5,11.40%,GAS6;MAP2K5;CSNK2A1;SH3RF1
828,prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.43760065376971274,-1.1716906363298547,0.2318840579710145,0.8779845490399462,1.0,4/5,11.40%,GAS6;MAP2K5;CSNK2A1;SH3RF1
829,prerank,regulation of interferon-gamma production (GO:0032649),0.7283841210275553,1.1716264259802727,0.2544,1.0,1.0,1/2,12.80%,PDE4B
830,prerank,protein localization to nucleus (GO:0034504),-0.41348088531187127,-1.1712497434438167,0.2542372881355932,0.8776359110378783,1.0,6/6,59.00%,TNPO1;PRICKLE1;MDM2;IPO8;WRN;NUP93
831,prerank,negative regulation of cytoskeleton organization (GO:0051494),0.5635171231424216,1.1708719151243396,0.2556894243641232,1.0,1.0,3/4,36.60%,SLIT2;KANK1;PLEKHH2
832,prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.6753507014028055,-1.170618599873926,0.2436548223350254,0.8787260433562833,1.0,2/2,32.70%,SH3RF1;FGFR1
833,prerank,response to insulin (GO:0032868),-0.41851106639839036,-1.1704578283872047,0.24299065420560748,0.8772984269655301,1.0,6/6,58.50%,INSR;HDAC5;KAT2B;LPIN1;GOT1;IRS1
834,prerank,coronary vasculature morphogenesis (GO:0060977),-0.8858858858858859,-1.1704351535836186,0.25806451612903225,0.87532514207683,1.0,1/1,11.60%,SPRED1
835,prerank,spermidine metabolic process (GO:0008216),-0.8808808808808809,-1.1699301770630743,0.24609375,0.8696140397578257,1.0,1/1,12.10%,SAT2
836,prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.8808808808808809,-1.1699301770630743,0.24609375,0.8696140397578257,1.0,1/1,12.10%,SAT2
837,prerank,polyamine biosynthetic process (GO:0006596),-0.8808808808808809,-1.1699301770630743,0.24609375,0.8696140397578257,1.0,1/1,12.10%,SAT2
838,prerank,polyamine metabolic process (GO:0006595),-0.8808808808808809,-1.1699301770630743,0.24609375,0.8696140397578257,1.0,1/1,12.10%,SAT2
839,prerank,macromolecule modification (GO:0043412),-0.8938938938938938,-1.1692961898710408,0.24950884086444008,0.8650782354784613,1.0,1/1,10.80%,SETD5
840,prerank,covalent chromatin modification (GO:0016569),-0.8938938938938938,-1.1692961898710408,0.24950884086444008,0.8650782354784613,1.0,1/1,10.80%,SETD5
841,prerank,regulation of cell junction assembly (GO:1901888),-0.8938938938938938,-1.1692961898710408,0.24950884086444008,0.8650782354784613,1.0,1/1,10.80%,SETD5
842,prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.8938938938938938,-1.1692961898710408,0.24950884086444008,0.8650782354784613,1.0,1/1,10.80%,SETD5
843,prerank,cardiac muscle cell differentiation (GO:0055007),0.7234468937875753,1.1690589255927326,0.22523961661341854,1.0,1.0,2/2,27.80%,NRG1;WT1
844,prerank,negative regulation of DNA metabolic process (GO:0051053),-0.6793587174348696,-1.1689273882026219,0.2810810810810811,0.8643026435045069,1.0,2/2,32.30%,KMT2A;ZRANB3
845,prerank,peroxisome organization (GO:0007031),-0.6863727454909819,-1.1688974050982857,0.23743016759776536,0.8624566705108544,1.0,2/2,31.60%,MFF;ABCD3
846,prerank,negative regulation of cell migration (GO:0030336),0.387165786894088,1.168628731189762,0.2724358974358974,1.0,1.0,7/16,28.00%,TMEFF2;SLIT2;MCC;MAGI2;LIMCH1;KANK1;DPEP1
847,prerank,negative regulation of hippo signaling (GO:0035331),0.7063336471318179,1.1685016982107954,0.24121405750798722,1.0,1.0,1/2,0.80%,SHANK2
848,prerank,neuron maturation (GO:0042551),-0.8688688688688688,-1.1680547834174175,0.24517374517374518,0.8605372006139003,1.0,1/1,13.30%,FARP2
849,prerank,regulation of integrin activation (GO:0033623),-0.8688688688688688,-1.1680547834174175,0.24517374517374518,0.8605372006139003,1.0,1/1,13.30%,FARP2
850,prerank,neuron remodeling (GO:0016322),-0.8688688688688688,-1.1680547834174175,0.24517374517374518,0.8605372006139003,1.0,1/1,13.30%,FARP2
851,prerank,cellular response to chemical stress (GO:0062197),0.569050383555088,1.1674965114004126,0.26649076517150394,1.0,1.0,3/4,30.10%,PPARGC1A;ETV5;TRPV4
852,prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.2948328267477204,-1.1671382090160252,0.25806451612903225,0.8601139581457347,1.0,13/13,71.00%,BTRC;PPP2R2A;CSNK1E;MNAT1;PLCB1;CCDC57;OPTN;CCNY;ENSA;CEP70;NINL;PRKAR2B;CDK14
853,prerank,cell cycle G2/M phase transition (GO:0044839),-0.2948328267477204,-1.1671382090160252,0.25806451612903225,0.8601139581457347,1.0,13/13,71.00%,BTRC;PPP2R2A;CSNK1E;MNAT1;PLCB1;CCDC57;OPTN;CCNY;ENSA;CEP70;NINL;PRKAR2B;CDK14
854,prerank,monoacylglycerol metabolic process (GO:0046462),-0.6943887775551102,-1.1669338434389018,0.2693333333333333,0.8552308787235481,1.0,2/2,30.80%,MGLL;PLA2G4A
855,prerank,glycerolipid catabolic process (GO:0046503),-0.6943887775551102,-1.1669338434389018,0.2693333333333333,0.8552308787235481,1.0,2/2,30.80%,MGLL;PLA2G4A
856,prerank,arachidonic acid metabolic process (GO:0019369),-0.6943887775551102,-1.1669338434389018,0.2693333333333333,0.8552308787235481,1.0,2/2,30.80%,MGLL;PLA2G4A
857,prerank,negative regulation of axonogenesis (GO:0050771),0.4953756092062166,1.1656778530275291,0.2668269230769231,1.0,1.0,2/6,11.20%,DCC;MAP2
858,prerank,negative regulation of developmental growth (GO:0048640),0.4953756092062166,1.1656778530275291,0.2668269230769231,1.0,1.0,2/6,11.20%,DCC;MAP2
859,prerank,mitochondrial fission (GO:0000266),-0.8678678678678678,-1.1656377601260413,0.2578125,0.8414473689485497,1.0,1/1,13.40%,MFF
860,prerank,mitochondrion morphogenesis (GO:0070584),-0.8678678678678678,-1.1656377601260413,0.2578125,0.8414473689485497,1.0,1/1,13.40%,MFF
861,prerank,regulation of mitochondrial fission (GO:0090140),-0.8678678678678678,-1.1656377601260413,0.2578125,0.8414473689485497,1.0,1/1,13.40%,MFF
862,prerank,positive regulation of mitochondrial fission (GO:0090141),-0.8678678678678678,-1.1656377601260413,0.2578125,0.8414473689485497,1.0,1/1,13.40%,MFF
863,prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.8678678678678678,-1.1656377601260413,0.2578125,0.8414473689485497,1.0,1/1,13.40%,MFF
864,prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.8678678678678678,-1.1656377601260413,0.2578125,0.8414473689485497,1.0,1/1,13.40%,MFF
865,prerank,cell part morphogenesis (GO:0032990),-0.8678678678678678,-1.1656377601260413,0.2578125,0.8414473689485497,1.0,1/1,13.40%,MFF
866,prerank,mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.8678678678678678,-1.1656377601260413,0.2578125,0.8414473689485497,1.0,1/1,13.40%,MFF
867,prerank,peroxisome fission (GO:0016559),-0.8678678678678678,-1.1656377601260413,0.2578125,0.8414473689485497,1.0,1/1,13.40%,MFF
868,prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.8678678678678678,-1.1656377601260413,0.2578125,0.8414473689485497,1.0,1/1,13.40%,MFF
869,prerank,aminophospholipid transport (GO:0015917),-0.8768768768768769,-1.164893617021276,0.23742454728370221,0.840697833820933,1.0,1/1,12.50%,ATP8A1
870,prerank,lipid translocation (GO:0034204),-0.8768768768768769,-1.164893617021276,0.23742454728370221,0.840697833820933,1.0,1/1,12.50%,ATP8A1
871,prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.5697091273821464,-1.163950762839137,0.2705479452054795,0.8427884424686111,1.0,3/3,43.30%,PLA2G4A;LPCAT1;MBOAT2
872,prerank,regulation of myelination (GO:0031641),0.7184368737474949,1.1635156268693052,0.27001569858712715,1.0,1.0,2/2,28.30%,TENM4;PARD3
873,prerank,positive regulation of nervous system process (GO:0031646),0.7184368737474949,1.1635156268693052,0.27001569858712715,1.0,1.0,2/2,28.30%,TENM4;PARD3
874,prerank,positive regulation of myelination (GO:0031643),0.7184368737474949,1.1635156268693052,0.27001569858712715,1.0,1.0,2/2,28.30%,TENM4;PARD3
875,prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.4084507042253521,-1.163039149425837,0.27218934911242604,0.8448040748496207,1.0,6/6,59.50%,CCND1;PLCB1;CDK10;CCND2;EGFR;MTBP
876,prerank,cellular response to hexose stimulus (GO:0071331),0.5711407917365937,1.1630209391967417,0.27466666666666667,1.0,1.0,1/4,1.20%,ADCY8
877,prerank,response to glucose (GO:0009749),0.5711407917365937,1.1630209391967417,0.27466666666666667,1.0,1.0,1/4,1.20%,ADCY8
878,prerank,calcineurin-mediated signaling (GO:0097720),-0.6773547094188376,-1.162845824282756,0.28150134048257375,0.8402073430384712,1.0,2/2,32.50%,PPP3CB;PPP3CA
879,prerank,inositol phosphate-mediated signaling (GO:0048016),-0.6773547094188376,-1.162845824282756,0.28150134048257375,0.8402073430384712,1.0,2/2,32.50%,PPP3CB;PPP3CA
880,prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.6773547094188376,-1.162845824282756,0.28150134048257375,0.8402073430384712,1.0,2/2,32.50%,PPP3CB;PPP3CA
881,prerank,response to amyloid-beta (GO:1904645),0.6224886673273237,1.1626886032708752,0.2655367231638418,1.0,1.0,2/3,17.50%,CACNA1A;CALCR
882,prerank,brain development (GO:0007420),0.3955496276778735,1.1608023776577774,0.29354838709677417,1.0,1.0,8/13,37.60%,CNTNAP2;ADGRL3;CDH2;ROBO2;MEIS1;ZIC1;ATXN1;MEIS2
883,prerank,gene expression (GO:0010467),-0.26497461928934013,-1.1601063852774223,0.26785714285714285,0.8504648298124333,1.0,15/15,74.00%,THOC2;AGO2;NUP58;MRPS21;UPF2;SMG6;TESC;CELF2;SRSF1;PPP5C;NUP93;ATXN1;NOVA1;DTX1;DHX8
884,prerank,regulation of cellular amide metabolic process (GO:0034248),-0.8708708708708709,-1.1598364036476567,0.25748502994011974,0.8478189580993882,1.0,1/1,13.10%,PUM3
885,prerank,regulation of cellular protein metabolic process (GO:0032268),-0.8708708708708709,-1.1598364036476567,0.25748502994011974,0.8478189580993882,1.0,1/1,13.10%,PUM3
886,prerank,cellular zinc ion homeostasis (GO:0006882),-0.8658658658658659,-1.159635372517311,0.25680933852140075,0.8414520978353452,1.0,1/1,13.60%,SLC39A10
887,prerank,zinc ion homeostasis (GO:0055069),-0.8658658658658659,-1.159635372517311,0.25680933852140075,0.8414520978353452,1.0,1/1,13.60%,SLC39A10
888,prerank,zinc ion import across plasma membrane (GO:0071578),-0.8658658658658659,-1.159635372517311,0.25680933852140075,0.8414520978353452,1.0,1/1,13.60%,SLC39A10
889,prerank,zinc ion transmembrane transport (GO:0071577),-0.8658658658658659,-1.159635372517311,0.25680933852140075,0.8414520978353452,1.0,1/1,13.60%,SLC39A10
890,prerank,actomyosin structure organization (GO:0031032),0.5203560785211261,1.1595041972301092,0.28294573643410853,1.0,1.0,3/5,21.60%,EPB41L5;CDC42BPA;OBSCN
891,prerank,regulation of ion transport (GO:0043269),0.8678678678678677,1.1594208955067946,0.248046875,1.0,1.0,1/1,13.30%,SPTBN4
892,prerank,regulation of actin filament-based movement (GO:1903115),0.8728728728728729,1.1589798797427509,0.2648752399232246,1.0,1.0,1/1,12.80%,PDE4B
893,prerank,regulation of cardiac muscle contraction (GO:0055117),0.8728728728728729,1.1589798797427509,0.2648752399232246,1.0,1.0,1/1,12.80%,PDE4B
894,prerank,cellular response to epinephrine stimulus (GO:0071872),0.8728728728728729,1.1589798797427509,0.2648752399232246,1.0,1.0,1/1,12.80%,PDE4B
895,prerank,positive regulation of interferon-gamma production (GO:0032729),0.8728728728728729,1.1589798797427509,0.2648752399232246,1.0,1.0,1/1,12.80%,PDE4B
896,prerank,negative regulation of relaxation of muscle (GO:1901078),0.8728728728728729,1.1589798797427509,0.2648752399232246,1.0,1.0,1/1,12.80%,PDE4B
897,prerank,positive regulation of interleukin-2 production (GO:0032743),0.8728728728728729,1.1589798797427509,0.2648752399232246,1.0,1.0,1/1,12.80%,PDE4B
898,prerank,cellular response to catecholamine stimulus (GO:0071870),0.8728728728728729,1.1589798797427509,0.2648752399232246,1.0,1.0,1/1,12.80%,PDE4B
899,prerank,regulation of interleukin-2 production (GO:0032663),0.8728728728728729,1.1589798797427509,0.2648752399232246,1.0,1.0,1/1,12.80%,PDE4B
900,prerank,response to epinephrine (GO:0071871),0.8728728728728729,1.1589798797427509,0.2648752399232246,1.0,1.0,1/1,12.80%,PDE4B
901,prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.8588588588588587,1.158920717936527,0.266,1.0,1.0,1/1,14.20%,HECW2
902,prerank,regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.8588588588588587,1.158920717936527,0.266,1.0,1.0,1/1,14.20%,HECW2
903,prerank,regulation of transmembrane transporter activity (GO:0022898),0.7034068136272544,1.1576660845116677,0.27488151658767773,1.0,1.0,2/2,29.80%,CHRM3;BCL2
904,prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.5292165375539712,1.157397534012092,0.2779874213836478,1.0,1.0,4/5,40.90%,AUTS2;TENM2;EPS8L2;FNBP1L
905,prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.8748748748748749,-1.156781277710972,0.2504970178926441,0.8489406095465117,1.0,1/1,12.70%,EMC2
906,prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.8748748748748749,-1.156781277710972,0.2504970178926441,0.8489406095465117,1.0,1/1,12.70%,EMC2
907,prerank,protein insertion into ER membrane (GO:0045048),-0.8748748748748749,-1.156781277710972,0.2504970178926441,0.8489406095465117,1.0,1/1,12.70%,EMC2
908,prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.8698698698698697,1.1566186315549947,0.2624254473161034,1.0,1.0,1/1,13.10%,BACH2
909,prerank,L-amino acid transport (GO:0015807),-0.48594377510040154,-1.156572392245073,0.268,0.8478861918240235,1.0,4/4,51.70%,SLC7A1;SLC1A3;SLC25A12;SFXN1
910,prerank,regulation of phagocytosis (GO:0050764),0.7090281351809009,1.1554755247364135,0.26357827476038337,1.0,1.0,1/2,14.40%,CAMK1D
911,prerank,positive regulation of phagocytosis (GO:0050766),0.7090281351809009,1.1554755247364135,0.26357827476038337,1.0,1.0,1/2,14.40%,CAMK1D
912,prerank,sodium ion transport (GO:0006814),0.47465229682411747,1.1552708695883709,0.26516052318668254,1.0,1.0,3/7,13.60%,ASIC2;SLC24A2;SCN3A
913,prerank,amide biosynthetic process (GO:0043604),-0.6653306613226453,-1.154258937344116,0.28388746803069054,0.8538795364698278,1.0,2/2,33.70%,SGMS1;CERS6
914,prerank,ceramide biosynthetic process (GO:0046513),-0.6653306613226453,-1.154258937344116,0.28388746803069054,0.8538795364698278,1.0,2/2,33.70%,SGMS1;CERS6
915,prerank,neuronal action potential (GO:0019228),0.8648648648648649,1.153667386961308,0.2652671755725191,1.0,1.0,1/1,13.60%,SCN3A
916,prerank,action potential (GO:0001508),0.8648648648648649,1.153667386961308,0.2652671755725191,1.0,1.0,1/1,13.60%,SCN3A
917,prerank,visual perception (GO:0007601),-0.6823647294589178,-1.1530172516871438,0.2966101694915254,0.8552144103335602,1.0,2/2,32.00%,OAT;COL11A1
918,prerank,sensory perception of light stimulus (GO:0050953),-0.6823647294589178,-1.1530172516871438,0.2966101694915254,0.8552144103335602,1.0,2/2,32.00%,OAT;COL11A1
919,prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.8668668668668669,1.1519922376287195,0.28431372549019607,1.0,1.0,1/1,13.40%,CACNG4
920,prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.4024144869215292,-1.1517078662038884,0.22857142857142856,0.8588780824745107,1.0,6/6,60.10%,BTRC;FAF1;UPF3A;PLD1;SAMD4A;CPEB3
921,prerank,long-chain fatty acid transport (GO:0015909),-0.5646940822467402,-1.1512746074296747,0.28716216216216217,0.855313112557323,1.0,3/3,43.80%,ACACA;ABCD3;ACACB
922,prerank,intracellular lipid transport (GO:0032365),-0.5646940822467402,-1.1512746074296747,0.28716216216216217,0.855313112557323,1.0,3/3,43.80%,ACACA;ABCD3;ACACB
923,prerank,fatty acid transmembrane transport (GO:1902001),-0.5646940822467402,-1.1512746074296747,0.28716216216216217,0.855313112557323,1.0,3/3,43.80%,ACACA;ABCD3;ACACB
924,prerank,regulation of bone remodeling (GO:0046850),-0.8608608608608609,-1.1503436841208539,0.26806083650190116,0.8579422521170276,1.0,1/1,14.10%,SUCO
925,prerank,electron transport chain (GO:0022900),0.8788788788788788,1.1501126074366859,0.2709551656920078,1.0,1.0,1/1,12.20%,PPARGC1A
926,prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.8788788788788788,1.1501126074366859,0.2709551656920078,1.0,1.0,1/1,12.20%,PPARGC1A
927,prerank,regulation of fatty acid oxidation (GO:0046320),0.8788788788788788,1.1501126074366859,0.2709551656920078,1.0,1.0,1/1,12.20%,PPARGC1A
928,prerank,brown fat cell differentiation (GO:0050873),0.8788788788788788,1.1501126074366859,0.2709551656920078,1.0,1.0,1/1,12.20%,PPARGC1A
929,prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.8788788788788788,1.1501126074366859,0.2709551656920078,1.0,1.0,1/1,12.20%,PPARGC1A
930,prerank,positive regulation of ATP biosynthetic process (GO:2001171),0.8788788788788788,1.1501126074366859,0.2709551656920078,1.0,1.0,1/1,12.20%,PPARGC1A
931,prerank,positive regulation of gluconeogenesis (GO:0045722),0.8788788788788788,1.1501126074366859,0.2709551656920078,1.0,1.0,1/1,12.20%,PPARGC1A
932,prerank,positive regulation of histone acetylation (GO:0035066),0.8788788788788788,1.1501126074366859,0.2709551656920078,1.0,1.0,1/1,12.20%,PPARGC1A
933,prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.8788788788788788,1.1501126074366859,0.2709551656920078,1.0,1.0,1/1,12.20%,PPARGC1A
934,prerank,regulation of gluconeogenesis (GO:0006111),0.8788788788788788,1.1501126074366859,0.2709551656920078,1.0,1.0,1/1,12.20%,PPARGC1A
935,prerank,regulation of ATP biosynthetic process (GO:2001169),0.8788788788788788,1.1501126074366859,0.2709551656920078,1.0,1.0,1/1,12.20%,PPARGC1A
936,prerank,hypotonic response (GO:0006971),0.7004008016032065,1.1489708939780667,0.26058631921824105,1.0,1.0,2/2,30.10%,STK39;TRPV4
937,prerank,cellular hypotonic response (GO:0071476),0.7004008016032065,1.1489708939780667,0.26058631921824105,1.0,1.0,2/2,30.10%,STK39;TRPV4
938,prerank,store-operated calcium entry (GO:0002115),-0.8718718718718719,-1.1486624117327537,0.2871287128712871,0.8609108509589105,1.0,1/1,13.00%,STIM2
939,prerank,positive regulation of store-operated calcium channel activity (GO:1901341),-0.8718718718718719,-1.1486624117327537,0.2871287128712871,0.8609108509589105,1.0,1/1,13.00%,STIM2
940,prerank,very long-chain fatty acid metabolic process (GO:0000038),0.5601075615568278,1.147955795961557,0.2868741542625169,1.0,1.0,3/4,31.00%,ELOVL2;ELOVL7;ELOVL6
941,prerank,Toll signaling pathway (GO:0008063),-0.8518518518518519,-1.1468728859647965,0.27165354330708663,0.8662536707751552,1.0,1/1,15.00%,PELI2
942,prerank,regulation of circadian sleep/wake cycle (GO:0042749),0.8448448448448449,1.1457549537684273,0.27037773359840955,1.0,1.0,1/1,15.60%,HCRTR2
943,prerank,regulation of nervous system development (GO:0051960),0.7071539376554125,1.1456331644243556,0.27450980392156865,1.0,1.0,1/2,7.80%,TENM4
944,prerank,ureteric bud development (GO:0001657),0.5533159630689191,1.1454750280239494,0.2728494623655914,1.0,1.0,3/4,27.80%,SLIT2;ROBO2;WT1
945,prerank,regulation of smoothened signaling pathway (GO:0008589),0.4463794319897434,1.1452188057949515,0.2746234067207416,1.0,1.0,6/8,45.90%,GLI3;RORA;EVC;ZIC1;DLG5;GPC3
946,prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.4721444980089078,1.1450752448344372,0.296028880866426,1.0,1.0,4/7,30.30%,HMGA2;SPRED2;EYA2;SPRED3
947,prerank,neuromuscular junction development (GO:0007528),0.6936585625813319,1.1447834483891361,0.2628951747088186,1.0,1.0,1/2,2.40%,CACNB2
948,prerank,RNA splicing (GO:0008380),0.49610671640053317,1.1447482703579248,0.2995110024449878,1.0,1.0,5/6,42.90%,PPARGC1A;DHX8;WT1;NOVA1;SRPK1
949,prerank,peripheral nervous system development (GO:0007422),0.6156926569412948,1.1432828148653171,0.27089337175792505,1.0,1.0,2/3,21.10%,ASIC2;ADGRB1
950,prerank,neuron migration (GO:0001764),0.44915010869061295,1.143278808008987,0.29466357308584684,1.0,1.0,3/8,17.70%,AUTS2;SEMA3A;ADGRL3
951,prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.421105527638191,-1.1425277409163168,0.2722772277227723,0.8828065068187749,1.0,5/5,58.20%,CSNK2A1;LPCAT1;SLC44A2;LPIN1;CHKA
952,prerank,negative regulation of mitotic cell cycle (GO:0045930),0.6151244542186605,1.1424656852948274,0.2818991097922849,1.0,1.0,2/3,24.90%,BRINP1;TOM1L1
953,prerank,calcium ion import across plasma membrane (GO:0098703),0.7004008016032064,1.14234357032545,0.29874213836477986,1.0,1.0,2/2,30.10%,SLC24A2;TRPV4
954,prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.7004008016032064,1.14234357032545,0.29874213836477986,1.0,1.0,2/2,30.10%,SLC24A2;TRPV4
955,prerank,calcium ion import into cytosol (GO:1902656),0.7004008016032064,1.14234357032545,0.29874213836477986,1.0,1.0,2/2,30.10%,SLC24A2;TRPV4
956,prerank,protein O-linked mannosylation (GO:0035269),-0.6703406813627254,-1.1422697475880397,0.29336734693877553,0.8817328154646509,1.0,2/2,33.20%,TMTC1;TMTC2
957,prerank,regulation of interleukin-1 production (GO:0032652),-0.658316633266533,-1.1415158083170271,0.29797979797979796,0.8827906441969888,1.0,2/2,34.40%,GAS6;FOXP1
958,prerank,positive regulation of DNA metabolic process (GO:0051054),0.4645892519301362,1.1411622725235073,0.3110846245530393,1.0,1.0,6/7,46.40%,EYA2;WT1;SMOC2;TOX;WRN;EGFR
959,prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.8478478478478478,1.1407439819971348,0.2869198312236287,1.0,1.0,1/1,15.30%,SEMA3A
960,prerank,dendrite arborization (GO:0140059),0.8478478478478478,1.1407439819971348,0.2869198312236287,1.0,1.0,1/1,15.30%,SEMA3A
961,prerank,ganglion development (GO:0061548),0.8478478478478478,1.1407439819971348,0.2869198312236287,1.0,1.0,1/1,15.30%,SEMA3A
962,prerank,sympathetic ganglion development (GO:0061549),0.8478478478478478,1.1407439819971348,0.2869198312236287,1.0,1.0,1/1,15.30%,SEMA3A
963,prerank,hematopoietic stem cell proliferation (GO:0071425),0.8378378378378378,1.1406743883663113,0.2874251497005988,1.0,1.0,1/1,16.30%,MECOM
964,prerank,negative regulation of JNK cascade (GO:0046329),0.8378378378378378,1.1406743883663113,0.2874251497005988,1.0,1.0,1/1,16.30%,MECOM
965,prerank,response to glucocorticoid (GO:0051384),0.6140672356546447,1.1403019299626198,0.2857142857142857,1.0,1.0,2/3,17.50%,SLIT2;CALCR
966,prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.8638638638638638,1.140113310129316,0.28076923076923077,1.0,1.0,1/1,13.70%,WNK3
967,prerank,positive regulation of sodium ion transport (GO:0010765),0.8638638638638638,1.140113310129316,0.28076923076923077,1.0,1.0,1/1,13.70%,WNK3
968,prerank,regulation of calcium ion import (GO:0090279),0.8638638638638638,1.140113310129316,0.28076923076923077,1.0,1.0,1/1,13.70%,WNK3
969,prerank,positive regulation of respiratory burst (GO:0060267),0.6935602589079227,1.13994561774186,0.2988505747126437,1.0,1.0,1/2,14.40%,CAMK1D
970,prerank,regulation of respiratory burst (GO:0060263),0.6935602589079227,1.13994561774186,0.2988505747126437,1.0,1.0,1/2,14.40%,CAMK1D
971,prerank,regulation of hippo signaling (GO:0035330),0.6018054162487461,1.139581089102706,0.3008720930232558,1.0,1.0,3/3,40.00%,SHANK2;MOB3B;DLG5
972,prerank,positive regulation of dendritic spine development (GO:0060999),0.5562248995983936,1.1389120434272872,0.30833333333333335,1.0,1.0,4/4,44.60%,LRP8;DLG5;CPEB3;CAPRIN2
973,prerank,cellular respiration (GO:0045333),0.708741382424324,1.1383224467173987,0.2900158478605388,1.0,1.0,1/2,12.20%,PPARGC1A
974,prerank,cellular response to topologically incorrect protein (GO:0035967),-0.6633266533066132,-1.1381953070935185,0.3125,0.8927993452960236,1.0,2/2,33.90%,TM7SF3;OPTN
975,prerank,cellular response to unfolded protein (GO:0034620),-0.6633266533066132,-1.1381953070935185,0.3125,0.8927993452960236,1.0,2/2,33.90%,TM7SF3;OPTN
976,prerank,muscle organ development (GO:0007517),0.7014028056112225,1.1381488873945464,0.2982456140350877,1.0,1.0,2/2,30.00%,LAMA2;EVC
977,prerank,purine nucleotide metabolic process (GO:0006163),-0.8498498498498498,-1.1381211308761718,0.32397003745318353,0.8840559910784487,1.0,1/1,15.20%,FHIT
978,prerank,nucleotide metabolic process (GO:0009117),-0.8498498498498498,-1.1381211308761718,0.32397003745318353,0.8840559910784487,1.0,1/1,15.20%,FHIT
979,prerank,diadenosine polyphosphate catabolic process (GO:0015961),-0.8498498498498498,-1.1381211308761718,0.32397003745318353,0.8840559910784487,1.0,1/1,15.20%,FHIT
980,prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.8498498498498498,-1.1381211308761718,0.32397003745318353,0.8840559910784487,1.0,1/1,15.20%,FHIT
981,prerank,purine-containing compound metabolic process (GO:0072521),-0.8498498498498498,-1.1381211308761718,0.32397003745318353,0.8840559910784487,1.0,1/1,15.20%,FHIT
982,prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.6633266533066132,-1.1380922021676518,0.31202046035805625,0.8806467586798672,1.0,2/2,33.90%,GGA2;OPTN
983,prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.6633266533066132,-1.1380922021676518,0.31202046035805625,0.8806467586798672,1.0,2/2,33.90%,GGA2;OPTN
984,prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.5566700100300903,-1.136519197084537,0.275974025974026,0.8854561306021133,1.0,3/3,44.60%,ARNT;TESC;ETS1
985,prerank,negative regulation of cell differentiation (GO:0045596),0.3615354708538303,1.1362951619434494,0.3291272344900105,1.0,1.0,12/18,46.50%,RORA;SPRED2;ABCA5;DTX1;SPRED3;MEIS1;CDK6;MEIS2;IL17RD;ANKRD26;EGFR;PRAME
986,prerank,protein localization to synapse (GO:0035418),0.8608608608608608,1.1361501111885985,0.29880478087649404,1.0,1.0,1/1,14.00%,PCLO
987,prerank,protein localization to cell junction (GO:1902414),0.8608608608608608,1.1361501111885985,0.29880478087649404,1.0,1.0,1/1,14.00%,PCLO
988,prerank,presynaptic active zone organization (GO:1990709),0.8608608608608608,1.1361501111885985,0.29880478087649404,1.0,1.0,1/1,14.00%,PCLO
989,prerank,dendrite self-avoidance (GO:0070593),-0.8548548548548548,-1.1357072179637717,0.2916666666666667,0.8872397247917536,1.0,1/1,14.70%,PALLD
990,prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.8578578578578578,1.1352966428671127,0.30218687872763417,1.0,1.0,1/1,14.30%,STK33
991,prerank,cellular component disassembly (GO:0022411),0.6965272884666405,1.1346442478207852,0.3003194888178914,1.0,1.0,1/2,8.40%,MMP16
992,prerank,extracellular matrix disassembly (GO:0022617),0.6965272884666405,1.1346442478207852,0.3003194888178914,1.0,1.0,1/2,8.40%,MMP16
993,prerank,ephrin receptor signaling pathway (GO:0048013),0.47806425614925424,1.1345961915815537,0.31143552311435524,1.0,1.0,2/7,9.50%,ANKS1B;TIAM1
994,prerank,epithelial cell morphogenesis (GO:0003382),0.8468468468468469,1.134282412186967,0.308,1.0,1.0,1/1,15.40%,COL22A1
995,prerank,endothelial cell development (GO:0001885),0.8468468468468469,1.134282412186967,0.308,1.0,1.0,1/1,15.40%,COL22A1
996,prerank,endothelial cell morphogenesis (GO:0001886),0.8468468468468469,1.134282412186967,0.308,1.0,1.0,1/1,15.40%,COL22A1
997,prerank,inorganic cation import across plasma membrane (GO:0098659),0.5191703531761598,1.133774446416796,0.2869897959183674,1.0,1.0,3/5,30.10%,SLC24A2;SLC9C1;TRPV4
998,prerank,peptidyl-proline hydroxylation (GO:0019511),-0.8408408408408409,-1.133328644990896,0.2953667953667954,0.8929276731277394,1.0,1/1,16.10%,P4HA1
999,prerank,peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.8408408408408409,-1.133328644990896,0.2953667953667954,0.8929276731277394,1.0,1/1,16.10%,P4HA1
1000,prerank,positive regulation of neutrophil migration (GO:1902624),0.8568568568568569,1.1333136599644273,0.28313253012048195,1.0,1.0,1/1,14.40%,CAMK1D
1001,prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.8568568568568569,1.1333136599644273,0.28313253012048195,1.0,1.0,1/1,14.40%,CAMK1D
1002,prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.8568568568568569,1.1333136599644273,0.28313253012048195,1.0,1.0,1/1,14.40%,CAMK1D
1003,prerank,TORC2 signaling (GO:0038203),-0.8488488488488488,-1.1328761931385964,0.3199195171026157,0.8910969442776265,1.0,1/1,15.30%,RICTOR
1004,prerank,TOR signaling (GO:0031929),-0.8488488488488488,-1.1328761931385964,0.3199195171026157,0.8910969442776265,1.0,1/1,15.30%,RICTOR
1005,prerank,protein localization to cilium (GO:0061512),0.8528528528528528,1.1321719657042717,0.2848605577689243,1.0,1.0,1/1,14.80%,ZNF423
1006,prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.658316633266533,-1.131920125015692,0.3165829145728643,0.8914489578027547,1.0,2/2,34.40%,PIAS2;FOXP1
1007,prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.658316633266533,-1.131920125015692,0.3165829145728643,0.8914489578027547,1.0,2/2,34.40%,PIAS2;FOXP1
1008,prerank,macroautophagy (GO:0016236),0.5244635743015672,1.131561013457056,0.31691919191919193,1.0,1.0,1/5,2.00%,TMEM74
1009,prerank,apoptotic DNA fragmentation (GO:0006309),0.689495621679938,1.1315573659154816,0.30914826498422715,1.0,1.0,1/2,1.80%,CECR2
1010,prerank,apoptotic nuclear changes (GO:0030262),0.689495621679938,1.1315573659154816,0.30914826498422715,1.0,1.0,1/2,1.80%,CECR2
1011,prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.8618618618618619,1.1313131313131324,0.32916666666666666,1.0,1.0,1/1,13.90%,NOS1AP
1012,prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.8618618618618619,1.1313131313131324,0.32916666666666666,1.0,1.0,1/1,13.90%,NOS1AP
1013,prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.8618618618618619,1.1313131313131324,0.32916666666666666,1.0,1.0,1/1,13.90%,NOS1AP
1014,prerank,regulation of nitric oxide metabolic process (GO:0080164),0.8618618618618619,1.1313131313131324,0.32916666666666666,1.0,1.0,1/1,13.90%,NOS1AP
1015,prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.8618618618618619,1.1313131313131324,0.32916666666666666,1.0,1.0,1/1,13.90%,NOS1AP
1016,prerank,positive regulation of monooxygenase activity (GO:0032770),0.8618618618618619,1.1313131313131324,0.32916666666666666,1.0,1.0,1/1,13.90%,NOS1AP
1017,prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.8618618618618619,1.1313131313131324,0.32916666666666666,1.0,1.0,1/1,13.90%,NOS1AP
1018,prerank,regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.8618618618618619,1.1313131313131324,0.32916666666666666,1.0,1.0,1/1,13.90%,NOS1AP
1019,prerank,cellular response to leucine (GO:0071233),-0.6613226452905812,-1.1311664371408712,0.28211586901763225,0.8890338932596022,1.0,2/2,34.10%,UBR2;SESN3
1020,prerank,response to leucine (GO:0043201),-0.6613226452905812,-1.1311664371408712,0.28211586901763225,0.8890338932596022,1.0,2/2,34.10%,UBR2;SESN3
1021,prerank,negative regulation of TOR signaling (GO:0032007),-0.6613226452905812,-1.1311664371408712,0.28211586901763225,0.8890338932596022,1.0,2/2,34.10%,UBR2;SESN3
1022,prerank,regulation of collagen fibril organization (GO:1904026),-0.8418418418418419,-1.1308728539746093,0.2845691382765531,0.876524570685216,1.0,1/1,16.00%,EMILIN1
1023,prerank,negative regulation of biosynthetic process (GO:0009890),-0.8418418418418419,-1.1308728539746093,0.2845691382765531,0.876524570685216,1.0,1/1,16.00%,EMILIN1
1024,prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.8418418418418419,-1.1308728539746093,0.2845691382765531,0.876524570685216,1.0,1/1,16.00%,EMILIN1
1025,prerank,positive regulation of extracellular matrix assembly (GO:1901203),-0.8418418418418419,-1.1308728539746093,0.2845691382765531,0.876524570685216,1.0,1/1,16.00%,EMILIN1
1026,prerank,regulation of cell activation (GO:0050865),-0.8418418418418419,-1.1308728539746093,0.2845691382765531,0.876524570685216,1.0,1/1,16.00%,EMILIN1
1027,prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.8418418418418419,-1.1308728539746093,0.2845691382765531,0.876524570685216,1.0,1/1,16.00%,EMILIN1
1028,prerank,regulation of extracellular matrix assembly (GO:1901201),-0.8418418418418419,-1.1308728539746093,0.2845691382765531,0.876524570685216,1.0,1/1,16.00%,EMILIN1
1029,prerank,elastic fiber assembly (GO:0048251),-0.8418418418418419,-1.1308728539746093,0.2845691382765531,0.876524570685216,1.0,1/1,16.00%,EMILIN1
1030,prerank,positive regulation of axonogenesis (GO:0050772),0.5195959723135177,1.1305931044748578,0.30395913154533843,1.0,1.0,3/5,25.20%,TIAM1;SLIT2;ROBO2
1031,prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.658316633266533,-1.1304441337778264,0.295,0.8729271384484137,1.0,2/2,34.40%,SLC39A10;FOXP1
1032,prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.658316633266533,-1.1304441337778264,0.295,0.8729271384484137,1.0,2/2,34.40%,SLC39A10;FOXP1
1033,prerank,positive regulation of B cell receptor signaling pathway (GO:0050861),-0.658316633266533,-1.1304441337778264,0.295,0.8729271384484137,1.0,2/2,34.40%,SLC39A10;FOXP1
1034,prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.658316633266533,-1.1301622468692167,0.31413612565445026,0.8720683962053742,1.0,2/2,34.40%,BMPR1A;FOXP1
1035,prerank,regulation of MAPK cascade (GO:0043408),-0.2589617669918728,-1.1285371741285608,0.2236842105263158,0.8765568827235186,1.0,12/13,58.00%,INSR;MAP4K4;SPRED1;PELI2;FGFR1;PHLPP1;EPHA2;NF1;ROR2;EGFR;FLT4;IGF1R
1036,prerank,fat cell differentiation (GO:0045444),0.5116594021761169,1.12830772075409,0.3038130381303813,1.0,1.0,2/5,12.20%,HMGA2;PPARGC1A
1037,prerank,gonad development (GO:0008406),0.5901992662794519,1.1281110597043669,0.3125925925925926,1.0,1.0,2/3,27.80%,MAMLD1;WT1
1038,prerank,negative regulation of cellular component organization (GO:0051129),0.6090500399113667,1.1278756850190192,0.2985714285714286,1.0,1.0,1/3,4.20%,TMEFF2
1039,prerank,camera-type eye morphogenesis (GO:0048593),0.6793890741287736,1.127827365173712,0.30307941653160453,1.0,1.0,1/2,5.90%,TENM3
1040,prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.5137833714672106,1.127395122031235,0.2918848167539267,1.0,1.0,4/5,38.40%,ELOVL2;ELOVL7;ELOVL6;HSD17B12
1041,prerank,eye development (GO:0001654),0.45515010740116046,1.1265802272390262,0.32926829268292684,1.0,1.0,5/7,39.10%,FBN2;WT1;MEIS1;MEIS2;CACNA1C
1042,prerank,lipid oxidation (GO:0034440),0.6883494451940743,1.1260889685045221,0.3248407643312102,1.0,1.0,1/2,12.20%,PPARGC1A
1043,prerank,amino acid transmembrane transport (GO:0003333),-0.48594377510040154,-1.1256139228435948,0.301255230125523,0.8857940152744903,1.0,4/4,51.70%,SLC7A1;SLC38A9;SLC25A12;SFXN1
1044,prerank,camera-type eye development (GO:0043010),0.5046766313282282,1.125500682166746,0.3019108280254777,1.0,1.0,4/5,39.10%,TENM3;FBN2;WT1;CACNA1C
1045,prerank,interstrand cross-link repair (GO:0036297),-0.6543086172344689,-1.1253333687745333,0.3161953727506427,0.8850151182191285,1.0,2/2,34.80%,NUCKS1;FANCC
1046,prerank,response to peptide (GO:1901652),0.5447954880264199,1.1251820505611636,0.31333333333333335,1.0,1.0,2/4,17.50%,CACNA1A;CALCR
1047,prerank,mitochondrion transport along microtubule (GO:0047497),-0.6513026052104208,-1.125170011952356,0.291005291005291,0.8839228320054265,1.0,2/2,35.10%,LRPPRC;SPAST
1048,prerank,generation of neurons (GO:0048699),0.4006881105467896,1.1246019769545341,0.33296582138919517,1.0,1.0,4/12,17.70%,AUTS2;PTPRD;SEMA3A;ADGRL3
1049,prerank,positive regulation of defense response (GO:0031349),-0.5566700100300903,-1.1245171308102107,0.32087227414330216,0.884927439789336,1.0,3/3,44.60%,NPAS2;OPTN;ETS1
1050,prerank,insulin receptor signaling pathway (GO:0008286),-0.4180904522613066,-1.1242802971940649,0.29850746268656714,0.8842742422152368,1.0,5/5,58.50%,INSR;FOXC2;ATP6V0A4;IGF1R;IRS1
1051,prerank,regulation of collateral sprouting (GO:0048670),0.6023387933304696,1.1232386593440962,0.3007299270072993,1.0,1.0,1/3,2.20%,DCC
1052,prerank,negative regulation of collateral sprouting (GO:0048671),0.6023387933304696,1.1232386593440962,0.3007299270072993,1.0,1.0,1/3,2.20%,DCC
1053,prerank,positive regulation of protein kinase activity (GO:0045860),0.426247208664543,1.1232357281928895,0.33141542002301494,1.0,1.0,6/9,47.10%,HMGA2;LRP8;TOM1L1;IL34;DDR2;PTK2
1054,prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.8358358358358359,1.1224165935440522,0.32341269841269843,1.0,1.0,1/1,16.50%,CADM1
1055,prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.8358358358358359,1.1224165935440522,0.32341269841269843,1.0,1.0,1/1,16.50%,CADM1
1056,prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.8358358358358359,1.1224165935440522,0.32341269841269843,1.0,1.0,1/1,16.50%,CADM1
1057,prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.8358358358358359,1.1224165935440522,0.32341269841269843,1.0,1.0,1/1,16.50%,CADM1
1058,prerank,T cell mediated immunity (GO:0002456),0.8358358358358359,1.1224165935440522,0.32341269841269843,1.0,1.0,1/1,16.50%,CADM1
1059,prerank,T cell mediated cytotoxicity (GO:0001913),0.8358358358358359,1.1224165935440522,0.32341269841269843,1.0,1.0,1/1,16.50%,CADM1
1060,prerank,regulation of protein kinase activity (GO:0045859),-0.37059415911379656,-1.1221092055698327,0.29559748427672955,0.8908721500092098,1.0,7/7,63.30%,GAS6;SPRED1;ITGB1BP1;NF1;PTK2;DDR2;UBASH3B
1061,prerank,regulation of calcium ion transport (GO:0051924),0.5009450360624925,1.1219088467969422,0.3058968058968059,1.0,1.0,3/5,29.80%,CACNB2;WNK3;BCL2
1062,prerank,membrane fission (GO:0090148),-0.6513026052104208,-1.1211689237348552,0.3002754820936639,0.8928044001269418,1.0,2/2,35.10%,TMCC1;SPAST
1063,prerank,regulation of DNA replication (GO:0006275),-0.46485943775100397,-1.121072723447078,0.2679245283018868,0.8913394525852477,1.0,4/4,53.80%,NUCKS1;FAF1;ORC3;EGFR
1064,prerank,positive regulation of actin nucleation (GO:0051127),0.8428428428428428,1.1205292761290717,0.3163265306122449,1.0,1.0,1/1,15.80%,WASF3
1065,prerank,actin filament polymerization (GO:0030041),0.8428428428428428,1.1205292761290717,0.3163265306122449,1.0,1.0,1/1,15.80%,WASF3
1066,prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.8428428428428428,1.1205292761290717,0.3163265306122449,1.0,1.0,1/1,15.80%,WASF3
1067,prerank,positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.8428428428428428,1.1205292761290717,0.3163265306122449,1.0,1.0,1/1,15.80%,WASF3
1068,prerank,regulation of phosphatidylinositol dephosphorylation (GO:0060304),-0.6593186372745491,-1.120373112229789,0.30917874396135264,0.8904268543385506,1.0,2/2,34.30%,MTMR2;MTMR1
1069,prerank,regulation of phospholipid metabolic process (GO:1903725),-0.6593186372745491,-1.120373112229789,0.30917874396135264,0.8904268543385506,1.0,2/2,34.30%,MTMR2;MTMR1
1070,prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6783567134268538,1.1196059351994574,0.3069620253164557,1.0,1.0,2/2,32.30%,IGF2BP2;NOVA1
1071,prerank,regulation of RNA metabolic process (GO:0051252),0.6783567134268538,1.1196059351994574,0.3069620253164557,1.0,1.0,2/2,32.30%,IGF2BP2;NOVA1
1072,prerank,polyol metabolic process (GO:0019751),0.5909831401669624,1.118604100556691,0.3159340659340659,1.0,1.0,1/3,4.40%,PLCH1
1073,prerank,inositol phosphate metabolic process (GO:0043647),0.5909831401669624,1.118604100556691,0.3159340659340659,1.0,1.0,1/3,4.40%,PLCH1
1074,prerank,regulation of interleukin-1 beta production (GO:0032651),-0.658316633266533,-1.1182787421577305,0.32160804020100503,0.8967875598748034,1.0,2/2,34.40%,NLRP1;FOXP1
1075,prerank,chromatin assembly (GO:0031497),0.5985054787143812,1.1181755495991172,0.33001422475106684,1.0,1.0,1/3,1.50%,HMGA2
1076,prerank,innate immune response (GO:0045087),-0.43015075376884426,-1.1179721669213651,0.3112244897959184,0.8962887135075107,1.0,5/5,57.30%,NLRP1;COLEC12;BPI;PTK2;SRPK1
1077,prerank,chondroitin sulfate metabolic process (GO:0030204),0.8508508508508509,1.117948663113042,0.33739837398373984,1.0,1.0,1/1,15.00%,CHST9
1078,prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.8508508508508509,1.117948663113042,0.33739837398373984,1.0,1.0,1/1,15.00%,CHST9
1079,prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.8508508508508509,1.117948663113042,0.33739837398373984,1.0,1.0,1/1,15.00%,CHST9
1080,prerank,aminoglycan metabolic process (GO:0006022),0.8508508508508509,1.117948663113042,0.33739837398373984,1.0,1.0,1/1,15.00%,CHST9
1081,prerank,regulation of protein dephosphorylation (GO:0035304),-0.5396188565697091,-1.1179343141653553,0.3003412969283277,0.8947674960875196,1.0,3/3,46.30%,PPP6R3;ENSA;CAMTA1
1082,prerank,positive regulation of oligodendrocyte differentiation (GO:0048714),0.6833667334669339,1.1178314869378336,0.3122977346278317,1.0,1.0,2/2,31.80%,TENM4;IL34
1083,prerank,positive regulation of glial cell differentiation (GO:0045687),0.6833667334669339,1.1178314869378336,0.3122977346278317,1.0,1.0,2/2,31.80%,TENM4;IL34
1084,prerank,peptidyl-methionine modification (GO:0018206),-0.8168168168168168,-1.1178200664536344,0.31334622823984526,0.8902580546836313,1.0,1/1,18.50%,METAP2
1085,prerank,N-terminal protein amino acid modification (GO:0031365),-0.8168168168168168,-1.1178200664536344,0.31334622823984526,0.8902580546836313,1.0,1/1,18.50%,METAP2
1086,prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.8168168168168168,-1.1178200664536344,0.31334622823984526,0.8902580546836313,1.0,1/1,18.50%,METAP2
1087,prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5888224191976686,1.1172733890713558,0.31556195965417866,1.0,1.0,2/3,27.80%,MAGI2;WT1
1088,prerank,regulation of supramolecular fiber organization (GO:1902903),0.6768169875939897,1.116991102041352,0.3092948717948718,1.0,1.0,1/2,11.20%,MAP2
1089,prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.6768169875939897,1.116991102041352,0.3092948717948718,1.0,1.0,1/2,11.20%,MAP2
1090,prerank,regulation of microtubule polymerization (GO:0031113),0.6768169875939897,1.116991102041352,0.3092948717948718,1.0,1.0,1/2,11.20%,MAP2
1091,prerank,regulation of protein polymerization (GO:0032271),0.6768169875939897,1.116991102041352,0.3092948717948718,1.0,1.0,1/2,11.20%,MAP2
1092,prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5475869192225171,1.1168525789857437,0.3076923076923077,1.0,1.0,2/4,21.70%,SLIT2;KANK1
1093,prerank,membrane depolarization during AV node cell action potential (GO:0086045),0.6746132797000367,1.116844929319036,0.3079416531604538,1.0,1.0,1/2,2.40%,CACNB2
1094,prerank,AV node cell action potential (GO:0086016),0.6746132797000367,1.116844929319036,0.3079416531604538,1.0,1.0,1/2,2.40%,CACNB2
1095,prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.6746132797000367,1.116844929319036,0.3079416531604538,1.0,1.0,1/2,2.40%,CACNB2
1096,prerank,atrial cardiac muscle cell action potential (GO:0086014),0.6746132797000367,1.116844929319036,0.3079416531604538,1.0,1.0,1/2,2.40%,CACNB2
1097,prerank,Golgi ribbon formation (GO:0090161),-0.6633266533066132,-1.1167610555488605,0.33163265306122447,0.8926189289290346,1.0,2/2,33.90%,STX6;OPTN
1098,prerank,relaxation of muscle (GO:0090075),-0.8278278278278278,-1.1165284176573498,0.33657587548638135,0.8755225938284643,1.0,1/1,17.40%,CAMK2D
1099,prerank,regulation of histone deacetylation (GO:0031063),-0.8278278278278278,-1.1165284176573498,0.33657587548638135,0.8755225938284643,1.0,1/1,17.40%,CAMK2D
1100,prerank,regulation of histone deacetylase activity (GO:1901725),-0.8278278278278278,-1.1165284176573498,0.33657587548638135,0.8755225938284643,1.0,1/1,17.40%,CAMK2D
1101,prerank,actin-mediated cell contraction (GO:0070252),-0.8278278278278278,-1.1165284176573498,0.33657587548638135,0.8755225938284643,1.0,1/1,17.40%,CAMK2D
1102,prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.8278278278278278,-1.1165284176573498,0.33657587548638135,0.8755225938284643,1.0,1/1,17.40%,CAMK2D
1103,prerank,cardiac muscle contraction (GO:0060048),-0.8278278278278278,-1.1165284176573498,0.33657587548638135,0.8755225938284643,1.0,1/1,17.40%,CAMK2D
1104,prerank,regulation of relaxation of muscle (GO:1901077),-0.8278278278278278,-1.1165284176573498,0.33657587548638135,0.8755225938284643,1.0,1/1,17.40%,CAMK2D
1105,prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.8278278278278278,-1.1165284176573498,0.33657587548638135,0.8755225938284643,1.0,1/1,17.40%,CAMK2D
1106,prerank,relaxation of cardiac muscle (GO:0055119),-0.8278278278278278,-1.1165284176573498,0.33657587548638135,0.8755225938284643,1.0,1/1,17.40%,CAMK2D
1107,prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.8278278278278278,-1.1165284176573498,0.33657587548638135,0.8755225938284643,1.0,1/1,17.40%,CAMK2D
1108,prerank,regulation of membrane depolarization (GO:0003254),-0.8278278278278278,-1.1165284176573498,0.33657587548638135,0.8755225938284643,1.0,1/1,17.40%,CAMK2D
1109,prerank,calcium ion transmembrane transport (GO:0070588),0.4420405346119707,1.1160513367577645,0.32681242807825084,1.0,1.0,5/8,42.80%,CACNA1A;SLC24A2;TRPV4;CACNA1C;TRPC1
1110,prerank,regulation of dendrite morphogenesis (GO:0048814),0.5355300265057297,1.1158516249764114,0.3151595744680851,1.0,1.0,2/4,14.20%,PTPRD;HECW2
1111,prerank,"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.8428428428428428,-1.1157563588361152,0.3435114503816794,0.8763758544976016,1.0,1/1,15.90%,LRPPRC
1112,prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.6663326653306613,-1.1149095576774468,0.34375,0.8762776647443639,1.0,2/2,33.60%,PSIP1;SRSF1
1113,prerank,mRNA 5'-splice site recognition (GO:0000395),-0.6663326653306613,-1.1149095576774468,0.34375,0.8762776647443639,1.0,2/2,33.60%,PSIP1;SRSF1
1114,prerank,nitrogen compound transport (GO:0071705),-0.551654964894684,-1.1142147948918277,0.2935153583617747,0.8774816337696438,1.0,3/3,45.10%,SLC7A1;SLC12A2;SLC44A2
1115,prerank,regulation of myotube differentiation (GO:0010830),-0.6372745490981964,-1.1141614201950885,0.32390745501285345,0.8760141720150574,1.0,2/2,36.50%,FBXO22;HDAC5
1116,prerank,negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.682031068367071,1.1138967203661498,0.303125,1.0,1.0,1/2,9.80%,SLIT2
1117,prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.682031068367071,1.1138967203661498,0.303125,1.0,1.0,1/2,9.80%,SLIT2
1118,prerank,regulation of chemokine-mediated signaling pathway (GO:0070099),0.682031068367071,1.1138967203661498,0.303125,1.0,1.0,1/2,9.80%,SLIT2
1119,prerank,Roundabout signaling pathway (GO:0035385),0.682031068367071,1.1138967203661498,0.303125,1.0,1.0,1/2,9.80%,SLIT2
1120,prerank,blood vessel endothelial cell migration (GO:0043534),0.682031068367071,1.1138967203661498,0.303125,1.0,1.0,1/2,9.80%,SLIT2
1121,prerank,negative regulation of hydrolase activity (GO:0051346),0.5942954591627639,1.113374912510703,0.31383737517831667,1.0,1.0,1/3,11.20%,MAP2
1122,prerank,renal system development (GO:0072001),0.6713426853707416,1.1133358333137489,0.33063209076175043,1.0,1.0,2/2,33.00%,WT1;GREB1L
1123,prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.5526579739217653,-1.1131784917069305,0.3146853146853147,0.8782129173861939,1.0,3/3,45.00%,CCND1;MNAT1;CCND2
1124,prerank,negative regulation of cell growth (GO:0030308),0.4058538597779128,1.1124569863515594,0.3307522123893805,1.0,1.0,3/10,11.20%,DCC;SLIT2;MAP2
1125,prerank,peptidyl-tyrosine modification (GO:0018212),-0.38128772635814895,-1.1120957971805452,0.2562814070351759,0.8804168268452068,1.0,6/6,62.20%,INSR;FGFR1;PTK2;EGFR;FLT4;DDR2
1126,prerank,negative regulation of programmed cell death (GO:0043069),0.34700753735979606,1.111987000720359,0.33401639344262296,1.0,1.0,14/22,47.10%,HMGA2;WNK3;MECOM;FMN2;WT1;DPEP1;BCL2;GRK5;PIDD1;IGF1R;FLT4;EGFR;PRAME;PTK2
1127,prerank,nuclear membrane organization (GO:0071763),-0.6513026052104208,-1.111712036536267,0.3162162162162162,0.8802707668171861,1.0,2/2,35.10%,UBXN2A;SPAST
1128,prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.6523046092184368,-1.1116099869550706,0.30456852791878175,0.8790885810899537,1.0,2/2,35.00%,BMPR1A;PTEN
1129,prerank,regulation of calcium-mediated signaling (GO:0050848),0.8408408408408409,1.1115607582208877,0.34709193245778613,1.0,1.0,1/1,16.00%,RIT2
1130,prerank,regulation of Cdc42 protein signal transduction (GO:0032489),0.8408408408408409,1.1115607582208877,0.34709193245778613,1.0,1.0,1/1,16.00%,RIT2
1131,prerank,regulation of cartilage development (GO:0061035),-0.5697091273821464,-1.1115316776743531,0.3026315789473684,0.8778478368763336,1.0,3/3,43.30%,KAT2A;TRPS1;MBOAT2
1132,prerank,exit from mitosis (GO:0010458),-0.6513026052104208,-1.1112685912710725,0.3134715025906736,0.875558637734355,1.0,2/2,35.10%,PPP2R2D;SPAST
1133,prerank,mitotic nuclear division (GO:0140014),-0.6513026052104208,-1.1112685912710725,0.3134715025906736,0.875558637734355,1.0,2/2,35.10%,PPP2R2D;SPAST
1134,prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.5864692669350702,1.1110355728907106,0.34252539912917274,1.0,1.0,2/3,31.80%,LRP8;IL34
1135,prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5864692669350702,1.1110355728907106,0.34252539912917274,1.0,1.0,2/3,31.80%,LRP8;IL34
1136,prerank,negative regulation of cellular metabolic process (GO:0031324),-0.6633266533066132,-1.110464800897973,0.3308457711442786,0.8766821914522651,1.0,2/2,33.90%,MTMR2;OPTN
1137,prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.596762077387266,1.1103648791624308,0.32865168539325845,1.0,1.0,1/3,9.80%,SLIT2
1138,prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.8438438438438438,-1.109813181761189,0.38293650793650796,0.875937004512185,1.0,1/1,15.80%,ASCC3
1139,prerank,DNA dealkylation (GO:0035510),-0.8438438438438438,-1.109813181761189,0.38293650793650796,0.875937004512185,1.0,1/1,15.80%,ASCC3
1140,prerank,protein hexamerization (GO:0034214),-0.6513026052104208,-1.1095224478124113,0.3247422680412371,0.8751219419570238,1.0,2/2,35.10%,YME1L1;SPAST
1141,prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.658316633266533,-1.1077226500657422,0.32891246684350134,0.879800449165772,1.0,2/2,34.40%,MAP2K5;FOXP1
1142,prerank,axonal transport (GO:0098930),-0.6513026052104208,-1.1073046538619942,0.3269230769230769,0.8796857924264012,1.0,2/2,35.10%,DST;SPAST
1143,prerank,regulation of mitotic nuclear division (GO:0007088),0.5357564683913518,1.1072307659587126,0.33602150537634407,1.0,1.0,2/4,24.90%,USP44;TOM1L1
1144,prerank,T cell receptor signaling pathway (GO:0050852),0.6827988945776988,1.1069208117732336,0.3409090909090909,1.0,1.0,1/2,12.80%,PDE4B
1145,prerank,homologous chromosome pairing at meiosis (GO:0007129),0.8308308308308309,1.1068095810266019,0.3684210526315789,1.0,1.0,1/1,17.00%,RNF212
1146,prerank,positive regulation of cell population proliferation (GO:0008284),0.31199332777131084,1.1064996595479202,0.33601609657947684,1.0,1.0,21/35,47.60%,NRG1;SHANK2;HMGA2;TIAM1;TET1;ACER2;BCL2;MEIS1;IL34;CDK6;GRK5;MEIS2;DDR2;IRS1;IGF1R;FLT4;TOX;EGFR;PRAME;PTK2;GCNT2
1147,prerank,regulation of epithelial cell migration (GO:0010632),0.47902574232201356,1.1062589697259968,0.32525951557093424,1.0,1.0,5/6,47.10%,MCC;SASH1;BMPER;RHOJ;PTK2
1148,prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.43115577889447243,-1.10567233439974,0.33771929824561403,0.8834556327984808,1.0,5/5,57.20%,PIP4K2A;MTMR2;MTMR1;PTEN;INPP5F
1149,prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.32880316040907015,1.1054395168682796,0.3275862068965517,1.0,1.0,19/30,49.30%,NRG1;ANKS1B;SHC3;ALK;TIAM1;FLRT2;SHC4;SPRED2;ANGPTL1;UBASH3B;DDR2;IRS1;IGF1R;FLT4;ATP6V0A4;EGFR;PTK2;SHC2;ROR2
1150,prerank,positive regulation of protein kinase A signaling (GO:0010739),0.8258258258258259,1.1053314259482658,0.3187250996015936,1.0,1.0,1/1,17.50%,CALCR
1151,prerank,negative regulation of signaling receptor activity (GO:2000272),0.8258258258258259,1.1053314259482658,0.3187250996015936,1.0,1.0,1/1,17.50%,CALCR
1152,prerank,amylin receptor signaling pathway (GO:0097647),0.8258258258258259,1.1053314259482658,0.3187250996015936,1.0,1.0,1/1,17.50%,CALCR
1153,prerank,calcitonin family receptor signaling pathway (GO:0097646),0.8258258258258259,1.1053314259482658,0.3187250996015936,1.0,1.0,1/1,17.50%,CALCR
1154,prerank,positive regulation of calcium ion import (GO:0090280),0.8258258258258259,1.1053314259482658,0.3187250996015936,1.0,1.0,1/1,17.50%,CALCR
1155,prerank,"negative regulation of complement activation, classical pathway (GO:0045959)",0.8388388388388388,1.1053284223773188,0.3373253493013972,1.0,1.0,1/1,16.20%,SUSD4
1156,prerank,negative regulation of innate immune response (GO:0045824),0.8388388388388388,1.1053284223773188,0.3373253493013972,1.0,1.0,1/1,16.20%,SUSD4
1157,prerank,negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.8388388388388388,1.1053284223773188,0.3373253493013972,1.0,1.0,1/1,16.20%,SUSD4
1158,prerank,"regulation of complement activation, classical pathway (GO:0030450)",0.8388388388388388,1.1053284223773188,0.3373253493013972,1.0,1.0,1/1,16.20%,SUSD4
1159,prerank,negative regulation of complement activation (GO:0045916),0.8388388388388388,1.1053284223773188,0.3373253493013972,1.0,1.0,1/1,16.20%,SUSD4
1160,prerank,mesoderm development (GO:0007498),-0.6402805611222444,-1.1048213980976669,0.3168831168831169,0.8849386240406361,1.0,2/2,36.20%,FOXC2;TBX3
1161,prerank,secondary alcohol biosynthetic process (GO:1902653),-0.6392785571142284,-1.1045267489711936,0.33879781420765026,0.8811178787352157,1.0,2/2,36.30%,CES1;IDI1
1162,prerank,sterol biosynthetic process (GO:0016126),-0.6392785571142284,-1.1045267489711936,0.33879781420765026,0.8811178787352157,1.0,2/2,36.30%,CES1;IDI1
1163,prerank,cholesterol biosynthetic process (GO:0006695),-0.6392785571142284,-1.1045267489711936,0.33879781420765026,0.8811178787352157,1.0,2/2,36.30%,CES1;IDI1
1164,prerank,neutrophil degranulation (GO:0043312),0.4119751423042061,1.104114825282778,0.3444075304540421,1.0,1.0,2/10,7.90%,LRRC7;PTPRN2
1165,prerank,neutrophil mediated immunity (GO:0002446),0.4119751423042061,1.104114825282778,0.3444075304540421,1.0,1.0,2/10,7.90%,LRRC7;PTPRN2
1166,prerank,regulation of cellular component movement (GO:0051270),0.4237142234326783,1.1039130953786103,0.34965831435079725,1.0,1.0,7/9,46.40%,NRG1;NRG2;ZSWIM5;CDK6;MYCBP2;INPP5F;EGFR
1167,prerank,negative regulation of wound healing (GO:0061045),-0.6523046092184368,-1.10388775691605,0.3118279569892473,0.8819293136801681,1.0,2/2,35.00%,SLC12A2;PTEN
1168,prerank,negative regulation of ubiquitin protein ligase activity (GO:1904667),0.8328328328328327,1.1034566226509772,0.3517110266159696,1.0,1.0,1/1,16.80%,USP44
1169,prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.8328328328328327,1.1034566226509772,0.3517110266159696,1.0,1.0,1/1,16.80%,USP44
1170,prerank,regulation of mitotic sister chromatid segregation (GO:0033047),0.8328328328328327,1.1034566226509772,0.3517110266159696,1.0,1.0,1/1,16.80%,USP44
1171,prerank,regulation of mitotic spindle checkpoint (GO:1903504),0.8328328328328327,1.1034566226509772,0.3517110266159696,1.0,1.0,1/1,16.80%,USP44
1172,prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.8328328328328327,1.1034566226509772,0.3517110266159696,1.0,1.0,1/1,16.80%,USP44
1173,prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.351460221550856,-1.103094919968422,0.3197278911564626,0.8833219456310919,1.0,7/7,65.20%,CCND1;DLG1;PLCB1;PTEN;CCND2;EGFR;CDK6
1174,prerank,regulation of keratinocyte migration (GO:0051547),-0.6523046092184368,-1.1030688895763014,0.3215258855585831,0.881864170250024,1.0,2/2,35.00%,MAP4K4;PTEN
1175,prerank,central nervous system myelination (GO:0022010),0.6716858117009077,1.1028525549254578,0.32892561983471075,1.0,1.0,1/2,7.80%,TENM4
1176,prerank,regulation of axon extension (GO:0030516),0.5304902871925089,1.1015507981631851,0.32329842931937175,1.0,1.0,2/4,15.30%,MAP2;SEMA3A
1177,prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.6650823663639729,1.1015016160320354,0.3443609022556391,1.0,1.0,1/2,4.20%,TMEFF2
1178,prerank,wound healing (GO:0042060),0.4967442792882697,1.1012155376280772,0.34125,1.0,1.0,1/5,0.50%,NRG1
1179,prerank,mesenchymal cell differentiation (GO:0048762),0.5863104753350267,1.1007517987570696,0.34839650145772594,1.0,1.0,1/3,1.50%,HMGA2
1180,prerank,second-messenger-mediated signaling (GO:0019932),0.6693240606511621,1.0998296301627095,0.3463338533541342,1.0,1.0,1/2,4.90%,CHRM3
1181,prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.46485943775100397,-1.0994946327006532,0.34,0.8911896723295052,1.0,4/4,53.80%,CCND1;CCNY;CCND2;EGFR
1182,prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.46485943775100397,-1.0994946327006532,0.34,0.8911896723295052,1.0,4/4,53.80%,CCND1;CCNY;CCND2;EGFR
1183,prerank,ribonucleoprotein complex assembly (GO:0022618),-0.43015075376884426,-1.0993616715613383,0.3145539906103286,0.8884991106568586,1.0,5/5,57.30%,LUC7L3;CELF2;SRSF1;GCFC2;SRPK1
1184,prerank,spliceosomal complex assembly (GO:0000245),-0.43015075376884426,-1.0993616715613383,0.3145539906103286,0.8884991106568586,1.0,5/5,57.30%,LUC7L3;CELF2;SRSF1;GCFC2;SRPK1
1185,prerank,negative regulation of cell death (GO:0060548),0.5057888931817023,1.099348545550604,0.33205619412515963,1.0,1.0,2/5,16.30%,PPARGC1A;MECOM
1186,prerank,histone H3-K14 acetylation (GO:0044154),-0.8088088088088088,-1.0990530292705003,0.3466933867735471,0.8879380347027281,1.0,1/1,19.30%,PHF14
1187,prerank,negative regulation of BMP signaling pathway (GO:0030514),0.494953277032141,1.0982049725823648,0.34430379746835443,1.0,1.0,2/5,20.50%,GREM2;BMPER
1188,prerank,regulation of primary metabolic process (GO:0080090),-0.31180625630676084,-1.0981683999061482,0.3119266055045872,0.8900263986582673,1.0,9/9,69.20%,ACACA;SREBF2;NFYC;CHD9;IDI1;ACACB;TBL1X;NCOA2;ELOVL6
1189,prerank,cell-cell adhesion mediated by cadherin (GO:0044331),0.8198198198198199,1.097250926916406,0.3624031007751938,1.0,1.0,1/1,18.10%,CDH2
1190,prerank,regulation of muscle cell differentiation (GO:0051147),0.8198198198198199,1.097250926916406,0.3624031007751938,1.0,1.0,1/1,18.10%,CDH2
1191,prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.6372745490981964,-1.096917298246394,0.34536082474226804,0.8924444679992275,1.0,2/2,36.50%,KMT2A;HDAC5
1192,prerank,negative regulation of MAPK cascade (GO:0043409),0.3849380472632584,1.0966857259631981,0.3522222222222222,1.0,1.0,5/11,30.30%,WNK2;SEMA6A;LMO3;SPRED2;SPRED3
1193,prerank,regulation of cell division (GO:0051302),-0.8198198198198198,-1.0961772020126073,0.3724279835390947,0.8933305594874345,1.0,1/1,18.20%,AHCTF1
1194,prerank,cAMP metabolic process (GO:0046058),0.582653244866885,1.0961186197229293,0.3338008415147265,1.0,1.0,2/3,26.40%,ADCY8;ADCY9
1195,prerank,Wnt signaling pathway (GO:0016055),-0.29494949494949496,-1.0959811451767127,0.28688524590163933,0.8923319435341154,1.0,10/10,70.90%,BTRC;CSNK1E;FZD6;CSNK1G2;PTEN;WLS;DIXDC1;GPC4;BCL9;TCF7L1
1196,prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.5436308926780341,-1.0958793319584288,0.33666666666666667,0.8911919200873913,1.0,3/3,45.90%,CAMSAP2;TTBK2;FGF13
1197,prerank,response to muramyl dipeptide (GO:0032495),-0.8128128128128128,-1.095878556232646,0.3530534351145038,0.8821841434908615,1.0,1/1,18.90%,NLRP1
1198,prerank,positive regulation of interleukin-1 production (GO:0032732),-0.8128128128128128,-1.095878556232646,0.3530534351145038,0.8821841434908615,1.0,1/1,18.90%,NLRP1
1199,prerank,pyroptosis (GO:0070269),-0.8128128128128128,-1.095878556232646,0.3530534351145038,0.8821841434908615,1.0,1/1,18.90%,NLRP1
1200,prerank,antiviral innate immune response (GO:0140374),-0.8128128128128128,-1.095878556232646,0.3530534351145038,0.8821841434908615,1.0,1/1,18.90%,NLRP1
1201,prerank,self proteolysis (GO:0097264),-0.8128128128128128,-1.095878556232646,0.3530534351145038,0.8821841434908615,1.0,1/1,18.90%,NLRP1
1202,prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.8128128128128128,-1.095878556232646,0.3530534351145038,0.8821841434908615,1.0,1/1,18.90%,NLRP1
1203,prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.5834925415629622,1.0947339782655636,0.35673352435530087,1.0,1.0,2/3,29.80%,PDE4B;BCL2
1204,prerank,regulation of smooth muscle cell migration (GO:0014910),0.6633057691593567,1.0945664731942693,0.3393739703459638,1.0,1.0,1/2,9.80%,SLIT2
1205,prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.6633057691593567,1.0945664731942693,0.3393739703459638,1.0,1.0,1/2,9.80%,SLIT2
1206,prerank,regulation of protein kinase A signaling (GO:0010738),0.5347100828043923,1.0943782735608405,0.33694181326116374,1.0,1.0,3/4,36.30%,CALCR;PRKAR2B;PRKAR1B
1207,prerank,autophagosome assembly (GO:0000045),-0.6442885771543085,-1.0938356639315847,0.3423913043478261,0.8856897091239431,1.0,2/2,35.80%,UBXN2A;ULK1
1208,prerank,autophagosome organization (GO:1905037),-0.6442885771543085,-1.0938356639315847,0.3423913043478261,0.8856897091239431,1.0,2/2,35.80%,UBXN2A;ULK1
1209,prerank,macromolecule catabolic process (GO:0009057),-0.8208208208208209,-1.0937952548353747,0.34860557768924305,0.8827948912332011,1.0,1/1,18.10%,SNX25
1210,prerank,receptor metabolic process (GO:0043112),-0.8208208208208209,-1.0937952548353747,0.34860557768924305,0.8827948912332011,1.0,1/1,18.10%,SNX25
1211,prerank,negative regulation of protein modification process (GO:0031400),0.4983706882209713,1.09347303907389,0.35797665369649806,1.0,1.0,2/5,12.30%,SLIT2;SH3GL2
1212,prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.6523046092184368,-1.093201364239905,0.3385012919896641,0.8818129180278539,1.0,2/2,35.00%,MTMR2;PTEN
1213,prerank,negative regulation of excitatory postsynaptic potential (GO:0090394),-0.6523046092184368,-1.093201364239905,0.3385012919896641,0.8818129180278539,1.0,2/2,35.00%,MTMR2;PTEN
1214,prerank,cellular amino acid catabolic process (GO:0009063),0.4481369587109768,1.09277393899938,0.36151960784313725,1.0,1.0,7/7,55.50%,HAAO;ABAT;AMDHD1;GOT1;HIBCH;DDAH1;ACADSB
1215,prerank,linoleic acid metabolic process (GO:0043651),0.8168168168168168,1.0924903935862358,0.36811023622047245,1.0,1.0,1/1,18.40%,ELOVL2
1216,prerank,alpha-linolenic acid metabolic process (GO:0036109),0.8168168168168168,1.0924903935862358,0.36811023622047245,1.0,1.0,1/1,18.40%,ELOVL2
1217,prerank,inorganic anion transmembrane transport (GO:0098661),-0.6412825651302605,-1.0915594329334795,0.329923273657289,0.8817071558727325,1.0,2/2,36.10%,SLC12A2;SLC1A3
1218,prerank,chloride transport (GO:0006821),-0.6412825651302605,-1.0915594329334795,0.329923273657289,0.8817071558727325,1.0,2/2,36.10%,SLC12A2;SLC1A3
1219,prerank,transepithelial transport (GO:0070633),-0.6412825651302605,-1.0915594329334795,0.329923273657289,0.8817071558727325,1.0,2/2,36.10%,SLC12A2;SLC1A3
1220,prerank,chloride transmembrane transport (GO:1902476),-0.6412825651302605,-1.0915594329334795,0.329923273657289,0.8817071558727325,1.0,2/2,36.10%,SLC12A2;SLC1A3
1221,prerank,T cell differentiation in thymus (GO:0033077),0.8188188188188188,1.0915209609560566,0.35564053537284895,1.0,1.0,1/1,18.20%,GLI3
1222,prerank,embryonic digestive tract development (GO:0048566),0.8188188188188188,1.0915209609560566,0.35564053537284895,1.0,1.0,1/1,18.20%,GLI3
1223,prerank,negative regulation of alpha-beta T cell activation (GO:0046636),0.8188188188188188,1.0915209609560566,0.35564053537284895,1.0,1.0,1/1,18.20%,GLI3
1224,prerank,T cell apoptotic process (GO:0070231),0.8188188188188188,1.0915209609560566,0.35564053537284895,1.0,1.0,1/1,18.20%,GLI3
1225,prerank,negative regulation of alpha-beta T cell differentiation (GO:0046639),0.8188188188188188,1.0915209609560566,0.35564053537284895,1.0,1.0,1/1,18.20%,GLI3
1226,prerank,digestive tract development (GO:0048565),0.8188188188188188,1.0915209609560566,0.35564053537284895,1.0,1.0,1/1,18.20%,GLI3
1227,prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.8188188188188188,1.0915209609560566,0.35564053537284895,1.0,1.0,1/1,18.20%,GLI3
1228,prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.8188188188188188,1.0915209609560566,0.35564053537284895,1.0,1.0,1/1,18.20%,GLI3
1229,prerank,positive regulation of T cell differentiation (GO:0045582),0.8188188188188188,1.0915209609560566,0.35564053537284895,1.0,1.0,1/1,18.20%,GLI3
1230,prerank,phosphate-containing compound metabolic process (GO:0006796),0.36945906067380396,1.0911796768677178,0.3640256959314775,1.0,1.0,3/14,10.10%,PLCH1;ALK;PTPRD
1231,prerank,response to calcium ion (GO:0051592),0.4152811597881178,1.090951901614394,0.37003405221339386,1.0,1.0,5/9,32.50%,ADCY8;KCNMA1;KCNMB1;DPEP1;CPNE5
1232,prerank,cellular response to organic cyclic compound (GO:0071407),0.4384835182864336,1.0907772313924389,0.34767441860465115,1.0,1.0,3/7,27.80%,ADCY8;RORA;WT1
1233,prerank,amino acid transport (GO:0006865),-0.6482965931863727,-1.0902561884422337,0.3609625668449198,0.8844468414270249,1.0,2/2,35.40%,SLC7A1;SLC38A9
1234,prerank,positive regulation of cell death (GO:0010942),0.5797527592878016,1.090244166728477,0.35942028985507246,1.0,1.0,2/3,28.20%,CALCR;ACER2
1235,prerank,peptidyl-proline modification (GO:0018208),-0.45281124497991965,-1.0902355748016788,0.31153846153846154,0.8830327040494506,1.0,4/4,55.00%,CWC27;PPIL2;FKBP5;FKBP10
1236,prerank,Golgi to lysosome transport (GO:0090160),0.7967967967967968,1.0887798391865051,0.3904382470119522,1.0,1.0,1/1,20.40%,RBSN
1237,prerank,early endosome to Golgi transport (GO:0034498),0.7967967967967968,1.0887798391865051,0.3904382470119522,1.0,1.0,1/1,20.40%,RBSN
1238,prerank,response to UV (GO:0009411),-0.37525150905432597,-1.0886478570086542,0.2804232804232804,0.8870355750182586,1.0,6/6,62.80%,CCND1;ZRANB3;DDB2;EGFR;WRN;CASP9
1239,prerank,positive regulation of intracellular protein transport (GO:0090316),-0.30030333670374115,-1.0884253825278878,0.2912621359223301,0.8863020094397354,1.0,11/11,70.40%,GAS6;UBE2D3;BCAS3;SREBF2;MFF;TFDP2;ITGB1BP1;TCAF1;NPEPPS;ZIC1;BCL2
1240,prerank,negative regulation of myoblast differentiation (GO:0045662),-0.6402805611222444,-1.0881949895560319,0.3229166666666667,0.8856547442648076,1.0,2/2,36.20%,PRICKLE1;TBX3
1241,prerank,regulation of myoblast differentiation (GO:0045661),-0.6402805611222444,-1.0876820304829369,0.3450134770889488,0.8859627108600526,1.0,2/2,36.20%,PLCB1;TBX3
1242,prerank,small GTPase mediated signal transduction (GO:0007264),0.4283935866742,1.0873283152219697,0.3778801843317972,1.0,1.0,3/8,16.00%,SHC3;TIAM1;RIT2
1243,prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.4268023899090413,1.0871177398493566,0.375,1.0,1.0,5/8,40.80%,SPTBN4;ANK1;COG7;PGAP1;CNIH3
1244,prerank,"phagocytosis, engulfment (GO:0006911)",0.4987049082287369,1.0862544159695424,0.37082818294190356,1.0,1.0,2/5,21.10%,XKR4;ADGRB1
1245,prerank,cellular response to amyloid-beta (GO:1904646),0.6649968398508203,1.0860928926152433,0.35748031496062993,1.0,1.0,1/2,3.50%,CACNA1A
1246,prerank,reelin-mediated signaling pathway (GO:0038026),0.7997997997997996,1.0858947816998132,0.3771186440677966,1.0,1.0,1/1,20.10%,LRP8
1247,prerank,regulation of innate immune response (GO:0045088),0.7997997997997996,1.0858947816998132,0.3771186440677966,1.0,1.0,1/1,20.10%,LRP8
1248,prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5851774491352407,1.0842470517244844,0.3546099290780142,1.0,1.0,1/3,6.80%,CNTNAP2
1249,prerank,regulation of histone modification (GO:0031056),-0.6322645290581161,-1.0834825667864871,0.3434343434343434,0.8968306040722451,1.0,2/2,37.00%,SETD5;PARG
1250,prerank,regulation of chromatin organization (GO:1902275),-0.6322645290581161,-1.0834825667864871,0.3434343434343434,0.8968306040722451,1.0,2/2,37.00%,SETD5;PARG
1251,prerank,negative regulation of viral genome replication (GO:0045071),0.526937460475319,1.0827360682259584,0.36315086782376504,1.0,1.0,1/4,1.50%,HMGA2
1252,prerank,neurotrophin signaling pathway (GO:0038179),0.8038038038038038,1.0825275248810264,0.3592233009708738,1.0,1.0,1/1,19.70%,MAGI2
1253,prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.8038038038038038,1.0825275248810264,0.3592233009708738,1.0,1.0,1/1,19.70%,MAGI2
1254,prerank,nerve growth factor signaling pathway (GO:0038180),0.8038038038038038,1.0825275248810264,0.3592233009708738,1.0,1.0,1/1,19.70%,MAGI2
1255,prerank,regulation of activin receptor signaling pathway (GO:0032925),0.8038038038038038,1.0825275248810264,0.3592233009708738,1.0,1.0,1/1,19.70%,MAGI2
1256,prerank,negative regulation of activin receptor signaling pathway (GO:0032926),0.8038038038038038,1.0825275248810264,0.3592233009708738,1.0,1.0,1/1,19.70%,MAGI2
1257,prerank,glomerular visceral epithelial cell development (GO:0072015),0.8038038038038038,1.0825275248810264,0.3592233009708738,1.0,1.0,1/1,19.70%,MAGI2
1258,prerank,positive regulation of phosphatase activity (GO:0010922),0.8038038038038038,1.0825275248810264,0.3592233009708738,1.0,1.0,1/1,19.70%,MAGI2
1259,prerank,glomerular epithelial cell development (GO:0072310),0.8038038038038038,1.0825275248810264,0.3592233009708738,1.0,1.0,1/1,19.70%,MAGI2
1260,prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.8188188188188188,-1.081673926571251,0.385395537525355,0.900664440482887,1.0,1/1,18.30%,TM7SF3
1261,prerank,chordate embryonic development (GO:0043009),-0.6262525050100199,-1.0815889524974869,0.35353535353535354,0.8994740552456827,1.0,2/2,37.60%,FGFR1;CHD7
1262,prerank,sphingolipid biosynthetic process (GO:0030148),0.4393234877538288,1.0814605004329476,0.37807881773399016,1.0,1.0,4/7,31.00%,ELOVL2;ELOVL7;ACER2;ELOVL6
1263,prerank,membrane lipid biosynthetic process (GO:0046467),0.4393234877538288,1.0814605004329476,0.37807881773399016,1.0,1.0,4/7,31.00%,ELOVL2;ELOVL7;ACER2;ELOVL6
1264,prerank,cardiac pacemaker cell development (GO:0060926),-0.6402805611222444,-1.0813896695914447,0.34177215189873417,0.8985406961767975,1.0,2/2,36.20%,BMPR1A;TBX3
1265,prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.4718875502008032,-1.0806234527434393,0.33884297520661155,0.8996006267657992,1.0,4/4,53.10%,CSNK2A1;PTEN;XPO1;PTK2
1266,prerank,toxin transport (GO:1901998),-0.8238238238238238,-1.0805795429116793,0.40451745379876797,0.8982521936290473,1.0,1/1,17.80%,ANTXR2
1267,prerank,methylguanosine-cap decapping (GO:0110156),-0.8068068068068068,-1.080179692097126,0.3597678916827853,0.8865691749272665,1.0,1/1,19.50%,DCP2
1268,prerank,deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.8068068068068068,-1.080179692097126,0.3597678916827853,0.8865691749272665,1.0,1/1,19.50%,DCP2
1269,prerank,RNA catabolic process (GO:0006401),-0.8068068068068068,-1.080179692097126,0.3597678916827853,0.8865691749272665,1.0,1/1,19.50%,DCP2
1270,prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.8068068068068068,-1.080179692097126,0.3597678916827853,0.8865691749272665,1.0,1/1,19.50%,DCP2
1271,prerank,histone mRNA metabolic process (GO:0008334),-0.8068068068068068,-1.080179692097126,0.3597678916827853,0.8865691749272665,1.0,1/1,19.50%,DCP2
1272,prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.8068068068068068,-1.080179692097126,0.3597678916827853,0.8865691749272665,1.0,1/1,19.50%,DCP2
1273,prerank,histone mRNA catabolic process (GO:0071044),-0.8068068068068068,-1.080179692097126,0.3597678916827853,0.8865691749272665,1.0,1/1,19.50%,DCP2
1274,prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.8068068068068068,-1.080179692097126,0.3597678916827853,0.8865691749272665,1.0,1/1,19.50%,DCP2
1275,prerank,mRNA catabolic process (GO:0006402),-0.8068068068068068,-1.080179692097126,0.3597678916827853,0.8865691749272665,1.0,1/1,19.50%,DCP2
1276,prerank,regulation of BMP signaling pathway (GO:0030510),0.4845991606002138,1.0799698581171726,0.3886075949367089,1.0,1.0,2/5,20.50%,ZNF423;BMPER
1277,prerank,positive regulation of mitochondrion organization (GO:0010822),0.6648473615910885,1.0798611128325566,0.3751962323390895,1.0,1.0,1/2,12.20%,PPARGC1A
1278,prerank,glutamine family amino acid metabolic process (GO:0009064),-0.46787148594377503,-1.079229730843578,0.33884297520661155,0.8880291840689672,1.0,4/4,53.50%,OAT;GCLM;DDAH1;GOT1
1279,prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.44016568510706217,1.0788024344662859,0.3723404255319149,1.0,1.0,3/7,21.10%,SEMA3E;SEMA6A;ADGRB1
1280,prerank,positive regulation of bone mineralization (GO:0030501),0.6577690213051168,1.0785790546252358,0.3832528180354267,1.0,1.0,1/2,10.20%,FBN2
1281,prerank,positive regulation of ossification (GO:0045778),0.6577690213051168,1.0785790546252358,0.3832528180354267,1.0,1.0,1/2,10.20%,FBN2
1282,prerank,positive regulation of biomineral tissue development (GO:0070169),0.6577690213051168,1.0785790546252358,0.3832528180354267,1.0,1.0,1/2,10.20%,FBN2
1283,prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.40502512562814075,-1.0779021484379911,0.3682008368200837,0.8906406817199386,1.0,5/5,59.80%,ARID1B;TAF1D;KAT2B;KAT2A;TAF1C
1284,prerank,regulation of cell development (GO:0060284),-0.46084337349397586,-1.0777891067604541,0.32669322709163345,0.8896475092289813,1.0,4/4,54.20%,PER2;NOTCH2;FBXO22;ADGRA2
1285,prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.7977977977977978,1.0772421454114665,0.3805668016194332,1.0,1.0,1/1,20.30%,SEMA6A
1286,prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7977977977977978,1.0772421454114665,0.3805668016194332,1.0,1.0,1/1,20.30%,SEMA6A
1287,prerank,cellular response to metal ion (GO:0071248),0.4424546769017679,1.0769020202324326,0.36873508353221957,1.0,1.0,4/7,32.50%,ADCY8;DLG2;DPEP1;CPNE5
1288,prerank,receptor-mediated endocytosis (GO:0006898),-0.4100502512562815,-1.0766356241243726,0.3230088495575221,0.8922133651864337,1.0,5/5,59.30%,INSR;AP2A2;COLEC12;INPP5F;FNBP1L
1289,prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.7957957957957957,1.076593552146362,0.3665338645418327,1.0,1.0,1/1,20.50%,BMPER
1290,prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.46485943775100397,-1.0760705865483076,0.36213991769547327,0.8910262259250915,1.0,4/4,53.80%,CCND1;PLCB1;CCND2;EGFR
1291,prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.46485943775100397,-1.0760705865483076,0.36213991769547327,0.8910262259250915,1.0,4/4,53.80%,CCND1;PLCB1;CCND2;EGFR
1292,prerank,protein phosphorylation (GO:0006468),0.2988995287768728,1.0759444260087112,0.37074148296593185,1.0,1.0,27/46,47.10%,WNK2;ALK;WNK3;STK33;CAMK1D;CDC42BPA;STK32B;STK39;MAP2K6;CDK14;AKT3;CDK6;GRK5;CAMK1G;PRKAR1B;DDR2;MAST2;MAP3K13;IGF1R;UHMK1;SRPK1;FLT4;STK32C;PRKCA;VRK1;EGFR;PTK2
1293,prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.5235538406245697,1.075356945246037,0.3832658569500675,1.0,1.0,2/4,19.50%,CACNB2;CTNNA3
1294,prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.628256513026052,-1.0752705827620639,0.35638297872340424,0.890901620833421,1.0,2/2,37.40%,PLA2G4A;LPCAT1
1295,prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.628256513026052,-1.0752705827620639,0.35638297872340424,0.890901620833421,1.0,2/2,37.40%,PLA2G4A;LPCAT1
1296,prerank,import into cell (GO:0098657),-0.6412825651302605,-1.0746348653356548,0.3790523690773067,0.8900798605145159,1.0,2/2,36.10%,SLC7A1;SLC1A3
1297,prerank,amino acid import across plasma membrane (GO:0089718),-0.6412825651302605,-1.0746348653356548,0.3790523690773067,0.8900798605145159,1.0,2/2,36.10%,SLC7A1;SLC1A3
1298,prerank,regulation of glycolytic process (GO:0006110),-0.4172897697709669,-1.0744287157443018,0.375,0.8893540014801142,1.0,4/5,23.00%,INSR;NUP58;ARNT;ZBTB20
1299,prerank,cellular response to ionizing radiation (GO:0071479),-0.45080321285140557,-1.0738038234582101,0.35793357933579334,0.8899494843192499,1.0,4/4,55.20%,SPIDR;NUCKS1;MDM2;WRN
1300,prerank,negative regulation of mononuclear cell migration (GO:0071676),0.6534910992256533,1.0721326407062113,0.3867924528301887,1.0,1.0,1/2,9.80%,SLIT2
1301,prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.8058058058058059,-1.0712559928149472,0.39923954372623577,0.8889094232745309,1.0,1/1,19.60%,MTMR2
1302,prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.8058058058058059,-1.0712559928149472,0.39923954372623577,0.8889094232745309,1.0,1/1,19.60%,MTMR2
1303,prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.8058058058058059,-1.0712559928149472,0.39923954372623577,0.8889094232745309,1.0,1/1,19.60%,MTMR2
1304,prerank,regulation of receptor catabolic process (GO:2000644),-0.8058058058058059,-1.0712559928149472,0.39923954372623577,0.8889094232745309,1.0,1/1,19.60%,MTMR2
1305,prerank,negative regulation of endocytosis (GO:0045806),-0.8058058058058059,-1.0712559928149472,0.39923954372623577,0.8889094232745309,1.0,1/1,19.60%,MTMR2
1306,prerank,negative regulation of receptor internalization (GO:0002091),-0.8058058058058059,-1.0712559928149472,0.39923954372623577,0.8889094232745309,1.0,1/1,19.60%,MTMR2
1307,prerank,positive regulation of early endosome to late endosome transport (GO:2000643),-0.8058058058058059,-1.0712559928149472,0.39923954372623577,0.8889094232745309,1.0,1/1,19.60%,MTMR2
1308,prerank,actin polymerization or depolymerization (GO:0008154),0.5291638742884327,1.0712193603697056,0.3722149410222805,1.0,1.0,2/4,21.50%,WASF3;ENAH
1309,prerank,modified amino acid transport (GO:0072337),0.8028028028028028,1.0709820728584125,0.3972602739726027,1.0,1.0,1/1,19.80%,SLC16A12
1310,prerank,parallel actin filament bundle assembly (GO:0030046),0.8008008008008007,1.0708864444490656,0.39029126213592236,1.0,1.0,1/1,20.00%,FMN2
1311,prerank,female gamete generation (GO:0007292),0.8008008008008007,1.0708864444490656,0.39029126213592236,1.0,1.0,1/1,20.00%,FMN2
1312,prerank,oogenesis (GO:0048477),0.8008008008008007,1.0708864444490656,0.39029126213592236,1.0,1.0,1/1,20.00%,FMN2
1313,prerank,MAPK cascade (GO:0000165),0.3276172104690296,1.0702119102891783,0.38508682328907046,1.0,1.0,18/23,58.20%,NRG1;LRRC7;SHC3;NRG2;SPTBN4;RIT2;DLG2;IRS1;IL17RD;GFRA1;ABHD17C;EGFR;PTK2;SHC2;FGF13;IL3RA;PPP5C;NF1
1314,prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.8078078078078078,-1.0698771911638754,0.3991769547325103,0.8895292804043098,1.0,1/1,19.40%,RAB3GAP2
1315,prerank,regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.8078078078078078,-1.0698771911638754,0.3991769547325103,0.8895292804043098,1.0,1/1,19.40%,RAB3GAP2
1316,prerank,regulation of protein lipidation (GO:1903059),-0.8078078078078078,-1.0698771911638754,0.3991769547325103,0.8895292804043098,1.0,1/1,19.40%,RAB3GAP2
1317,prerank,regulation of protein autoubiquitination (GO:1902498),0.8088088088088088,1.0693071192250025,0.40467625899280574,1.0,1.0,1/1,19.20%,SASH1
1318,prerank,positive regulation of JUN kinase activity (GO:0043507),0.8088088088088088,1.0693071192250025,0.40467625899280574,1.0,1.0,1/1,19.20%,SASH1
1319,prerank,regulation of protein K63-linked ubiquitination (GO:1900044),0.8088088088088088,1.0693071192250025,0.40467625899280574,1.0,1.0,1/1,19.20%,SASH1
1320,prerank,regulation of JUN kinase activity (GO:0043506),0.8088088088088088,1.0693071192250025,0.40467625899280574,1.0,1.0,1/1,19.20%,SASH1
1321,prerank,regulation of cellular pH (GO:0030641),0.7827827827827828,1.0690908059506747,0.4087136929460581,1.0,1.0,1/1,21.80%,SLC9C1
1322,prerank,regulation of intracellular pH (GO:0051453),0.7827827827827828,1.0690908059506747,0.4087136929460581,1.0,1.0,1/1,21.80%,SLC9C1
1323,prerank,phosphatidylinositol metabolic process (GO:0046488),-0.33669354838709675,-1.0688026880114223,0.32867132867132864,0.8916602098696063,1.0,8/8,66.70%,PIP4K2A;MTMR2;PLCB1;PLA2G4A;MTMR1;PTEN;INPP5F;PGAP1
1324,prerank,cellular response to amino acid stimulus (GO:0071230),-0.4020100502512563,-1.0686089543503876,0.3486238532110092,0.890826739234494,1.0,5/5,60.10%,UBR2;CAPN2;SESN3;SLC38A9;CPEB3
1325,prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.7957957957957957,-1.068466657196867,0.3821138211382114,0.8873938135175511,1.0,1/1,20.60%,ARNT
1326,prerank,regulation of hormone biosynthetic process (GO:0046885),-0.7957957957957957,-1.068466657196867,0.3821138211382114,0.8873938135175511,1.0,1/1,20.60%,ARNT
1327,prerank,positive regulation of hormone metabolic process (GO:0032352),-0.7957957957957957,-1.068466657196867,0.3821138211382114,0.8873938135175511,1.0,1/1,20.60%,ARNT
1328,prerank,type B pancreatic cell development (GO:0003323),0.6513026052104208,1.0678779097492093,0.4094616639477977,1.0,1.0,2/2,35.00%,CDH2;CDK6
1329,prerank,type B pancreatic cell differentiation (GO:0003309),0.6513026052104208,1.0678779097492093,0.4094616639477977,1.0,1.0,2/2,35.00%,CDH2;CDK6
1330,prerank,glandular epithelial cell development (GO:0002068),0.6513026052104208,1.0678779097492093,0.4094616639477977,1.0,1.0,2/2,35.00%,CDH2;CDK6
1331,prerank,cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.8058058058058057,1.0676253481712699,0.3850687622789784,1.0,1.0,1/1,19.50%,CTNNA3
1332,prerank,bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),0.8058058058058057,1.0676253481712699,0.3850687622789784,1.0,1.0,1/1,19.50%,CTNNA3
1333,prerank,bundle of His cell to Purkinje myocyte communication (GO:0086069),0.8058058058058057,1.0676253481712699,0.3850687622789784,1.0,1.0,1/1,19.50%,CTNNA3
1334,prerank,neuron projection regeneration (GO:0031102),0.8068068068068068,1.0666161546705002,0.4137254901960784,1.0,1.0,1/1,19.40%,MAPK8IP3
1335,prerank,response to axon injury (GO:0048678),0.8068068068068068,1.0666161546705002,0.4137254901960784,1.0,1.0,1/1,19.40%,MAPK8IP3
1336,prerank,axon regeneration (GO:0031103),0.8068068068068068,1.0666161546705002,0.4137254901960784,1.0,1.0,1/1,19.40%,MAPK8IP3
1337,prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.8098098098098099,1.0661704189108938,0.39723320158102765,1.0,1.0,1/1,19.10%,SEMA3E
1338,prerank,recombinational repair (GO:0000725),-0.4591656681632908,-1.0658532953577522,0.35390946502057613,0.8930303037778119,1.0,3/4,9.40%,SPIDR;NUCKS1;REV3L
1339,prerank,double-strand break repair via homologous recombination (GO:0000724),-0.4591656681632908,-1.0658532953577522,0.35390946502057613,0.8930303037778119,1.0,3/4,9.40%,SPIDR;NUCKS1;REV3L
1340,prerank,organic anion transport (GO:0015711),-0.6202404809619237,-1.065727914297953,0.35990338164251207,0.8920003322816598,1.0,2/2,38.20%,SLCO3A1;CA5B
1341,prerank,chemical homeostasis (GO:0048878),0.49065286696379473,1.0655547638910259,0.3864795918367347,1.0,1.0,2/5,13.70%,WNK2;WNK3
1342,prerank,regulation of gene silencing by RNA (GO:0060966),-0.41306532663316586,-1.0650319238716957,0.3696682464454976,0.8898998198409714,1.0,5/5,59.00%,AGO2;NUP58;TNRC6A;IPO8;NUP93
1343,prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.41306532663316586,-1.0650319238716957,0.3696682464454976,0.8898998198409714,1.0,5/5,59.00%,AGO2;NUP58;TNRC6A;IPO8;NUP93
1344,prerank,regulation of gene silencing by miRNA (GO:0060964),-0.41306532663316586,-1.0650319238716957,0.3696682464454976,0.8898998198409714,1.0,5/5,59.00%,AGO2;NUP58;TNRC6A;IPO8;NUP93
1345,prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.7987987987987988,-1.0641360539247033,0.38551859099804303,0.8863924377411518,1.0,1/1,20.30%,MDM2
1346,prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.7987987987987988,-1.0641360539247033,0.38551859099804303,0.8863924377411518,1.0,1/1,20.30%,MDM2
1347,prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.7987987987987988,-1.0641360539247033,0.38551859099804303,0.8863924377411518,1.0,1/1,20.30%,MDM2
1348,prerank,cellular response to antibiotic (GO:0071236),-0.7987987987987988,-1.0641360539247033,0.38551859099804303,0.8863924377411518,1.0,1/1,20.30%,MDM2
1349,prerank,regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.7987987987987988,-1.0641360539247033,0.38551859099804303,0.8863924377411518,1.0,1/1,20.30%,MDM2
1350,prerank,regulation of cytokinesis (GO:0032465),-0.4,-1.0640971632238523,0.3870967741935484,0.8852237205568809,1.0,5/5,60.30%,PKN2;AHCTF1;CDC14A;SPAST;CDC14B
1351,prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3640500559328502,1.0640343063691227,0.39445628997867804,1.0,1.0,9/14,47.60%,NRG1;NRG2;CALCR;HIP1;IRS1;IGF1R;EGFR;PTK2;GCNT2
1352,prerank,sterol homeostasis (GO:0055092),0.4846979789573306,1.0635684530081146,0.3706467661691542,1.0,1.0,4/5,45.40%,RORA;ABCA5;GRAMD1B;LIPG
1353,prerank,cholesterol homeostasis (GO:0042632),0.4846979789573306,1.0635684530081146,0.3706467661691542,1.0,1.0,4/5,45.40%,RORA;ABCA5;GRAMD1B;LIPG
1354,prerank,establishment of vesicle localization (GO:0051650),0.7987987987987988,1.0624060389184145,0.3856858846918489,1.0,1.0,1/1,20.20%,KIF5C
1355,prerank,synaptic vesicle localization (GO:0097479),0.7987987987987988,1.0624060389184145,0.3856858846918489,1.0,1.0,1/1,20.20%,KIF5C
1356,prerank,synaptic vesicle transport (GO:0048489),0.7987987987987988,1.0624060389184145,0.3856858846918489,1.0,1.0,1/1,20.20%,KIF5C
1357,prerank,anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),0.7987987987987988,1.0624060389184145,0.3856858846918489,1.0,1.0,1/1,20.20%,KIF5C
1358,prerank,anterograde dendritic transport (GO:0098937),0.7987987987987988,1.0624060389184145,0.3856858846918489,1.0,1.0,1/1,20.20%,KIF5C
1359,prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.7887887887887887,1.0614784263078239,0.4144329896907217,1.0,1.0,1/1,21.20%,HIP1
1360,prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.7887887887887887,1.0614784263078239,0.4144329896907217,1.0,1.0,1/1,21.20%,HIP1
1361,prerank,clathrin coat assembly (GO:0048268),0.7887887887887887,1.0614784263078239,0.4144329896907217,1.0,1.0,1/1,21.20%,HIP1
1362,prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.7887887887887887,1.0614784263078239,0.4144329896907217,1.0,1.0,1/1,21.20%,HIP1
1363,prerank,regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.7887887887887887,1.0614784263078239,0.4144329896907217,1.0,1.0,1/1,21.20%,HIP1
1364,prerank,phosphatidic acid metabolic process (GO:0046473),-0.44879518072289154,-1.0612864732142178,0.3598326359832636,0.8912408370085453,1.0,4/4,55.40%,PLD1;PLA2G4A;LPCAT1;DDHD2
1365,prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.44879518072289154,-1.0612864732142178,0.3598326359832636,0.8912408370085453,1.0,4/4,55.40%,PLD1;PLA2G4A;LPCAT1;DDHD2
1366,prerank,cartilage development (GO:0051216),0.5652266633894439,1.060001541429107,0.4090909090909091,1.0,1.0,1/3,1.50%,HMGA2
1367,prerank,cellular response to peptide (GO:1901653),0.569088059180929,1.0598651470124487,0.40714285714285714,1.0,1.0,1/3,3.50%,CACNA1A
1368,prerank,DNA metabolic process (GO:0006259),-0.22341391241333264,-1.0594510867012121,0.40425531914893614,0.8954490679312902,1.0,15/16,61.40%,PRIM2;SMARCAD1;CSNK1E;MNAT1;ORC3;CHD1L;RFC1;ORC4;ZRANB3;FANCC;PARG;DDB2;DNASE1;WRN;RFC3
1369,prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.5786187293782827,1.059329496192975,0.39652677279305354,1.0,1.0,2/3,30.10%,BAIAP2L1;TRPV4
1370,prerank,regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.8028028028028028,-1.0587130240521725,0.42735042735042733,0.8965439177523251,1.0,1/1,19.90%,ROBO1
1371,prerank,central nervous system development (GO:0007417),0.3300946801701673,1.058365170013131,0.40890269151138714,1.0,1.0,11/21,37.60%,ASIC2;CNTNAP2;SH3GL2;ADGRL3;CDH2;SNTG2;ROBO2;MEIS1;ZIC1;ATXN1;MEIS2
1372,prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.7927927927927928,-1.0582976866955507,0.39014373716632444,0.8909339793665978,1.0,1/1,20.90%,PFKP
1373,prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.7927927927927928,-1.0582976866955507,0.39014373716632444,0.8909339793665978,1.0,1/1,20.90%,PFKP
1374,prerank,glucose catabolic process to pyruvate (GO:0061718),-0.7927927927927928,-1.0582976866955507,0.39014373716632444,0.8909339793665978,1.0,1/1,20.90%,PFKP
1375,prerank,canonical glycolysis (GO:0061621),-0.7927927927927928,-1.0582976866955507,0.39014373716632444,0.8909339793665978,1.0,1/1,20.90%,PFKP
1376,prerank,"fructose 1,6-bisphosphate metabolic process (GO:0030388)",-0.7927927927927928,-1.0582976866955507,0.39014373716632444,0.8909339793665978,1.0,1/1,20.90%,PFKP
1377,prerank,RNA biosynthetic process (GO:0032774),-0.7897897897897898,-1.057750468818577,0.4027777777777778,0.8902094567187487,1.0,1/1,21.20%,PRIM2
1378,prerank,"DNA replication, synthesis of RNA primer (GO:0006269)",-0.7897897897897898,-1.057750468818577,0.4027777777777778,0.8902094567187487,1.0,1/1,21.20%,PRIM2
1379,prerank,regulation of ruffle assembly (GO:1900027),0.5682877006153859,1.0575881277776689,0.4118476727785614,1.0,1.0,2/3,31.20%,KANK1;EPS8L2
1380,prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.7917917917917918,-1.0575599634962598,0.41286307053941906,0.8880814298074474,1.0,1/1,21.00%,EXT1
1381,prerank,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.7917917917917918,-1.0575599634962598,0.41286307053941906,0.8880814298074474,1.0,1/1,21.00%,EXT1
1382,prerank,positive regulation of cell cycle process (GO:0090068),-0.4,-1.0575074341316297,0.3761904761904762,0.8870633177942033,1.0,5/5,60.30%,INSR;PKN2;CDC14A;SPAST;CDC14B
1383,prerank,long-chain fatty acid metabolic process (GO:0001676),0.479570077141784,1.0570614083267786,0.3904639175257732,1.0,1.0,3/5,31.00%,GLYATL2;ELOVL2;ELOVL6
1384,prerank,cellular cation homeostasis (GO:0030003),0.8138138138138138,1.0564848162876268,0.4308617234468938,1.0,1.0,1/1,18.70%,CLDN16
1385,prerank,negative regulation of developmental process (GO:0051093),0.43094312181356087,1.0564525917326848,0.41211401425178146,1.0,1.0,4/7,35.00%,DCC;KANK1;BCL11A;CDK6
1386,prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.7837837837837838,1.0564152401531133,0.4003831417624521,1.0,1.0,1/1,21.70%,KANK1
1387,prerank,glomerular visceral epithelial cell migration (GO:0090521),0.7837837837837838,1.0564152401531133,0.4003831417624521,1.0,1.0,1/1,21.70%,KANK1
1388,prerank,actin filament organization (GO:0007015),0.3648572114130868,1.0562844460219414,0.41566920565832427,1.0,1.0,6/14,30.10%,SHROOM3;GAS2;HIP1;ENAH;BAIAP2L1;TRPV4
1389,prerank,O-glycan processing (GO:0016266),0.5132462549185177,1.0539729829227642,0.3895582329317269,1.0,1.0,3/4,37.10%,GALNT14;MUC6;MUC5AC
1390,prerank,regulation of response to DNA damage stimulus (GO:2001020),0.5082340808017447,1.0532975925496002,0.4037184594953519,1.0,1.0,1/4,1.50%,HMGA2
1391,prerank,regulation of microvillus organization (GO:0032530),-0.7997997997997998,-1.0528493294933727,0.43013100436681223,0.8987375665611056,1.0,1/1,20.20%,PLD1
1392,prerank,regulation of microvillus assembly (GO:0032534),-0.7997997997997998,-1.0528493294933727,0.43013100436681223,0.8987375665611056,1.0,1/1,20.20%,PLD1
1393,prerank,regulation of small molecule metabolic process (GO:0062012),0.7947947947947948,1.0520830433644928,0.4432773109243697,1.0,1.0,1/1,20.60%,RORA
1394,prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7947947947947948,1.0520830433644928,0.4432773109243697,1.0,1.0,1/1,20.60%,RORA
1395,prerank,muscle cell differentiation (GO:0042692),0.7947947947947948,1.0520830433644928,0.4432773109243697,1.0,1.0,1/1,20.60%,RORA
1396,prerank,regulation of steroid metabolic process (GO:0019218),0.7947947947947948,1.0520830433644928,0.4432773109243697,1.0,1.0,1/1,20.60%,RORA
1397,prerank,triglyceride homeostasis (GO:0070328),0.7947947947947948,1.0520830433644928,0.4432773109243697,1.0,1.0,1/1,20.60%,RORA
1398,prerank,acylglycerol homeostasis (GO:0055090),0.7947947947947948,1.0520830433644928,0.4432773109243697,1.0,1.0,1/1,20.60%,RORA
1399,prerank,negative regulation of defense response (GO:0031348),0.7947947947947948,1.0520830433644928,0.4432773109243697,1.0,1.0,1/1,20.60%,RORA
1400,prerank,response to sterol (GO:0036314),0.7947947947947948,1.0520830433644928,0.4432773109243697,1.0,1.0,1/1,20.60%,RORA
1401,prerank,kidney development (GO:0001822),0.5095428456420441,1.0516518221790716,0.38722826086956524,1.0,1.0,3/4,33.00%,ROBO2;WT1;GREB1L
1402,prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.568550063603253,1.051386914791211,0.4175977653631285,1.0,1.0,1/3,1.50%,HMGA2
1403,prerank,mitotic G2/M transition checkpoint (GO:0044818),0.568550063603253,1.051386914791211,0.4175977653631285,1.0,1.0,1/3,1.50%,HMGA2
1404,prerank,regulation of relaxation of cardiac muscle (GO:1901897),0.646195629158882,1.0512132005388248,0.40345368916797486,1.0,1.0,1/2,12.80%,PDE4B
1405,prerank,glycosaminoglycan metabolic process (GO:0030203),0.4554266116169915,1.0511344534014428,0.4141656662665066,1.0,1.0,5/6,47.60%,HS3ST5;CHST9;GPC4;GPC3;GCNT2
1406,prerank,protein import into nucleus (GO:0006606),-0.41306532663316586,-1.0509704308603536,0.36764705882352944,0.9031262520683373,1.0,5/5,59.00%,TNPO1;PRICKLE1;KPNA5;IPO8;NUP93
1407,prerank,protein mannosylation (GO:0035268),-0.5155466399197592,-1.0508696581265677,0.37694704049844235,0.9021845981839717,1.0,3/3,48.70%,TMTC1;TMTC2;DPY19L3
1408,prerank,positive regulation of angiogenesis (GO:0045766),0.41773234674052456,1.050789719553517,0.40046565774155995,1.0,1.0,4/8,29.50%,HMGA2;SASH1;BMPER;SMOC2
1409,prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.511489156092312,1.0501587789377407,0.412483039348711,1.0,1.0,2/4,23.50%,SEMA3E;BAIAP2L1
1410,prerank,negative regulation of response to external stimulus (GO:0032102),0.5048386988307622,1.0499952083606987,0.3991769547325103,1.0,1.0,2/4,20.60%,GRID2;RORA
1411,prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.4020100502512563,-1.0494128605163935,0.3698630136986301,0.9053981499420424,1.0,5/5,60.10%,AGO2;ZC3HAV1;TNRC6A;TNRC6B;CPEB3
1412,prerank,histone H3 acetylation (GO:0043966),-0.43674698795180716,-1.0484947128407984,0.3794466403162055,0.906635608439777,1.0,4/4,56.60%,PHF14;KAT2B;KAT2A;KAT6B
1413,prerank,glucose homeostasis (GO:0042593),0.413144872301526,1.0483440695676045,0.4149425287356322,1.0,1.0,2/8,12.20%,ADCY8;PPARGC1A
1414,prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.7897897897897896,1.0483260997128097,0.44163424124513617,1.0,1.0,1/1,21.10%,ADGRB1
1415,prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.7897897897897896,1.0483260997128097,0.44163424124513617,1.0,1.0,1/1,21.10%,ADGRB1
1416,prerank,positive regulation of myoblast fusion (GO:1901741),0.7897897897897896,1.0483260997128097,0.44163424124513617,1.0,1.0,1/1,21.10%,ADGRB1
1417,prerank,regulation of myoblast fusion (GO:1901739),0.7897897897897896,1.0483260997128097,0.44163424124513617,1.0,1.0,1/1,21.10%,ADGRB1
1418,prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.7897897897897896,1.0483260997128097,0.44163424124513617,1.0,1.0,1/1,21.10%,ADGRB1
1419,prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.7897897897897896,1.0483260997128097,0.44163424124513617,1.0,1.0,1/1,21.10%,ADGRB1
1420,prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.5135406218655968,-1.0482627622629161,0.3836477987421384,0.9060474319359066,1.0,3/3,48.90%,DCP2;CNOT6;SAMD4A
1421,prerank,regulation of cAMP-mediated signaling (GO:0043949),0.6382765531062125,1.04802293042991,0.4304635761589404,1.0,1.0,2/2,36.30%,PRKAR2B;PRKAR1B
1422,prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6382765531062125,1.04802293042991,0.4304635761589404,1.0,1.0,2/2,36.30%,PRKAR2B;PRKAR1B
1423,prerank,negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.6382765531062125,1.04802293042991,0.4304635761589404,1.0,1.0,2/2,36.30%,PRKAR2B;PRKAR1B
1424,prerank,signal transduction in response to DNA damage (GO:0042770),0.5078141667369267,1.0471301409163967,0.3904382470119522,1.0,1.0,3/4,37.40%,STK33;ACER2;CASP9
1425,prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.5652339428099272,1.0466196084138537,0.4307004470938897,1.0,1.0,2/3,21.20%,SH3GL2;HIP1
1426,prerank,DNA double-strand break processing (GO:0000729),-0.7847847847847848,-1.0464698966648107,0.434878587196468,0.9085343738433794,1.0,1/1,21.70%,SMARCAD1
1427,prerank,histone H4 deacetylation (GO:0070933),-0.7847847847847848,-1.0464698966648107,0.434878587196468,0.9085343738433794,1.0,1/1,21.70%,SMARCAD1
1428,prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.40502512562814075,-1.0460384306889574,0.3853211009174312,0.9084859848740987,1.0,5/5,59.80%,TAF1D;HDAC5;KAT2B;KAT2A;TAF1C
1429,prerank,positive regulation of behavior (GO:0048520),-0.7797797797797797,-1.0450526405094642,0.4288537549407115,0.9102156805332454,1.0,1/1,22.20%,NPAS2
1430,prerank,protein-containing complex assembly (GO:0065003),0.32296225175611093,1.0447719931800294,0.41649484536082476,1.0,1.0,11/22,40.80%,ADCY8;TIAM1;PPARGC1A;WASF3;TRAPPC9;LIN7A;PARD3;TCF7L1;BCL9;CD2AP;CNIH3
1431,prerank,regulation of cell adhesion molecule production (GO:0060353),-0.7867867867867868,-1.0446887403384162,0.4302554027504912,0.9048747774197802,1.0,1/1,21.50%,COLEC12
1432,prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.7867867867867868,-1.0446887403384162,0.4302554027504912,0.9048747774197802,1.0,1/1,21.50%,COLEC12
1433,prerank,cellular response to exogenous dsRNA (GO:0071360),-0.7867867867867868,-1.0446887403384162,0.4302554027504912,0.9048747774197802,1.0,1/1,21.50%,COLEC12
1434,prerank,response to exogenous dsRNA (GO:0043330),-0.7867867867867868,-1.0446887403384162,0.4302554027504912,0.9048747774197802,1.0,1/1,21.50%,COLEC12
1435,prerank,cellular response to dsRNA (GO:0071359),-0.7867867867867868,-1.0446887403384162,0.4302554027504912,0.9048747774197802,1.0,1/1,21.50%,COLEC12
1436,prerank,positive regulation of TORC1 signaling (GO:1904263),0.7807807807807807,1.04425483473581,0.43313373253493015,1.0,1.0,1/1,22.00%,GPR137C
1437,prerank,DNA duplex unwinding (GO:0032508),-0.45080321285140557,-1.0435116557666735,0.4098939929328622,0.9070786001420721,1.0,4/4,55.20%,ASCC3;CHD1L;DDB2;WRN
1438,prerank,metal ion transport (GO:0030001),0.4718596569565875,1.043378481798482,0.41992433795712486,1.0,1.0,4/5,42.80%,CACNA1A;TRPV4;CACNA1C;TRPC1
1439,prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.6152304609218436,-1.0430320942285851,0.41581632653061223,0.9060606026255371,1.0,2/2,38.70%,DCP2;CNOT6
1440,prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.6152304609218436,-1.0430320942285851,0.41581632653061223,0.9060606026255371,1.0,2/2,38.70%,DCP2;CNOT6
1441,prerank,acylglycerol metabolic process (GO:0006639),-0.6132264529058116,-1.0421871881859899,0.4088541666666667,0.9073313922929336,1.0,2/2,38.90%,MGLL;GK
1442,prerank,regulation of vasoconstriction (GO:0019229),0.5576728455133965,1.0413987619662914,0.413447782546495,1.0,1.0,1/3,4.90%,CHRM3
1443,prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.7797797797797797,1.0411532623496051,0.4488517745302714,1.0,1.0,1/1,22.10%,STK39
1444,prerank,negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.7797797797797797,1.0411532623496051,0.4488517745302714,1.0,1.0,1/1,22.10%,STK39
1445,prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.7797797797797797,1.0411532623496051,0.4488517745302714,1.0,1.0,1/1,22.10%,STK39
1446,prerank,positive regulation of T cell migration (GO:2000406),0.7797797797797797,1.0411532623496051,0.4488517745302714,1.0,1.0,1/1,22.10%,STK39
1447,prerank,positive regulation of T cell chemotaxis (GO:0010820),0.7797797797797797,1.0411532623496051,0.4488517745302714,1.0,1.0,1/1,22.10%,STK39
1448,prerank,chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),0.7797797797797797,1.0411532623496051,0.4488517745302714,1.0,1.0,1/1,22.10%,STK39
1449,prerank,regulation of T cell chemotaxis (GO:0010819),0.7797797797797797,1.0411532623496051,0.4488517745302714,1.0,1.0,1/1,22.10%,STK39
1450,prerank,negative regulation of potassium ion transport (GO:0043267),0.7797797797797797,1.0411532623496051,0.4488517745302714,1.0,1.0,1/1,22.10%,STK39
1451,prerank,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.7837837837837838,-1.0411392487570108,0.4294117647058823,0.9065636733774267,1.0,1/1,21.80%,PAPSS1
1452,prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.7837837837837838,-1.0411392487570108,0.4294117647058823,0.9065636733774267,1.0,1/1,21.80%,PAPSS1
1453,prerank,purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.7837837837837838,-1.0411392487570108,0.4294117647058823,0.9065636733774267,1.0,1/1,21.80%,PAPSS1
1454,prerank,T cell proliferation (GO:0042098),0.6286191816441908,1.0410778676795942,0.4135702746365105,1.0,1.0,1/2,16.50%,CADM1
1455,prerank,DNA biosynthetic process (GO:0071897),0.551654964894684,1.04062660192847,0.4301994301994302,1.0,1.0,3/3,45.00%,POLE;RFC3;WRN
1456,prerank,aortic valve morphogenesis (GO:0003180),0.5087978384260017,1.0400677059919052,0.41655716162943496,1.0,1.0,2/4,25.20%,SLIT2;ROBO2
1457,prerank,aortic valve development (GO:0003176),0.5087978384260017,1.0400677059919052,0.41655716162943496,1.0,1.0,2/4,25.20%,SLIT2;ROBO2
1458,prerank,regulation of cellular biosynthetic process (GO:0031326),0.5599923356080978,1.0398428867973315,0.41125541125541126,1.0,1.0,1/3,13.90%,NOS1AP
1459,prerank,negative regulation of binding (GO:0051100),0.4764919584457096,1.0397962715789333,0.4354005167958656,1.0,1.0,1/5,1.50%,HMGA2
1460,prerank,L-arginine import across plasma membrane (GO:0097638),-0.7857857857857857,-1.039294815706701,0.44315992292870904,0.9028760249455531,1.0,1/1,21.60%,SLC7A1
1461,prerank,positive regulation of T cell proliferation (GO:0042102),-0.7857857857857857,-1.039294815706701,0.44315992292870904,0.9028760249455531,1.0,1/1,21.60%,SLC7A1
1462,prerank,L-ornithine transmembrane transport (GO:1903352),-0.7857857857857857,-1.039294815706701,0.44315992292870904,0.9028760249455531,1.0,1/1,21.60%,SLC7A1
1463,prerank,ornithine transport (GO:0015822),-0.7857857857857857,-1.039294815706701,0.44315992292870904,0.9028760249455531,1.0,1/1,21.60%,SLC7A1
1464,prerank,L-arginine transmembrane transport (GO:1903400),-0.7857857857857857,-1.039294815706701,0.44315992292870904,0.9028760249455531,1.0,1/1,21.60%,SLC7A1
1465,prerank,basic amino acid transport (GO:0015802),-0.7857857857857857,-1.039294815706701,0.44315992292870904,0.9028760249455531,1.0,1/1,21.60%,SLC7A1
1466,prerank,positive regulation of T cell activation (GO:0050870),-0.7857857857857857,-1.039294815706701,0.44315992292870904,0.9028760249455531,1.0,1/1,21.60%,SLC7A1
1467,prerank,cellular defense response (GO:0006968),-0.7727727727727728,-1.038792518958161,0.43023255813953487,0.9033233589535044,1.0,1/1,22.90%,LSP1
1468,prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.6316501743174229,1.0384820739920466,0.4587301587301587,1.0,1.0,1/2,19.70%,MAGI2
1469,prerank,plasma membrane phospholipid scrambling (GO:0017121),0.6411077304025992,1.0384460428119866,0.4294770206022187,1.0,1.0,1/2,10.00%,PLSCR2
1470,prerank,sensory organ morphogenesis (GO:0090596),0.6367352836170199,1.0377920306726418,0.43820224719101125,1.0,1.0,1/2,18.20%,GLI3
1471,prerank,presynaptic membrane organization (GO:0097090),0.6321379084763097,1.03717915147083,0.432258064516129,1.0,1.0,1/2,10.10%,PTPRD
1472,prerank,presynaptic membrane assembly (GO:0097105),0.6321379084763097,1.03717915147083,0.432258064516129,1.0,1.0,1/2,10.10%,PTPRD
1473,prerank,oligosaccharide metabolic process (GO:0009311),-0.7827827827827828,-1.0365672648765356,0.4431137724550898,0.9033410175880698,1.0,1/1,21.90%,ST3GAL3
1474,prerank,keratan sulfate biosynthetic process (GO:0018146),-0.7827827827827828,-1.0365672648765356,0.4431137724550898,0.9033410175880698,1.0,1/1,21.90%,ST3GAL3
1475,prerank,oligosaccharide biosynthetic process (GO:0009312),-0.7827827827827828,-1.0365672648765356,0.4431137724550898,0.9033410175880698,1.0,1/1,21.90%,ST3GAL3
1476,prerank,carbohydrate biosynthetic process (GO:0016051),-0.7827827827827828,-1.0365672648765356,0.4431137724550898,0.9033410175880698,1.0,1/1,21.90%,ST3GAL3
1477,prerank,keratan sulfate metabolic process (GO:0042339),-0.7827827827827828,-1.0365672648765356,0.4431137724550898,0.9033410175880698,1.0,1/1,21.90%,ST3GAL3
1478,prerank,diterpenoid metabolic process (GO:0016101),0.5426278836509528,1.0354962621553745,0.44363103953147875,1.0,1.0,3/3,45.90%,LRP8;GPC4;GPC3
1479,prerank,retinoid metabolic process (GO:0001523),0.5426278836509528,1.0354962621553745,0.44363103953147875,1.0,1.0,3/3,45.90%,LRP8;GPC4;GPC3
1480,prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.7747747747747747,-1.0353786790157848,0.44536082474226807,0.8965041355554815,1.0,1/1,22.70%,TP53BP1
1481,prerank,regulation of isotype switching (GO:0045191),-0.7747747747747747,-1.0353786790157848,0.44536082474226807,0.8965041355554815,1.0,1/1,22.70%,TP53BP1
1482,prerank,DNA integrity checkpoint signaling (GO:0031570),-0.7747747747747747,-1.0353786790157848,0.44536082474226807,0.8965041355554815,1.0,1/1,22.70%,TP53BP1
1483,prerank,positive regulation of immunoglobulin production (GO:0002639),-0.7747747747747747,-1.0353786790157848,0.44536082474226807,0.8965041355554815,1.0,1/1,22.70%,TP53BP1
1484,prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.7747747747747747,-1.0353786790157848,0.44536082474226807,0.8965041355554815,1.0,1/1,22.70%,TP53BP1
1485,prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.7747747747747747,-1.0353786790157848,0.44536082474226807,0.8965041355554815,1.0,1/1,22.70%,TP53BP1
1486,prerank,positive regulation of DNA recombination (GO:0045911),-0.7747747747747747,-1.0353786790157848,0.44536082474226807,0.8965041355554815,1.0,1/1,22.70%,TP53BP1
1487,prerank,positive regulation of isotype switching (GO:0045830),-0.7747747747747747,-1.0353786790157848,0.44536082474226807,0.8965041355554815,1.0,1/1,22.70%,TP53BP1
1488,prerank,inflammatory response (GO:0006954),0.4709025336931146,1.0349394102477567,0.42098609355246525,1.0,1.0,1/5,1.20%,ADCY8
1489,prerank,inner mitochondrial membrane organization (GO:0007007),-0.7777777777777778,-1.034474588318919,0.4597457627118644,0.8963498784320173,1.0,1/1,22.40%,CHCHD3
1490,prerank,cristae formation (GO:0042407),-0.7777777777777778,-1.034474588318919,0.4597457627118644,0.8963498784320173,1.0,1/1,22.40%,CHCHD3
1491,prerank,positive regulation of cell differentiation (GO:0045597),0.34671898631500786,1.0336573068631951,0.43816631130063965,1.0,1.0,5/14,23.90%,TIAM1;FBN2;BRINP1;CDH2;LMO3
1492,prerank,cellular response to nutrient levels (GO:0031669),-0.45080321285140557,-1.0335852943683643,0.3592592592592593,0.8978127425140319,1.0,4/4,55.20%,SREBF2;ULK1;USP33;WRN
1493,prerank,negative regulation of protein catabolic process (GO:0042177),0.552767384465995,1.0328378827451832,0.43820224719101125,1.0,1.0,2/3,21.10%,FMN2;ADGRB1
1494,prerank,negative regulation of protein metabolic process (GO:0051248),0.552767384465995,1.0328378827451832,0.43820224719101125,1.0,1.0,2/3,21.10%,FMN2;ADGRB1
1495,prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.34441087613293053,-1.0327096403543619,0.39520958083832336,0.8992080291015228,1.0,7/7,65.90%,ARNT;NOTCH2;CLDN1;EGFR;PRKCA;FLT4;AKT3
1496,prerank,epithelial to mesenchymal transition (GO:0001837),0.5025534328967671,1.0326459197362146,0.42953929539295393,1.0,1.0,1/4,1.50%,HMGA2
1497,prerank,cellular response to light stimulus (GO:0071482),0.627254509018036,1.0322454094361708,0.435,1.0,1.0,2/2,37.40%,GNGT1;CASP9
1498,prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.7717717717717718,-1.0309060946690074,0.44889779559118237,0.9019220520846124,1.0,1/1,23.00%,ZBTB20
1499,prerank,positive regulation of lipid metabolic process (GO:0045834),-0.7717717717717718,-1.0309060946690074,0.44889779559118237,0.9019220520846124,1.0,1/1,23.00%,ZBTB20
1500,prerank,regulation of complement activation (GO:0030449),0.6366422719666384,1.0303278620777847,0.4560260586319218,1.0,1.0,1/2,16.20%,SUSD4
1501,prerank,regulation of humoral immune response (GO:0002920),0.6366422719666384,1.0303278620777847,0.4560260586319218,1.0,1.0,1/2,16.20%,SUSD4
1502,prerank,regulation of immune effector process (GO:0002697),0.6366422719666384,1.0303278620777847,0.4560260586319218,1.0,1.0,1/2,16.20%,SUSD4
1503,prerank,divalent inorganic cation homeostasis (GO:0072507),-0.5931863727454909,-1.030229147894914,0.4467005076142132,0.902628180406181,1.0,2/2,40.90%,TMTC2;CNNM2
1504,prerank,ameboidal-type cell migration (GO:0001667),0.41982662555036193,1.0298972128525274,0.42992874109263657,1.0,1.0,3/7,20.30%,SEMA3A;SEMA3E;SEMA6A
1505,prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.5991983967935871,-1.0296307040157948,0.4076086956521739,0.9031943438859406,1.0,2/2,40.30%,AHCTF1;XPO1
1506,prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.7647647647647647,-1.0289104079627776,0.46292585170340683,0.9003280123023372,1.0,1/1,23.70%,MNAT1
1507,prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.7647647647647647,-1.0289104079627776,0.46292585170340683,0.9003280123023372,1.0,1/1,23.70%,MNAT1
1508,prerank,7-methylguanosine mRNA capping (GO:0006370),-0.7647647647647647,-1.0289104079627776,0.46292585170340683,0.9003280123023372,1.0,1/1,23.70%,MNAT1
1509,prerank,7-methylguanosine RNA capping (GO:0009452),-0.7647647647647647,-1.0289104079627776,0.46292585170340683,0.9003280123023372,1.0,1/1,23.70%,MNAT1
1510,prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.5514894014797955,1.0286749701828284,0.4624277456647399,1.0,1.0,2/3,30.30%,SPRED2;SPRED3
1511,prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.5514894014797955,1.0286749701828284,0.4624277456647399,1.0,1.0,2/3,30.30%,SPRED2;SPRED3
1512,prerank,regulation of lens fiber cell differentiation (GO:1902746),0.5514894014797955,1.0286749701828284,0.4624277456647399,1.0,1.0,2/3,30.30%,SPRED2;SPRED3
1513,prerank,regulation of protein deacetylation (GO:0090311),0.5514894014797955,1.0286749701828284,0.4624277456647399,1.0,1.0,2/3,30.30%,SPRED2;SPRED3
1514,prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5514894014797955,1.0286749701828284,0.4624277456647399,1.0,1.0,2/3,30.30%,SPRED2;SPRED3
1515,prerank,negative regulation of lens fiber cell differentiation (GO:1902747),0.5514894014797955,1.0286749701828284,0.4624277456647399,1.0,1.0,2/3,30.30%,SPRED2;SPRED3
1516,prerank,regulation of cGMP-mediated signaling (GO:0010752),0.7777777777777778,1.0284115070590238,0.4578313253012048,1.0,1.0,1/1,22.30%,PDE10A
1517,prerank,negative regulation of cGMP-mediated signaling (GO:0010754),0.7777777777777778,1.0284115070590238,0.4578313253012048,1.0,1.0,1/1,22.30%,PDE10A
1518,prerank,regulation of protein ADP-ribosylation (GO:0010835),-0.6022044088176353,-1.026969354710989,0.4121951219512195,0.9045535198383523,1.0,2/2,40.00%,PUM3;KAT2B
1519,prerank,tryptophan metabolic process (GO:0006568),0.7717717717717718,1.025122463261021,0.4834307992202729,1.0,1.0,1/1,22.90%,HAAO
1520,prerank,indolalkylamine catabolic process (GO:0046218),0.7717717717717718,1.025122463261021,0.4834307992202729,1.0,1.0,1/1,22.90%,HAAO
1521,prerank,response to zinc ion (GO:0010043),0.7717717717717718,1.025122463261021,0.4834307992202729,1.0,1.0,1/1,22.90%,HAAO
1522,prerank,pyridine-containing compound metabolic process (GO:0072524),0.7717717717717718,1.025122463261021,0.4834307992202729,1.0,1.0,1/1,22.90%,HAAO
1523,prerank,aromatic amino acid family catabolic process (GO:0009074),0.7717717717717718,1.025122463261021,0.4834307992202729,1.0,1.0,1/1,22.90%,HAAO
1524,prerank,tryptophan catabolic process (GO:0006569),0.7717717717717718,1.025122463261021,0.4834307992202729,1.0,1.0,1/1,22.90%,HAAO
1525,prerank,nicotinamide nucleotide biosynthetic process (GO:0019359),0.7717717717717718,1.025122463261021,0.4834307992202729,1.0,1.0,1/1,22.90%,HAAO
1526,prerank,cellular iron ion homeostasis (GO:0006879),0.7677677677677678,1.0247532870418914,0.4909456740442656,1.0,1.0,1/1,23.30%,SCARA5
1527,prerank,iron ion transmembrane transport (GO:0034755),0.7677677677677678,1.0247532870418914,0.4909456740442656,1.0,1.0,1/1,23.30%,SCARA5
1528,prerank,protein homotrimerization (GO:0070207),0.7677677677677678,1.0247532870418914,0.4909456740442656,1.0,1.0,1/1,23.30%,SCARA5
1529,prerank,iron ion homeostasis (GO:0055072),0.7677677677677678,1.0247532870418914,0.4909456740442656,1.0,1.0,1/1,23.30%,SCARA5
1530,prerank,protein trimerization (GO:0070206),0.7677677677677678,1.0247532870418914,0.4909456740442656,1.0,1.0,1/1,23.30%,SCARA5
1531,prerank,monovalent inorganic anion homeostasis (GO:0055083),-0.7697697697697697,-1.0247513757619127,0.4773662551440329,0.9001101527644335,1.0,1/1,23.20%,SLC12A2
1532,prerank,positive regulation of anion transport (GO:1903793),-0.7697697697697697,-1.0247513757619127,0.4773662551440329,0.9001101527644335,1.0,1/1,23.20%,SLC12A2
1533,prerank,cellular sodium ion homeostasis (GO:0006883),-0.7697697697697697,-1.0247513757619127,0.4773662551440329,0.9001101527644335,1.0,1/1,23.20%,SLC12A2
1534,prerank,chloride ion homeostasis (GO:0055064),-0.7697697697697697,-1.0247513757619127,0.4773662551440329,0.9001101527644335,1.0,1/1,23.20%,SLC12A2
1535,prerank,positive regulation of amino acid transport (GO:0051957),-0.7697697697697697,-1.0247513757619127,0.4773662551440329,0.9001101527644335,1.0,1/1,23.20%,SLC12A2
1536,prerank,potassium ion import across plasma membrane (GO:1990573),-0.7697697697697697,-1.0247513757619127,0.4773662551440329,0.9001101527644335,1.0,1/1,23.20%,SLC12A2
1537,prerank,T cell chemotaxis (GO:0010818),-0.7697697697697697,-1.0247513757619127,0.4773662551440329,0.9001101527644335,1.0,1/1,23.20%,SLC12A2
1538,prerank,T cell migration (GO:0072678),-0.7697697697697697,-1.0247513757619127,0.4773662551440329,0.9001101527644335,1.0,1/1,23.20%,SLC12A2
1539,prerank,ammonium transport (GO:0015696),-0.7697697697697697,-1.0247513757619127,0.4773662551440329,0.9001101527644335,1.0,1/1,23.20%,SLC12A2
1540,prerank,cellular response to retinoic acid (GO:0071300),0.624248126537074,1.0247277562775277,0.4451510333863275,1.0,1.0,1/2,11.80%,BRINP1
1541,prerank,regulation of exocytosis (GO:0017157),0.5486459378134404,1.0241881339606034,0.45203488372093026,1.0,1.0,3/3,45.30%,CADPS2;STXBP5;CPLX1
1542,prerank,negative regulation of fat cell proliferation (GO:0070345),-0.7757757757757757,-1.023557705083576,0.48490945674044267,0.8940053507894772,1.0,1/1,22.60%,PER2
1543,prerank,white fat cell differentiation (GO:0050872),-0.7757757757757757,-1.023557705083576,0.48490945674044267,0.8940053507894772,1.0,1/1,22.60%,PER2
1544,prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.7757757757757757,-1.023557705083576,0.48490945674044267,0.8940053507894772,1.0,1/1,22.60%,PER2
1545,prerank,negative regulation of circadian rhythm (GO:0042754),-0.7757757757757757,-1.023557705083576,0.48490945674044267,0.8940053507894772,1.0,1/1,22.60%,PER2
1546,prerank,regulation of fat cell proliferation (GO:0070344),-0.7757757757757757,-1.023557705083576,0.48490945674044267,0.8940053507894772,1.0,1/1,22.60%,PER2
1547,prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.7757757757757757,-1.023557705083576,0.48490945674044267,0.8940053507894772,1.0,1/1,22.60%,PER2
1548,prerank,regulation of neurogenesis (GO:0050767),-0.7757757757757757,-1.023557705083576,0.48490945674044267,0.8940053507894772,1.0,1/1,22.60%,PER2
1549,prerank,photoperiodism (GO:0009648),-0.7757757757757757,-1.023557705083576,0.48490945674044267,0.8940053507894772,1.0,1/1,22.60%,PER2
1550,prerank,cellular response to decreased oxygen levels (GO:0036294),0.4972342016833259,1.022877621199412,0.45161290322580644,1.0,1.0,3/4,38.90%,FMN2;RORA;NPEPPS
1551,prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.4357429718875502,-1.022701777941405,0.42323651452282157,0.8953378703465139,1.0,4/4,56.70%,ELMO1;SHC2;PTK2;FLT4
1552,prerank,regulation of cholesterol transport (GO:0032374),0.5476429287863591,1.020952214064249,0.4577259475218659,1.0,1.0,3/3,45.40%,OSBPL6;ABCA5;LIPG
1553,prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.3889447236180905,-1.0206636519171446,0.4369369369369369,0.8996581927127718,1.0,5/5,61.40%,CHD1L;RFC1;DDB2;DNASE1;RFC3
1554,prerank,positive regulation of cellular process (GO:0048522),0.28369519836802914,1.0202664812493398,0.4718875502008032,1.0,1.0,23/42,47.60%,NRG1;SHANK2;HMGA2;TENM4;TIAM1;TET1;CAMK1D;CALCR;ACER2;PARD3;BCL2;MEIS1;IL34;GRK5;MEIS2;IRS1;IGF1R;FLT4;PRKCA;EGFR;PRAME;PTK2;GCNT2
1555,prerank,negative regulation of p38MAPK cascade (GO:1903753),-0.7587587587587588,-1.0201856955556152,0.47713717693836977,0.8962400125515612,1.0,1/1,24.30%,DLG1
1556,prerank,cortical actin cytoskeleton organization (GO:0030866),-0.7587587587587588,-1.0201856955556152,0.47713717693836977,0.8962400125515612,1.0,1/1,24.30%,DLG1
1557,prerank,astral microtubule organization (GO:0030953),-0.7587587587587588,-1.0201856955556152,0.47713717693836977,0.8962400125515612,1.0,1/1,24.30%,DLG1
1558,prerank,regulation of potassium ion export across plasma membrane (GO:1903764),-0.7587587587587588,-1.0201856955556152,0.47713717693836977,0.8962400125515612,1.0,1/1,24.30%,DLG1
1559,prerank,neuron projection development (GO:0031175),0.36276837551304436,1.0200677388097268,0.45206971677559915,1.0,1.0,4/12,19.40%,CNTNAP2;MAP2;SH3GL2;MAPK8IP3
1560,prerank,cell junction organization (GO:0034330),0.49317778069274554,1.019470395209623,0.43989431968295906,1.0,1.0,2/4,19.10%,SDK1;SEMA3E
1561,prerank,regulation of chemotaxis (GO:0050920),0.5416248746238717,1.0181532940150604,0.44971264367816094,1.0,1.0,3/3,46.00%,ZSWIM5;MYCBP2;ADGRA2
1562,prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.5429647532255044,1.0178408277450608,0.44645340751043117,1.0,1.0,1/3,1.80%,CECR2
1563,prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.4186746987951807,-1.017515793719007,0.4230769230769231,0.9023731089050381,1.0,4/4,58.40%,MDM2;TFDP2;CNOT6;PIDD1
1564,prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.7667667667667668,-1.0168848371284323,0.4756637168141593,0.9029523699982835,1.0,1/1,23.50%,ARHGAP12
1565,prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.41767068273092367,-1.0164708093204131,0.4314516129032258,0.9029957311991959,1.0,4/4,58.50%,PTEN;NF1;IGF1R;IRS1
1566,prerank,ventricular septum development (GO:0003281),0.49380747562275873,1.0146150270653111,0.46808510638297873,1.0,1.0,2/4,25.20%,SLIT2;ROBO2
1567,prerank,ventricular septum morphogenesis (GO:0060412),0.49380747562275873,1.0146150270653111,0.46808510638297873,1.0,1.0,2/4,25.20%,SLIT2;ROBO2
1568,prerank,central nervous system neuron development (GO:0021954),0.6161130888140353,1.0143854314938487,0.47549019607843135,1.0,1.0,1/2,11.20%,MAP2
1569,prerank,protein localization to organelle (GO:0033365),0.43685160881722507,1.0142046741637558,0.45165394402035625,1.0,1.0,3/6,30.20%,ZNF423;OBSCN;COG7
1570,prerank,regulation of viral genome replication (GO:0045069),-0.429718875502008,-1.0137754920064816,0.411522633744856,0.9090830279145294,1.0,4/4,57.30%,ZC3HAV1;PKN2;ILF3;SRPK1
1571,prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.7547547547547547,-1.0134515021369093,0.4609375,0.9064305001182731,1.0,1/1,24.70%,CRLF3
1572,prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.7547547547547547,-1.0134515021369093,0.4609375,0.9064305001182731,1.0,1/1,24.70%,CRLF3
1573,prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.7547547547547547,-1.0134515021369093,0.4609375,0.9064305001182731,1.0,1/1,24.70%,CRLF3
1574,prerank,DNA replication initiation (GO:0006270),0.4868091127949607,1.0129928462887077,0.46216216216216216,1.0,1.0,1/4,6.00%,POLE
1575,prerank,positive regulation of signaling (GO:0023056),-0.43072289156626503,-1.0126215725487846,0.4,0.9075070262036635,1.0,4/4,57.20%,CLSTN1;WLS;ECE1;INPP5F
1576,prerank,sprouting angiogenesis (GO:0002040),0.41278739729473735,1.012323373261915,0.45798816568047335,1.0,1.0,3/7,20.50%,SLIT2;SEMA3E;BMPER
1577,prerank,cellular response to peptide hormone stimulus (GO:0071375),0.36656463128622685,1.0114969760105985,0.46196868008948544,1.0,1.0,7/10,47.50%,ADCY8;ADCY9;PRKAR2B;PRKAR1B;IRS1;GOT1;LPIN1
1578,prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.5015045135406219,-1.0110560803279036,0.4186851211072664,0.9104087093752444,1.0,3/3,50.10%,SLC7A1;SLC1A3;SLC25A12
1579,prerank,morphogenesis of a polarized epithelium (GO:0001738),0.7637637637637638,1.010576787093545,0.48254620123203285,1.0,1.0,1/1,23.70%,LAMA3
1580,prerank,epidermis development (GO:0008544),0.7637637637637638,1.010576787093545,0.48254620123203285,1.0,1.0,1/1,23.70%,LAMA3
1581,prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.7517517517517518,1.010562324197693,0.46586345381526106,1.0,1.0,1/1,24.90%,TOM1L1
1582,prerank,positive regulation of protein autophosphorylation (GO:0031954),0.7517517517517518,1.010562324197693,0.46586345381526106,1.0,1.0,1/1,24.90%,TOM1L1
1583,prerank,regulation of interleukin-8 production (GO:0032677),-0.4974924774322969,-1.010216566533424,0.39215686274509803,0.9115610130527614,1.0,3/3,50.50%,MAP2K5;BPI;TLR5
1584,prerank,positive regulation of neuron differentiation (GO:0045666),0.6143800186492664,1.0100118636376545,0.48184818481848185,1.0,1.0,1/2,11.80%,BRINP1
1585,prerank,positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.7617617617617618,1.0100011306796477,0.48073022312373226,1.0,1.0,1/1,23.90%,LMO3
1586,prerank,regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.7617617617617618,1.0100011306796477,0.48073022312373226,1.0,1.0,1/1,23.90%,LMO3
1587,prerank,positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.7617617617617618,1.0100011306796477,0.48073022312373226,1.0,1.0,1/1,23.90%,LMO3
1588,prerank,negative regulation of heart contraction (GO:0045822),0.6176987116750935,1.0097936290858296,0.4820846905537459,1.0,1.0,1/2,13.30%,SPTBN4
1589,prerank,negative regulation of heart rate (GO:0010459),0.6176987116750935,1.0097936290858296,0.4820846905537459,1.0,1.0,1/2,13.30%,SPTBN4
1590,prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7707707707707707,-1.0088614980672448,0.5089463220675944,0.9140883766930913,1.0,1/1,23.10%,CSNK1E
1591,prerank,protein acylation (GO:0043543),-0.5961923847695391,-1.0088511909616542,0.4430379746835443,0.907074469990412,1.0,2/2,40.60%,KAT2B;KAT2A
1592,prerank,internal protein amino acid acetylation (GO:0006475),-0.5961923847695391,-1.0088511909616542,0.4430379746835443,0.907074469990412,1.0,2/2,40.60%,KAT2B;KAT2A
1593,prerank,negative regulation of centriole replication (GO:0046600),-0.5961923847695391,-1.0088511909616542,0.4430379746835443,0.907074469990412,1.0,2/2,40.60%,KAT2B;KAT2A
1594,prerank,regulation of centriole replication (GO:0046599),-0.5961923847695391,-1.0088511909616542,0.4430379746835443,0.907074469990412,1.0,2/2,40.60%,KAT2B;KAT2A
1595,prerank,negative regulation of centrosome duplication (GO:0010826),-0.5961923847695391,-1.0088511909616542,0.4430379746835443,0.907074469990412,1.0,2/2,40.60%,KAT2B;KAT2A
1596,prerank,peptidyl-lysine acetylation (GO:0018394),-0.5961923847695391,-1.0088511909616542,0.4430379746835443,0.907074469990412,1.0,2/2,40.60%,KAT2B;KAT2A
1597,prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.7557557557557557,-1.0079477230320026,0.4834307992202729,0.9071847123377635,1.0,1/1,24.60%,RNLS
1598,prerank,negative regulation of blood pressure (GO:0045776),-0.7557557557557557,-1.0079477230320026,0.4834307992202729,0.9071847123377635,1.0,1/1,24.60%,RNLS
1599,prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.5991983967935871,-1.0078888849669971,0.4293193717277487,0.9061607074886411,1.0,2/2,40.30%,NVL;XPO1
1600,prerank,nuclear transport (GO:0051169),-0.5991983967935871,-1.007731958762887,0.4733893557422969,0.905503964374199,1.0,2/2,40.30%,PSIP1;XPO1
1601,prerank,neutrophil activation involved in immune response (GO:0002283),0.36596841010132847,1.0073974745776375,0.4496208017334778,1.0,1.0,2/11,7.90%,LRRC7;PTPRN2
1602,prerank,positive regulation of double-strand break repair (GO:2000781),0.6129502154242059,1.005717108575196,0.48792270531400966,1.0,1.0,1/2,20.00%,FMN2
1603,prerank,regulation of double-strand break repair (GO:2000779),0.6129502154242059,1.005717108575196,0.48792270531400966,1.0,1.0,1/2,20.00%,FMN2
1604,prerank,spindle assembly (GO:0051225),-0.7497497497497497,-1.0053502727379902,0.49101796407185627,0.9107237310895672,1.0,1/1,25.20%,NEK7
1605,prerank,mesodermal cell fate commitment (GO:0001710),0.7537537537537538,1.0051858051294893,0.490234375,1.0,1.0,1/1,24.70%,EYA2
1606,prerank,regulation of filopodium assembly (GO:0051489),0.500766759496422,1.0042495146859312,0.4786096256684492,1.0,1.0,3/4,40.90%,TENM2;MYO10;FNBP1L
1607,prerank,toll-like receptor signaling pathway (GO:0002224),-0.4974924774322969,-1.002936657285277,0.4222222222222222,0.9159643072768543,1.0,3/3,50.50%,UBE2D3;COLEC12;TLR5
1608,prerank,pulmonary valve development (GO:0003177),0.4897853430757415,1.0025126565352702,0.48840381991814463,1.0,1.0,2/4,25.20%,SLIT2;ROBO2
1609,prerank,pulmonary valve morphogenesis (GO:0003184),0.4897853430757415,1.0025126565352702,0.48840381991814463,1.0,1.0,2/4,25.20%,SLIT2;ROBO2
1610,prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.41113976433109767,1.0022086973937925,0.46261682242990654,1.0,1.0,4/7,39.90%,HMGA2;STK33;EME2;CDC14B
1611,prerank,regulation of mitochondrion organization (GO:0010821),0.5412132424875383,1.0018474980749252,0.48787446504992865,1.0,1.0,1/3,12.20%,PPARGC1A
1612,prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.3440643863179075,-1.0018400838004158,0.4397905759162304,0.91796897271782,1.0,6/6,65.90%,FOXC2;FGFR1;ETS1;PRKCA;RHOJ;AKT3
1613,prerank,cellular response to molecule of bacterial origin (GO:0071219),0.6199387852049846,1.001761620571577,0.49029126213592233,1.0,1.0,1/2,12.80%,PDE4B
1614,prerank,pentose metabolic process (GO:0019321),0.6162324649298597,1.0017501095584278,0.49369085173501576,1.0,1.0,2/2,38.50%,XYLB;FGGY
1615,prerank,regulation of transforming growth factor beta2 production (GO:0032909),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1616,prerank,dorsal aorta morphogenesis (GO:0035912),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1617,prerank,mitral valve morphogenesis (GO:0003183),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1618,prerank,endocardial cushion morphogenesis (GO:0003203),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1619,prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1620,prerank,cardiac ventricle morphogenesis (GO:0003208),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1621,prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1622,prerank,tricuspid valve morphogenesis (GO:0003186),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1623,prerank,atrioventricular valve development (GO:0003171),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1624,prerank,tricuspid valve development (GO:0003175),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1625,prerank,dorsal/ventral pattern formation (GO:0009953),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1626,prerank,ventricular compact myocardium morphogenesis (GO:0003223),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1627,prerank,pharyngeal arch artery morphogenesis (GO:0061626),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1628,prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1629,prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1630,prerank,pharyngeal system development (GO:0060037),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1631,prerank,BMP signaling pathway involved in heart development (GO:0061312),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1632,prerank,mitral valve development (GO:0003174),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1633,prerank,BMP signaling pathway (GO:0030509),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1634,prerank,dorsal aorta development (GO:0035907),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1635,prerank,cellular response to BMP stimulus (GO:0071773),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1636,prerank,atrioventricular valve morphogenesis (GO:0003181),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1637,prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1638,prerank,mesenchyme morphogenesis (GO:0072132),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1639,prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1640,prerank,endocardial cushion development (GO:0003197),-0.7447447447447447,-1.0012759590511158,0.5049900199600799,0.8902340187061366,1.0,1/1,25.70%,BMPR1A
1641,prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.6132264529058116,1.0010213184208765,0.5127388535031847,1.0,1.0,2/2,38.80%,POLE;RFC3
1642,prerank,peptide metabolic process (GO:0006518),0.6122244488977956,1.000994495888379,0.48635634028892455,1.0,1.0,2/2,38.90%,DPEP1;NPEPPS
1643,prerank,regulation of multicellular organismal development (GO:2000026),-0.5961923847695391,-1.000196535127517,0.47761194029850745,0.8920625043796088,1.0,2/2,40.60%,INSR;KAT2A
1644,prerank,positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.5392052264880305,0.9997585227398659,0.47701149425287354,1.0,1.0,2/3,29.50%,ADAMTS3;SMOC2
1645,prerank,regulation of telomere maintenance (GO:0032204),-0.7377377377377378,-0.9996300863131928,0.5,0.8882955747720628,1.0,1/1,26.40%,SMG6
1646,prerank,negative regulation of telomere capping (GO:1904354),-0.7377377377377378,-0.9996300863131928,0.5,0.8882955747720628,1.0,1/1,26.40%,SMG6
1647,prerank,regulation of transferase activity (GO:0051338),-0.7377377377377378,-0.9996300863131928,0.5,0.8882955747720628,1.0,1/1,26.40%,SMG6
1648,prerank,regulation of chromosome organization (GO:0033044),-0.7377377377377378,-0.9996300863131928,0.5,0.8882955747720628,1.0,1/1,26.40%,SMG6
1649,prerank,regulation of phosphate metabolic process (GO:0019220),-0.7377377377377378,-0.9996300863131928,0.5,0.8882955747720628,1.0,1/1,26.40%,SMG6
1650,prerank,histone deubiquitination (GO:0016578),-0.5961923847695391,-0.9994172494172493,0.4489795918367347,0.8877359933749401,1.0,2/2,40.60%,USP22;KAT2A
1651,prerank,adrenergic receptor signaling pathway (GO:0071875),0.7367367367367368,0.9993743260693048,0.49411764705882355,1.0,1.0,1/1,26.40%,ADCY9
1652,prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7367367367367368,0.9993743260693048,0.49411764705882355,1.0,1.0,1/1,26.40%,ADCY9
1653,prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.6213071127266978,0.9991324575157561,0.5022970903522205,1.0,1.0,1/2,12.20%,PPARGC1A
1654,prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.7407407407407407,-0.9990560227630292,0.47410358565737054,0.8874901607286397,1.0,1/1,26.10%,CXCL1
1655,prerank,protein localization to basolateral plasma membrane (GO:1903361),0.7527527527527527,0.9987416456270172,0.5272727272727272,1.0,1.0,1/1,24.80%,LIN7A
1656,prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.7517517517517518,-0.998037488603527,0.5077519379844961,0.8892580265731025,1.0,1/1,25.00%,REEP3
1657,prerank,basement membrane organization (GO:0071711),0.5396188565697092,0.9978655795101461,0.5034674063800277,1.0,1.0,3/3,46.20%,FLRT2;PXDN;NTN4
1658,prerank,phospholipid dephosphorylation (GO:0046839),-0.43072289156626503,-0.9978197258573838,0.45185185185185184,0.8877329382456864,1.0,4/4,57.20%,MTMR2;MTMR1;PTEN;INPP5F
1659,prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.43072289156626503,-0.9978197258573838,0.45185185185185184,0.8877329382456864,1.0,4/4,57.20%,MTMR2;MTMR1;PTEN;INPP5F
1660,prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.7427427427427428,-0.997458750736594,0.50293542074364,0.8833000882307133,1.0,1/1,25.90%,CREB3L1
1661,prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.7427427427427428,-0.997458750736594,0.50293542074364,0.8833000882307133,1.0,1/1,25.90%,CREB3L1
1662,prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.7427427427427428,-0.997458750736594,0.50293542074364,0.8833000882307133,1.0,1/1,25.90%,CREB3L1
1663,prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.7427427427427428,-0.997458750736594,0.50293542074364,0.8833000882307133,1.0,1/1,25.90%,CREB3L1
1664,prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.7427427427427428,-0.997458750736594,0.50293542074364,0.8833000882307133,1.0,1/1,25.90%,CREB3L1
1665,prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.5861723446893787,-0.9968083450101203,0.46954314720812185,0.8832351189875279,1.0,2/2,41.60%,GAS6;BPI
1666,prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.5861723446893787,-0.9968083450101203,0.46954314720812185,0.8832351189875279,1.0,2/2,41.60%,GAS6;BPI
1667,prerank,collagen-activated signaling pathway (GO:0038065),0.62124248496994,0.9959780223184613,0.49754500818330605,1.0,1.0,2/2,38.00%,UBASH3B;DDR2
1668,prerank,collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),0.62124248496994,0.9959780223184613,0.49754500818330605,1.0,1.0,2/2,38.00%,UBASH3B;DDR2
1669,prerank,regulation of microtubule binding (GO:1904526),0.6011336844467723,0.9953322928494149,0.48673946957878317,1.0,1.0,1/2,11.20%,MAP2
1670,prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.45770806071081543,0.9949406657369296,0.48366013071895425,1.0,1.0,2/5,21.20%,MAGI2;HIP1
1671,prerank,membrane depolarization during action potential (GO:0086010),0.6102204408817635,0.9944285927711364,0.4919093851132686,1.0,1.0,2/2,39.10%,SCN3A;CACNA1C
1672,prerank,regulation of programmed cell death (GO:0043067),0.35582853847607626,0.9941090228976429,0.49503858875413453,1.0,1.0,5/11,28.20%,ALK;MECOM;LRP8;HIP1;ACER2
1673,prerank,negative regulation of apoptotic process (GO:0043066),0.3042757589520156,0.9940887024326479,0.49693251533742333,1.0,1.0,15/26,47.10%,HMGA2;PPARGC1A;WNK3;FMN2;WT1;DPEP1;BCL2;GRK5;PIDD1;IGF1R;FLT4;PRKCA;EGFR;PRAME;PTK2
1674,prerank,sphingomyelin metabolic process (GO:0006684),-0.7367367367367368,-0.9939541201406803,0.49613899613899615,0.8899240535338935,1.0,1/1,26.50%,SGMS1
1675,prerank,regulation of embryonic development (GO:0045995),-0.5035105315947843,-0.9938267063505333,0.4594594594594595,0.8891543433778804,1.0,3/3,49.90%,INSR;PLCB1;NR2C2
1676,prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.7507507507507507,0.9935179173560632,0.5237154150197628,1.0,1.0,1/1,25.00%,ABCA5
1677,prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.7507507507507507,0.9935179173560632,0.5237154150197628,1.0,1.0,1/1,25.00%,ABCA5
1678,prerank,cholesterol efflux (GO:0033344),0.7507507507507507,0.9935179173560632,0.5237154150197628,1.0,1.0,1/1,25.00%,ABCA5
1679,prerank,negative regulation of neurogenesis (GO:0050768),-0.5821643286573146,-0.9933661605799471,0.472,0.8892488756475674,1.0,2/2,42.00%,PTEN;NF1
1680,prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.3440643863179075,-0.9929088375218301,0.39520958083832336,0.8896649038771284,1.0,6/6,65.90%,MAP2K5;ITGB1BP1;FOXC2;HDAC5;RHOJ;AKT3
1681,prerank,DNA damage checkpoint signaling (GO:0000077),0.610774801495295,0.9928201797721239,0.5031545741324921,1.0,1.0,1/2,14.30%,STK33
1682,prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.6012024048096193,0.9920322196140382,0.5128205128205128,1.0,1.0,2/2,40.00%,EVC;DLG5
1683,prerank,regulation of angiogenesis (GO:0045765),0.3180329680490376,0.9918895087427467,0.4757481940144479,1.0,1.0,11/18,47.00%,HMGA2;SEMA3E;SASH1;SEMA6A;BMPER;ADGRB1;SMOC2;RHOJ;PRKCA;ADGRA2;AMOT
1684,prerank,mitotic cell cycle phase transition (GO:0044772),-0.16860318393630513,-0.9916955170716417,0.4230769230769231,0.8916705448285583,1.0,20/21,71.00%,CCND1;BTRC;CUL5;PPP2R2A;PPP2R2D;CSNK1E;MNAT1;CRLF3;PLCB1;CCDC57;OPTN;CCNY;SPAST;ENSA;CCND2;CEP70;NINL;CDK6;PRKAR2B;CDK14
1685,prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.530591775325978,0.9914433168355739,0.5167597765363129,1.0,1.0,3/3,47.10%,SHC3;EGFR;PTK2
1686,prerank,regulation of mononuclear cell migration (GO:0071675),0.530591775325978,0.9911661242459576,0.5071633237822349,1.0,1.0,3/3,47.10%,SLIT2;IL34;PTK2
1687,prerank,cellular response to oxygen-containing compound (GO:1901701),0.3285152455843075,0.990987564483334,0.5,1.0,1.0,9/15,46.40%,SLIT2;BRINP1;PDE4B;RORA;WT1;DPEP1;CPEB3;IRS1;EGFR
1688,prerank,negative regulation of synapse organization (GO:1905809),0.7487487487487487,0.9907820398453764,0.5,1.0,1.0,1/1,25.20%,ROBO2
1689,prerank,negative regulation of nervous system development (GO:0051961),0.7487487487487487,0.9907820398453764,0.5,1.0,1.0,1/1,25.20%,ROBO2
1690,prerank,forebrain neuron development (GO:0021884),0.7487487487487487,0.9907820398453764,0.5,1.0,1.0,1/1,25.20%,ROBO2
1691,prerank,response to retinoic acid (GO:0032526),0.4815765184724604,0.9901867176838633,0.4893048128342246,1.0,1.0,2/4,28.20%,BRINP1;ACER2
1692,prerank,regulation of DNA biosynthetic process (GO:2000278),0.5244926159960138,0.9899613002595871,0.5022156573116692,1.0,1.0,2/3,29.50%,TOM1L1;SMOC2
1693,prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.2639029322548028,-0.9898486722699784,0.44761904761904764,0.8951710692242719,1.0,11/11,74.00%,CCAR1;RBMX;PNN;CWC27;CSTF3;SRSF1;GCFC2;SRPK1;PRPF40B;NOVA1;DHX8
1694,prerank,inositol lipid-mediated signaling (GO:0048017),0.40569397008291486,0.9897259131208661,0.5041322314049587,1.0,1.0,5/7,43.00%,PLCH1;MUC5AC;IRS1;IGF1R;INPP5F
1695,prerank,histone lysine methylation (GO:0034968),-0.4884653961885657,-0.9896522137424285,0.4380952380952381,0.8943923926764504,1.0,3/3,51.40%,KMT2A;SMYD3;PRDM5
1696,prerank,detection of calcium ion (GO:0005513),0.7317317317317318,0.9892028217595487,0.5009596928982726,1.0,1.0,1/1,26.90%,KCNMB1
1697,prerank,negative regulation of interleukin-8 production (GO:0032717),-0.5861723446893787,-0.9890316036184591,0.4794520547945205,0.8951582669628118,1.0,2/2,41.60%,MAP2K5;BPI
1698,prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5305917753259781,0.988642838941013,0.5071022727272727,1.0,1.0,3/3,47.10%,CAMK1D;IL34;PTK2
1699,prerank,regulation of cell migration (GO:0030334),0.28578608875061773,0.9886392503292557,0.5186680121089808,1.0,1.0,20/33,49.30%,TMEFF2;TIAM1;SLIT2;SEMA3A;SEMA3E;SASH1;MAGI2;SEMA6A;LIMCH1;KANK1;DPEP1;DOCK10;DLG5;IGF1R;PRKCA;EGFR;AMOT;PTK2;GCNT2;ROR2
1700,prerank,mitotic nuclear membrane disassembly (GO:0007077),0.526579739217653,0.9871879576587225,0.5,1.0,1.0,3/3,47.50%,PRKCA;VRK1;LPIN1
1701,prerank,nuclear membrane disassembly (GO:0051081),0.526579739217653,0.9871879576587225,0.5,1.0,1.0,3/3,47.50%,PRKCA;VRK1;LPIN1
1702,prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.45101917199426006,0.986874200280455,0.5012562814070352,1.0,1.0,3/5,32.30%,ZNF423;MAP2K6;NOVA1
1703,prerank,negative regulation of metabolic process (GO:0009892),0.45101917199426006,0.986874200280455,0.5012562814070352,1.0,1.0,3/5,32.30%,ZNF423;MAP2K6;NOVA1
1704,prerank,calcium ion transport into cytosol (GO:0060402),0.6102204408817635,0.9868333202212451,0.5225375626043406,1.0,1.0,2/2,39.10%,TRPV4;CACNA1C
1705,prerank,ribonucleoprotein complex disassembly (GO:0032988),0.7387387387387387,0.9863007249788157,0.49902152641878667,1.0,1.0,1/1,26.20%,DHX8
1706,prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5761523046092184,-0.9860350812777471,0.45498783454987834,0.8982787806844181,1.0,2/2,42.60%,CHD1L;DDB2
1707,prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.5761523046092184,-0.9860350812777471,0.45498783454987834,0.8982787806844181,1.0,2/2,42.60%,CHD1L;DDB2
1708,prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5761523046092184,-0.9860350812777471,0.45498783454987834,0.8982787806844181,1.0,2/2,42.60%,CHD1L;DDB2
1709,prerank,global genome nucleotide-excision repair (GO:0070911),-0.5761523046092184,-0.9860350812777471,0.45498783454987834,0.8982787806844181,1.0,2/2,42.60%,CHD1L;DDB2
1710,prerank,nuclear DNA replication (GO:0033260),-0.7467467467467468,-0.9852422591549147,0.5430327868852459,0.8980361392572322,1.0,1/1,25.50%,ORC3
1711,prerank,pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.7467467467467468,-0.9852422591549147,0.5430327868852459,0.8980361392572322,1.0,1/1,25.50%,ORC3
1712,prerank,negative regulation of protein phosphorylation (GO:0001933),0.3436117850838781,0.9849703653389499,0.5027322404371585,1.0,1.0,6/12,36.90%,SLIT2;SH3GL2;SPRED2;PARD3;SPRED3;UBASH3B
1713,prerank,regulation of presynapse organization (GO:0099174),0.5961923847695391,0.9840489003397969,0.5287539936102237,1.0,1.0,2/2,40.50%,PTPRD;GPC4
1714,prerank,regulation of presynapse assembly (GO:1905606),0.5961923847695391,0.9840489003397969,0.5287539936102237,1.0,1.0,2/2,40.50%,PTPRD;GPC4
1715,prerank,regulation of receptor recycling (GO:0001919),-0.43072289156626503,-0.9835762288491494,0.45864661654135336,0.9014656017754956,1.0,4/4,57.20%,OPTN;ECE1;TBC1D16;INPP5F
1716,prerank,glycoprotein metabolic process (GO:0009100),-0.7387387387387387,-0.9825356804145171,0.5096525096525096,0.8995158983692968,1.0,1/1,26.30%,ADAMTS9
1717,prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.7387387387387387,-0.9825356804145171,0.5096525096525096,0.8995158983692968,1.0,1/1,26.30%,ADAMTS9
1718,prerank,glycoprotein catabolic process (GO:0006516),-0.7387387387387387,-0.9825356804145171,0.5096525096525096,0.8995158983692968,1.0,1/1,26.30%,ADAMTS9
1719,prerank,carbohydrate derivative catabolic process (GO:1901136),-0.7387387387387387,-0.9825356804145171,0.5096525096525096,0.8995158983692968,1.0,1/1,26.30%,ADAMTS9
1720,prerank,positive regulation of BMP signaling pathway (GO:0030513),0.5944374938570297,0.9824096513048075,0.5141509433962265,1.0,1.0,1/2,14.80%,ZNF423
1721,prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.2966700302724521,-0.9821350226164582,0.4573643410852713,0.8995747462333041,1.0,9/9,70.70%,INSR;FAF1;UPF3A;PLD1;SAMD4A;EGFR;IRS1;CPEB3;SMOC2
1722,prerank,zymogen activation (GO:0031638),0.7467467467467468,0.9820676782870059,0.5326732673267327,1.0,1.0,1/1,25.40%,PRSS12
1723,prerank,negative regulation of gene expression (GO:0010629),-0.20351021251418927,-0.9820540470183307,0.4576271186440678,0.8986618836899586,1.0,16/19,48.90%,AGO2;EMILIN1;DCP2;ROBO1;TNRC6A;BMPR1A;CREB3L1;NOTCH2;LGR4;FOXP1;ILF3;KAT2B;RBMS3;HAND2;TNRC6B;SAMD4A
1724,prerank,dense core granule cytoskeletal transport (GO:0099519),-0.7437437437437437,-0.9799510476209539,0.5426944971537002,0.9032588350346491,1.0,1/1,25.80%,TANC2
1725,prerank,sodium-independent organic anion transport (GO:0043252),-0.7357357357357357,-0.9798192691730111,0.5316205533596838,0.9004730658773478,1.0,1/1,26.60%,SLCO3A1
1726,prerank,prostaglandin transport (GO:0015732),-0.7357357357357357,-0.9798192691730111,0.5316205533596838,0.9004730658773478,1.0,1/1,26.60%,SLCO3A1
1727,prerank,icosanoid transport (GO:0071715),-0.7357357357357357,-0.9798192691730111,0.5316205533596838,0.9004730658773478,1.0,1/1,26.60%,SLCO3A1
1728,prerank,proteoglycan biosynthetic process (GO:0030166),0.6074903246011072,0.9798147044268751,0.5244094488188976,1.0,1.0,1/2,15.00%,CHST9
1729,prerank,positive regulation of cell growth (GO:0030307),0.44635727673997144,0.9796754527252589,0.512258064516129,1.0,1.0,4/5,46.40%,BCL2;CPNE5;MAP3K13;EGFR
1730,prerank,negative regulation of leukocyte migration (GO:0002686),0.5246960017573278,0.9796254682711426,0.527086383601757,1.0,1.0,1/3,9.80%,SLIT2
1731,prerank,regulation of myeloid cell differentiation (GO:0045637),-0.31822759315206445,-0.9791491499475513,0.4110429447852761,0.9010432216222798,1.0,7/7,68.50%,KMT2A;TNRC6A;KAT2B;TNRC6B;MEIS2;CDK6;MEIS1
1732,prerank,histone H2A ubiquitination (GO:0033522),-0.5761523046092184,-0.9790040593944063,0.4868421052631579,0.900283046191398,1.0,2/2,42.60%,UBR2;DDB2
1733,prerank,ion transport (GO:0006811),0.5276132616984315,0.9789817020372648,0.5174418604651163,1.0,1.0,1/3,8.60%,SLC24A2
1734,prerank,neurogenesis (GO:0022008),0.5220491970158665,0.978355307650067,0.5312934631432545,1.0,1.0,2/3,35.00%,BTBD2;CDK6
1735,prerank,regulation of axon guidance (GO:1902667),0.591182364729459,0.9782007265130728,0.5169628432956381,1.0,1.0,2/2,41.00%,ZSWIM5;MYCBP2
1736,prerank,cardiac cell fate commitment (GO:0060911),0.7227227227227226,0.9778562920731779,0.5355731225296443,1.0,1.0,1/1,27.80%,WT1
1737,prerank,positive regulation of gonad development (GO:1905941),0.7227227227227226,0.9778562920731779,0.5355731225296443,1.0,1.0,1/1,27.80%,WT1
1738,prerank,ureteric bud morphogenesis (GO:0060675),0.7227227227227226,0.9778562920731779,0.5355731225296443,1.0,1.0,1/1,27.80%,WT1
1739,prerank,regulation of animal organ morphogenesis (GO:2000027),0.7227227227227226,0.9778562920731779,0.5355731225296443,1.0,1.0,1/1,27.80%,WT1
1740,prerank,regulation of male gonad development (GO:2000018),0.7227227227227226,0.9778562920731779,0.5355731225296443,1.0,1.0,1/1,27.80%,WT1
1741,prerank,kidney epithelium development (GO:0072073),0.7227227227227226,0.9778562920731779,0.5355731225296443,1.0,1.0,1/1,27.80%,WT1
1742,prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.7227227227227226,0.9778562920731779,0.5355731225296443,1.0,1.0,1/1,27.80%,WT1
1743,prerank,cellular response to cAMP (GO:0071320),0.7227227227227226,0.9778562920731779,0.5355731225296443,1.0,1.0,1/1,27.80%,WT1
1744,prerank,positive regulation of male gonad development (GO:2000020),0.7227227227227226,0.9778562920731779,0.5355731225296443,1.0,1.0,1/1,27.80%,WT1
1745,prerank,metanephric epithelium development (GO:0072207),0.7227227227227226,0.9778562920731779,0.5355731225296443,1.0,1.0,1/1,27.80%,WT1
1746,prerank,response to gonadotropin (GO:0034698),0.7227227227227226,0.9778562920731779,0.5355731225296443,1.0,1.0,1/1,27.80%,WT1
1747,prerank,muscle cell fate commitment (GO:0042693),0.7227227227227226,0.9778562920731779,0.5355731225296443,1.0,1.0,1/1,27.80%,WT1
1748,prerank,cellular response to gonadotropin stimulus (GO:0071371),0.7227227227227226,0.9778562920731779,0.5355731225296443,1.0,1.0,1/1,27.80%,WT1
1749,prerank,cation transmembrane transport (GO:0098655),0.5238849817897923,0.9771460555126872,0.5258493353028065,1.0,1.0,1/3,6.70%,ASIC2
1750,prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2927319541532003,0.9770898947422539,0.5313765182186235,1.0,1.0,11/27,34.70%,ESRRG;HMGA2;ZNF536;PPARGC1A;ZNF423;RORA;WT1;TCF7L1;NCOA2;BNC2;ATXN1
1751,prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.7427427427427428,0.9769096802686518,0.5443037974683544,1.0,1.0,1/1,25.80%,MAP2K6
1752,prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.7427427427427428,0.9769096802686518,0.5443037974683544,1.0,1.0,1/1,25.80%,MAP2K6
1753,prerank,DNA damage induced protein phosphorylation (GO:0006975),0.7427427427427428,0.9769096802686518,0.5443037974683544,1.0,1.0,1/1,25.80%,MAP2K6
1754,prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.7427427427427428,0.9769096802686518,0.5443037974683544,1.0,1.0,1/1,25.80%,MAP2K6
1755,prerank,regulation of protein localization to nucleus (GO:1900180),-0.7287287287287287,-0.9766843860718561,0.5198412698412699,0.9028652833108105,1.0,1/1,27.30%,NVL
1756,prerank,ribosomal large subunit biogenesis (GO:0042273),-0.7287287287287287,-0.9766843860718561,0.5198412698412699,0.9028652833108105,1.0,1/1,27.30%,NVL
1757,prerank,regulation of protein localization to nucleolus (GO:1904749),-0.7287287287287287,-0.9766843860718561,0.5198412698412699,0.9028652833108105,1.0,1/1,27.30%,NVL
1758,prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.7297297297297297,0.9762303314362247,0.5304878048780488,1.0,1.0,1/1,27.10%,EME2
1759,prerank,resolution of meiotic recombination intermediates (GO:0000712),0.7297297297297297,0.9762303314362247,0.5304878048780488,1.0,1.0,1/1,27.10%,EME2
1760,prerank,positive regulation of vasculature development (GO:1904018),0.41946174395567154,0.9755903830387994,0.488456865127582,1.0,1.0,3/6,29.50%,HMGA2;SASH1;SMOC2
1761,prerank,response to light stimulus (GO:0009416),-0.5761523046092184,-0.9755164498852333,0.48739495798319327,0.9047549291064139,1.0,2/2,42.60%,ZRANB3;DDB2
1762,prerank,"transcription, DNA-templated (GO:0006351)",-0.29838709677419356,-0.975001298396155,0.47586206896551725,0.9048082543444117,1.0,8/8,70.50%,TAF15;RBMX;MNAT1;NFIX;PPP5C;TAF4B;TAF1C;DTX1
1763,prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.5751503006012023,-0.9731592477586631,0.49184782608695654,0.9082793912408385,1.0,2/2,42.70%,PER2;HAND2
1764,prerank,vascular transport (GO:0010232),-0.31997152230494874,-0.9729022159683418,0.503030303030303,0.9067859579076445,1.0,6/7,36.10%,INSR;ATP8A1;SLC7A1;SLC12A2;SLCO3A1;SLC1A3
1765,prerank,transport across blood-brain barrier (GO:0150104),-0.31997152230494874,-0.9729022159683418,0.503030303030303,0.9067859579076445,1.0,6/7,36.10%,INSR;ATP8A1;SLC7A1;SLC12A2;SLCO3A1;SLC1A3
1766,prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.7307307307307307,-0.9711681060804322,0.5327868852459017,0.9096851230250388,1.0,1/1,27.10%,KPNA5
1767,prerank,establishment of protein localization to organelle (GO:0072594),-0.4126506024096385,-0.9710071129917655,0.48,0.9090728190582915,1.0,4/4,59.00%,TNPO1;PRICKLE1;IPO8;NUP93
1768,prerank,regulation of glucose metabolic process (GO:0010906),0.5841683366733467,0.9709339338147813,0.5126582278481012,1.0,1.0,2/2,41.70%,RORA;IRS1
1769,prerank,regulation of AMPA receptor activity (GO:2000311),0.5931863727454909,0.9706127161451575,0.5329052969502408,1.0,1.0,2/2,40.80%,CACNG4;CNIH3
1770,prerank,amino acid import (GO:0043090),-0.485456369107322,-0.9686266420619929,0.4692556634304207,0.9140206003047956,1.0,3/3,51.70%,SLC7A1;SLC1A3;SFXN1
1771,prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.3440643863179075,-0.9685435930967659,0.5,0.913282622448186,1.0,6/6,65.90%,FGFR1;EPHA2;NF1;ETS1;PRKCA;AKT3
1772,prerank,negative regulation of leukocyte activation (GO:0002695),-0.5861723446893787,-0.9680502395086067,0.518005540166205,0.9113949159109327,1.0,2/2,41.60%,CD200;BPI
1773,prerank,regulation of macrophage activation (GO:0043030),-0.5861723446893787,-0.9680502395086067,0.518005540166205,0.9113949159109327,1.0,2/2,41.60%,CD200;BPI
1774,prerank,negative regulation of macrophage activation (GO:0043031),-0.5861723446893787,-0.9680502395086067,0.518005540166205,0.9113949159109327,1.0,2/2,41.60%,CD200;BPI
1775,prerank,regulation of osteoclast development (GO:2001204),-0.7207207207207207,-0.9668522740012707,0.5231910946196661,0.905293170824274,1.0,1/1,28.10%,NOTCH2
1776,prerank,regulation of keratinocyte proliferation (GO:0010837),-0.7207207207207207,-0.9668522740012707,0.5231910946196661,0.905293170824274,1.0,1/1,28.10%,NOTCH2
1777,prerank,atrial septum development (GO:0003283),-0.7207207207207207,-0.9668522740012707,0.5231910946196661,0.905293170824274,1.0,1/1,28.10%,NOTCH2
1778,prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.7207207207207207,-0.9668522740012707,0.5231910946196661,0.905293170824274,1.0,1/1,28.10%,NOTCH2
1779,prerank,atrial septum morphogenesis (GO:0060413),-0.7207207207207207,-0.9668522740012707,0.5231910946196661,0.905293170824274,1.0,1/1,28.10%,NOTCH2
1780,prerank,Notch signaling involved in heart development (GO:0061314),-0.7207207207207207,-0.9668522740012707,0.5231910946196661,0.905293170824274,1.0,1/1,28.10%,NOTCH2
1781,prerank,cardiac atrium morphogenesis (GO:0003209),-0.7207207207207207,-0.9668522740012707,0.5231910946196661,0.905293170824274,1.0,1/1,28.10%,NOTCH2
1782,prerank,positive regulation of keratinocyte proliferation (GO:0010838),-0.7207207207207207,-0.9668522740012707,0.5231910946196661,0.905293170824274,1.0,1/1,28.10%,NOTCH2
1783,prerank,regulation of growth rate (GO:0040009),-0.7207207207207207,-0.9668522740012707,0.5231910946196661,0.905293170824274,1.0,1/1,28.10%,NOTCH2
1784,prerank,positive regulation of protein acetylation (GO:1901985),-0.7217217217217217,-0.9668451772068112,0.5448717948717948,0.9042733505970332,1.0,1/1,28.00%,DIP2B
1785,prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4643237457276921,0.96668622945333,0.532,1.0,1.0,2/4,20.10%,PTPRD;LRP8
1786,prerank,negative regulation of neuron apoptotic process (GO:0043524),0.5145756235256251,0.9665464589598733,0.5401662049861495,1.0,1.0,2/3,29.80%,PPARGC1A;BCL2
1787,prerank,regulation of G0 to G1 transition (GO:0070316),-0.7277277277277278,-0.9652672746789738,0.5625,0.9061686258929014,1.0,1/1,27.40%,TFDP2
1788,prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.7277277277277278,-0.9652672746789738,0.5625,0.9061686258929014,1.0,1/1,27.40%,TFDP2
1789,prerank,regulation of cell-cell adhesion (GO:0022407),0.51833286885627,0.9650577330586719,0.5476190476190477,1.0,1.0,1/3,5.90%,TENM3
1790,prerank,commissural neuron axon guidance (GO:0071679),-0.7327327327327328,-0.9641055241443542,0.5657370517928287,0.9071195708376849,1.0,1/1,26.90%,NFIB
1791,prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.7327327327327328,-0.9641055241443542,0.5657370517928287,0.9071195708376849,1.0,1/1,26.90%,NFIB
1792,prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.579831394287605,0.9627804562041645,0.5562805872756933,1.0,1.0,1/2,16.30%,MECOM
1793,prerank,phospholipid translocation (GO:0045332),0.5242285314535378,0.9627310077191168,0.5361702127659574,1.0,1.0,1/3,10.00%,PLSCR2
1794,prerank,neurotransmitter transport (GO:0006836),0.43605310840299727,0.9620499520692845,0.517948717948718,1.0,1.0,4/5,45.30%,PTPRN2;LIN7A;SLC6A16;CPLX1
1795,prerank,carnitine shuttle (GO:0006853),-0.564128256513026,-0.9618250283986737,0.5235602094240838,0.9084578880554762,1.0,2/2,43.80%,ACACA;ACACB
1796,prerank,acetyl-CoA metabolic process (GO:0006084),-0.564128256513026,-0.9618250283986737,0.5235602094240838,0.9084578880554762,1.0,2/2,43.80%,ACACA;ACACB
1797,prerank,protein homotetramerization (GO:0051289),-0.564128256513026,-0.9618250283986737,0.5235602094240838,0.9084578880554762,1.0,2/2,43.80%,ACACA;ACACB
1798,prerank,protein tetramerization (GO:0051262),-0.564128256513026,-0.9618250283986737,0.5235602094240838,0.9084578880554762,1.0,2/2,43.80%,ACACA;ACACB
1799,prerank,cellular response to estradiol stimulus (GO:0071392),-0.46439317953861586,-0.9616053133313013,0.477124183006536,0.907057348429033,1.0,3/3,53.80%,NRIP1;LCOR;EGFR
1800,prerank,response to estradiol (GO:0032355),-0.46439317953861586,-0.9616053133313013,0.477124183006536,0.907057348429033,1.0,3/3,53.80%,NRIP1;LCOR;EGFR
1801,prerank,regulation of cell motility (GO:2000145),0.360692140360758,0.9615587595099112,0.5208568207440811,1.0,1.0,7/10,47.00%,NRG1;NRG2;DOCK10;CDK6;INPP5F;EGFR;AMOT
1802,prerank,aflatoxin metabolic process (GO:0046222),0.7207207207207207,0.9611671315168414,0.5555555555555556,1.0,1.0,1/1,28.00%,DPEP1
1803,prerank,cellular response to nitric oxide (GO:0071732),0.7207207207207207,0.9611671315168414,0.5555555555555556,1.0,1.0,1/1,28.00%,DPEP1
1804,prerank,sulfur compound catabolic process (GO:0044273),0.7207207207207207,0.9611671315168414,0.5555555555555556,1.0,1.0,1/1,28.00%,DPEP1
1805,prerank,homocysteine metabolic process (GO:0050667),0.7207207207207207,0.9611671315168414,0.5555555555555556,1.0,1.0,1/1,28.00%,DPEP1
1806,prerank,mycotoxin metabolic process (GO:0043385),0.7207207207207207,0.9611671315168414,0.5555555555555556,1.0,1.0,1/1,28.00%,DPEP1
1807,prerank,organic heteropentacyclic compound metabolic process (GO:1901376),0.7207207207207207,0.9611671315168414,0.5555555555555556,1.0,1.0,1/1,28.00%,DPEP1
1808,prerank,sulfur amino acid metabolic process (GO:0000096),0.7207207207207207,0.9611671315168414,0.5555555555555556,1.0,1.0,1/1,28.00%,DPEP1
1809,prerank,cellular response to reactive nitrogen species (GO:1902170),0.7207207207207207,0.9611671315168414,0.5555555555555556,1.0,1.0,1/1,28.00%,DPEP1
1810,prerank,response to nitric oxide (GO:0071731),0.7207207207207207,0.9611671315168414,0.5555555555555556,1.0,1.0,1/1,28.00%,DPEP1
1811,prerank,glutathione catabolic process (GO:0006751),0.7207207207207207,0.9611671315168414,0.5555555555555556,1.0,1.0,1/1,28.00%,DPEP1
1812,prerank,cellular modified amino acid catabolic process (GO:0042219),0.7207207207207207,0.9611671315168414,0.5555555555555556,1.0,1.0,1/1,28.00%,DPEP1
1813,prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.40963855421686746,-0.9607376422176235,0.5098814229249012,0.9083431078330056,1.0,4/4,59.30%,MYO1B;TANC2;MYO1D;FNBP1L
1814,prerank,phosphatidylcholine metabolic process (GO:0046470),-0.2923387096774194,-0.9607070234874295,0.5079365079365079,0.907347259542623,1.0,8/8,71.10%,CSNK2A1;PLA2G4A;LPCAT1;MBOAT2;SLC44A2;LPIN1;CHKA;MBOAT1
1815,prerank,peripheral nervous system neuron differentiation (GO:0048934),0.7127127127127126,0.9605663547697959,0.5472837022132797,1.0,1.0,1/1,28.80%,ETV1
1816,prerank,peripheral nervous system neuron development (GO:0048935),0.7127127127127126,0.9605663547697959,0.5472837022132797,1.0,1.0,1/1,28.80%,ETV1
1817,prerank,organelle organization (GO:0006996),0.29075454322645644,0.9605054601134836,0.5592705167173252,1.0,1.0,7/26,21.00%,CECR2;PPARGC1A;PCLO;WASF3;KIF5C;SEMA6A;ANK1
1818,prerank,positive regulation of protein phosphorylation (GO:0001934),0.302582457829804,0.9598628026563443,0.5405405405405406,1.0,1.0,11/19,47.10%,WNK3;CALCR;LRP8;LIMCH1;TOM1L1;IL34;DDR2;FLT4;CAPRIN2;EGFR;PTK2
1819,prerank,collagen fibril organization (GO:0030199),0.31552917523304513,0.9597290423493066,0.5359408033826638,1.0,1.0,8/16,38.00%,COL25A1;COL22A1;COL8A1;LAMA3;ADAMTS3;PXDN;COL5A3;DDR2
1820,prerank,regulation of keratinocyte differentiation (GO:0045616),0.7167167167167168,0.959445079415127,0.5441176470588235,1.0,1.0,1/1,28.40%,ETV4
1821,prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.7167167167167168,0.959445079415127,0.5441176470588235,1.0,1.0,1/1,28.40%,ETV4
1822,prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.7167167167167168,0.959445079415127,0.5441176470588235,1.0,1.0,1/1,28.40%,ETV4
1823,prerank,gland development (GO:0048732),0.433476792356382,0.9591112279499642,0.5287356321839081,1.0,1.0,1/5,0.50%,NRG1
1824,prerank,ceramide catabolic process (GO:0046514),0.7187187187187187,0.9589022038835769,0.5604166666666667,1.0,1.0,1/1,28.20%,ACER2
1825,prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.7187187187187187,0.9589022038835769,0.5604166666666667,1.0,1.0,1/1,28.20%,ACER2
1826,prerank,sphingolipid catabolic process (GO:0030149),0.7187187187187187,0.9589022038835769,0.5604166666666667,1.0,1.0,1/1,28.20%,ACER2
1827,prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.7187187187187187,0.9589022038835769,0.5604166666666667,1.0,1.0,1/1,28.20%,ACER2
1828,prerank,sphingoid biosynthetic process (GO:0046520),0.7187187187187187,0.9589022038835769,0.5604166666666667,1.0,1.0,1/1,28.20%,ACER2
1829,prerank,sphingosine biosynthetic process (GO:0046512),0.7187187187187187,0.9589022038835769,0.5604166666666667,1.0,1.0,1/1,28.20%,ACER2
1830,prerank,sphingosine metabolic process (GO:0006670),0.7187187187187187,0.9589022038835769,0.5604166666666667,1.0,1.0,1/1,28.20%,ACER2
1831,prerank,diol biosynthetic process (GO:0034312),0.7187187187187187,0.9589022038835769,0.5604166666666667,1.0,1.0,1/1,28.20%,ACER2
1832,prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.5091727967088845,0.9588016955158734,0.5473833097595474,1.0,1.0,1/3,12.30%,SH3GL2
1833,prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.5091727967088845,0.9588016955158734,0.5473833097595474,1.0,1.0,1/3,12.30%,SH3GL2
1834,prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.5091727967088845,0.9588016955158734,0.5473833097595474,1.0,1.0,1/3,12.30%,SH3GL2
1835,prerank,negative regulation of ruffle assembly (GO:1900028),0.5811500117600035,0.9587241765182197,0.5372907153729072,1.0,1.0,1/2,21.70%,KANK1
1836,prerank,regulation of chondrocyte differentiation (GO:0032330),-0.5691382765531061,-0.9586065296360639,0.5187165775401069,0.9115270995712476,1.0,2/2,43.30%,TRPS1;MBOAT2
1837,prerank,cellular component maintenance (GO:0043954),-0.4226907630522088,-0.9582506706071592,0.448,0.9114578576469643,1.0,4/4,58.00%,INSR;MTMR2;CLDN1;IGF1R
1838,prerank,regulation of vesicle-mediated transport (GO:0060627),0.3956602054174376,0.9568825792933908,0.535377358490566,1.0,1.0,5/7,45.30%,RIT2;HIP1;STXBP5;INPP5F;CPLX1
1839,prerank,neutrophil migration (GO:1990266),0.518365160636872,0.9568689955434111,0.5522827687776142,1.0,1.0,1/3,12.80%,PDE4B
1840,prerank,neutrophil chemotaxis (GO:0030593),0.518365160636872,0.9568689955434111,0.5522827687776142,1.0,1.0,1/3,12.80%,PDE4B
1841,prerank,granulocyte chemotaxis (GO:0071621),0.518365160636872,0.9568689955434111,0.5522827687776142,1.0,1.0,1/3,12.80%,PDE4B
1842,prerank,positive regulation of acrosome reaction (GO:2000344),-0.7137137137137137,-0.9568596751195234,0.5645833333333333,0.9036904954203163,1.0,1/1,28.80%,PLCB1
1843,prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.7137137137137137,-0.9568596751195234,0.5645833333333333,0.9036904954203163,1.0,1/1,28.80%,PLCB1
1844,prerank,cellular response to interleukin-15 (GO:0071350),-0.7137137137137137,-0.9568596751195234,0.5645833333333333,0.9036904954203163,1.0,1/1,28.80%,PLCB1
1845,prerank,negative regulation of cellular extravasation (GO:0002692),-0.7137137137137137,-0.9568596751195234,0.5645833333333333,0.9036904954203163,1.0,1/1,28.80%,PLCB1
1846,prerank,cellular response to interleukin-12 (GO:0071349),-0.7137137137137137,-0.9568596751195234,0.5645833333333333,0.9036904954203163,1.0,1/1,28.80%,PLCB1
1847,prerank,positive regulation of interleukin-12 production (GO:0032735),-0.7137137137137137,-0.9568596751195234,0.5645833333333333,0.9036904954203163,1.0,1/1,28.80%,PLCB1
1848,prerank,regulation of acrosome reaction (GO:0060046),-0.7137137137137137,-0.9568596751195234,0.5645833333333333,0.9036904954203163,1.0,1/1,28.80%,PLCB1
1849,prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.7137137137137137,-0.9568596751195234,0.5645833333333333,0.9036904954203163,1.0,1/1,28.80%,PLCB1
1850,prerank,regulation of fertilization (GO:0080154),-0.7137137137137137,-0.9568596751195234,0.5645833333333333,0.9036904954203163,1.0,1/1,28.80%,PLCB1
1851,prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.7137137137137137,-0.9568596751195234,0.5645833333333333,0.9036904954203163,1.0,1/1,28.80%,PLCB1
1852,prerank,positive regulation of myoblast differentiation (GO:0045663),-0.7137137137137137,-0.9568596751195234,0.5645833333333333,0.9036904954203163,1.0,1/1,28.80%,PLCB1
1853,prerank,monocarboxylic acid metabolic process (GO:0032787),-0.3370221327967807,-0.9565086790895382,0.4973544973544973,0.9033771117961759,1.0,6/6,66.60%,PER2;HAGH;AASDH;ACADSB;ACSF2;ABAT
1854,prerank,regulation of cell-substrate adhesion (GO:0010810),-0.47141424272818455,-0.9561792460945779,0.5017543859649123,0.9034130960560159,1.0,3/3,53.10%,NF1;GCNT2;PTK2
1855,prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.7157157157157157,-0.9554729726066756,0.5963488843813387,0.9040652049062736,1.0,1/1,28.60%,LGR4
1856,prerank,positive regulation of cytokinesis (GO:0032467),-0.39959839357429716,-0.955333201011398,0.49606299212598426,0.9022882088288745,1.0,4/4,60.30%,PKN2;CDC14A;SPAST;CDC14B
1857,prerank,positive regulation of cell division (GO:0051781),-0.39959839357429716,-0.955333201011398,0.49606299212598426,0.9022882088288745,1.0,4/4,60.30%,PKN2;CDC14A;SPAST;CDC14B
1858,prerank,RNA polyadenylation (GO:0043631),-0.7247247247247247,-0.9552536777968296,0.5636704119850188,0.89747039465508,1.0,1/1,27.70%,CSTF3
1859,prerank,termination of RNA polymerase II transcription (GO:0006369),-0.7247247247247247,-0.9552536777968296,0.5636704119850188,0.89747039465508,1.0,1/1,27.70%,CSTF3
1860,prerank,mRNA cleavage (GO:0006379),-0.7247247247247247,-0.9552536777968296,0.5636704119850188,0.89747039465508,1.0,1/1,27.70%,CSTF3
1861,prerank,mRNA polyadenylation (GO:0006378),-0.7247247247247247,-0.9552536777968296,0.5636704119850188,0.89747039465508,1.0,1/1,27.70%,CSTF3
1862,prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.7247247247247247,-0.9552536777968296,0.5636704119850188,0.89747039465508,1.0,1/1,27.70%,CSTF3
1863,prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.279249050067101,0.9551946181549759,0.5626262626262626,1.0,1.0,12/31,34.70%,ESRRG;HMGA2;ZNF536;PPARGC1A;ZNF423;RORA;TOM1L1;WT1;TCF7L1;NCOA2;BNC2;ATXN1
1864,prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.40651647422591475,0.9539364762322416,0.5250917992656059,1.0,1.0,4/6,41.80%,HIP1;ACER2;CASP9;PIDD1
1865,prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.40651647422591475,0.9539364762322416,0.5250917992656059,1.0,1.0,4/6,41.80%,HIP1;ACER2;CASP9;PIDD1
1866,prerank,positive regulation of megakaryocyte differentiation (GO:0045654),-0.7147147147147147,-0.9538584120154566,0.5606361829025845,0.8965357744344981,1.0,1/1,28.70%,TESC
1867,prerank,positive regulation of granulocyte differentiation (GO:0030854),-0.7147147147147147,-0.9538584120154566,0.5606361829025845,0.8965357744344981,1.0,1/1,28.70%,TESC
1868,prerank,regulation of granulocyte differentiation (GO:0030852),-0.7147147147147147,-0.9538584120154566,0.5606361829025845,0.8965357744344981,1.0,1/1,28.70%,TESC
1869,prerank,regulation of sodium:proton antiporter activity (GO:0032415),-0.7147147147147147,-0.9538584120154566,0.5606361829025845,0.8965357744344981,1.0,1/1,28.70%,TESC
1870,prerank,selective autophagy (GO:0061912),-0.5711422845691382,-0.9538519347058616,0.5326370757180157,0.8955739554606095,1.0,2/2,43.10%,ULK1;ARL13B
1871,prerank,peptidyl-threonine modification (GO:0018210),0.3786061740396764,0.9537055830058736,0.5368663594470046,1.0,1.0,3/8,22.10%,WNK3;CDC42BPA;STK39
1872,prerank,peptidyl-threonine phosphorylation (GO:0018107),0.3786061740396764,0.9537055830058736,0.5368663594470046,1.0,1.0,3/8,22.10%,WNK3;CDC42BPA;STK39
1873,prerank,tRNA modification (GO:0006400),0.46084337349397597,0.9533713873495068,0.5410691003911343,1.0,1.0,4/4,54.10%,TARBP1;TPRKB;NSUN6;QTRT1
1874,prerank,ether lipid metabolic process (GO:0046485),-0.7167167167167167,-0.9526408927524347,0.5553359683794467,0.8942959276366037,1.0,1/1,28.50%,FAR1
1875,prerank,glycerolipid biosynthetic process (GO:0045017),-0.7167167167167167,-0.9526408927524347,0.5553359683794467,0.8942959276366037,1.0,1/1,28.50%,FAR1
1876,prerank,cellular lipid biosynthetic process (GO:0097384),-0.7167167167167167,-0.9526408927524347,0.5553359683794467,0.8942959276366037,1.0,1/1,28.50%,FAR1
1877,prerank,glycerol ether biosynthetic process (GO:0046504),-0.7167167167167167,-0.9526408927524347,0.5553359683794467,0.8942959276366037,1.0,1/1,28.50%,FAR1
1878,prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.7057057057057057,0.9523704068695564,0.5409836065573771,1.0,1.0,1/1,29.50%,SMOC2
1879,prerank,positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),0.7057057057057057,0.9523704068695564,0.5409836065573771,1.0,1.0,1/1,29.50%,SMOC2
1880,prerank,positive regulation of chemotaxis (GO:0050921),0.7057057057057057,0.9523704068695564,0.5409836065573771,1.0,1.0,1/1,29.50%,SMOC2
1881,prerank,organophosphate ester transport (GO:0015748),0.7067067067067068,0.9518963947289495,0.5651302605210421,1.0,1.0,1/1,29.40%,PITPNC1
1882,prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5731462925851704,0.9517114540281759,0.552099533437014,1.0,1.0,2/2,42.80%,CALCR;TRPC1
1883,prerank,protein-containing complex subunit organization (GO:0043933),0.3566212777087064,0.9515882871435553,0.5469798657718121,1.0,1.0,5/10,37.90%,PPARGC1A;WASF3;LIN7A;PARD3;CD2AP
1884,prerank,aminoglycan biosynthetic process (GO:0006023),0.4349379554636349,0.9513855943187504,0.5375,1.0,1.0,4/5,47.60%,HS3ST5;GPC4;GPC3;GCNT2
1885,prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.3277086252519482,-0.9512264548377536,0.4972375690607735,0.8967249269336133,1.0,5/6,34.00%,RICTOR;NOTCH2;EFNA5;CDK10;RHOBTB1
1886,prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5841683366733468,0.9506158282853697,0.5501567398119123,1.0,1.0,2/2,41.70%,PPARGC1A;IRS1
1887,prerank,positive regulation of glucose metabolic process (GO:0010907),0.5841683366733468,0.9506158282853697,0.5501567398119123,1.0,1.0,2/2,41.70%,PPARGC1A;IRS1
1888,prerank,cellular protein metabolic process (GO:0044267),0.33902200634938234,0.9500872457580098,0.5509761388286334,1.0,1.0,3/12,19.00%,CHRM3;CDH2;PAPPA
1889,prerank,vascular process in circulatory system (GO:0003018),-0.5480961923847695,-0.9485209010133173,0.5086848635235732,0.9011486156164519,1.0,2/2,45.40%,ITGB1BP1;GCLM
1890,prerank,regulation of tube diameter (GO:0035296),-0.5480961923847695,-0.9485209010133173,0.5086848635235732,0.9011486156164519,1.0,2/2,45.40%,ITGB1BP1;GCLM
1891,prerank,acylglycerol biosynthetic process (GO:0046463),-0.4754262788365095,-0.9483407597306152,0.535593220338983,0.9007169936001777,1.0,3/3,52.70%,PLA2G4A;GK;LPIN1
1892,prerank,glutamate metabolic process (GO:0006536),-0.4674022066198596,-0.9479630765947235,0.5049180327868853,0.9006882266927612,1.0,3/3,53.50%,OAT;GCLM;GOT1
1893,prerank,negative regulation of neuron differentiation (GO:0045665),0.7037037037037037,0.9475101552783428,0.5683168316831683,1.0,1.0,1/1,29.70%,DTX1
1894,prerank,regulation of cellular response to stress (GO:0080135),0.4077909831127832,0.9467532600054004,0.5312117503059975,1.0,1.0,1/6,1.20%,ADCY8
1895,prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.21722006472169691,-0.9466523343574692,0.4931506849315068,0.9027624365216457,1.0,13/15,48.20%,AGO2;EMILIN1;MTMR2;ROBO1;TNRC6A;BMPR1A;CREB3L1;NOTCH2;OPTN;FOXP1;RBMS3;HAND2;TNRC6B
1896,prerank,regulation of alpha-beta T cell differentiation (GO:0046637),0.5939028625631221,0.9463706047518439,0.5973813420621932,1.0,1.0,1/2,18.20%,GLI3
1897,prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.4079124794996939,0.9456249351074584,0.5547355473554736,1.0,1.0,2/6,19.70%,TIAM1;MAGI2
1898,prerank,establishment of epithelial cell polarity (GO:0090162),0.7177177177177176,0.9455057381139079,0.5714285714285714,1.0,1.0,1/1,28.30%,PARD3
1899,prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.7177177177177176,0.9455057381139079,0.5714285714285714,1.0,1.0,1/1,28.30%,PARD3
1900,prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.34757507685847283,0.9452002750691678,0.5559246954595792,1.0,1.0,5/10,37.90%,TIAM1;SLIT2;OBSCN;RHOJ;CD2AP
1901,prerank,"DNA-templated transcription, termination (GO:0006353)",-0.4046184738955823,-0.9448403559524873,0.5182481751824818,0.9059125469613628,1.0,4/4,59.80%,TAF1D;MNAT1;CSTF3;TAF1C
1902,prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.5480961923847695,-0.9441743127666977,0.519893899204244,0.9047604237513905,1.0,2/2,45.40%,HAGH;GCLM
1903,prerank,glutathione biosynthetic process (GO:0006750),-0.5480961923847695,-0.9441743127666977,0.519893899204244,0.9047604237513905,1.0,2/2,45.40%,HAGH;GCLM
1904,prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.5480961923847695,-0.9441743127666977,0.519893899204244,0.9047604237513905,1.0,2/2,45.40%,HAGH;GCLM
1905,prerank,positive regulation of circadian rhythm (GO:0042753),0.5815286494973326,0.9440969387128241,0.5619546247818499,1.0,1.0,1/2,20.60%,RORA
1906,prerank,protein deacylation (GO:0035601),-0.4633901705115346,-0.9440912490650702,0.49673202614379086,0.9041226470536,1.0,3/3,53.90%,LYPLAL1;HDAC5;ABHD17C
1907,prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4596828347184276,0.9437631311032668,0.5609103078982597,1.0,1.0,3/4,46.40%,CALCR;CAPRIN2;EGFR
1908,prerank,negative regulation of multicellular organismal process (GO:0051241),0.31108165937763016,0.9432628027085144,0.5729166666666666,1.0,1.0,7/18,32.30%,HS3ST5;ZNF423;MCC;SPRED2;MAP2K6;SPRED3;NOVA1
1909,prerank,B cell homeostasis (GO:0001782),0.7017017017017018,0.9431125223585943,0.5670498084291188,1.0,1.0,1/1,29.90%,DOCK10
1910,prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.2636363636363636,-0.9425195213549613,0.48695652173913045,0.9067112802459937,1.0,10/10,74.00%,CCAR1;RBMX;PNN;CWC27;CSTF3;SRSF1;GCFC2;PRPF40B;NOVA1;DHX8
1911,prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3029015693545075,0.9422836226561312,0.5678496868475992,1.0,1.0,8/17,40.00%,SHANK2;SLIT2;MAGI2;RORA;PDE10A;BCL2;CD2AP;DLG5
1912,prerank,histone monoubiquitination (GO:0010390),-0.5761523046092184,-0.9417436497053221,0.5511811023622047,0.907378549800319,1.0,2/2,42.60%,WAC;DDB2
1913,prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.4016064257028112,-0.9417418858339817,0.5261044176706827,0.905450068408565,1.0,4/4,60.10%,AGO2;TNRC6A;TNRC6B;CPEB3
1914,prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.4016064257028112,-0.9417418858339817,0.5261044176706827,0.905450068408565,1.0,4/4,60.10%,AGO2;TNRC6A;TNRC6B;CPEB3
1915,prerank,acylglycerol acyl-chain remodeling (GO:0036155),-0.7037037037037037,-0.9413144659814581,0.57,0.9018538541044145,1.0,1/1,29.80%,MGLL
1916,prerank,monoacylglycerol catabolic process (GO:0052651),-0.7037037037037037,-0.9413144659814581,0.57,0.9018538541044145,1.0,1/1,29.80%,MGLL
1917,prerank,regulation of sensory perception (GO:0051931),-0.7037037037037037,-0.9413144659814581,0.57,0.9018538541044145,1.0,1/1,29.80%,MGLL
1918,prerank,regulation of sensory perception of pain (GO:0051930),-0.7037037037037037,-0.9413144659814581,0.57,0.9018538541044145,1.0,1/1,29.80%,MGLL
1919,prerank,neutral lipid catabolic process (GO:0046461),-0.7037037037037037,-0.9413144659814581,0.57,0.9018538541044145,1.0,1/1,29.80%,MGLL
1920,prerank,positive regulation of fibroblast proliferation (GO:0048146),0.50503540412184,0.9412822096197577,0.5781021897810219,1.0,1.0,2/3,38.00%,CDK6;DDR2
1921,prerank,regulation of intracellular transport (GO:0032386),0.5711422845691383,0.9409665208584926,0.5709624796084829,1.0,1.0,2/2,43.00%,MAP2;INPP5F
1922,prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4319820923927791,0.9399289294022253,0.5699745547073791,1.0,1.0,1/5,7.10%,AUTS2
1923,prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1924,prerank,regulation of transmembrane transport (GO:0034762),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1925,prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1926,prerank,regulation of mitochondrial depolarization (GO:0051900),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1927,prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1928,prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1929,prerank,B cell receptor signaling pathway (GO:0050853),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1930,prerank,positive regulation of B cell proliferation (GO:0030890),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1931,prerank,B cell proliferation (GO:0042100),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1932,prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1933,prerank,regulation of B cell proliferation (GO:0030888),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1934,prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1935,prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1936,prerank,negative regulation of autophagy (GO:0010507),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1937,prerank,intracellular pH elevation (GO:0051454),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1938,prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1939,prerank,response to iron ion (GO:0010039),0.7027027027027026,0.9397412818236044,0.6149193548387096,1.0,1.0,1/1,29.80%,BCL2
1940,prerank,negative regulation of T cell migration (GO:2000405),-0.6966966966966966,-0.9396281325788197,0.5828343313373253,0.8980517520458786,1.0,1/1,30.50%,CD200
1941,prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.6966966966966966,-0.9396281325788197,0.5828343313373253,0.8980517520458786,1.0,1/1,30.50%,CD200
1942,prerank,regulation of T cell migration (GO:2000404),-0.6966966966966966,-0.9396281325788197,0.5828343313373253,0.8980517520458786,1.0,1/1,30.50%,CD200
1943,prerank,regulation of leukocyte activation (GO:0002694),-0.6966966966966966,-0.9396281325788197,0.5828343313373253,0.8980517520458786,1.0,1/1,30.50%,CD200
1944,prerank,regulation of neuroinflammatory response (GO:0150077),-0.6966966966966966,-0.9396281325788197,0.5828343313373253,0.8980517520458786,1.0,1/1,30.50%,CD200
1945,prerank,negative regulation of lymphocyte migration (GO:2000402),-0.6966966966966966,-0.9396281325788197,0.5828343313373253,0.8980517520458786,1.0,1/1,30.50%,CD200
1946,prerank,negative regulation of immune system process (GO:0002683),-0.6966966966966966,-0.9396281325788197,0.5828343313373253,0.8980517520458786,1.0,1/1,30.50%,CD200
1947,prerank,regulation of transforming growth factor beta production (GO:0071634),-0.6966966966966966,-0.9396281325788197,0.5828343313373253,0.8980517520458786,1.0,1/1,30.50%,CD200
1948,prerank,visual system development (GO:0150063),0.4904714142427281,0.9394666951311305,0.5651537335285505,1.0,1.0,3/3,51.10%,MEIS1;MEIS2;PBX1
1949,prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.5561122244488977,-0.9394041976980371,0.5243243243243243,0.8975492482767414,1.0,2/2,44.60%,ARNT;ETS1
1950,prerank,cotranslational protein targeting to membrane (GO:0006613),-0.7047047047047047,-0.9386739857620732,0.5828460038986355,0.8984984995436482,1.0,1/1,29.70%,SIL1
1951,prerank,B cell differentiation (GO:0030183),-0.5571142284569138,-0.9385558798904805,0.5254691689008043,0.897836128777205,1.0,2/2,44.50%,HDAC5;TPD52
1952,prerank,histone H3-K4 demethylation (GO:0034720),-0.7087087087087087,-0.9381825148476928,0.6104417670682731,0.8966400885617792,1.0,1/1,29.30%,KDM5B
1953,prerank,histone lysine demethylation (GO:0070076),-0.7087087087087087,-0.9381825148476928,0.6104417670682731,0.8966400885617792,1.0,1/1,29.30%,KDM5B
1954,prerank,negative regulation of protein localization to membrane (GO:1905476),-0.7067067067067067,-0.9381801597785742,0.6094674556213018,0.8891848823311352,1.0,1/1,29.50%,ITGB1BP1
1955,prerank,negative regulation of protein targeting to membrane (GO:0090315),-0.7067067067067067,-0.9381801597785742,0.6094674556213018,0.8891848823311352,1.0,1/1,29.50%,ITGB1BP1
1956,prerank,negative regulation of fibroblast migration (GO:0010764),-0.7067067067067067,-0.9381801597785742,0.6094674556213018,0.8891848823311352,1.0,1/1,29.50%,ITGB1BP1
1957,prerank,myoblast migration (GO:0051451),-0.7067067067067067,-0.9381801597785742,0.6094674556213018,0.8891848823311352,1.0,1/1,29.50%,ITGB1BP1
1958,prerank,integrin activation (GO:0033622),-0.7067067067067067,-0.9381801597785742,0.6094674556213018,0.8891848823311352,1.0,1/1,29.50%,ITGB1BP1
1959,prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.7067067067067067,-0.9381801597785742,0.6094674556213018,0.8891848823311352,1.0,1/1,29.50%,ITGB1BP1
1960,prerank,negative regulation of intracellular protein transport (GO:0090317),-0.7067067067067067,-0.9381801597785742,0.6094674556213018,0.8891848823311352,1.0,1/1,29.50%,ITGB1BP1
1961,prerank,muscle cell migration (GO:0014812),-0.7067067067067067,-0.9381801597785742,0.6094674556213018,0.8891848823311352,1.0,1/1,29.50%,ITGB1BP1
1962,prerank,cellular response to cytokine stimulus (GO:0071345),0.3133937564971385,0.9381145510413307,0.5834230355220668,1.0,1.0,6/15,31.80%,GREM2;LRP8;RORA;STK39;BCL2;IL34
1963,prerank,chromosome organization (GO:0051276),0.39819888133430503,0.9380744177150756,0.55875,1.0,1.0,1/6,1.50%,HMGA2
1964,prerank,positive regulation of cell migration (GO:0030335),0.3015710641453524,0.9378228592456991,0.587737843551797,1.0,1.0,11/18,49.30%,TIAM1;SEMA3A;SEMA3E;SEMA6A;DDR2;IGF1R;PRKCA;EGFR;PTK2;GCNT2;ROR2
1965,prerank,protein repair (GO:0030091),-0.6976976976976977,-0.9367111406680795,0.6206185567010309,0.8916328508216159,1.0,1/1,30.40%,MSRB3
1966,prerank,positive regulation of cell motility (GO:2000147),0.30774097460354766,0.9363638547946774,0.5847457627118644,1.0,1.0,10/16,49.30%,TIAM1;SEMA3A;SEMA3E;SEMA6A;IGF1R;PRKCA;EGFR;PTK2;GCNT2;ROR2
1967,prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.6906906906906907,0.9344981973855951,0.5774647887323944,1.0,1.0,1/1,31.00%,ELOVL6
1968,prerank,fatty acid oxidation (GO:0019395),0.504017686273628,0.9342764353156923,0.5951704545454546,1.0,1.0,1/3,12.20%,PPARGC1A
1969,prerank,pyruvate metabolic process (GO:0006090),-0.6996996996996997,-0.9334070854048991,0.5984405458089669,0.8988331950912782,1.0,1/1,30.20%,HAGH
1970,prerank,icosanoid biosynthetic process (GO:0046456),-0.6936936936936937,-0.9328146365257455,0.5821782178217821,0.8882990271857685,1.0,1/1,30.80%,PLA2G4A
1971,prerank,monoacylglycerol biosynthetic process (GO:0006640),-0.6936936936936937,-0.9328146365257455,0.5821782178217821,0.8882990271857685,1.0,1/1,30.80%,PLA2G4A
1972,prerank,prostanoid biosynthetic process (GO:0046457),-0.6936936936936937,-0.9328146365257455,0.5821782178217821,0.8882990271857685,1.0,1/1,30.80%,PLA2G4A
1973,prerank,cardiolipin metabolic process (GO:0032048),-0.6936936936936937,-0.9328146365257455,0.5821782178217821,0.8882990271857685,1.0,1/1,30.80%,PLA2G4A
1974,prerank,cardiolipin acyl-chain remodeling (GO:0035965),-0.6936936936936937,-0.9328146365257455,0.5821782178217821,0.8882990271857685,1.0,1/1,30.80%,PLA2G4A
1975,prerank,carboxylic acid metabolic process (GO:0019752),-0.6936936936936937,-0.9328146365257455,0.5821782178217821,0.8882990271857685,1.0,1/1,30.80%,PLA2G4A
1976,prerank,leukotriene biosynthetic process (GO:0019370),-0.6936936936936937,-0.9328146365257455,0.5821782178217821,0.8882990271857685,1.0,1/1,30.80%,PLA2G4A
1977,prerank,platelet activating factor metabolic process (GO:0046469),-0.6936936936936937,-0.9328146365257455,0.5821782178217821,0.8882990271857685,1.0,1/1,30.80%,PLA2G4A
1978,prerank,positive regulation of cell activation (GO:0050867),-0.6936936936936937,-0.9328146365257455,0.5821782178217821,0.8882990271857685,1.0,1/1,30.80%,PLA2G4A
1979,prerank,prostaglandin biosynthetic process (GO:0001516),-0.6936936936936937,-0.9328146365257455,0.5821782178217821,0.8882990271857685,1.0,1/1,30.80%,PLA2G4A
1980,prerank,prostaglandin metabolic process (GO:0006693),-0.6936936936936937,-0.9328146365257455,0.5821782178217821,0.8882990271857685,1.0,1/1,30.80%,PLA2G4A
1981,prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.6936936936936937,-0.9328146365257455,0.5821782178217821,0.8882990271857685,1.0,1/1,30.80%,PLA2G4A
1982,prerank,phosphatidylcholine catabolic process (GO:0034638),-0.6936936936936937,-0.9328146365257455,0.5821782178217821,0.8882990271857685,1.0,1/1,30.80%,PLA2G4A
1983,prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4544615411223457,0.9327067319675347,0.5792276964047937,1.0,1.0,3/4,41.90%,ALK;PIDD1;MAP3K13
1984,prerank,membrane fusion (GO:0061025),-0.5501002004008015,-0.9324429677203788,0.5437158469945356,0.8881766431762099,1.0,2/2,45.20%,UBXN2A;HACE1
1985,prerank,double-strand break repair (GO:0006302),-0.2721774193548387,-0.9319414723836674,0.5862068965517241,0.8886699538874046,1.0,8/8,73.10%,SPIDR;NUCKS1;REV3L;SMARCAD1;TP53BP1;PPP5C;WRN;EME2
1986,prerank,negative regulation of T cell differentiation (GO:0045581),0.5691382765531062,0.9311465859491609,0.5878693623639192,1.0,1.0,2/2,43.20%,GLI3;ZC3H8
1987,prerank,protein K48-linked ubiquitination (GO:0070936),-0.5501002004008015,-0.9293975544010517,0.5674931129476584,0.8936775112546299,1.0,2/2,45.20%,UBE2D3;HACE1
1988,prerank,lipid catabolic process (GO:0016042),0.49731744850674375,0.9277322462067109,0.5864022662889519,1.0,1.0,1/3,9.70%,GLYATL2
1989,prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.46439317953861586,-0.927542765934118,0.5472312703583062,0.8968755424302061,1.0,3/3,53.80%,AGO2;TNRC6B;EGFR
1990,prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.4944187010452664,0.927365934539113,0.5838235294117647,1.0,1.0,2/3,31.80%,TENM4;IL34
1991,prerank,protein complex oligomerization (GO:0051259),0.3708271057305266,0.9271692629167874,0.5583524027459954,1.0,1.0,1/8,1.20%,ADCY8
1992,prerank,sphingolipid metabolic process (GO:0006665),0.3631897665186685,0.9268111469016613,0.5698924731182796,1.0,1.0,4/8,31.00%,ELOVL2;ELOVL7;ACER2;ELOVL6
1993,prerank,carbohydrate homeostasis (GO:0033500),0.37678432763256964,0.9267579645212887,0.5699177438307873,1.0,1.0,1/7,1.20%,ADCY8
1994,prerank,cell junction maintenance (GO:0034331),-0.5490981963927856,-0.9257705765673409,0.5699208443271768,0.9002189082649267,1.0,2/2,45.30%,CLDN1;CBLN2
1995,prerank,regulation of skeletal muscle fiber development (GO:0048742),-0.7017017017017017,-0.9257358919717493,0.6378269617706237,0.899347519066423,1.0,1/1,30.00%,FBXO22
1996,prerank,regulation of endothelial cell proliferation (GO:0001936),-0.34371859296482415,-0.9239417103542731,0.5427350427350427,0.9026618648379892,1.0,5/5,65.90%,ARNT;NF1;PRKCA;FLT4;AKT3
1997,prerank,positive regulation of vascular permeability (GO:0043117),0.6996996996996997,0.9235054977743599,0.6125760649087221,1.0,1.0,1/1,30.10%,TRPV4
1998,prerank,cellular response to heat (GO:0034605),0.6996996996996997,0.9235054977743599,0.6125760649087221,1.0,1.0,1/1,30.10%,TRPV4
1999,prerank,delamination (GO:0060232),0.6996996996996997,0.9235054977743599,0.6125760649087221,1.0,1.0,1/1,30.10%,TRPV4
2000,prerank,positive regulation of protein depolymerization (GO:1901881),0.6996996996996997,0.9235054977743599,0.6125760649087221,1.0,1.0,1/1,30.10%,TRPV4
2001,prerank,endochondral bone morphogenesis (GO:0060350),0.6996996996996997,0.9235054977743599,0.6125760649087221,1.0,1.0,1/1,30.10%,TRPV4
2002,prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6996996996996997,0.9235054977743599,0.6125760649087221,1.0,1.0,1/1,30.10%,TRPV4
2003,prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.49776782449364915,0.9228393515294551,0.6069364161849711,1.0,1.0,1/3,6.00%,POLE
2004,prerank,regulation of phosphorylation (GO:0042325),-0.4126506024096385,-0.9225895330949105,0.5550847457627118,0.9049073210621549,1.0,4/4,59.00%,NUP58;PTK2;EGFR;NUP93
2005,prerank,regulation of cilium assembly (GO:1902017),-0.35376884422110555,-0.9218141784686658,0.5544554455445545,0.9057268882323083,1.0,5/5,64.90%,TBC1D5;CDK10;RABGAP1;TBC1D16;SGSM3
2006,prerank,regulation of cell morphogenesis (GO:0022604),-0.6886886886886887,-0.9216931475729689,0.6328600405679513,0.90322832321929,1.0,1/1,31.30%,EFNA5
2007,prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.6886886886886887,-0.9216931475729689,0.6328600405679513,0.90322832321929,1.0,1/1,31.30%,EFNA5
2008,prerank,regulation of microtubule-based process (GO:0032886),-0.6886886886886887,-0.9216931475729689,0.6328600405679513,0.90322832321929,1.0,1/1,31.30%,EFNA5
2009,prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6916916916916918,0.9208720236288975,0.603415559772296,1.0,1.0,1/1,30.90%,MUC6
2010,prerank,epithelial structure maintenance (GO:0010669),0.6916916916916918,0.9208720236288975,0.603415559772296,1.0,1.0,1/1,30.90%,MUC6
2011,prerank,regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.5697253717155581,0.9206779816540906,0.6203554119547657,1.0,1.0,1/2,23.90%,LMO3
2012,prerank,regulation of Ras protein signal transduction (GO:0046578),0.424085766199892,0.9205780460536057,0.6178010471204188,1.0,1.0,3/5,35.30%,KANK1;EPS8L2;SGSM3
2013,prerank,regulation of T cell differentiation in thymus (GO:0033081),0.5561122244488977,0.9204522043596751,0.6280193236714976,1.0,1.0,2/2,44.50%,ZC3H8;TOX
2014,prerank,regulation of protein transport (GO:0051223),0.5614375063102474,0.9203805894956208,0.6012558869701727,1.0,1.0,1/2,24.40%,STXBP5
2015,prerank,regulation of cyclase activity (GO:0031279),0.6896896896896897,0.9202127659574475,0.6204238921001927,1.0,1.0,1/1,31.10%,CAP2
2016,prerank,regulation of lyase activity (GO:0051339),0.6896896896896897,0.9202127659574475,0.6204238921001927,1.0,1.0,1/1,31.10%,CAP2
2017,prerank,very long-chain fatty acid catabolic process (GO:0042760),-0.6856856856856857,-0.9196558053113392,0.6139240506329114,0.9072411525706544,1.0,1/1,31.60%,ABCD3
2018,prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.34740270383836236,0.9192513050844354,0.5751121076233184,1.0,1.0,3/9,21.70%,SLIT2;MAP2;KANK1
2019,prerank,histone-threonine phosphorylation (GO:0035405),0.5571142284569139,0.9181461161243814,0.6296900489396411,1.0,1.0,2/2,44.40%,PRKCA;VRK1
2020,prerank,regulation of macrophage differentiation (GO:0045649),0.5581162324649298,0.9181039862147756,0.6160267111853088,1.0,1.0,2/2,44.30%,IL34;PRKCA
2021,prerank,positive regulation of macrophage differentiation (GO:0045651),0.5581162324649298,0.9181039862147756,0.6160267111853088,1.0,1.0,2/2,44.30%,IL34;PRKCA
2022,prerank,secondary alcohol metabolic process (GO:1902652),0.5612659535117563,0.9180983441804845,0.62402496099844,1.0,1.0,1/2,25.00%,ABCA5
2023,prerank,sterol metabolic process (GO:0016125),0.5612659535117563,0.9180983441804845,0.62402496099844,1.0,1.0,1/2,25.00%,ABCA5
2024,prerank,peptidyl-serine phosphorylation (GO:0018105),0.2893866577484626,0.9171942239464155,0.6248704663212435,1.0,1.0,11/20,44.40%,CAMK1D;STK32B;STK39;AKT3;CAMK1G;MAST2;MAP3K13;UHMK1;STK32C;PRKCA;VRK1
2025,prerank,peptidyl-serine modification (GO:0018209),0.2893866577484626,0.9171942239464155,0.6248704663212435,1.0,1.0,11/20,44.40%,CAMK1D;STK32B;STK39;AKT3;CAMK1G;MAST2;MAP3K13;UHMK1;STK32C;PRKCA;VRK1
2026,prerank,hydrogen peroxide catabolic process (GO:0042744),0.6876876876876876,0.9169752525383682,0.6303501945525292,1.0,1.0,1/1,31.30%,PXDN
2027,prerank,hydrogen peroxide metabolic process (GO:0042743),0.6876876876876876,0.9169752525383682,0.6303501945525292,1.0,1.0,1/1,31.30%,PXDN
2028,prerank,microtubule bundle formation (GO:0001578),-0.5350701402805611,-0.9169736915187088,0.5660377358490566,0.912258796091971,1.0,2/2,46.70%,SPAST;NCKAP5
2029,prerank,dendrite morphogenesis (GO:0048813),0.44425271267428135,0.9169084784077306,0.5965834428383706,1.0,1.0,3/4,41.50%,MAP2;DOCK10;FARP1
2030,prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.3885542168674698,-0.9160874849860363,0.5617977528089888,0.9123882233350695,1.0,4/4,61.40%,CHD1L;RFC1;DDB2;RFC3
2031,prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3885542168674698,-0.9160874849860363,0.5617977528089888,0.9123882233350695,1.0,4/4,61.40%,CHD1L;RFC1;DDB2;RFC3
2032,prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.531062124248497,-0.9159213713433942,0.5660377358490566,0.9118630493739609,1.0,2/2,47.10%,TNPO1;IFT172
2033,prerank,response to metal ion (GO:0010038),0.3608183472308424,0.9150585089118037,0.5992990654205608,1.0,1.0,7/8,57.00%,KCNMA1;HAAO;BCL2;TRPC1;GPHN;SLC25A12;PPP5C
2034,prerank,positive regulation of multicellular organismal process (GO:0051240),0.2900950935371773,0.9145280977928109,0.6149131767109295,1.0,1.0,5/21,16.50%,ESRRG;TIAM1;EBF2;PPARGC1A;CADM1
2035,prerank,monocarboxylic acid transport (GO:0015718),0.4964558763636535,0.9142337050580588,0.5968436154949784,1.0,1.0,2/3,32.60%,SLC16A12;NCOA2
2036,prerank,positive regulation of embryonic development (GO:0040019),0.4980333380148799,0.914156305765177,0.6036931818181818,1.0,1.0,1/3,7.80%,TENM4
2037,prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.6876876876876877,-0.9131101002347841,0.643312101910828,0.9170983392645978,1.0,1/1,31.40%,FOXC2
2038,prerank,regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.5430861723446894,-0.9130423338451413,0.5677083333333334,0.9163406603681421,1.0,2/2,45.90%,CAMK2D;FGF13
2039,prerank,nucleic acid metabolic process (GO:0090304),-0.45035105315947843,-0.9129395409870141,0.5623003194888179,0.9156209802643036,1.0,3/3,55.20%,RBMX;RBFOX2;WRN
2040,prerank,hemopoiesis (GO:0030097),0.3784220159311425,0.9127754731106343,0.579874213836478,1.0,1.0,4/6,44.50%,MECOM;MEIS1;FLT4;TOX
2041,prerank,neuron cell-cell adhesion (GO:0007158),0.5604869051157664,0.9126873435572008,0.6062602965403624,1.0,1.0,1/2,10.40%,NRXN3
2042,prerank,protein processing involved in protein targeting to mitochondrion (GO:0006627),-0.6916916916916916,-0.9123459727411303,0.6257425742574257,0.9160166627476977,1.0,1/1,31.00%,IMMP1L
2043,prerank,embryonic organ morphogenesis (GO:0048562),0.5591182364729461,0.9121899521413801,0.6136012364760433,1.0,1.0,2/2,44.20%,FBN2;HOXB3
2044,prerank,postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.5541082164328657,0.9120742026935377,0.6304700162074555,1.0,1.0,2/2,44.70%,CACNG4;GPHN
2045,prerank,neurotransmitter receptor diffusion trapping (GO:0099628),0.5541082164328657,0.9120742026935377,0.6304700162074555,1.0,1.0,2/2,44.70%,CACNG4;GPHN
2046,prerank,protein prenylation (GO:0018342),-0.6866866866866866,-0.9119889917712398,0.6206185567010309,0.9149750585511076,1.0,1/1,31.50%,CHM
2047,prerank,protein geranylgeranylation (GO:0018344),-0.6866866866866866,-0.9119889917712398,0.6206185567010309,0.9149750585511076,1.0,1/1,31.50%,CHM
2048,prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.407730038961716,0.9119471165712696,0.5966494845360825,1.0,1.0,1/5,1.20%,ADCY8
2049,prerank,positive regulation of dendrite extension (GO:1903861),0.6756756756756757,0.9115042021035689,0.6314699792960663,1.0,1.0,1/1,32.50%,CPNE5
2050,prerank,regulation of dendrite extension (GO:1903859),0.6756756756756757,0.9115042021035689,0.6314699792960663,1.0,1.0,1/1,32.50%,CPNE5
2051,prerank,positive regulation of ruffle assembly (GO:1900029),0.6886886886886887,0.9107868930877783,0.634453781512605,1.0,1.0,1/1,31.20%,EPS8L2
2052,prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.33296653577535085,0.9090730126148616,0.590702947845805,1.0,1.0,7/10,49.30%,CALCR;BMPER;FLT4;PRKCA;EGFR;GCNT2;ROR2
2053,prerank,regulation of sprouting angiogenesis (GO:1903670),0.4068137680657825,0.9090262114068988,0.6215189873417721,1.0,1.0,3/5,37.20%,SEMA6A;BMPER;RHOJ
2054,prerank,replication fork protection (GO:0048478),-0.6786786786786787,-0.9089570234879806,0.6289308176100629,0.9201552619619865,1.0,1/1,32.30%,ZRANB3
2055,prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6786786786786787,-0.9089570234879806,0.6289308176100629,0.9201552619619865,1.0,1/1,32.30%,ZRANB3
2056,prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.36679309733166643,0.9087562574937945,0.5778834720570749,1.0,1.0,2/7,20.50%,SLIT2;BMPER
2057,prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.49247743229689056,0.9085918137229511,0.6121562952243126,1.0,1.0,3/3,50.90%,NOS1AP;EGFR;DDAH1
2058,prerank,regulation of monooxygenase activity (GO:0032768),0.49247743229689056,0.9085918137229511,0.6121562952243126,1.0,1.0,3/3,50.90%,NOS1AP;EGFR;DDAH1
2059,prerank,positive regulation of dendritic spine morphogenesis (GO:0061003),0.5551102204408818,0.9085399049624419,0.6334459459459459,1.0,1.0,2/2,44.60%,LRP8;CAPRIN2
2060,prerank,regulation of cell differentiation (GO:0045595),0.3286147623862487,0.9083625359323785,0.6069042316258352,1.0,1.0,11/11,67.50%,ALK;TIAM1;CDK6;ST7;PRAME;PTK2;MBOAT2;NF1;TRPS1;LTBP4;FGFR1
2061,prerank,regulation of growth hormone receptor signaling pathway (GO:0060398),-0.6846846846846847,-0.9082900995800656,0.6435643564356436,0.9197954146574412,1.0,1/1,31.70%,MBD5
2062,prerank,regulation of multicellular organism growth (GO:0040014),-0.6846846846846847,-0.9082900995800656,0.6435643564356436,0.9197954146574412,1.0,1/1,31.70%,MBD5
2063,prerank,protein N-linked glycosylation (GO:0006487),-0.6836836836836837,-0.9082899447861612,0.6390532544378699,0.9161755001800032,1.0,1/1,31.80%,TUSC3
2064,prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.6836836836836837,-0.9082899447861612,0.6390532544378699,0.9161755001800032,1.0,1/1,31.80%,TUSC3
2065,prerank,peptidyl-asparagine modification (GO:0018196),-0.6836836836836837,-0.9082899447861612,0.6390532544378699,0.9161755001800032,1.0,1/1,31.80%,TUSC3
2066,prerank,magnesium ion transport (GO:0015693),-0.6836836836836837,-0.9082899447861612,0.6390532544378699,0.9161755001800032,1.0,1/1,31.80%,TUSC3
2067,prerank,Rac protein signal transduction (GO:0016601),0.4428807445584985,0.9079723785154722,0.6136363636363636,1.0,1.0,1/4,9.50%,TIAM1
2068,prerank,DNA geometric change (GO:0032392),-0.45035105315947843,-0.9069159643795424,0.5608108108108109,0.9182928764932856,1.0,3/3,55.20%,ASCC3;ZRANB3;WRN
2069,prerank,telomere maintenance (GO:0000723),0.5511022044088179,0.905502250286115,0.6202945990180033,1.0,1.0,2/2,45.00%,TPRKB;WRN
2070,prerank,regulation of Golgi organization (GO:1903358),0.5536420677951028,0.9053144895298013,0.6356073211314476,1.0,1.0,1/2,20.40%,RBSN
2071,prerank,positive regulation of monocyte differentiation (GO:0045657),0.6826826826826826,0.9050150643887861,0.6666666666666666,1.0,1.0,1/1,31.80%,IL34
2072,prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.26664958217651735,-0.9046192769948478,0.6194029850746269,0.9224393876629936,1.0,6/8,32.50%,AGO2;PPP3CB;TNRC6A;FZD6;PLCB1;PPP3CA
2073,prerank,regulation of protein import into nucleus (GO:0042306),0.6736736736736737,0.9043297044600535,0.6347305389221557,1.0,1.0,1/1,32.70%,ZIC1
2074,prerank,positive regulation of protein import (GO:1904591),0.6736736736736737,0.9043297044600535,0.6347305389221557,1.0,1.0,1/1,32.70%,ZIC1
2075,prerank,positive regulation of protein localization to nucleus (GO:1900182),0.6736736736736737,0.9043297044600535,0.6347305389221557,1.0,1.0,1/1,32.70%,ZIC1
2076,prerank,positive regulation of protein import into nucleus (GO:0042307),0.6736736736736737,0.9043297044600535,0.6347305389221557,1.0,1.0,1/1,32.70%,ZIC1
2077,prerank,positive regulation of cell adhesion (GO:0045785),-0.44332998996990974,-0.9043282649910963,0.5915032679738562,0.9223339953268463,1.0,3/3,55.90%,FOXC2;PPP3CA;PRKCA
2078,prerank,RNA processing (GO:0006396),0.3336705506841404,0.9042218352417059,0.6080178173719376,1.0,1.0,6/10,42.90%,PPARGC1A;DHX8;WT1;NOVA1;ATXN1;SRPK1
2079,prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6816816816816816,-0.9039408163212294,0.6516634050880626,0.9213232046097918,1.0,1/1,32.00%,COL11A1
2080,prerank,detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.6816816816816816,-0.9039408163212294,0.6516634050880626,0.9213232046097918,1.0,1/1,32.00%,COL11A1
2081,prerank,regulation of miRNA mediated inhibition of translation (GO:1905616),-0.5200400801603206,-0.9032282348773358,0.5877862595419847,0.9209852605402293,1.0,2/2,48.20%,AGO2;TNRC6B
2082,prerank,positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.5200400801603206,-0.9032282348773358,0.5877862595419847,0.9209852605402293,1.0,2/2,48.20%,AGO2;TNRC6B
2083,prerank,protein processing (GO:0016485),0.371930090906729,0.9025280710926412,0.6021634615384616,1.0,1.0,5/7,50.60%,MMP16;PRSS12;ADAMTS3;PIDD1;ECE1
2084,prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.34371859296482415,-0.900978765392401,0.5914893617021276,0.9255855033425492,1.0,5/5,65.90%,ARNT;FGFR1;PRKCA;FLT4;AKT3
2085,prerank,regulation of protein phosphorylation (GO:0001932),0.28607563905948996,0.9006997715867954,0.6145077720207254,1.0,1.0,5/18,20.80%,SLIT2;SH3GL2;SPTBN4;BMPER;LIMCH1
2086,prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.48187104278134507,0.9001160214024626,0.6344238975817923,1.0,1.0,2/3,37.10%,MUC6;MUC5AC
2087,prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.48187104278134507,0.9001160214024626,0.6344238975817923,1.0,1.0,2/3,37.10%,MUC6;MUC5AC
2088,prerank,cellular response to lectin (GO:1990858),0.48187104278134507,0.9001160214024626,0.6344238975817923,1.0,1.0,2/3,37.10%,MUC6;MUC5AC
2089,prerank,positive regulation of endocytosis (GO:0045807),0.5420841683366734,0.899634842906944,0.6205211726384365,1.0,1.0,2/2,45.90%,HIP1;GPC3
2090,prerank,positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.5581162324649298,0.8994167053191005,0.6464,1.0,1.0,2/2,44.30%,SASH1;PRKCA
2091,prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5581162324649298,0.8994167053191005,0.6464,1.0,1.0,2/2,44.30%,SASH1;PRKCA
2092,prerank,positive regulation of response to biotic stimulus (GO:0002833),0.5581162324649298,0.8994167053191005,0.6464,1.0,1.0,2/2,44.30%,SASH1;PRKCA
2093,prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.2593340060544904,-0.899182588554809,0.5586206896551724,0.9285972335093449,1.0,9/9,74.40%,PIP4K2A;TAF15;CSNK2A1;RICTOR;MDM2;TAF4B;WRN;RFC3;MAP2K6
2094,prerank,regulation of protein localization to membrane (GO:1905475),0.5420841683366733,0.8991773405573804,0.6288492706645057,1.0,1.0,2/2,45.90%,GPC4;GPC3
2095,prerank,aminoglycan catabolic process (GO:0006026),0.5420841683366733,0.8991773405573804,0.6288492706645057,1.0,1.0,2/2,45.90%,GPC4;GPC3
2096,prerank,glycosaminoglycan catabolic process (GO:0006027),0.5420841683366733,0.8991773405573804,0.6288492706645057,1.0,1.0,2/2,45.90%,GPC4;GPC3
2097,prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.4107530685619346,0.8991435073958254,0.6356687898089172,1.0,1.0,1/5,5.20%,OSBPL6
2098,prerank,regulation of chromatin binding (GO:0035561),-0.6756756756756757,-0.898743339265989,0.6592292089249493,0.9286556216995439,1.0,1/1,32.60%,BTAF1
2099,prerank,positive regulation of protein polymerization (GO:0032273),0.5592126550150178,0.8983160620524241,0.6413570274636511,1.0,1.0,1/2,23.50%,BAIAP2L1
2100,prerank,positive regulation of actin filament polymerization (GO:0030838),0.5592126550150178,0.8983160620524241,0.6413570274636511,1.0,1.0,1/2,23.50%,BAIAP2L1
2101,prerank,skeletal muscle tissue regeneration (GO:0043403),-0.6766766766766766,-0.8975092155579288,0.6487025948103793,0.9304699074316375,1.0,1/1,32.50%,PPP3CA
2102,prerank,glial cell differentiation (GO:0010001),0.544628874007783,0.8972892548525578,0.6473429951690821,1.0,1.0,1/2,18.10%,CDH2
2103,prerank,positive regulation of lipase activity (GO:0060193),-0.6746746746746747,-0.8971574947568831,0.6337209302325582,0.9266298345254695,1.0,1/1,32.70%,FGFR1
2104,prerank,regulation of phospholipase C activity (GO:1900274),-0.6746746746746747,-0.8971574947568831,0.6337209302325582,0.9266298345254695,1.0,1/1,32.70%,FGFR1
2105,prerank,regulation of phospholipase activity (GO:0010517),-0.6746746746746747,-0.8971574947568831,0.6337209302325582,0.9266298345254695,1.0,1/1,32.70%,FGFR1
2106,prerank,positive regulation of phospholipase activity (GO:0010518),-0.6746746746746747,-0.8971574947568831,0.6337209302325582,0.9266298345254695,1.0,1/1,32.70%,FGFR1
2107,prerank,regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),-0.6746746746746747,-0.8971574947568831,0.6337209302325582,0.9266298345254695,1.0,1/1,32.70%,FGFR1
2108,prerank,protein polymerization (GO:0051258),0.4843430072550065,0.8968775574386603,0.6355555555555555,1.0,1.0,2/3,30.10%,WASF3;TRPV4
2109,prerank,triglyceride metabolic process (GO:0006641),-0.4543630892678034,-0.8963126998270349,0.5960264900662252,0.927717549624925,1.0,3/3,54.80%,GK;LPIN1;LIPG
2110,prerank,organelle disassembly (GO:1903008),-0.44433299899699097,-0.8958210751990043,0.5986622073578596,0.9278779569527876,1.0,3/3,55.80%,GBF1;ULK1;VRK1
2111,prerank,nucleotide-sugar metabolic process (GO:0009225),-0.5360721442885771,-0.8950786372907642,0.6196473551637279,0.9287156259888185,1.0,2/2,46.60%,PARG;GMDS
2112,prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5430361677818384,0.8949109048240688,0.636215334420881,1.0,1.0,1/2,23.50%,BAIAP2L1
2113,prerank,iron ion transport (GO:0006826),0.5430861723446894,0.8943124164227915,0.6449044585987261,1.0,1.0,2/2,45.80%,SCARA5;ATP6V0A4
2114,prerank,negative regulation of cell adhesion (GO:0007162),0.4071129673907883,0.8942838113882433,0.640960809102402,1.0,1.0,4/5,47.60%,SEMA6A;ACER2;PTK2;GCNT2
2115,prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.5130260521042084,-0.893657154318538,0.5843520782396088,0.9311307404832729,1.0,2/2,48.90%,CNOT6;SAMD4A
2116,prerank,cell-matrix adhesion (GO:0007160),0.43054622028724304,0.8929820753679534,0.624,1.0,1.0,1/4,9.50%,TIAM1
2117,prerank,apoptotic process (GO:0006915),0.3152465966696075,0.8929687069772753,0.6379888268156425,1.0,1.0,6/12,41.80%,DCC;SEMA6A;HIP1;BCL2;CASP9;PIDD1
2118,prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.436308926780341,-0.8927838866870876,0.6148867313915858,0.9319589076922269,1.0,3/3,56.60%,KAT2B;KAT2A;KAT6B
2119,prerank,positive regulation of MAPK cascade (GO:0043410),0.2865619068929542,0.8923536595946604,0.6228813559322034,1.0,1.0,11/18,49.30%,RIT2;CALCR;BMPER;IL34;MID1;IGF1R;FLT4;PRKCA;EGFR;GCNT2;ROR2
2120,prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.44332998996990974,-0.8918151166803838,0.6217105263157895,0.9313477809277977,1.0,3/3,55.90%,CAMK2D;HAND2;PRKCA
2121,prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.44332998996990974,-0.8918151166803838,0.6217105263157895,0.9313477809277977,1.0,3/3,55.90%,CAMK2D;HAND2;PRKCA
2122,prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.44332998996990974,-0.8918151166803838,0.6217105263157895,0.9313477809277977,1.0,3/3,55.90%,CAMK2D;HAND2;PRKCA
2123,prerank,receptor catabolic process (GO:0032801),-0.4312938816449348,-0.8917666450497197,0.6123778501628665,0.9305635444133357,1.0,3/3,57.10%,AP2A2;SNX25;ZNRF3
2124,prerank,fatty acid biosynthetic process (GO:0006633),0.3834277109001173,0.8916759214653982,0.6271393643031785,1.0,1.0,4/6,45.40%,ELOVL2;ELOVL7;ELOVL6;LIPG
2125,prerank,respiratory electron transport chain (GO:0022904),0.5471192509085342,0.891578157377318,0.6229749631811488,1.0,1.0,1/2,12.20%,PPARGC1A
2126,prerank,positive regulation of ATP metabolic process (GO:1903580),0.4313055398578787,0.8915694453419808,0.6350067842605156,1.0,1.0,1/4,12.20%,PPARGC1A
2127,prerank,myofibril assembly (GO:0030239),0.5400801603206413,0.8914926003630348,0.6416666666666667,1.0,1.0,2/2,46.10%,OBSCN;TNNT3
2128,prerank,sarcomere organization (GO:0045214),0.5400801603206413,0.8914926003630348,0.6416666666666667,1.0,1.0,2/2,46.10%,OBSCN;TNNT3
2129,prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4402035391162834,0.891368991172894,0.6373193166885677,1.0,1.0,1/4,4.20%,TMEFF2
2130,prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.38044389078608976,0.8910501498210041,0.5980392156862745,1.0,1.0,4/6,46.40%,SPTBN4;CALCR;CAPRIN2;EGFR
2131,prerank,high-density lipoprotein particle remodeling (GO:0034375),0.5470941883767535,0.8905601361761595,0.6703821656050956,1.0,1.0,2/2,45.40%,ABCA5;LIPG
2132,prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.6566566566566567,0.8897847356006298,0.649402390438247,1.0,1.0,1/1,34.40%,CRMP1
2133,prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.6566566566566567,0.8897847356006298,0.649402390438247,1.0,1.0,1/1,34.40%,CRMP1
2134,prerank,nucleobase catabolic process (GO:0046113),0.6566566566566567,0.8897847356006298,0.649402390438247,1.0,1.0,1/1,34.40%,CRMP1
2135,prerank,pyrimidine nucleobase catabolic process (GO:0006208),0.6566566566566567,0.8897847356006298,0.649402390438247,1.0,1.0,1/1,34.40%,CRMP1
2136,prerank,regulation of protein autophosphorylation (GO:0031952),0.5482147400753563,0.8897597871217645,0.6741573033707865,1.0,1.0,1/2,24.90%,TOM1L1
2137,prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.4295389048176169,0.8896011114163943,0.6323529411764706,1.0,1.0,2/4,31.80%,LRP8;IL34
2138,prerank,negative regulation of cilium assembly (GO:1902018),-0.6686686686686687,-0.8889650893177882,0.6646216768916156,0.9359866093781954,1.0,1/1,33.30%,CDK10
2139,prerank,synaptic vesicle exocytosis (GO:0016079),0.5480961923847696,0.8888360797925083,0.646677471636953,1.0,1.0,2/2,45.30%,PCLO;CPLX1
2140,prerank,synaptic vesicle cycle (GO:0099504),0.5480961923847696,0.8888360797925083,0.646677471636953,1.0,1.0,2/2,45.30%,PCLO;CPLX1
2141,prerank,protein depolymerization (GO:0051261),-0.5350701402805611,-0.8884279826580311,0.6246648793565683,0.9361973696719085,1.0,2/2,46.70%,MICAL3;NCKAP5
2142,prerank,microtubule nucleation (GO:0007020),-0.6666666666666666,-0.888202803177047,0.6955602536997886,0.9359279460730631,1.0,1/1,33.50%,CCDC57
2143,prerank,gliogenesis (GO:0042063),0.4713369814590522,0.8879778471994522,0.6506550218340611,1.0,1.0,2/3,35.00%,CDH2;CDK6
2144,prerank,autonomic nervous system development (GO:0048483),0.5370938997773491,0.8878171477579139,0.6835871404399323,1.0,1.0,1/2,15.30%,SEMA3A
2145,prerank,sympathetic nervous system development (GO:0048485),0.5370938997773491,0.8878171477579139,0.6835871404399323,1.0,1.0,1/2,15.30%,SEMA3A
2146,prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.36048744111320086,0.8873943967880285,0.6113744075829384,1.0,1.0,2/7,20.40%,SNX32;RBSN
2147,prerank,cellular response to glucose starvation (GO:0042149),-0.6606606606606606,-0.8871265835545555,0.6653846153846154,0.9353444807240863,1.0,1/1,34.10%,SESN3
2148,prerank,cellular response to leucine starvation (GO:1990253),-0.6606606606606606,-0.8871265835545555,0.6653846153846154,0.9353444807240863,1.0,1/1,34.10%,SESN3
2149,prerank,negative regulation of TORC1 signaling (GO:1904262),-0.6606606606606606,-0.8871265835545555,0.6653846153846154,0.9353444807240863,1.0,1/1,34.10%,SESN3
2150,prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.4787492089573856,0.8870504850284026,0.6506364922206507,1.0,1.0,2/3,36.90%,NOS1AP;UBASH3B
2151,prerank,axonal transport of mitochondrion (GO:0019896),-0.6506506506506506,-0.8863979086328312,0.6535269709543569,0.9350148240990217,1.0,1/1,35.10%,SPAST
2152,prerank,mitotic cytokinesis (GO:0000281),-0.6506506506506506,-0.8863979086328312,0.6535269709543569,0.9350148240990217,1.0,1/1,35.10%,SPAST
2153,prerank,regulation of heart contraction (GO:0008016),-0.4282848545636911,-0.8854493137360859,0.6286644951140065,0.9362093796205815,1.0,3/3,57.40%,CAMK2D;CELF2;TRPC1
2154,prerank,gamma-aminobutyric acid metabolic process (GO:0009448),0.6646646646646647,0.8852293309802393,0.6557377049180327,1.0,1.0,1/1,33.60%,ABAT
2155,prerank,GPI anchor metabolic process (GO:0006505),0.6656656656656657,0.8849247988807276,0.6719367588932806,1.0,1.0,1/1,33.50%,PGAP1
2156,prerank,GPI anchor biosynthetic process (GO:0006506),0.6656656656656657,0.8849247988807276,0.6719367588932806,1.0,1.0,1/1,33.50%,PGAP1
2157,prerank,glycolipid metabolic process (GO:0006664),0.6656656656656657,0.8849247988807276,0.6719367588932806,1.0,1.0,1/1,33.50%,PGAP1
2158,prerank,regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.6656656656656657,0.8849247988807276,0.6719367588932806,1.0,1.0,1/1,33.50%,PGAP1
2159,prerank,attachment of GPI anchor to protein (GO:0016255),0.6656656656656657,0.8849247988807276,0.6719367588932806,1.0,1.0,1/1,33.50%,PGAP1
2160,prerank,carboxylic acid transport (GO:0046942),0.5395609539748116,0.8842037917128359,0.6550632911392406,1.0,1.0,1/2,19.80%,SLC16A12
2161,prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.6656656656656657,-0.8841925552169605,0.6883629191321499,0.9378619288875409,1.0,1/1,33.60%,SRSF1
2162,prerank,positive regulation of organelle organization (GO:0010638),0.477352709733704,0.8840574930704145,0.6411347517730497,1.0,1.0,1/3,12.20%,PPARGC1A
2163,prerank,metal ion export (GO:0070839),0.6696696696696697,0.8839624563133857,0.6896551724137931,1.0,1.0,1/1,33.10%,KCNT2
2164,prerank,potassium ion export across plasma membrane (GO:0097623),0.6696696696696697,0.8839624563133857,0.6896551724137931,1.0,1.0,1/1,33.10%,KCNT2
2165,prerank,organic hydroxy compound transport (GO:0015850),0.6746746746746747,0.881621975147155,0.6767068273092369,1.0,1.0,1/1,32.60%,NCOA2
2166,prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.6746746746746747,0.881621975147155,0.6767068273092369,1.0,1.0,1/1,32.60%,NCOA2
2167,prerank,bile acid and bile salt transport (GO:0015721),0.6746746746746747,0.881621975147155,0.6767068273092369,1.0,1.0,1/1,32.60%,NCOA2
2168,prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4733294855852464,0.8815416140897885,0.6666666666666666,1.0,1.0,1/3,9.50%,TIAM1
2169,prerank,response to corticosteroid (GO:0031960),0.5340681362725451,0.8800346520621826,0.66110183639399,1.0,1.0,2/2,46.70%,CALCR;GOT1
2170,prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.29607250755287007,-0.8799000281798178,0.5652173913043478,0.9462138793600423,1.0,7/7,70.70%,USP22;PKN2;MDM2;CCDC57;PRKCA;MEIS2;SMOC2
2171,prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.6506506506506506,0.879719051799824,0.688622754491018,1.0,1.0,1/1,35.00%,CDK6
2172,prerank,astrocyte differentiation (GO:0048708),0.6506506506506506,0.879719051799824,0.688622754491018,1.0,1.0,1/1,35.00%,CDK6
2173,prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.6506506506506506,0.879719051799824,0.688622754491018,1.0,1.0,1/1,35.00%,CDK6
2174,prerank,non-motile cilium assembly (GO:1905515),-0.5190380761523046,-0.8790437313446717,0.6246575342465753,0.9472133116263411,1.0,2/2,48.30%,ARL13B;TBC1D32
2175,prerank,regulation of cytokine production (GO:0001817),0.37145749356148233,0.8783091451630974,0.6411837237977805,1.0,1.0,2/6,16.50%,IGF2BP2;CADM1
2176,prerank,regulation of Rho protein signal transduction (GO:0035023),0.362959170017662,0.8779772865155995,0.6358381502890174,1.0,1.0,3/7,31.20%,RIT2;KANK1;EPS8L2
2177,prerank,positive regulation of TOR signaling (GO:0032008),-0.3036377309881949,-0.8771983482986705,0.6057142857142858,0.9502773309804109,1.0,5/6,35.70%,GAS6;RICTOR;WDR59;SLC38A9;MIOS
2178,prerank,basement membrane assembly (GO:0070831),0.5390781563126252,0.8758967173455989,0.6702290076335878,1.0,1.0,2/2,46.20%,PXDN;NTN4
2179,prerank,microtubule polymerization or depolymerization (GO:0031109),0.4583751253761283,0.8758107520928835,0.6288951841359773,1.0,1.0,3/3,54.30%,TRPV4;NCKAP5;FGF13
2180,prerank,regulation of protein kinase B signaling (GO:0051896),0.28451978969012515,0.8758066014239204,0.6579497907949791,1.0,1.0,5/18,21.20%,NRG1;NRG2;CALCR;MAGI2;HIP1
2181,prerank,mitochondrial genome maintenance (GO:0000002),0.6576576576576576,0.8757256909131726,0.6715176715176715,1.0,1.0,1/1,34.30%,AKT3
2182,prerank,positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.6626626626626626,-0.8754885653287124,0.7073643410852714,0.9531178133848086,1.0,1/1,33.90%,OPTN
2183,prerank,regulation of JNK cascade (GO:0046328),0.32187566580254645,0.8753616633926443,0.6328555678059536,1.0,1.0,6/10,46.40%,SEMA3A;MECOM;MAPK8IP3;IGF1R;FLT4;EGFR
2184,prerank,positive regulation of protein secretion (GO:0050714),-0.37951807228915657,-0.8753511855038015,0.6138211382113821,0.9524720976584814,1.0,4/4,62.30%,TM7SF3;FRMD4A;WLS;CD2AP
2185,prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.5370741482965933,0.8746763773789378,0.678513731825525,1.0,1.0,2/2,46.40%,SH3GL2;EGFR
2186,prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5370741482965933,0.8746763773789378,0.678513731825525,1.0,1.0,2/2,46.40%,SH3GL2;EGFR
2187,prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.42146667272888905,0.874359700357353,0.6662198391420912,1.0,1.0,3/4,49.60%,TRAPPC9;CNIH3;SEC23IP
2188,prerank,COPII vesicle coating (GO:0048208),0.42146667272888905,0.874359700357353,0.6662198391420912,1.0,1.0,3/4,49.60%,TRAPPC9;CNIH3;SEC23IP
2189,prerank,COPII-coated vesicle budding (GO:0090114),0.42146667272888905,0.874359700357353,0.6662198391420912,1.0,1.0,3/4,49.60%,TRAPPC9;CNIH3;SEC23IP
2190,prerank,vesicle coating (GO:0006901),0.42146667272888905,0.874359700357353,0.6662198391420912,1.0,1.0,3/4,49.60%,TRAPPC9;CNIH3;SEC23IP
2191,prerank,arginine catabolic process (GO:0006527),-0.5090180360721442,-0.8742417071806566,0.6388888888888888,0.9539760333149235,1.0,2/2,49.30%,OAT;DDAH1
2192,prerank,regulation of cellular metabolic process (GO:0031323),-0.43329989969909727,-0.8735545023696684,0.6354166666666666,0.9544552962994738,1.0,3/3,56.90%,ACACA;ACACB;TBC1D16
2193,prerank,circulatory system development (GO:0072359),0.31515151515151507,0.8735302401088945,0.6436651583710408,1.0,1.0,10/10,68.80%,WT1;CACNA1C;FLT4;ECE1;HAND2;NF1;KAT2A;KAT2B;PTEN;FOXC2
2194,prerank,dicarboxylic acid biosynthetic process (GO:0043650),0.534068136272545,0.8732441044139307,0.6510500807754442,1.0,1.0,2/2,46.70%,HAAO;GOT1
2195,prerank,stress-activated MAPK cascade (GO:0051403),-0.4192577733199599,-0.8726278742501162,0.6242236024844721,0.9554319535634355,1.0,3/3,58.30%,MAP2K4;BTRC;MAP3K13
2196,prerank,negative regulation of viral process (GO:0048525),-0.4292878635907723,-0.8721907661461157,0.6158940397350994,0.9554525748809585,1.0,3/3,57.30%,ZC3HAV1;ILF3;SRPK1
2197,prerank,blood vessel morphogenesis (GO:0048514),0.41967871485943786,0.8721657814480754,0.6743869209809265,1.0,1.0,4/4,58.20%,CDH2;WT1;FLT4;NF1
2198,prerank,regulation of nitric oxide mediated signal transduction (GO:0010749),0.5370741482965932,0.8717167550269604,0.684640522875817,1.0,1.0,2/2,46.40%,NOS1AP;EGFR
2199,prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5366523447085445,0.8713042000587217,0.7089430894308943,1.0,1.0,1/2,20.60%,RORA
2200,prerank,regulation of defense response to bacterium (GO:1900424),-0.6576576576576576,-0.8711909799685635,0.7120315581854043,0.9442181117525373,1.0,1/1,34.40%,FOXP1
2201,prerank,regulation of chemokine production (GO:0032642),-0.6576576576576576,-0.8711909799685635,0.7120315581854043,0.9442181117525373,1.0,1/1,34.40%,FOXP1
2202,prerank,macrophage activation (GO:0042116),-0.6576576576576576,-0.8711909799685635,0.7120315581854043,0.9442181117525373,1.0,1/1,34.40%,FOXP1
2203,prerank,regulation of endothelial tube morphogenesis (GO:1901509),-0.6576576576576576,-0.8711909799685635,0.7120315581854043,0.9442181117525373,1.0,1/1,34.40%,FOXP1
2204,prerank,negative regulation of lymphocyte apoptotic process (GO:0070229),-0.6576576576576576,-0.8711909799685635,0.7120315581854043,0.9442181117525373,1.0,1/1,34.40%,FOXP1
2205,prerank,regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.6576576576576576,-0.8711909799685635,0.7120315581854043,0.9442181117525373,1.0,1/1,34.40%,FOXP1
2206,prerank,myeloid cell development (GO:0061515),-0.6576576576576576,-0.8711909799685635,0.7120315581854043,0.9442181117525373,1.0,1/1,34.40%,FOXP1
2207,prerank,regulation of morphogenesis of an epithelium (GO:1905330),-0.6576576576576576,-0.8711909799685635,0.7120315581854043,0.9442181117525373,1.0,1/1,34.40%,FOXP1
2208,prerank,T-helper cell differentiation (GO:0042093),-0.6576576576576576,-0.8711909799685635,0.7120315581854043,0.9442181117525373,1.0,1/1,34.40%,FOXP1
2209,prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.6576576576576576,-0.8711909799685635,0.7120315581854043,0.9442181117525373,1.0,1/1,34.40%,FOXP1
2210,prerank,negative regulation of B cell apoptotic process (GO:0002903),-0.6576576576576576,-0.8711909799685635,0.7120315581854043,0.9442181117525373,1.0,1/1,34.40%,FOXP1
2211,prerank,monocyte activation (GO:0042117),-0.6576576576576576,-0.8711909799685635,0.7120315581854043,0.9442181117525373,1.0,1/1,34.40%,FOXP1
2212,prerank,response to molecule of bacterial origin (GO:0002237),-0.6576576576576576,-0.8711909799685635,0.7120315581854043,0.9442181117525373,1.0,1/1,34.40%,FOXP1
2213,prerank,bone cell development (GO:0098751),-0.6576576576576576,-0.8711909799685635,0.7120315581854043,0.9442181117525373,1.0,1/1,34.40%,FOXP1
2214,prerank,regulation of B cell apoptotic process (GO:0002902),-0.6576576576576576,-0.8711909799685635,0.7120315581854043,0.9442181117525373,1.0,1/1,34.40%,FOXP1
2215,prerank,negative regulation of cell cycle (GO:0045786),0.4633229578581072,0.8711181155222929,0.6519823788546255,1.0,1.0,2/3,35.00%,BRINP1;CDK6
2216,prerank,regulation of vasculature development (GO:1901342),0.39597989949748735,0.8711048930253648,0.6624203821656051,1.0,1.0,5/5,60.60%,BMPER;ADGRA2;ETS1;NF1;EPHA2
2217,prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2218,prerank,negative regulation of organ growth (GO:0046621),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2219,prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2220,prerank,negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2221,prerank,myelin maintenance (GO:0043217),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2222,prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2223,prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2224,prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2225,prerank,negative regulation of cell size (GO:0045792),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2226,prerank,inositol phosphate catabolic process (GO:0071545),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2227,prerank,regulation of organ growth (GO:0046620),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2228,prerank,postsynaptic density assembly (GO:0097107),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2229,prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2230,prerank,brain morphogenesis (GO:0048854),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2231,prerank,"regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2232,prerank,postsynaptic density organization (GO:0097106),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2233,prerank,inositol phosphate dephosphorylation (GO:0046855),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2234,prerank,negative regulation of dendritic spine development (GO:0061000),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2235,prerank,regulation of cellular component size (GO:0032535),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2236,prerank,negative regulation of cell cycle phase transition (GO:1901988),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2237,prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2238,prerank,regulation of cell size (GO:0008361),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2239,prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2240,prerank,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.6516516516516516,-0.8706056662844481,0.6878612716763006,0.9246471356773912,1.0,1/1,35.00%,PTEN
2241,prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.5370741482965932,0.8698907426324239,0.6853932584269663,1.0,1.0,2/2,46.40%,IGF1R;EGFR
2242,prerank,Ras protein signal transduction (GO:0007265),0.299236157991162,0.8695643575547387,0.6652452025586354,1.0,1.0,6/14,35.30%,SHC3;TIAM1;RIT2;EPS8L2;RRAS2;SGSM3
2243,prerank,anterior/posterior axis specification (GO:0009948),-0.5180360721442885,-0.8694629994294069,0.6454081632653061,0.9260784749210431,1.0,2/2,48.40%,TBX3;WLS
2244,prerank,carboxylic acid transmembrane transport (GO:1905039),-0.6476476476476476,-0.8694464577266626,0.6986564299424184,0.9252766692708047,1.0,1/1,35.40%,SLC38A9
2245,prerank,response to cadmium ion (GO:0046686),0.5370741482965932,0.8694185745235367,0.677938808373591,1.0,1.0,2/2,46.40%,HAAO;EGFR
2246,prerank,positive regulation of lipid kinase activity (GO:0090218),0.530060120240481,0.8688199997132872,0.6837060702875399,1.0,1.0,2/2,47.10%,IRS1;PTK2
2247,prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.530060120240481,0.8688199997132872,0.6837060702875399,1.0,1.0,2/2,47.10%,IRS1;PTK2
2248,prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.530060120240481,0.8688199997132872,0.6837060702875399,1.0,1.0,2/2,47.10%,IRS1;PTK2
2249,prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.4270506075738646,0.8674523549566822,0.6962552011095701,1.0,1.0,2/4,30.30%,SPRED2;SPRED3
2250,prerank,positive regulation of cell communication (GO:0010647),-0.5180360721442885,-0.8673377209962577,0.6373626373626373,0.9287072409614564,1.0,2/2,48.40%,CLSTN1;WLS
2251,prerank,negative regulation of kinase activity (GO:0033673),-0.36947791164658633,-0.8670559569183842,0.6479400749063671,0.9276916813735155,1.0,4/4,63.30%,SPRED1;ITGB1BP1;NF1;UBASH3B
2252,prerank,negative regulation of protein kinase activity (GO:0006469),-0.36947791164658633,-0.8670559569183842,0.6479400749063671,0.9276916813735155,1.0,4/4,63.30%,SPRED1;ITGB1BP1;NF1;UBASH3B
2253,prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.46080919912089474,0.8662300576039429,0.7094499294781382,1.0,1.0,2/3,37.90%,SLIT2;CD2AP
2254,prerank,positive regulation of anion transmembrane transport (GO:1903961),-0.6496496496496497,-0.8657099227205663,0.7027027027027027,0.9287555513979034,1.0,1/1,35.20%,TCAF1
2255,prerank,regulation of anion channel activity (GO:0010359),-0.6496496496496497,-0.8657099227205663,0.7027027027027027,0.9287555513979034,1.0,1/1,35.20%,TCAF1
2256,prerank,metanephros development (GO:0001656),0.41611059897617386,0.8653455187469226,0.6794520547945205,1.0,1.0,2/4,27.80%,ROBO2;WT1
2257,prerank,regulation of tissue remodeling (GO:0034103),-0.3805220883534136,-0.8646432884574613,0.6401515151515151,0.9299181146806093,1.0,4/4,62.20%,SUCO;HAND2;FLT4;DDR2
2258,prerank,detection of mechanical stimulus (GO:0050982),0.5300601202404811,0.8645001210212956,0.700626959247649,1.0,1.0,2/2,47.10%,CDH2;PTK2
2259,prerank,detection of muscle stretch (GO:0035995),0.5300601202404811,0.8645001210212956,0.700626959247649,1.0,1.0,2/2,47.10%,CDH2;PTK2
2260,prerank,response to muscle stretch (GO:0035994),0.5300601202404811,0.8645001210212956,0.700626959247649,1.0,1.0,2/2,47.10%,CDH2;PTK2
2261,prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5370741482965932,0.8644355889829761,0.6800618238021638,1.0,1.0,2/2,46.40%,SASH1;EGFR
2262,prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5110220440881763,-0.864363478493187,0.6798029556650246,0.9296017445901225,1.0,2/2,49.10%,KAT2B;PBX1
2263,prerank,regulation of cell population proliferation (GO:0042127),0.2351257460430023,0.8640613084645142,0.7101303911735206,1.0,1.0,26/46,50.90%,NRG1;SHANK2;WNK2;ALK;TIAM1;TET1;MAGI2;ADGRB1;WT1;ACER2;BCL2;MEIS1;IL34;CDK6;GRK5;MEIS2;DLG5;IRS1;IGF1R;FLT4;EGFR;PRAME;PTK2;GCNT2;ROR2;DDAH1
2264,prerank,regulation of protein ubiquitination (GO:0031396),0.3955280753975361,0.8640315815928112,0.6608910891089109,1.0,1.0,3/5,41.00%,SASH1;ADGRB1;MYCBP2
2265,prerank,response to purine-containing compound (GO:0014074),-0.6486486486486487,-0.8634550475606017,0.6695095948827292,0.9308847510309664,1.0,1/1,35.30%,VGF
2266,prerank,isopentenyl diphosphate biosynthetic process (GO:0009240),-0.6386386386386387,-0.8619292083220759,0.7131313131313132,0.9321303523048265,1.0,1/1,36.30%,IDI1
2267,prerank,isoprenoid biosynthetic process (GO:0008299),-0.6386386386386387,-0.8619292083220759,0.7131313131313132,0.9321303523048265,1.0,1/1,36.30%,IDI1
2268,prerank,mitotic recombination (GO:0006312),0.6456456456456456,0.8614270104010693,0.7090909090909091,1.0,1.0,1/1,35.50%,TPRKB
2269,prerank,tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.6456456456456456,0.8614270104010693,0.7090909090909091,1.0,1.0,1/1,35.50%,TPRKB
2270,prerank,telomere maintenance via recombination (GO:0000722),0.6456456456456456,0.8614270104010693,0.7090909090909091,1.0,1.0,1/1,35.50%,TPRKB
2271,prerank,regulation of epithelial cell proliferation (GO:0050678),0.42068273092369485,0.8612091661097152,0.6875,1.0,1.0,4/4,58.10%,MCC;CDK6;EGFR;MAGED1
2272,prerank,positive regulation of macrophage migration (GO:1905523),0.5300601202404811,0.8610799283367949,0.6976,1.0,1.0,2/2,47.10%,IL34;PTK2
2273,prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.5300601202404811,0.8610799283367949,0.6976,1.0,1.0,2/2,47.10%,IL34;PTK2
2274,prerank,regulation of macrophage proliferation (GO:0120040),0.5300601202404811,0.8610799283367949,0.6976,1.0,1.0,2/2,47.10%,IL34;PTK2
2275,prerank,positive regulation of macrophage proliferation (GO:0120041),0.5300601202404811,0.8610799283367949,0.6976,1.0,1.0,2/2,47.10%,IL34;PTK2
2276,prerank,regulation of macrophage chemotaxis (GO:0010758),0.5300601202404811,0.8610799283367949,0.6976,1.0,1.0,2/2,47.10%,IL34;PTK2
2277,prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5300601202404811,0.8610799283367949,0.6976,1.0,1.0,2/2,47.10%,IL34;PTK2
2278,prerank,tachykinin receptor signaling pathway (GO:0007217),0.6496496496496497,0.8608384032433629,0.7115009746588694,1.0,1.0,1/1,35.10%,GRK5
2279,prerank,protein secretion (GO:0009306),-0.5170340681362725,-0.8606870396544608,0.6605263157894737,0.9338556112237828,1.0,2/2,48.50%,WLS;OLFM2
2280,prerank,histone modification (GO:0016570),-0.2512307181037174,-0.8606033901472865,0.628099173553719,0.9331520211550917,1.0,8/9,56.60%,USP22;RCOR3;HDAC5;KAT2A;MTA3;PRDM5;TBL1X;KAT6B
2281,prerank,protein homooligomerization (GO:0051260),0.3449358612155706,0.8605616176607355,0.6597938144329897,1.0,1.0,1/8,1.20%,ADCY8
2282,prerank,beta-catenin-TCF complex assembly (GO:1904837),0.45977553964985296,0.8602988872384869,0.6899109792284867,1.0,1.0,2/3,36.20%,TCF7L1;BCL9
2283,prerank,histidine metabolic process (GO:0006547),0.6406406406406406,0.8601230392842557,0.7040816326530612,1.0,1.0,1/1,36.00%,AMDHD1
2284,prerank,histidine catabolic process (GO:0006548),0.6406406406406406,0.8601230392842557,0.7040816326530612,1.0,1.0,1/1,36.00%,AMDHD1
2285,prerank,protein sumoylation (GO:0016925),0.3880626559954032,0.8600273742472868,0.6603295310519645,1.0,1.0,3/5,41.20%,RNF212;BCL11A;NUP93
2286,prerank,regulation of fat cell differentiation (GO:0045598),0.3851848474476662,0.85980831971605,0.6733668341708543,1.0,1.0,2/5,23.90%,RORA;LMO3
2287,prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.41449190932087004,0.8595835596970492,0.6916890080428955,1.0,1.0,3/4,45.90%,TIAM1;ZNRF3;GPC3
2288,prerank,DNA synthesis involved in DNA repair (GO:0000731),0.4208114813704217,0.8593496977107328,0.6993288590604027,1.0,1.0,3/4,45.00%,POLE;RFC3;WRN
2289,prerank,tRNA methylation (GO:0030488),0.5170340681362725,0.8589708592710051,0.6796875,1.0,1.0,2/2,48.40%,TARBP1;NSUN6
2290,prerank,RNA methylation (GO:0001510),0.5170340681362725,0.8589708592710051,0.6796875,1.0,1.0,2/2,48.40%,TARBP1;NSUN6
2291,prerank,positive regulation of fibroblast migration (GO:0010763),0.5300601202404811,0.8588261992992829,0.7147435897435898,1.0,1.0,2/2,47.10%,DDR2;PTK2
2292,prerank,regulation of Rab protein signal transduction (GO:0032483),0.6476476476476476,0.8587883402786106,0.7151277013752456,1.0,1.0,1/1,35.30%,SGSM3
2293,prerank,Rap protein signal transduction (GO:0032486),0.6476476476476476,0.8587883402786106,0.7151277013752456,1.0,1.0,1/1,35.30%,SGSM3
2294,prerank,positive regulation of secretion by cell (GO:1903532),0.3912805209627568,0.8584467364384771,0.6627450980392157,1.0,1.0,3/5,37.90%,CADPS2;STXBP5;CD2AP
2295,prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.526052104208417,0.8580189421001865,0.7113884555382215,1.0,1.0,2/2,47.50%,CHKA;LPIN1
2296,prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.526052104208417,0.8580189421001865,0.7113884555382215,1.0,1.0,2/2,47.50%,CHKA;LPIN1
2297,prerank,L-aspartate transmembrane transport (GO:0070778),-0.6406406406406406,-0.85651168764449,0.7216890595009597,0.9398920795151822,1.0,1/1,36.10%,SLC1A3
2298,prerank,neurotransmitter uptake (GO:0001504),-0.6406406406406406,-0.85651168764449,0.7216890595009597,0.9398920795151822,1.0,1/1,36.10%,SLC1A3
2299,prerank,acidic amino acid transport (GO:0015800),-0.501002004008016,-0.8560096848800226,0.6649076517150396,0.9383610006553703,1.0,2/2,50.10%,SLC1A3;SLC25A12
2300,prerank,L-glutamate transmembrane transport (GO:0015813),-0.501002004008016,-0.8560096848800226,0.6649076517150396,0.9383610006553703,1.0,2/2,50.10%,SLC1A3;SLC25A12
2301,prerank,dicarboxylic acid transport (GO:0006835),-0.501002004008016,-0.8560096848800226,0.6649076517150396,0.9383610006553703,1.0,2/2,50.10%,SLC1A3;SLC25A12
2302,prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6356356356356356,0.8543113833128805,0.7196652719665272,1.0,1.0,1/1,36.50%,MID1
2303,prerank,protein localization to microtubule (GO:0035372),0.6356356356356356,0.8543113833128805,0.7196652719665272,1.0,1.0,1/1,36.50%,MID1
2304,prerank,protein localization to microtubule cytoskeleton (GO:0072698),0.6356356356356356,0.8543113833128805,0.7196652719665272,1.0,1.0,1/1,36.50%,MID1
2305,prerank,response to lipopolysaccharide (GO:0032496),0.45232651001326357,0.853988884566857,0.6774193548387096,1.0,1.0,1/3,12.80%,PDE4B
2306,prerank,heart development (GO:0007507),0.28814158152296265,0.8536323095008433,0.667741935483871,1.0,1.0,13/14,68.80%,FLRT2;WT1;CACNA1C;GPC3;PTK2;ECE1;HAND2;NF1;KAT2A;KAT2B;CHD7;PTEN;FOXC2
2307,prerank,heterotypic cell-cell adhesion (GO:0034113),0.5142569197926024,0.85322291363637,0.6872037914691943,1.0,1.0,1/2,19.50%,CTNNA3
2308,prerank,cellular lipid catabolic process (GO:0044242),0.526052104208417,0.8525180551134786,0.694488188976378,1.0,1.0,2/2,47.50%,LIPG;LPIN1
2309,prerank,peptide catabolic process (GO:0043171),0.42469879518072307,0.8521928875359435,0.6851595006934813,1.0,1.0,4/4,57.70%,DPEP1;NPEPPS;ECE1;XPNPEP1
2310,prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.6426426426426426,0.8512194807372349,0.7315175097276264,1.0,1.0,1/1,35.80%,ACOX3
2311,prerank,regulation of endocytosis (GO:0030100),0.386972998689364,0.8495543263569514,0.6863979848866498,1.0,1.0,2/5,21.20%,RIT2;HIP1
2312,prerank,branched-chain amino acid catabolic process (GO:0009083),-0.5080160320641283,-0.8494437481425969,0.6966580976863753,0.9507490150361957,1.0,2/2,49.40%,ACADSB;HIBCH
2313,prerank,branched-chain amino acid metabolic process (GO:0009081),-0.5080160320641283,-0.8494437481425969,0.6966580976863753,0.9507490150361957,1.0,2/2,49.40%,ACADSB;HIBCH
2314,prerank,regulation of bone mineralization (GO:0030500),0.4540171225437114,0.8492056707497487,0.6975748930099858,1.0,1.0,2/3,38.00%,FBN2;DDR2
2315,prerank,positive regulation of myoblast proliferation (GO:2000288),0.6246246246246245,0.8490081402597537,0.7053231939163498,1.0,1.0,1/1,37.60%,MEIS2
2316,prerank,negative regulation of actin filament depolymerization (GO:0030835),0.6346346346346347,0.848802560112076,0.7236286919831224,1.0,1.0,1/1,36.60%,PLEKHH2
2317,prerank,regulation of actin filament depolymerization (GO:0030834),0.6346346346346347,0.848802560112076,0.7236286919831224,1.0,1.0,1/1,36.60%,PLEKHH2
2318,prerank,positive regulation of kinase activity (GO:0033674),0.30578105400645755,0.8487955103189618,0.6826280623608018,1.0,1.0,7/11,49.30%,ALK;DDR2;IGF1R;FLT4;EGFR;PTK2;ROR2
2319,prerank,dicarboxylic acid metabolic process (GO:0043648),0.45336008024072216,0.8485978721635676,0.7039764359351989,1.0,1.0,3/3,54.80%,HAAO;GOT1;GCLM
2320,prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.6336336336336337,0.8483863975214395,0.7534516765285996,1.0,1.0,1/1,36.70%,RSAD1
2321,prerank,reticulophagy (GO:0061709),-0.6436436436436437,-0.8478755640416374,0.738,0.9448594428887374,1.0,1/1,35.80%,ULK1
2322,prerank,lysosomal microautophagy (GO:0016237),-0.6436436436436437,-0.8478755640416374,0.738,0.9448594428887374,1.0,1/1,35.80%,ULK1
2323,prerank,piecemeal microautophagy of the nucleus (GO:0034727),-0.6436436436436437,-0.8478755640416374,0.738,0.9448594428887374,1.0,1/1,35.80%,ULK1
2324,prerank,mitochondrion disassembly (GO:0061726),-0.6436436436436437,-0.8478755640416374,0.738,0.9448594428887374,1.0,1/1,35.80%,ULK1
2325,prerank,autophagy of mitochondrion (GO:0000422),-0.6436436436436437,-0.8478755640416374,0.738,0.9448594428887374,1.0,1/1,35.80%,ULK1
2326,prerank,autophagy of nucleus (GO:0044804),-0.6436436436436437,-0.8478755640416374,0.738,0.9448594428887374,1.0,1/1,35.80%,ULK1
2327,prerank,late nucleophagy (GO:0044805),-0.6436436436436437,-0.8478755640416374,0.738,0.9448594428887374,1.0,1/1,35.80%,ULK1
2328,prerank,positive regulation by symbiont of host autophagy (GO:0075044),-0.6436436436436437,-0.8478755640416374,0.738,0.9448594428887374,1.0,1/1,35.80%,ULK1
2329,prerank,modulation by symbiont of host autophagy (GO:0075071),-0.6436436436436437,-0.8478755640416374,0.738,0.9448594428887374,1.0,1/1,35.80%,ULK1
2330,prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.6436436436436437,-0.8478755640416374,0.738,0.9448594428887374,1.0,1/1,35.80%,ULK1
2331,prerank,response to nutrient levels (GO:0031667),-0.6436436436436437,-0.8478755640416374,0.738,0.9448594428887374,1.0,1/1,35.80%,ULK1
2332,prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.5169728260555623,0.8475277044400243,0.7147335423197492,1.0,1.0,1/2,21.10%,ADGRB1
2333,prerank,negative regulation of protein ubiquitination (GO:0031397),0.5169728260555623,0.8475277044400243,0.7147335423197492,1.0,1.0,1/2,21.10%,ADGRB1
2334,prerank,regulation of protein catabolic process (GO:0042176),0.3238685822108906,0.8474362575659763,0.6871508379888268,1.0,1.0,3/9,21.10%,HECW2;FMN2;ADGRB1
2335,prerank,"base-excision repair, gap-filling (GO:0006287)",0.4112973850201259,0.8470777080844889,0.7052489905787349,1.0,1.0,1/4,6.00%,POLE
2336,prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5211837502306333,0.8469259740531438,0.717391304347826,1.0,1.0,1/2,22.10%,STK39
2337,prerank,positive regulation of filopodium assembly (GO:0051491),0.4608209060269104,0.8468206846241523,0.7078014184397163,1.0,1.0,2/3,40.90%,TENM2;FNBP1L
2338,prerank,sodium ion import across plasma membrane (GO:0098719),0.5054462147199552,0.8466749586553128,0.7112561174551386,1.0,1.0,1/2,21.80%,SLC9C1
2339,prerank,female genitalia development (GO:0030540),-0.6396396396396397,-0.8465462379437144,0.7233644859813084,0.9385528074464341,1.0,1/1,36.20%,TBX3
2340,prerank,regulation of cell proliferation involved in heart morphogenesis (GO:2000136),-0.6396396396396397,-0.8465462379437144,0.7233644859813084,0.9385528074464341,1.0,1/1,36.20%,TBX3
2341,prerank,tripartite regional subdivision (GO:0007351),-0.6396396396396397,-0.8465462379437144,0.7233644859813084,0.9385528074464341,1.0,1/1,36.20%,TBX3
2342,prerank,mesoderm morphogenesis (GO:0048332),-0.6396396396396397,-0.8465462379437144,0.7233644859813084,0.9385528074464341,1.0,1/1,36.20%,TBX3
2343,prerank,heart looping (GO:0001947),-0.6396396396396397,-0.8465462379437144,0.7233644859813084,0.9385528074464341,1.0,1/1,36.20%,TBX3
2344,prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.6396396396396397,-0.8465462379437144,0.7233644859813084,0.9385528074464341,1.0,1/1,36.20%,TBX3
2345,prerank,sinoatrial node cell differentiation (GO:0060921),-0.6396396396396397,-0.8465462379437144,0.7233644859813084,0.9385528074464341,1.0,1/1,36.20%,TBX3
2346,prerank,determination of heart left/right asymmetry (GO:0061371),-0.6396396396396397,-0.8465462379437144,0.7233644859813084,0.9385528074464341,1.0,1/1,36.20%,TBX3
2347,prerank,embryonic axis specification (GO:0000578),-0.6396396396396397,-0.8465462379437144,0.7233644859813084,0.9385528074464341,1.0,1/1,36.20%,TBX3
2348,prerank,embryonic heart tube morphogenesis (GO:0003143),-0.6396396396396397,-0.8465462379437144,0.7233644859813084,0.9385528074464341,1.0,1/1,36.20%,TBX3
2349,prerank,"anterior/posterior axis specification, embryo (GO:0008595)",-0.6396396396396397,-0.8465462379437144,0.7233644859813084,0.9385528074464341,1.0,1/1,36.20%,TBX3
2350,prerank,cytoplasmic microtubule organization (GO:0031122),-0.3018108651911469,-0.8463329511998725,0.6630434782608695,0.9380858446427072,1.0,6/6,70.10%,CAMSAP2;DST;DLG1;SPAST;KATNAL2;TRPV4
2351,prerank,phosphorylation (GO:0016310),0.24435336597311136,0.8461311113414841,0.7383838383838384,1.0,1.0,17/35,44.40%,WNK2;ALK;WNK3;CDC42BPA;STK39;CDK14;AKT3;CDK6;GRK5;PRKAR1B;XYLB;FGGY;MAST2;MAP3K13;SRPK1;PRKCA;VRK1
2352,prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.6266266266266266,0.8458617945487098,0.7177914110429447,1.0,1.0,1/1,37.40%,CASP9
2353,prerank,sensory organ development (GO:0007423),0.3758793969849246,0.8455960049911173,0.6795865633074936,1.0,1.0,5/5,62.60%,MEIS1;MEIS2;ECE1;PBX1;CHD7
2354,prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.4515162352625519,0.8451854376778658,0.6948424068767909,1.0,1.0,1/3,13.90%,NOS1AP
2355,prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.4515162352625519,0.8451854376778658,0.6948424068767909,1.0,1.0,1/3,13.90%,NOS1AP
2356,prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.4515162352625519,0.8451854376778658,0.6948424068767909,1.0,1.0,1/3,13.90%,NOS1AP
2357,prerank,cellular response to sterol (GO:0036315),0.4510044589968124,0.8449480067659926,0.6947960618846695,1.0,1.0,2/3,43.40%,RORA;GRAMD1B
2358,prerank,dendritic spine maintenance (GO:0097062),-0.4222668004012036,-0.8446849397742305,0.6225806451612903,0.9405341680527658,1.0,3/3,58.00%,INSR;MTMR2;IGF1R
2359,prerank,nucleocytoplasmic transport (GO:0006913),0.45169789680467387,0.8445273739331326,0.698140200286123,1.0,1.0,2/3,34.70%,BACH2;ATXN1
2360,prerank,negative regulation of protein depolymerization (GO:1901880),-0.3664658634538152,-0.8445190667700996,0.6324110671936759,0.940022568191687,1.0,4/4,63.60%,CAMSAP2;TTBK2;FGF13;PLEKHH2
2361,prerank,protein targeting to membrane (GO:0006612),-0.3416676996153037,-0.8438882734663444,0.6631016042780749,0.9404088524303057,1.0,4/5,31.60%,ATAD1;SIL1;CHM;ABCD3
2362,prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.38534471981872687,0.8429514537174336,0.6838046272493573,1.0,1.0,2/5,24.10%,FLRT2;SPRED2
2363,prerank,blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),0.5036447728890773,0.8423211703627463,0.6952224052718287,1.0,1.0,1/2,20.50%,BMPER
2364,prerank,glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.6366366366366367,0.8419870895312938,0.722,1.0,1.0,1/1,36.40%,XYLB
2365,prerank,xylulose 5-phosphate biosynthetic process (GO:1901159),0.6366366366366367,0.8419870895312938,0.722,1.0,1.0,1/1,36.40%,XYLB
2366,prerank,pentose catabolic process (GO:0019323),0.6366366366366367,0.8419870895312938,0.722,1.0,1.0,1/1,36.40%,XYLB
2367,prerank,glucuronate catabolic process (GO:0006064),0.6366366366366367,0.8419870895312938,0.722,1.0,1.0,1/1,36.40%,XYLB
2368,prerank,regulation of signal transduction (GO:0009966),0.2852841723598236,0.8415455913632214,0.7161152614727855,1.0,1.0,7/15,36.90%,RGS11;RORA;TCF7L1;DTX1;ZIC1;GRK5;UBASH3B
2369,prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.49699398797595185,-0.8415385490322467,0.6815642458100558,0.944032264403784,1.0,2/2,50.50%,LGR4;TLR5
2370,prerank,peptide hormone secretion (GO:0030072),-0.6356356356356356,-0.8414348419638116,0.7399193548387096,0.9425942693578848,1.0,1/1,36.60%,LTBP4
2371,prerank,growth hormone secretion (GO:0030252),-0.6356356356356356,-0.8414348419638116,0.7399193548387096,0.9425942693578848,1.0,1/1,36.60%,LTBP4
2372,prerank,histone methylation (GO:0016571),-0.6336336336336337,-0.8412342981977063,0.7397260273972602,0.9413119179300937,1.0,1/1,36.80%,SMYD3
2373,prerank,peptidyl-lysine methylation (GO:0018022),-0.6336336336336337,-0.8412342981977063,0.7397260273972602,0.9413119179300937,1.0,1/1,36.80%,SMYD3
2374,prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3464516012579842,0.8411279378092031,0.6892857142857143,1.0,1.0,3/7,28.20%,SEMA3E;KANK1;ACER2
2375,prerank,regulation of establishment of cell polarity (GO:2000114),0.44346390314348716,0.8410555728631486,0.698744769874477,1.0,1.0,1/3,21.70%,KANK1
2376,prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.44346390314348716,0.8410555728631486,0.698744769874477,1.0,1.0,1/3,21.70%,KANK1
2377,prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.413278537726799,0.840964119036106,0.7077131258457375,1.0,1.0,2/4,29.80%,EYA2;BCL2
2378,prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.413278537726799,0.840964119036106,0.7077131258457375,1.0,1.0,2/4,29.80%,EYA2;BCL2
2379,prerank,cellular response to mechanical stimulus (GO:0071260),-0.49699398797595185,-0.8403997617314182,0.6848958333333334,0.9421878168896491,1.0,2/2,50.50%,MAP2K4;TLR5
2380,prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2584369885441203,0.8401333126980339,0.6986584107327142,1.0,1.0,12/21,49.30%,WNK2;CALCR;SEMA6A;BMPER;LMO3;SPRED2;SPRED3;FLT4;PRKCA;EGFR;GCNT2;ROR2
2381,prerank,regulation of growth hormone secretion (GO:0060123),-0.6256256256256256,-0.8395239694331376,0.7215447154471545,0.9406758833893049,1.0,1/1,37.60%,CHD7
2382,prerank,cranial nerve development (GO:0021545),-0.6256256256256256,-0.8395239694331376,0.7215447154471545,0.9406758833893049,1.0,1/1,37.60%,CHD7
2383,prerank,in utero embryonic development (GO:0001701),-0.6256256256256256,-0.8395239694331376,0.7215447154471545,0.9406758833893049,1.0,1/1,37.60%,CHD7
2384,prerank,secondary palate development (GO:0062009),-0.6256256256256256,-0.8395239694331376,0.7215447154471545,0.9406758833893049,1.0,1/1,37.60%,CHD7
2385,prerank,tRNA processing (GO:0008033),-0.48396793587174347,-0.8392439425881536,0.703601108033241,0.9395069300046229,1.0,2/2,51.80%,QTRT1;NSUN6
2386,prerank,RNA modification (GO:0009451),-0.48396793587174347,-0.8392439425881536,0.703601108033241,0.9395069300046229,1.0,2/2,51.80%,QTRT1;NSUN6
2387,prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.24217961654894046,-0.8391363226139527,0.7478991596638656,0.9388886921398043,1.0,9/9,76.10%,SPRED1;EMILIN1;SNX25;BAMBI;LTBP4;IL17RD;BCL9;SPRED3;SPRED2
2388,prerank,skin development (GO:0043588),-0.34939759036144574,-0.8389013649150138,0.6666666666666666,0.9385114648721419,1.0,4/4,65.30%,COL5A1;EPHA2;CLDN1;COL5A3
2389,prerank,alpha-amino acid metabolic process (GO:1901605),0.3798154727153952,0.8388419612495478,0.6916461916461917,1.0,1.0,4/5,50.90%,DPEP1;GOT1;SLC25A12;DDAH1
2390,prerank,fatty acid catabolic process (GO:0009062),0.45035398586736686,0.8378234969255032,0.7200577200577201,1.0,1.0,1/3,9.70%,GLYATL2
2391,prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.4172517552657974,-0.8374878030506322,0.6702508960573477,0.9405826529366466,1.0,3/3,58.50%,PLCB1;IGF1R;IRS1
2392,prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.6256256256256256,0.83724385412269,0.7555555555555555,1.0,1.0,1/1,37.50%,NINL
2393,prerank,microtubule anchoring at centrosome (GO:0034454),0.6256256256256256,0.83724385412269,0.7555555555555555,1.0,1.0,1/1,37.50%,NINL
2394,prerank,negative regulation of bone resorption (GO:0045779),0.6316316316316316,0.8365570375108656,0.7295719844357976,1.0,1.0,1/1,36.90%,UBASH3B
2395,prerank,regulation of osteoclast differentiation (GO:0045670),0.6316316316316316,0.8365570375108656,0.7295719844357976,1.0,1.0,1/1,36.90%,UBASH3B
2396,prerank,regulation of sequestering of calcium ion (GO:0051282),0.6316316316316316,0.8365570375108656,0.7295719844357976,1.0,1.0,1/1,36.90%,UBASH3B
2397,prerank,homotypic cell-cell adhesion (GO:0034109),0.6316316316316316,0.8365570375108656,0.7295719844357976,1.0,1.0,1/1,36.90%,UBASH3B
2398,prerank,platelet aggregation (GO:0070527),0.6316316316316316,0.8365570375108656,0.7295719844357976,1.0,1.0,1/1,36.90%,UBASH3B
2399,prerank,negative regulation of bone remodeling (GO:0046851),0.6316316316316316,0.8365570375108656,0.7295719844357976,1.0,1.0,1/1,36.90%,UBASH3B
2400,prerank,negative regulation of cell communication (GO:0010648),0.6316316316316316,0.8365570375108656,0.7295719844357976,1.0,1.0,1/1,36.90%,UBASH3B
2401,prerank,anion transport (GO:0006820),-0.6296296296296297,-0.8361700291759016,0.742393509127789,0.9399157986092277,1.0,1/1,37.20%,SLC13A4
2402,prerank,sulfate transport (GO:0008272),-0.6296296296296297,-0.8361700291759016,0.742393509127789,0.9399157986092277,1.0,1/1,37.20%,SLC13A4
2403,prerank,inorganic anion transport (GO:0015698),-0.6296296296296297,-0.8361700291759016,0.742393509127789,0.9399157986092277,1.0,1/1,37.20%,SLC13A4
2404,prerank,sulfur compound transport (GO:0072348),-0.6296296296296297,-0.8361700291759016,0.742393509127789,0.9399157986092277,1.0,1/1,37.20%,SLC13A4
2405,prerank,negative regulation of angiogenesis (GO:0016525),0.31028875134965694,0.8361239063672368,0.6974885844748858,1.0,1.0,3/10,21.10%,SEMA3E;SEMA6A;ADGRB1
2406,prerank,response to chemokine (GO:1990868),0.5023124782366662,0.8354210283851622,0.722397476340694,1.0,1.0,1/2,22.10%,STK39
2407,prerank,actin filament-based transport (GO:0099515),-0.4092276830491474,-0.8352756531690576,0.7123287671232876,0.9400375387867911,1.0,3/3,59.30%,MYO1B;MYO1D;FNBP1L
2408,prerank,vesicle transport along actin filament (GO:0030050),-0.4092276830491474,-0.8352756531690576,0.7123287671232876,0.9400375387867911,1.0,3/3,59.30%,MYO1B;MYO1D;FNBP1L
2409,prerank,cellular response to inorganic substance (GO:0071241),0.5084032019830982,0.8349278356551426,0.7408585055643879,1.0,1.0,1/2,28.00%,DPEP1
2410,prerank,cellular response to organonitrogen compound (GO:0071417),0.3724021572573938,0.8349217742038566,0.7031055900621118,1.0,1.0,3/5,40.10%,SLIT2;WT1;CPEB3
2411,prerank,cellular transition metal ion homeostasis (GO:0046916),0.5170444904848027,0.8345387489548878,0.7287581699346405,1.0,1.0,1/2,23.30%,SCARA5
2412,prerank,"substrate-dependent cell migration, cell extension (GO:0006930)",0.6216216216216216,0.8336986146268867,0.7550200803212851,1.0,1.0,1/1,37.90%,CD2AP
2413,prerank,limb development (GO:0060173),0.3758793969849246,0.8329653478915836,0.7019354838709677,1.0,1.0,5/5,62.60%,GLI3;ZNRF3;KAT2A;KAT2B;CHD7
2414,prerank,cell projection organization (GO:0030030),0.6286286286286287,0.832403238448898,0.7583497053045186,1.0,1.0,1/1,37.20%,RHOJ
2415,prerank,cell projection assembly (GO:0030031),0.6286286286286287,0.832403238448898,0.7583497053045186,1.0,1.0,1/1,37.20%,RHOJ
2416,prerank,Cdc42 protein signal transduction (GO:0032488),0.6286286286286287,0.832403238448898,0.7583497053045186,1.0,1.0,1/1,37.20%,RHOJ
2417,prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.6366366366366366,-0.8322389943287478,0.7648221343873518,0.9443523612491697,1.0,1/1,36.50%,HDAC5
2418,prerank,negative regulation of myotube differentiation (GO:0010832),-0.6366366366366366,-0.8322389943287478,0.7648221343873518,0.9443523612491697,1.0,1/1,36.50%,HDAC5
2419,prerank,protein O-linked glycosylation (GO:0006493),0.32604124130437756,0.8321847629230333,0.6977567886658795,1.0,1.0,4/8,37.10%,TET1;GALNT14;MUC6;MUC5AC
2420,prerank,regulation of transport (GO:0051049),0.5020040080160321,0.8318206417525438,0.724960254372019,1.0,1.0,2/2,49.90%,EPB41;ICA1L
2421,prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.32361809045226136,-0.8313426545486816,0.6666666666666666,0.9454457747088485,1.0,5/5,67.90%,RBMX;CELF2;RBFOX2;SRPK1;NOVA1
2422,prerank,regulation of cellular localization (GO:0060341),0.40274234573194595,0.8313328621441065,0.6997389033942559,1.0,1.0,1/4,11.20%,MAP2
2423,prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.4759519038076152,-0.8309386857140085,0.7340720221606648,0.9454261063057695,1.0,2/2,52.60%,MAP2K5;GCNT2
2424,prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.4012036108324975,-0.8308630447220943,0.7049180327868853,0.943934174485052,1.0,3/3,60.10%,AGO2;TNRC6B;CPEB3
2425,prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.4012036108324975,-0.8308630447220943,0.7049180327868853,0.943934174485052,1.0,3/3,60.10%,AGO2;TNRC6B;CPEB3
2426,prerank,response to cytokine (GO:0034097),0.3975903614457832,0.8308414773089909,0.7249666221628839,1.0,1.0,4/4,60.40%,BCL2;PRKCA;PTPN9;PTPN4
2427,prerank,regulation of endothelial cell differentiation (GO:0045601),-0.6236236236236237,-0.8306846395594768,0.7484787018255578,0.9427693936993793,1.0,1/1,37.80%,APOLD1
2428,prerank,regulation of epithelial cell differentiation (GO:0030856),-0.6236236236236237,-0.8306846395594768,0.7484787018255578,0.9427693936993793,1.0,1/1,37.80%,APOLD1
2429,prerank,bicarbonate transport (GO:0015701),-0.6196196196196196,-0.8304566798343221,0.746031746031746,0.9425237539844425,1.0,1/1,38.20%,CA5B
2430,prerank,positive regulation of extracellular matrix disassembly (GO:0090091),0.6206206206206205,0.8304531774059499,0.7208835341365462,1.0,1.0,1/1,38.00%,DDR2
2431,prerank,regulation of ossification (GO:0030278),0.6206206206206205,0.8304531774059499,0.7208835341365462,1.0,1.0,1/1,38.00%,DDR2
2432,prerank,regulation of extracellular matrix organization (GO:1903053),0.6206206206206205,0.8304531774059499,0.7208835341365462,1.0,1.0,1/1,38.00%,DDR2
2433,prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6206206206206205,0.8304531774059499,0.7208835341365462,1.0,1.0,1/1,38.00%,DDR2
2434,prerank,regulation of Notch signaling pathway (GO:0008593),-0.2977867203219316,-0.8292973091256604,0.7105263157894737,0.9440135237050348,1.0,6/6,70.50%,SREBF2;ITGB1BP1;KAT2B;RFNG;EGFR;DTX1
2435,prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.3206030150753769,-0.8289766594562807,0.7180616740088106,0.9437496257003297,1.0,5/5,68.20%,CSNK1E;TTBK2;CEP70;NINL;PRKAR2B
2436,prerank,positive regulation of fat cell differentiation (GO:0045600),0.5138354415760072,0.8289640373100281,0.7422680412371134,1.0,1.0,1/2,23.90%,LMO3
2437,prerank,positive regulation of intracellular signal transduction (GO:1902533),0.24861686966221808,0.8286229304113577,0.7497456765005086,1.0,1.0,24/29,68.00%,NRG1;NRG2;NOS1AP;RIT2;CALCR;SASH1;HIP1;BCL2;DLG5;IRS1;IGF1R;FLT4;EGFR;PTK2;GCNT2;ROR2;WLS;SLC44A2;PPP5C;UNC5B;MIOS;SLC38A9;FGFR1;WDR59
2438,prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.2837022132796781,-0.8283492224614823,0.6686746987951807,0.9427787325420001,1.0,6/6,71.90%,BAMBI;BMPR1A;ZFYVE9;GCNT2;PTK2;PARD3
2439,prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.2837022132796781,-0.8283492224614823,0.6686746987951807,0.9427787325420001,1.0,6/6,71.90%,BAMBI;BMPR1A;ZFYVE9;GCNT2;PTK2;PARD3
2440,prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.2837022132796781,-0.8283492224614823,0.6686746987951807,0.9427787325420001,1.0,6/6,71.90%,BAMBI;BMPR1A;ZFYVE9;GCNT2;PTK2;PARD3
2441,prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2898638757168888,0.8280868916467499,0.7024070021881839,1.0,1.0,8/13,51.30%,PPARGC1A;NOS1AP;SMOC2;CPEB3;IRS1;EGFR;DDAH1;SAMD4A
2442,prerank,regulation of cellular response to heat (GO:1900034),-0.41223671013039115,-0.8267142737826779,0.7024221453287197,0.9451262565262198,1.0,3/3,59.00%,NUP58;CAMK2D;NUP93
2443,prerank,regulation of histone acetylation (GO:0035065),0.40587611006230373,0.8255965721655985,0.7361477572559367,1.0,1.0,1/4,12.20%,PPARGC1A
2444,prerank,regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.6146146146146146,-0.8253937593643472,0.7631067961165049,0.9468878737097897,1.0,1/1,38.70%,CNOT6
2445,prerank,canonical Wnt signaling pathway (GO:0060070),-0.29376257545271633,-0.8250341183028573,0.6413043478260869,0.9467764790347116,1.0,6/6,70.90%,CSNK1E;FZD6;PTEN;DIXDC1;BCL9;TCF7L1
2446,prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.6186186186186187,-0.8249169462201394,0.7545638945233266,0.9446439796236007,1.0,1/1,38.30%,NDUFAF6
2447,prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.6186186186186187,-0.8249169462201394,0.7545638945233266,0.9446439796236007,1.0,1/1,38.30%,NDUFAF6
2448,prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.6186186186186187,-0.8249169462201394,0.7545638945233266,0.9446439796236007,1.0,1/1,38.30%,NDUFAF6
2449,prerank,T cell differentiation (GO:0030217),0.5102371444311457,0.824908419711404,0.7411575562700965,1.0,1.0,1/2,18.20%,GLI3
2450,prerank,nose development (GO:0043584),0.5102371444311457,0.824908419711404,0.7411575562700965,1.0,1.0,1/2,18.20%,GLI3
2451,prerank,acyl-CoA metabolic process (GO:0006637),-0.3524096385542168,-0.8248074664498779,0.6961538461538461,0.9441290469823418,1.0,4/4,65.00%,ACACA;ACACB;ACBD6;ACSF2
2452,prerank,regulation of kinase activity (GO:0043549),0.31126306622705824,0.8247056001575735,0.6786127167630058,1.0,1.0,6/9,49.30%,ALK;DDR2;IGF1R;FLT4;EGFR;ROR2
2453,prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5013706208303758,0.8241247741346907,0.7433070866141732,1.0,1.0,1/2,21.70%,KANK1
2454,prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5013706208303758,0.8241247741346907,0.7433070866141732,1.0,1.0,1/2,21.70%,KANK1
2455,prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.4759519038076152,-0.8240957180555079,0.7338935574229691,0.944715410812243,1.0,2/2,52.60%,PUM3;GCNT2
2456,prerank,transcription by RNA polymerase I (GO:0006360),-0.40421263791374124,-0.8231966607054273,0.7037037037037037,0.944014236678771,1.0,3/3,59.80%,TAF1D;MNAT1;TAF1C
2457,prerank,termination of RNA polymerase I transcription (GO:0006363),-0.40421263791374124,-0.8231966607054273,0.7037037037037037,0.944014236678771,1.0,3/3,59.80%,TAF1D;MNAT1;TAF1C
2458,prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.40421263791374124,-0.8231966607054273,0.7037037037037037,0.944014236678771,1.0,3/3,59.80%,TAF1D;MNAT1;TAF1C
2459,prerank,DNA repair (GO:0006281),0.2731109977828906,0.8219777057422012,0.7035069075451648,1.0,1.0,2/15,6.00%,HMGA2;POLE
2460,prerank,cell cycle G1/S phase transition (GO:0044843),0.34463454446070285,0.8205054805660178,0.7061668681983071,1.0,1.0,1/6,6.00%,POLE
2461,prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.2688821752265861,-0.8203969167108143,0.6474820143884892,0.9485538305982351,1.0,7/7,73.40%,PLD1;TBC1D5;RABGAP1;EPHA2;TBC1D16;SGSM3;MYO10
2462,prerank,regulation of response to biotic stimulus (GO:0002831),0.49282313700871194,0.8199950577928528,0.7569444444444444,1.0,1.0,1/2,20.10%,LRP8
2463,prerank,histone acetylation (GO:0016573),0.39959839357429716,0.8190007183125091,0.747612551159618,1.0,1.0,4/4,60.20%,EP400;KAT6B;KAT2A;KAT2B
2464,prerank,regulation of MAP kinase activity (GO:0043405),-0.31859296482412064,-0.8189260356769229,0.6699507389162561,0.9505405218373414,1.0,5/5,68.40%,ROBO1;FGFR1;NF1;EGFR;IL34
2465,prerank,glycerol-3-phosphate metabolic process (GO:0006072),-0.6126126126126126,-0.8188755863614086,0.7810077519379846,0.9482257936900819,1.0,1/1,38.90%,GK
2466,prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.6126126126126126,-0.8188755863614086,0.7810077519379846,0.9482257936900819,1.0,1/1,38.90%,GK
2467,prerank,alditol metabolic process (GO:0019400),-0.6126126126126126,-0.8188755863614086,0.7810077519379846,0.9482257936900819,1.0,1/1,38.90%,GK
2468,prerank,actin filament depolymerization (GO:0030042),-0.6166166166166166,-0.818548535933306,0.7916666666666666,0.9481828416071619,1.0,1/1,38.50%,MICAL3
2469,prerank,negative regulation of neuron death (GO:1901215),0.39661006830643275,0.8184458050649307,0.7371202113606341,1.0,1.0,2/4,29.80%,PPARGC1A;BCL2
2470,prerank,protein modification by small protein conjugation (GO:0032446),0.2514104967604523,0.8175676464390721,0.7290589451913133,1.0,1.0,9/21,43.10%,HIF3A;MKRN3;HECW2;RNF212;BCL11A;DTX1;MYCBP2;NUP93;ZNRF3
2471,prerank,regulation of exit from mitosis (GO:0007096),-0.399197592778335,-0.8172900602702601,0.678082191780822,0.9497685958953445,1.0,3/3,60.30%,ANAPC16;CDC14A;CDC14B
2472,prerank,regulation of monocyte differentiation (GO:0045655),0.43084130953640687,0.8170858179910669,0.7496339677891655,1.0,1.0,2/3,35.00%,IL34;CDK6
2473,prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.49742433422542376,0.8166337141848448,0.7516556291390728,1.0,1.0,1/2,22.10%,STK39
2474,prerank,negative regulation of fat cell differentiation (GO:0045599),0.43151571356155993,0.8162728665924557,0.7457386363636364,1.0,1.0,2/3,44.90%,RORA;ANKRD26
2475,prerank,aspartate family amino acid metabolic process (GO:0009066),0.5000000000000001,0.8157450621339289,0.7543581616481775,1.0,1.0,2/2,50.10%,GOT1;SLC25A12
2476,prerank,phospholipid biosynthetic process (GO:0008654),-0.29962740725764975,-0.815437293412211,0.7276785714285714,0.9523941580456757,1.0,4/5,37.40%,SGMS1;FAR1;IDI1;LPCAT1
2477,prerank,response to amino acid (GO:0043200),-0.4012036108324975,-0.8150559274390794,0.7031802120141343,0.9515055338043601,1.0,3/3,60.10%,CAPN2;SLC38A9;CPEB3
2478,prerank,cellular response to acid chemical (GO:0071229),-0.4012036108324975,-0.8150559274390794,0.7031802120141343,0.9515055338043601,1.0,3/3,60.10%,CAPN2;SLC38A9;CPEB3
2479,prerank,purine ribonucleotide metabolic process (GO:0009150),0.3955823293172692,0.814139176919109,0.7576564580559254,1.0,1.0,4/4,60.60%,ACSF2;AK3;ACBD6;EPHA2
2480,prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.2898076957899196,0.8135867085578318,0.7203947368421053,1.0,1.0,4/11,30.30%,MAGI2;BMPER;SPRED2;SPRED3
2481,prerank,protein maturation (GO:0051604),0.36749425430962546,0.8134356521257299,0.7218628719275549,1.0,1.0,2/5,25.90%,MMP16;ADAMTS3
2482,prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.6096096096096095,0.8131667660319187,0.7633744855967078,1.0,1.0,1/1,39.10%,CACNA1C
2483,prerank,cardiac muscle cell action potential (GO:0086001),0.6096096096096095,0.8131667660319187,0.7633744855967078,1.0,1.0,1/1,39.10%,CACNA1C
2484,prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.6096096096096095,0.8131667660319187,0.7633744855967078,1.0,1.0,1/1,39.10%,CACNA1C
2485,prerank,positive regulation of receptor recycling (GO:0001921),0.49498997995992,0.8130506799708456,0.7353433835845896,1.0,1.0,2/2,50.60%,INPP5F;ECE1
2486,prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.32045276560622593,0.8126641022494866,0.6950354609929078,1.0,1.0,5/8,47.60%,TIAM1;SPRED2;SPRED3;IL17RD;GCNT2
2487,prerank,histone H2A acetylation (GO:0043968),0.6136136136136137,0.8125813177421026,0.7741273100616016,1.0,1.0,1/1,38.70%,EP400
2488,prerank,carbohydrate phosphorylation (GO:0046835),0.6156156156156156,0.8125605566810534,0.8058823529411765,1.0,1.0,1/1,38.50%,FGGY
2489,prerank,regulation of dendritic spine development (GO:0060998),-0.4002006018054162,-0.8115792791125246,0.6953846153846154,0.9574160830806819,1.0,3/3,60.20%,TANC2;CPEB3;DLG5
2490,prerank,regulation of organelle assembly (GO:1902115),-0.35341365461847385,-0.8109703845956515,0.7280701754385965,0.957675836428583,1.0,4/4,64.90%,TBC1D5;RABGAP1;TBC1D16;SGSM3
2491,prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.47094188376753504,-0.8109033114073126,0.7364130434782609,0.9570560504344486,1.0,2/2,53.10%,MAP2K5;PTK2
2492,prerank,embryonic appendage morphogenesis (GO:0035113),-0.6096096096096096,-0.8107885930653849,0.7879417879417879,0.9564585500654401,1.0,1/1,39.20%,FBXW4
2493,prerank,skeletal system morphogenesis (GO:0048705),0.43086614124624156,0.8107583761346279,0.7521008403361344,1.0,1.0,1/3,10.20%,FBN2
2494,prerank,DNA strand elongation (GO:0022616),0.6126126126126126,0.8105448025087623,0.7932405566600398,1.0,1.0,1/1,38.80%,RFC3
2495,prerank,positive regulation of DNA-directed DNA polymerase activity (GO:1900264),0.6126126126126126,0.8105448025087623,0.7932405566600398,1.0,1.0,1/1,38.80%,RFC3
2496,prerank,regulation of DNA-directed DNA polymerase activity (GO:1900262),0.6126126126126126,0.8105448025087623,0.7932405566600398,1.0,1.0,1/1,38.80%,RFC3
2497,prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.36325941547770685,0.8094702010569613,0.7203495630461922,1.0,1.0,2/5,27.10%,POLE;EME2
2498,prerank,calcium-mediated signaling (GO:0019722),0.3671267705003341,0.8085397924578934,0.7698309492847855,1.0,1.0,1/5,4.90%,CHRM3
2499,prerank,natural killer cell differentiation (GO:0001779),0.48997995991983967,0.8081885763750379,0.7824675324675324,1.0,1.0,2/2,51.10%,TOX;PBX1
2500,prerank,natural killer cell activation (GO:0030101),0.48997995991983967,0.8081885763750379,0.7824675324675324,1.0,1.0,2/2,51.10%,TOX;PBX1
2501,prerank,glycoprotein biosynthetic process (GO:0009101),0.40052730642233336,0.8076716560109962,0.7699468085106383,1.0,1.0,3/4,47.60%,CHST9;COG7;GCNT2
2502,prerank,cellular response to lipopolysaccharide (GO:0071222),0.43794211735012195,0.8074931835806076,0.745269286754003,1.0,1.0,1/3,12.80%,PDE4B
2503,prerank,chemokine-mediated signaling pathway (GO:0070098),0.49260682796981947,0.8074496772312644,0.7913188647746243,1.0,1.0,1/2,22.10%,STK39
2504,prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.6016016016016016,-0.8072298954603299,0.7890625,0.9602207499305322,1.0,1/1,40.00%,KAT2B
2505,prerank,regulation of rRNA processing (GO:2000232),-0.6016016016016016,-0.8072298954603299,0.7890625,0.9602207499305322,1.0,1/1,40.00%,KAT2B
2506,prerank,negative regulation of RNA metabolic process (GO:0051253),-0.6016016016016016,-0.8072298954603299,0.7890625,0.9602207499305322,1.0,1/1,40.00%,KAT2B
2507,prerank,protein acetylation (GO:0006473),-0.6016016016016016,-0.8072298954603299,0.7890625,0.9602207499305322,1.0,1/1,40.00%,KAT2B
2508,prerank,regulation of cell-matrix adhesion (GO:0001952),0.32231911629529847,0.8071319348117016,0.7476525821596244,1.0,1.0,4/8,35.00%,SEMA3E;LIMCH1;ACER2;CDK6
2509,prerank,mammary gland duct morphogenesis (GO:0060603),-0.6056056056056056,-0.806922192027475,0.7833333333333333,0.9537232024284037,1.0,1/1,39.60%,EPHA2
2510,prerank,cell chemotaxis (GO:0060326),-0.6056056056056056,-0.806922192027475,0.7833333333333333,0.9537232024284037,1.0,1/1,39.60%,EPHA2
2511,prerank,mammary gland epithelium development (GO:0061180),-0.6056056056056056,-0.806922192027475,0.7833333333333333,0.9537232024284037,1.0,1/1,39.60%,EPHA2
2512,prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6056056056056056,-0.806922192027475,0.7833333333333333,0.9537232024284037,1.0,1/1,39.60%,EPHA2
2513,prerank,lens fiber cell development (GO:0070307),-0.6056056056056056,-0.806922192027475,0.7833333333333333,0.9537232024284037,1.0,1/1,39.60%,EPHA2
2514,prerank,regulation of lamellipodium organization (GO:1902743),-0.6056056056056056,-0.806922192027475,0.7833333333333333,0.9537232024284037,1.0,1/1,39.60%,EPHA2
2515,prerank,keratinocyte differentiation (GO:0030216),-0.6056056056056056,-0.806922192027475,0.7833333333333333,0.9537232024284037,1.0,1/1,39.60%,EPHA2
2516,prerank,epidermal cell differentiation (GO:0009913),-0.6056056056056056,-0.806922192027475,0.7833333333333333,0.9537232024284037,1.0,1/1,39.60%,EPHA2
2517,prerank,positive regulation of bicellular tight junction assembly (GO:1903348),-0.6056056056056056,-0.806922192027475,0.7833333333333333,0.9537232024284037,1.0,1/1,39.60%,EPHA2
2518,prerank,sensory perception of sound (GO:0007605),0.34348930251438536,0.8068852364163849,0.7307221542227662,1.0,1.0,4/6,45.80%,SPTBN4;EPS8L2;TBL1X;ATP6V0A4
2519,prerank,sensory perception of mechanical stimulus (GO:0050954),0.34348930251438536,0.8068852364163849,0.7307221542227662,1.0,1.0,4/6,45.80%,SPTBN4;EPS8L2;TBL1X;ATP6V0A4
2520,prerank,nuclear export (GO:0051168),-0.3473895582329317,-0.8060659660655102,0.7289719626168224,0.9544636984799729,1.0,4/4,65.50%,THOC2;SRSF1;XPO1;ATXN1
2521,prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.32125835578860407,0.8059308956474704,0.7482598607888631,1.0,1.0,2/8,15.00%,HS3ST5;CHST9
2522,prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.34935138468630295,0.8047863947124442,0.7406060606060606,1.0,1.0,4/6,46.40%,MAPK8IP3;MID1;IGF1R;EGFR
2523,prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.46492985971943884,-0.8046281212827658,0.721763085399449,0.9564072927333842,1.0,2/2,53.70%,ASXL1;PRAME
2524,prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.6006006006006005,0.8040817644589401,0.8232931726907631,1.0,1.0,1/1,40.00%,DLG5
2525,prerank,negative regulation of T cell proliferation (GO:0042130),0.6006006006006005,0.8040817644589401,0.8232931726907631,1.0,1.0,1/1,40.00%,DLG5
2526,prerank,negative regulation of T cell activation (GO:0050868),0.6006006006006005,0.8040817644589401,0.8232931726907631,1.0,1.0,1/1,40.00%,DLG5
2527,prerank,positive regulation of hippo signaling (GO:0035332),0.6006006006006005,0.8040817644589401,0.8232931726907631,1.0,1.0,1/1,40.00%,DLG5
2528,prerank,regulation of fibroblast proliferation (GO:0048145),-0.3504016064257028,-0.8021130364263885,0.75,0.9599165040143722,1.0,4/4,65.20%,GAS6;NF1;DDR2;CDK6
2529,prerank,cellular response to oxidative stress (GO:0034599),0.36508037549650624,0.8019540100911392,0.7481203007518797,1.0,1.0,2/5,23.40%,PPARGC1A;ETV5
2530,prerank,positive regulation of sequestering of triglyceride (GO:0010890),0.6046046046046046,0.8015806999550461,0.8032454361054767,1.0,1.0,1/1,39.60%,OSBPL11
2531,prerank,regulation of sequestering of triglyceride (GO:0010889),0.6046046046046046,0.8015806999550461,0.8032454361054767,1.0,1.0,1/1,39.60%,OSBPL11
2532,prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.42860273370598556,0.801468791913388,0.7753623188405797,1.0,1.0,2/3,39.10%,CTNNA3;CACNA1C
2533,prerank,cellular response to potassium ion (GO:0035865),0.4938096114568583,0.8013593749507157,0.7768729641693811,1.0,1.0,1/2,22.80%,DLG2
2534,prerank,response to potassium ion (GO:0035864),0.4938096114568583,0.8013593749507157,0.7768729641693811,1.0,1.0,1/2,22.80%,DLG2
2535,prerank,retrograde axonal transport (GO:0008090),0.5001800712146698,0.8013161463835372,0.7816091954022989,1.0,1.0,1/2,22.80%,DLG2
2536,prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3162046955204667,0.8005216494557108,0.7414806110458284,1.0,1.0,1/8,1.50%,HMGA2
2537,prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.399197592778335,-0.8003574209185206,0.7157190635451505,0.961841043939273,1.0,3/3,60.30%,BTRC;PTEN;CDC14B
2538,prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.399197592778335,-0.8003574209185206,0.7157190635451505,0.961841043939273,1.0,3/3,60.30%,BTRC;PTEN;CDC14B
2539,prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.36152857849244424,0.8000849851410765,0.7693333333333333,1.0,1.0,3/5,41.70%,KANK1;PTPRE;IRS1
2540,prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.36152857849244424,0.8000849851410765,0.7693333333333333,1.0,1.0,3/5,41.70%,KANK1;PTPRE;IRS1
2541,prerank,regulation of Wnt signaling pathway (GO:0030111),0.2885611701628106,0.7996531329367679,0.7154017857142857,1.0,1.0,4/11,29.30%,TIAM1;KANK1;CDK14;TCF7L1
2542,prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.31276091622806024,0.7990302066391404,0.752046783625731,1.0,1.0,4/8,42.10%,FBN2;SPRED2;SPRED3;IL17RD
2543,prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.3206030150753769,-0.7983477470930149,0.7603686635944701,0.9645979965273327,1.0,5/5,68.20%,CCND1;CSNK1E;CEP70;NINL;PRKAR2B
2544,prerank,histone H4 acetylation (GO:0043967),-0.38716148445336007,-0.7978930959139032,0.7371794871794872,0.9646271932110382,1.0,3/3,61.50%,KANSL1;KMT2A;EP400
2545,prerank,ribosomal subunit export from nucleus (GO:0000054),-0.5985985985985985,-0.7978307366478651,0.8113948919449901,0.959234784815874,1.0,1/1,40.30%,XPO1
2546,prerank,ribosomal small subunit export from nucleus (GO:0000056),-0.5985985985985985,-0.7978307366478651,0.8113948919449901,0.959234784815874,1.0,1/1,40.30%,XPO1
2547,prerank,protein export from nucleus (GO:0006611),-0.5985985985985985,-0.7978307366478651,0.8113948919449901,0.959234784815874,1.0,1/1,40.30%,XPO1
2548,prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.5985985985985985,-0.7978307366478651,0.8113948919449901,0.959234784815874,1.0,1/1,40.30%,XPO1
2549,prerank,rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.5985985985985985,-0.7978307366478651,0.8113948919449901,0.959234784815874,1.0,1/1,40.30%,XPO1
2550,prerank,ribosome localization (GO:0033750),-0.5985985985985985,-0.7978307366478651,0.8113948919449901,0.959234784815874,1.0,1/1,40.30%,XPO1
2551,prerank,ribosomal large subunit export from nucleus (GO:0000055),-0.5985985985985985,-0.7978307366478651,0.8113948919449901,0.959234784815874,1.0,1/1,40.30%,XPO1
2552,prerank,regulation of establishment of planar polarity (GO:0090175),0.3635003428218538,0.7971035788731091,0.7623888182973316,1.0,1.0,1/5,9.50%,TIAM1
2553,prerank,skeletal system development (GO:0001501),0.2862494120121668,0.7964640314798952,0.7309812568908489,1.0,1.0,2/11,8.40%,SHOX;MMP16
2554,prerank,negative regulation of mitotic nuclear division (GO:0045839),0.48636490493193757,0.7961278143952258,0.8029801324503312,1.0,1.0,1/2,24.90%,TOM1L1
2555,prerank,negative regulation of nuclear division (GO:0051784),0.48636490493193757,0.7961278143952258,0.8029801324503312,1.0,1.0,1/2,24.90%,TOM1L1
2556,prerank,regulation of T cell differentiation (GO:0045580),-0.5955955955955956,-0.7958550540368721,0.8041825095057035,0.9594883254772859,1.0,1/1,40.60%,KAT2A
2557,prerank,regulation of T cell activation (GO:0050863),-0.5955955955955956,-0.7958550540368721,0.8041825095057035,0.9594883254772859,1.0,1/1,40.60%,KAT2A
2558,prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.5955955955955956,-0.7958550540368721,0.8041825095057035,0.9594883254772859,1.0,1/1,40.60%,KAT2A
2559,prerank,regulation of lymphocyte activation (GO:0051249),-0.5955955955955956,-0.7958550540368721,0.8041825095057035,0.9594883254772859,1.0,1/1,40.60%,KAT2A
2560,prerank,defense response to tumor cell (GO:0002357),-0.5965965965965966,-0.7957192219939775,0.8237623762376237,0.9589950695646472,1.0,1/1,40.50%,RBMS3
2561,prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.47094188376753504,-0.7957012991792729,0.7527173913043478,0.9582908785339134,1.0,2/2,53.10%,PTEN;PTK2
2562,prerank,positive regulation of cholesterol transport (GO:0032376),0.4249764847599119,0.7951177552846186,0.7907303370786517,1.0,1.0,2/3,45.40%,ABCA5;LIPG
2563,prerank,cholesterol transport (GO:0030301),0.4249764847599119,0.7951177552846186,0.7907303370786517,1.0,1.0,2/3,45.40%,ABCA5;LIPG
2564,prerank,reverse cholesterol transport (GO:0043691),0.4249764847599119,0.7951177552846186,0.7907303370786517,1.0,1.0,2/3,45.40%,ABCA5;LIPG
2565,prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.4203848345013533,0.7950092368079633,0.770098730606488,1.0,1.0,1/3,10.10%,PTPRD
2566,prerank,embryonic limb morphogenesis (GO:0030326),0.36180904522613055,0.7949861230817664,0.7633289986996099,1.0,1.0,5/5,64.00%,GLI3;CACNA1C;ECE1;FBXW4;TBX3
2567,prerank,clathrin-dependent endocytosis (GO:0072583),0.4269895913601428,0.7944680131108642,0.797432239657632,1.0,1.0,2/3,43.00%,FNBP1L;INPP5F
2568,prerank,regulation of interleukin-12 production (GO:0032655),-0.39317953861584753,-0.794463536477079,0.745819397993311,0.9598687927461719,1.0,3/3,60.90%,PLCB1;FOXP1;MAST2
2569,prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3596492077511949,0.7941124735184273,0.7663316582914573,1.0,1.0,1/5,12.30%,SH3GL2
2570,prerank,peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.5905905905905906,-0.79403575964717,0.8104166666666667,0.9591658361013,1.0,1/1,41.10%,DPH6
2571,prerank,peptidyl-diphthamide metabolic process (GO:0017182),-0.5905905905905906,-0.79403575964717,0.8104166666666667,0.9591658361013,1.0,1/1,41.10%,DPH6
2572,prerank,triglyceride biosynthetic process (GO:0019432),-0.4749498997995992,-0.7938121527009774,0.7574123989218329,0.9587386443335253,1.0,2/2,52.70%,GK;LPIN1
2573,prerank,negative regulation of cellular protein localization (GO:1903828),-0.6006006006006006,-0.793267854660244,0.8082474226804124,0.9589016268918683,1.0,1/1,40.10%,TTBK2
2574,prerank,cellular macromolecule catabolic process (GO:0044265),-0.46793587174348694,-0.7924961195407714,0.7546666666666667,0.9595445675716158,1.0,2/2,53.40%,ADAMTS9;DNASE1
2575,prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5995995995995996,0.7922430167298017,0.8275862068965517,1.0,1.0,1/1,40.10%,CPEB3
2576,prerank,negative regulation of cytoplasmic translation (GO:2000766),0.5995995995995996,0.7922430167298017,0.8275862068965517,1.0,1.0,1/1,40.10%,CPEB3
2577,prerank,regulation of cytoplasmic translation (GO:2000765),0.5995995995995996,0.7922430167298017,0.8275862068965517,1.0,1.0,1/1,40.10%,CPEB3
2578,prerank,mRNA destabilization (GO:0061157),0.5995995995995996,0.7922430167298017,0.8275862068965517,1.0,1.0,1/1,40.10%,CPEB3
2579,prerank,regulation of mRNA polyadenylation (GO:1900363),0.5995995995995996,0.7922430167298017,0.8275862068965517,1.0,1.0,1/1,40.10%,CPEB3
2580,prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5995995995995996,0.7922430167298017,0.8275862068965517,1.0,1.0,1/1,40.10%,CPEB3
2581,prerank,NAD biosynthetic process (GO:0009435),0.48681795528398064,0.7918595658394397,0.7772357723577236,1.0,1.0,1/2,22.90%,HAAO
2582,prerank,neuromuscular process (GO:0050905),0.5905905905905906,0.790375066513007,0.810379241516966,1.0,1.0,1/1,41.00%,MYCBP2
2583,prerank,error-prone translesion synthesis (GO:0042276),-0.3881644934804413,-0.789710831004392,0.7515527950310559,0.9632069553873848,1.0,3/3,61.40%,REV3L;RFC1;RFC3
2584,prerank,translesion synthesis (GO:0019985),-0.3881644934804413,-0.789710831004392,0.7515527950310559,0.9632069553873848,1.0,3/3,61.40%,REV3L;RFC1;RFC3
2585,prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.5915915915915916,-0.7894089188052164,0.7992125984251969,0.9621010842094863,1.0,1/1,41.00%,RBFOX2
2586,prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5915915915915916,-0.7894089188052164,0.7992125984251969,0.9621010842094863,1.0,1/1,41.00%,RBFOX2
2587,prerank,smooth muscle tissue development (GO:0048745),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2588,prerank,liver development (GO:0001889),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2589,prerank,negative regulation of MAP kinase activity (GO:0043407),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2590,prerank,hepaticobiliary system development (GO:0061008),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2591,prerank,muscle tissue development (GO:0060537),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2592,prerank,regulation of neuroblast proliferation (GO:1902692),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2593,prerank,negative regulation of glial cell differentiation (GO:0045686),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2594,prerank,regulation of glial cell differentiation (GO:0045685),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2595,prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2596,prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2597,prerank,positive regulation of neuron death (GO:1901216),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2598,prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2599,prerank,negative regulation of oligodendrocyte differentiation (GO:0048715),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2600,prerank,Schwann cell differentiation (GO:0014037),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2601,prerank,spinal cord development (GO:0021510),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2602,prerank,negative regulation of neural precursor cell proliferation (GO:2000178),-0.5815815815815816,-0.7892568049042816,0.7996070726915521,0.9500920245817297,1.0,1/1,42.00%,NF1
2603,prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.5845845845845846,-0.7885025053256913,0.8161616161616162,0.9507177438333589,1.0,1/1,41.70%,RCL1
2604,prerank,phospholipid catabolic process (GO:0009395),-0.4539078156312625,-0.7875793930839803,0.7768817204301075,0.9516756389533336,1.0,2/2,54.80%,PLA2G4A;LIPG
2605,prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.24445434102933422,0.78747805523521,0.7769784172661871,1.0,1.0,5/23,19.70%,HMGA2;PPARGC1A;NOS1AP;CALCR;MAGI2
2606,prerank,negative regulation of insulin secretion (GO:0046676),0.5835835835835836,0.7874067985209345,0.7984344422700587,1.0,1.0,1/1,41.70%,IRS1
2607,prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.5835835835835836,0.7874067985209345,0.7984344422700587,1.0,1.0,1/1,41.70%,IRS1
2608,prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.5835835835835836,0.7874067985209345,0.7984344422700587,1.0,1.0,1/1,41.70%,IRS1
2609,prerank,positive regulation of lipid catabolic process (GO:0050996),0.5835835835835836,0.7874067985209345,0.7984344422700587,1.0,1.0,1/1,41.70%,IRS1
2610,prerank,cellular response to fatty acid (GO:0071398),0.5835835835835836,0.7874067985209345,0.7984344422700587,1.0,1.0,1/1,41.70%,IRS1
2611,prerank,positive regulation of fatty acid beta-oxidation (GO:0032000),0.5835835835835836,0.7874067985209345,0.7984344422700587,1.0,1.0,1/1,41.70%,IRS1
2612,prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5835835835835836,0.7874067985209345,0.7984344422700587,1.0,1.0,1/1,41.70%,IRS1
2613,prerank,response to peptide hormone (GO:0043434),0.5835835835835836,0.7874067985209345,0.7984344422700587,1.0,1.0,1/1,41.70%,IRS1
2614,prerank,negative regulation of peptide hormone secretion (GO:0090278),0.5835835835835836,0.7874067985209345,0.7984344422700587,1.0,1.0,1/1,41.70%,IRS1
2615,prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.5835835835835836,0.7874067985209345,0.7984344422700587,1.0,1.0,1/1,41.70%,IRS1
2616,prerank,regulation of mitochondrial membrane potential (GO:0051881),0.47258555668505625,0.7866599726725335,0.7934272300469484,1.0,1.0,1/2,29.80%,BCL2
2617,prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.38353413654618473,0.786432844789513,0.7791164658634538,1.0,1.0,4/4,61.80%,IGF2BP2;CPEB3;SAMD4A;ILF3
2618,prerank,magnesium ion homeostasis (GO:0010960),-0.5925925925925926,-0.7850680612001605,0.8343434343434344,0.955275051896206,1.0,1/1,40.90%,CNNM2
2619,prerank,glycerol metabolic process (GO:0006071),-0.4669338677354709,-0.7849941972250621,0.7789203084832905,0.9547328500102727,1.0,2/2,53.50%,GK;GOT1
2620,prerank,regulation of postsynapse organization (GO:0099175),-0.4629258517034068,-0.7849767013138161,0.77,0.9539964995799259,1.0,2/2,53.90%,TANC2;ABHD17C
2621,prerank,striated muscle contraction (GO:0006941),-0.4609218436873747,-0.7849452510943232,0.7621483375959079,0.9532958704694496,1.0,2/2,54.10%,DTNA;TNNT3
2622,prerank,glycogen metabolic process (GO:0005977),0.421342383952922,0.7848851666728337,0.7834757834757835,1.0,1.0,1/3,13.50%,GYG2
2623,prerank,glycogen biosynthetic process (GO:0005978),0.421342383952922,0.7848851666728337,0.7834757834757835,1.0,1.0,1/3,13.50%,GYG2
2624,prerank,glucan biosynthetic process (GO:0009250),0.421342383952922,0.7848851666728337,0.7834757834757835,1.0,1.0,1/3,13.50%,GYG2
2625,prerank,organophosphate biosynthetic process (GO:0090407),0.37349397590361444,0.7844553702534997,0.7702523240371846,1.0,1.0,4/4,62.80%,MBOAT1;GPHN;GK;LPCAT1
2626,prerank,regulation of adenylate cyclase activity (GO:0045761),0.41925777331995995,0.7843995810481017,0.7937685459940653,1.0,1.0,3/3,58.20%,CAP2;CACNA1C;NF1
2627,prerank,positive regulation of growth (GO:0045927),-0.2984924623115578,-0.7833799819419991,0.746606334841629,0.955102503500522,1.0,5/5,70.40%,INSR;CSNK2A1;PLCB1;EGFR;BCL2
2628,prerank,vesicle organization (GO:0016050),0.5915915915915915,0.783291020583525,0.8212180746561886,1.0,1.0,1/1,40.90%,FNBP1L
2629,prerank,plasma membrane tubulation (GO:0097320),0.5915915915915915,0.783291020583525,0.8212180746561886,1.0,1.0,1/1,40.90%,FNBP1L
2630,prerank,membrane invagination (GO:0010324),0.5915915915915915,0.783291020583525,0.8212180746561886,1.0,1.0,1/1,40.90%,FNBP1L
2631,prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.3881644934804413,-0.7829640279252279,0.7582781456953642,0.9551218297497923,1.0,3/3,61.40%,MNAT1;RFC1;RFC3
2632,prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.3891675025075226,-0.7821549974966402,0.7712418300653595,0.9550226059562739,1.0,3/3,61.30%,UBE2D3;SREBF2;NPEPPS
2633,prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.3891675025075226,-0.7821549974966402,0.7712418300653595,0.9550226059562739,1.0,3/3,61.30%,UBE2D3;SREBF2;NPEPPS
2634,prerank,negative regulation of signal transduction (GO:0009968),0.2381228448079849,0.7819233028568139,0.7793814432989691,1.0,1.0,11/23,46.50%,DCC;GLI3;SEMA6A;KANK1;BCL2;UBASH3B;PTPRE;IRS1;GPC3;EGFR;PRAME
2635,prerank,morphogenesis of an epithelium (GO:0002009),0.4789792903788942,0.7818631053893161,0.8092307692307692,1.0,1.0,1/2,23.70%,LAMA3
2636,prerank,proton transmembrane transport (GO:1902600),-0.4579158316633266,-0.7818390521510434,0.7917737789203085,0.9547838067897536,1.0,2/2,54.40%,NNT;ATP6V0A4
2637,prerank,mesenchymal to epithelial transition (GO:0060231),0.47074237351646697,0.7816361951553575,0.8174342105263158,1.0,1.0,1/2,27.80%,WT1
2638,prerank,kidney mesenchyme development (GO:0072074),0.47074237351646697,0.7816361951553575,0.8174342105263158,1.0,1.0,1/2,27.80%,WT1
2639,prerank,glomerular epithelial cell differentiation (GO:0072311),0.47074237351646697,0.7816361951553575,0.8174342105263158,1.0,1.0,1/2,27.80%,WT1
2640,prerank,regulation of heart growth (GO:0060420),0.47074237351646697,0.7816361951553575,0.8174342105263158,1.0,1.0,1/2,27.80%,WT1
2641,prerank,metanephric mesenchyme development (GO:0072075),0.47074237351646697,0.7816361951553575,0.8174342105263158,1.0,1.0,1/2,27.80%,WT1
2642,prerank,diaphragm development (GO:0060539),0.47074237351646697,0.7816361951553575,0.8174342105263158,1.0,1.0,1/2,27.80%,WT1
2643,prerank,"zygotic determination of anterior/posterior axis, embryo (GO:0007354)",0.47074237351646697,0.7816361951553575,0.8174342105263158,1.0,1.0,1/2,27.80%,WT1
2644,prerank,thorax and anterior abdomen determination (GO:0007356),0.47074237351646697,0.7816361951553575,0.8174342105263158,1.0,1.0,1/2,27.80%,WT1
2645,prerank,renal filtration cell differentiation (GO:0061318),0.47074237351646697,0.7816361951553575,0.8174342105263158,1.0,1.0,1/2,27.80%,WT1
2646,prerank,skeletal muscle organ development (GO:0060538),0.47074237351646697,0.7816361951553575,0.8174342105263158,1.0,1.0,1/2,27.80%,WT1
2647,prerank,protein localization to kinetochore (GO:0034501),0.5935935935935936,0.7815213588427635,0.8522954091816367,1.0,1.0,1/1,40.70%,MTBP
2648,prerank,protein localization to condensed chromosome (GO:1903083),0.5935935935935936,0.7815213588427635,0.8522954091816367,1.0,1.0,1/1,40.70%,MTBP
2649,prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.5935935935935936,0.7815213588427635,0.8522954091816367,1.0,1.0,1/1,40.70%,MTBP
2650,prerank,positive regulation of cytokine production (GO:0001819),0.28673621048339615,0.7812349177895714,0.7598647125140925,1.0,1.0,3/10,20.60%,PDE4B;CADM1;RORA
2651,prerank,acylglycerol catabolic process (GO:0046464),-0.4539078156312625,-0.7812098426908329,0.8365650969529086,0.9552819439245807,1.0,2/2,54.80%,MGLL;LIPG
2652,prerank,positive regulation of DNA replication (GO:0045740),-0.4639278557114228,-0.7809653895338984,0.7527173913043478,0.9549564499788555,1.0,2/2,53.80%,FAF1;EGFR
2653,prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.47766316113837803,0.7799022546742728,0.7973856209150327,1.0,1.0,1/2,32.70%,ZIC1
2654,prerank,negative regulation of cell population proliferation (GO:0008285),0.2372672282173004,0.7798885435740878,0.7823834196891192,1.0,1.0,21/22,74.10%,WNK2;MCC;MAGI2;ADGRB1;WT1;CDK6;DLG5;ROR2;DDAH1;ETS1;MAGED1;NF1;KAT2B;TBX3;PTEN;TNS2;CDK10;CD200;ITGB1BP1;TESC;CXCL1
2655,prerank,membrane assembly (GO:0071709),0.3790447766952896,0.7793179469575341,0.7771883289124668,1.0,1.0,1/4,10.10%,PTPRD
2656,prerank,hemidesmosome assembly (GO:0031581),0.4871596644588728,0.7788233065994016,0.8266666666666667,1.0,1.0,1/2,23.70%,LAMA3
2657,prerank,cell-substrate junction assembly (GO:0007044),0.4871596644588728,0.7788233065994016,0.8266666666666667,1.0,1.0,1/2,23.70%,LAMA3
2658,prerank,synaptic membrane adhesion (GO:0099560),0.41504622419404064,0.7782301807461687,0.7864506627393225,1.0,1.0,1/3,10.10%,PTPRD
2659,prerank,positive regulation of catalytic activity (GO:0043085),-0.44989979959919835,-0.7780225966338136,0.7741116751269036,0.9596381081979035,1.0,2/2,55.20%,BCAS3;WRN
2660,prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.28241206030150756,-0.7776670809025724,0.7584541062801933,0.9595079415033692,1.0,5/5,72.00%,MDM2;TFDP2;CNOT6;PIDD1;ACER2
2661,prerank,regulation of secretion by cell (GO:1903530),0.42142190518154604,0.7776152089165419,0.7939042089985486,1.0,1.0,2/3,45.30%,STXBP5;CPLX1
2662,prerank,peptidyl-amino acid modification (GO:0018193),-0.4519038076152304,-0.7773377555566557,0.783289817232376,0.9593456001320734,1.0,2/2,55.00%,METAP2;FKBP10
2663,prerank,positive regulation of p38MAPK cascade (GO:1900745),0.47882121568893277,0.7772634701945789,0.821917808219178,1.0,1.0,1/2,19.20%,SASH1
2664,prerank,positive regulation of phospholipase C activity (GO:0010863),-0.4639278557114228,-0.776470952640126,0.7572559366754618,0.960293057445,1.0,2/2,53.80%,FGFR1;EGFR
2665,prerank,mRNA metabolic process (GO:0016071),0.3738345645043205,0.7759018084101996,0.7802631578947369,1.0,1.0,1/4,12.20%,PPARGC1A
2666,prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.2984924623115578,-0.7753944937212081,0.7252252252252253,0.9613730962842585,1.0,5/5,70.40%,UBE2D3;SREBF2;TFDP2;NPEPPS;BCL2
2667,prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.4549098196392785,-0.7753606043268216,0.7934508816120907,0.9584185887930011,1.0,2/2,54.70%,DCAKD;SLC25A16
2668,prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.4549098196392785,-0.7753606043268216,0.7934508816120907,0.9584185887930011,1.0,2/2,54.70%,DCAKD;SLC25A16
2669,prerank,coenzyme A metabolic process (GO:0015936),-0.4549098196392785,-0.7753606043268216,0.7934508816120907,0.9584185887930011,1.0,2/2,54.70%,DCAKD;SLC25A16
2670,prerank,coenzyme A biosynthetic process (GO:0015937),-0.4549098196392785,-0.7753606043268216,0.7934508816120907,0.9584185887930011,1.0,2/2,54.70%,DCAKD;SLC25A16
2671,prerank,regulation of neuron projection arborization (GO:0150011),0.5815815815815816,0.7750896241964728,0.8397683397683398,1.0,1.0,1/1,41.90%,MAP3K13
2672,prerank,positive regulation of axon extension (GO:0045773),0.5815815815815816,0.7750896241964728,0.8397683397683398,1.0,1.0,1/1,41.90%,MAP3K13
2673,prerank,positive regulation of neuron projection arborization (GO:0150012),0.5815815815815816,0.7750896241964728,0.8397683397683398,1.0,1.0,1/1,41.90%,MAP3K13
2674,prerank,cytosolic transport (GO:0016482),0.30120857234917797,0.7750520058412385,0.7781609195402299,1.0,1.0,2/8,20.40%,SNX32;RBSN
2675,prerank,axon choice point recognition (GO:0016198),0.47326865722121503,0.7744975072884209,0.8211009174311926,1.0,1.0,1/2,25.20%,ROBO2
2676,prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.5855855855855856,-0.773232041876012,0.8330019880715706,0.9612755131289985,1.0,1/1,41.60%,BPI
2677,prerank,thyroid hormone generation (GO:0006590),-0.5895895895895896,-0.7731353098301493,0.858252427184466,0.960775893971946,1.0,1/1,41.20%,DIO1
2678,prerank,regulation of DNA methylation (GO:0044030),0.4724471203489016,0.7730088010386631,0.8159203980099502,1.0,1.0,1/2,27.80%,WT1
2679,prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.33016746960882526,0.7729306113184856,0.7815230961298377,1.0,1.0,2/6,19.50%,NOS1AP;CTNNA3
2680,prerank,plasma membrane organization (GO:0007009),0.37853895746816923,0.7724096789982529,0.7968337730870713,1.0,1.0,1/4,10.00%,PLSCR2
2681,prerank,dendritic spine organization (GO:0097061),-0.29949748743718596,-0.7721769021270204,0.7565217391304347,0.9617428012512326,1.0,5/5,70.30%,INSR;MTMR2;PTEN;IGF1R;DOCK10
2682,prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.2984924623115578,-0.7720411070099708,0.7813953488372093,0.9612435967085152,1.0,5/5,70.40%,CUL5;FHIT;EPHA2;CASP9;BCL2
2683,prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.3321773335221165,0.771796792559282,0.787765293383271,1.0,1.0,2/6,19.50%,PDE4B;CTNNA3
2684,prerank,cellular response to organic substance (GO:0071310),0.31524936028907613,0.7716304496491391,0.7735849056603774,1.0,1.0,3/7,32.60%,SLIT2;ROBO2;NCOA2
2685,prerank,positive regulation of GTPase activity (GO:0043547),0.2768015330998149,0.7713544891064076,0.7617486338797814,1.0,1.0,6/12,43.30%,RGS7;TIAM1;GRTP1;DOCK10;SGSM3;TBC1D16
2686,prerank,regulation of TORC1 signaling (GO:1903432),0.4662107939692053,0.7712586039656901,0.8104575163398693,1.0,1.0,1/2,22.00%,GPR137C
2687,prerank,positive regulation of protein transport (GO:0051222),-0.37913741223671016,-0.7712001853568115,0.7697160883280757,0.9620282971274137,1.0,3/3,62.30%,BCAS3;FRMD4A;CD2AP
2688,prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.37611532935210523,0.7707402361369132,0.8019257221458047,1.0,1.0,3/4,47.70%,PRKAR2B;NINL;CEP70
2689,prerank,transition metal ion transport (GO:0000041),0.5725725725725725,0.770678923177939,0.8265107212475633,1.0,1.0,1/1,42.80%,TRPC1
2690,prerank,manganese ion transport (GO:0006828),0.5725725725725725,0.770678923177939,0.8265107212475633,1.0,1.0,1/1,42.80%,TRPC1
2691,prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.5725725725725725,0.770678923177939,0.8265107212475633,1.0,1.0,1/1,42.80%,TRPC1
2692,prerank,phenol-containing compound biosynthetic process (GO:0046189),0.5725725725725725,0.770678923177939,0.8265107212475633,1.0,1.0,1/1,42.80%,TRPC1
2693,prerank,regulation of cardiac conduction (GO:1903779),0.5725725725725725,0.770678923177939,0.8265107212475633,1.0,1.0,1/1,42.80%,TRPC1
2694,prerank,melanin biosynthetic process (GO:0042438),0.5725725725725725,0.770678923177939,0.8265107212475633,1.0,1.0,1/1,42.80%,TRPC1
2695,prerank,protein depalmitoylation (GO:0002084),-0.4629258517034068,-0.7704097145680519,0.7720797720797721,0.9610979702953651,1.0,2/2,53.90%,LYPLAL1;ABHD17C
2696,prerank,lipoprotein catabolic process (GO:0042159),-0.4629258517034068,-0.7704097145680519,0.7720797720797721,0.9610979702953651,1.0,2/2,53.90%,LYPLAL1;ABHD17C
2697,prerank,macromolecule depalmitoylation (GO:0098734),-0.4629258517034068,-0.7704097145680519,0.7720797720797721,0.9610979702953651,1.0,2/2,53.90%,LYPLAL1;ABHD17C
2698,prerank,regulation of cell cycle (GO:0051726),0.2383055261085973,0.7695540899211231,0.7721123829344433,1.0,1.0,9/21,42.60%,HMGA2;BRINP1;MECOM;MAGI2;MAP2K6;CDK6;GRK5;CDC14B;UHMK1
2699,prerank,regulation of synapse organization (GO:0050807),-0.4629258517034068,-0.7691102049490619,0.776595744680851,0.9626879290716468,1.0,2/2,53.90%,SETD5;ABHD17C
2700,prerank,protein autoprocessing (GO:0016540),0.5825825825825826,0.768798006457436,0.8565737051792829,1.0,1.0,1/1,41.80%,PIDD1
2701,prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3475567686984292,0.7683986486775612,0.7781954887218046,1.0,1.0,1/5,6.90%,LRRTM3
2702,prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.41186841746028824,0.76834877162794,0.8219971056439942,1.0,1.0,2/3,41.00%,SPTBN4;MYCBP2
2703,prerank,response to gamma radiation (GO:0010332),-0.44989979959919835,-0.7678586969765536,0.816793893129771,0.963292975864113,1.0,2/2,55.20%,MDM2;WRN
2704,prerank,cellular response to gamma radiation (GO:0071480),-0.44989979959919835,-0.7678586969765536,0.816793893129771,0.963292975864113,1.0,2/2,55.20%,MDM2;WRN
2705,prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3691073219658977,-0.7675621558484899,0.79,0.9630736230547302,1.0,3/3,63.30%,TNS2;PTPN9;UBASH3B
2706,prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.2675857462602235,0.7673080999083325,0.7494481236203091,1.0,1.0,7/12,50.30%,ESRRG;PPARGC1A;RORA;NR6A1;TBL1X;TAF4B;NR2C2
2707,prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5745745745745745,0.7668574021325396,0.8721174004192872,1.0,1.0,1/1,42.60%,UHMK1
2708,prerank,positive regulation of translational initiation (GO:0045948),0.5745745745745745,0.7668574021325396,0.8721174004192872,1.0,1.0,1/1,42.60%,UHMK1
2709,prerank,regulation of blood vessel remodeling (GO:0060312),0.5655655655655656,0.7666278460698327,0.8603696098562629,1.0,1.0,1/1,43.50%,FLT4
2710,prerank,positive regulation of protein kinase C signaling (GO:0090037),0.5655655655655656,0.7666278460698327,0.8603696098562629,1.0,1.0,1/1,43.50%,FLT4
2711,prerank,regulation of protein kinase C signaling (GO:0090036),0.5655655655655656,0.7666278460698327,0.8603696098562629,1.0,1.0,1/1,43.50%,FLT4
2712,prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.5655655655655656,0.7666278460698327,0.8603696098562629,1.0,1.0,1/1,43.50%,FLT4
2713,prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.5655655655655656,0.7666278460698327,0.8603696098562629,1.0,1.0,1/1,43.50%,FLT4
2714,prerank,vasculature development (GO:0001944),0.5655655655655656,0.7666278460698327,0.8603696098562629,1.0,1.0,1/1,43.50%,FLT4
2715,prerank,response to UV-A (GO:0070141),-0.4639278557114228,-0.766382336844073,0.7903225806451613,0.9643165186010831,1.0,2/2,53.80%,CCND1;EGFR
2716,prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.47286205064025993,0.7661076883613737,0.835820895522388,1.0,1.0,1/2,30.20%,COG7
2717,prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.4092368148723099,0.765810764696517,0.810126582278481,1.0,1.0,2/3,47.10%,IL34;PTK2
2718,prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.40888185860102694,0.7657596975760252,0.8041666666666667,1.0,1.0,2/3,37.20%,AKT3;RHOJ
2719,prerank,norepinephrine biosynthetic process (GO:0042421),-0.5745745745745746,-0.7657260133401751,0.854043392504931,0.9594714811559891,1.0,1/1,42.70%,HAND2
2720,prerank,adult heart development (GO:0007512),-0.5745745745745746,-0.7657260133401751,0.854043392504931,0.9594714811559891,1.0,1/1,42.70%,HAND2
2721,prerank,negative regulation of cardiac muscle cell apoptotic process (GO:0010667),-0.5745745745745746,-0.7657260133401751,0.854043392504931,0.9594714811559891,1.0,1/1,42.70%,HAND2
2722,prerank,noradrenergic neuron differentiation (GO:0003357),-0.5745745745745746,-0.7657260133401751,0.854043392504931,0.9594714811559891,1.0,1/1,42.70%,HAND2
2723,prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.5745745745745746,-0.7657260133401751,0.854043392504931,0.9594714811559891,1.0,1/1,42.70%,HAND2
2724,prerank,negative regulation of striated muscle cell apoptotic process (GO:0010664),-0.5745745745745746,-0.7657260133401751,0.854043392504931,0.9594714811559891,1.0,1/1,42.70%,HAND2
2725,prerank,positive regulation of DNA binding (GO:0043388),-0.5745745745745746,-0.7657260133401751,0.854043392504931,0.9594714811559891,1.0,1/1,42.70%,HAND2
2726,prerank,thymus development (GO:0048538),-0.5745745745745746,-0.7657260133401751,0.854043392504931,0.9594714811559891,1.0,1/1,42.70%,HAND2
2727,prerank,lipid biosynthetic process (GO:0008610),-0.29145728643216084,-0.7654615516933821,0.7625570776255708,0.9591318861209392,1.0,5/5,71.10%,ACACA;ABCD3;LPCAT1;LIPG;MBOAT1
2728,prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.28859737638748745,0.7653218353395954,0.7957110609480813,1.0,1.0,9/9,71.40%,PLCH1;MUC5AC;IRS1;IGF1R;INPP5F;NF1;PTEN;FGFR1;PLCB1
2729,prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4107105972705249,0.7643660845419074,0.8323615160349854,1.0,1.0,2/3,41.20%,ZNF423;NUP93
2730,prerank,heparin metabolic process (GO:0030202),-0.5715715715715716,-0.7639738643596632,0.8543689320388349,0.9594614862827838,1.0,1/1,43.00%,SLC10A7
2731,prerank,carbohydrate derivative transport (GO:1901264),-0.5715715715715716,-0.7639738643596632,0.8543689320388349,0.9594614862827838,1.0,1/1,43.00%,SLC10A7
2732,prerank,bone development (GO:0060348),-0.5715715715715716,-0.7639738643596632,0.8543689320388349,0.9594614862827838,1.0,1/1,43.00%,SLC10A7
2733,prerank,snRNA transcription by RNA polymerase III (GO:0042796),0.5685685685685684,0.7639373774057098,0.8704061895551257,1.0,1.0,1/1,43.20%,ZC3H8
2734,prerank,T cell homeostasis (GO:0043029),0.5685685685685684,0.7639373774057098,0.8704061895551257,1.0,1.0,1/1,43.20%,ZC3H8
2735,prerank,negative regulation of T cell differentiation in thymus (GO:0033085),0.5685685685685684,0.7639373774057098,0.8704061895551257,1.0,1.0,1/1,43.20%,ZC3H8
2736,prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.5685685685685684,0.7639373774057098,0.8704061895551257,1.0,1.0,1/1,43.20%,ZC3H8
2737,prerank,positive regulation of transcription by RNA polymerase III (GO:0045945),0.5685685685685684,0.7639373774057098,0.8704061895551257,1.0,1.0,1/1,43.20%,ZC3H8
2738,prerank,transcription by RNA polymerase III (GO:0006383),0.5685685685685684,0.7639373774057098,0.8704061895551257,1.0,1.0,1/1,43.20%,ZC3H8
2739,prerank,regulation of thymocyte apoptotic process (GO:0070243),0.5685685685685684,0.7639373774057098,0.8704061895551257,1.0,1.0,1/1,43.20%,ZC3H8
2740,prerank,positive regulation of T cell apoptotic process (GO:0070234),0.5685685685685684,0.7639373774057098,0.8704061895551257,1.0,1.0,1/1,43.20%,ZC3H8
2741,prerank,"DNA-templated transcription, initiation (GO:0006352)",0.25884348296304077,0.7634159627158246,0.7728260869565218,1.0,1.0,8/14,50.30%,ESRRG;PPARGC1A;RORA;NR6A1;TAF1C;TBL1X;TAF4B;NR2C2
2742,prerank,regulation of fibroblast migration (GO:0010762),-0.3801404212637914,-0.7629354718144087,0.8045602605863192,0.9604820327470375,1.0,3/3,62.20%,ITGB1BP1;PTK2;DDR2
2743,prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.2954773869346734,-0.7623246139647969,0.7420814479638009,0.9609227070076143,1.0,5/5,70.70%,TNKS2;NEK7;NVL;RFC3;SMOC2
2744,prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.5755755755755756,-0.7622697628870277,0.8781925343811395,0.9587843430560514,1.0,1/1,42.60%,DDB2
2745,prerank,UV-damage excision repair (GO:0070914),-0.5755755755755756,-0.7622697628870277,0.8781925343811395,0.9587843430560514,1.0,1/1,42.60%,DDB2
2746,prerank,histone H2A monoubiquitination (GO:0035518),-0.5755755755755756,-0.7622697628870277,0.8781925343811395,0.9587843430560514,1.0,1/1,42.60%,DDB2
2747,prerank,phospholipid metabolic process (GO:0006644),-0.29145728643216084,-0.760983480383109,0.7927927927927928,0.9602383146417794,1.0,5/5,71.10%,PIP4K2A;PLA2G4A;LPCAT1;LIPG;MBOAT1
2748,prerank,positive regulation of protein dephosphorylation (GO:0035307),0.46192384769539085,0.7606862189388542,0.8509615384615384,1.0,1.0,2/2,53.90%,MAGI2;CAMTA1
2749,prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.35197674649499006,0.7601709336906416,0.7984395318595578,1.0,1.0,2/5,30.10%,SLC24A2;TRPV4
2750,prerank,regulation of endocytic recycling (GO:2001135),0.5705705705705706,0.7599364155765649,0.8603238866396761,1.0,1.0,1/1,43.00%,INPP5F
2751,prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5705705705705706,0.7599364155765649,0.8603238866396761,1.0,1.0,1/1,43.00%,INPP5F
2752,prerank,negative regulation of neuron projection regeneration (GO:0070571),0.5705705705705706,0.7599364155765649,0.8603238866396761,1.0,1.0,1/1,43.00%,INPP5F
2753,prerank,negative regulation of axon regeneration (GO:0048681),0.5705705705705706,0.7599364155765649,0.8603238866396761,1.0,1.0,1/1,43.00%,INPP5F
2754,prerank,cardiac muscle hypertrophy (GO:0003300),0.5705705705705706,0.7599364155765649,0.8603238866396761,1.0,1.0,1/1,43.00%,INPP5F
2755,prerank,negative regulation of response to wounding (GO:1903035),0.5705705705705706,0.7599364155765649,0.8603238866396761,1.0,1.0,1/1,43.00%,INPP5F
2756,prerank,regulation of axon regeneration (GO:0048679),0.5705705705705706,0.7599364155765649,0.8603238866396761,1.0,1.0,1/1,43.00%,INPP5F
2757,prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5705705705705706,0.7599364155765649,0.8603238866396761,1.0,1.0,1/1,43.00%,INPP5F
2758,prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.5705705705705706,0.7599364155765649,0.8603238866396761,1.0,1.0,1/1,43.00%,INPP5F
2759,prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.5705705705705706,0.7599364155765649,0.8603238866396761,1.0,1.0,1/1,43.00%,INPP5F
2760,prerank,regulation of platelet activation (GO:0010543),-0.4428857715430861,-0.759764934798637,0.8350253807106599,0.961629036259732,1.0,2/2,55.90%,PLA2G4A;PRKCA
2761,prerank,vasculogenesis (GO:0001570),0.4630807468388606,0.7597448883661944,0.835,1.0,1.0,1/2,27.80%,WT1
2762,prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3440106184493046,0.7585249745873391,0.796875,1.0,1.0,3/5,42.10%,SPRED2;SPRED3;IL17RD
2763,prerank,Golgi inheritance (GO:0048313),-0.44388777555110215,-0.7571532682063474,0.8096446700507615,0.9644678331732602,1.0,2/2,55.80%,GBF1;VRK1
2764,prerank,Golgi disassembly (GO:0090166),-0.44388777555110215,-0.7571532682063474,0.8096446700507615,0.9644678331732602,1.0,2/2,55.80%,GBF1;VRK1
2765,prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.5725725725725725,-0.7551905715873235,0.861003861003861,0.9663530349020645,1.0,1/1,42.90%,ENSA
2766,prerank,negative regulation of dephosphorylation (GO:0035305),-0.5725725725725725,-0.7551905715873235,0.861003861003861,0.9663530349020645,1.0,1/1,42.90%,ENSA
2767,prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.30923570041828297,0.7547984533976818,0.8139810426540285,1.0,1.0,4/7,43.50%,SEMA3A;SASH1;MID1;FLT4
2768,prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.323293172690763,-0.7546871812469904,0.796,0.9663031843883547,1.0,4/4,67.90%,RBMX;CELF2;RBFOX2;NOVA1
2769,prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.5595595595595596,-0.7539761055249213,0.8877755511022044,0.9659921531194015,1.0,1/1,44.20%,CDYL
2770,prerank,spermatid development (GO:0007286),-0.5595595595595596,-0.7539761055249213,0.8877755511022044,0.9659921531194015,1.0,1/1,44.20%,CDYL
2771,prerank,negative regulation of glial cell apoptotic process (GO:0034351),-0.4428857715430861,-0.7539231294064139,0.7876543209876543,0.9653507785885101,1.0,2/2,55.90%,GAS6;PRKCA
2772,prerank,regulation of peptide hormone secretion (GO:0090276),0.30870593652464373,0.7536617372682864,0.7822966507177034,1.0,1.0,1/7,3.50%,CACNA1A
2773,prerank,positive regulation of developmental growth (GO:0048639),-0.3253012048192771,-0.7528169518542127,0.7947761194029851,0.9664269031214696,1.0,4/4,67.70%,INSR;PLCB1;MAP3K13;CPNE5
2774,prerank,regulation of mRNA metabolic process (GO:1903311),0.5715715715715716,0.7516657230590734,0.8834745762711864,1.0,1.0,1/1,42.90%,SRPK1
2775,prerank,regulation of mRNA processing (GO:0050684),0.5715715715715716,0.7516657230590734,0.8834745762711864,1.0,1.0,1/1,42.90%,SRPK1
2776,prerank,regulation of RNA splicing (GO:0043484),0.5715715715715716,0.7516657230590734,0.8834745762711864,1.0,1.0,1/1,42.90%,SRPK1
2777,prerank,barbed-end actin filament capping (GO:0051016),-0.5735735735735735,-0.7514733985322228,0.8714285714285714,0.967157455646393,1.0,1/1,42.80%,ADD3
2778,prerank,actin filament capping (GO:0051693),-0.5735735735735735,-0.7514733985322228,0.8714285714285714,0.967157455646393,1.0,1/1,42.80%,ADD3
2779,prerank,protein localization to non-motile cilium (GO:0097499),-0.5705705705705706,-0.7512487150340367,0.8722986247544204,0.9646632413508474,1.0,1/1,43.10%,ARL13B
2780,prerank,neural tube development (GO:0021915),-0.5705705705705706,-0.7512487150340367,0.8722986247544204,0.9646632413508474,1.0,1/1,43.10%,ARL13B
2781,prerank,protein localization to ciliary membrane (GO:1903441),-0.5705705705705706,-0.7512487150340367,0.8722986247544204,0.9646632413508474,1.0,1/1,43.10%,ARL13B
2782,prerank,aggrephagy (GO:0035973),-0.5705705705705706,-0.7512487150340367,0.8722986247544204,0.9646632413508474,1.0,1/1,43.10%,ARL13B
2783,prerank,regulation of receptor internalization (GO:0002090),-0.2894382840890728,-0.7497398662737618,0.7981651376146789,0.9664486233776631,1.0,4/5,28.30%,INSR;MTMR2;ATAD1;TBC1D5
2784,prerank,response to lead ion (GO:0010288),-0.5695695695695696,-0.7496828133641307,0.8580246913580247,0.9650617264888341,1.0,1/1,43.20%,PPP5C
2785,prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.5695695695695696,-0.7496828133641307,0.8580246913580247,0.9650617264888341,1.0,1/1,43.20%,PPP5C
2786,prerank,secretion (GO:0046903),-0.5565565565565566,-0.748808198061299,0.890020366598778,0.9657781324995561,1.0,1/1,44.50%,TPD52
2787,prerank,response to interleukin-1 (GO:0070555),-0.4428857715430861,-0.7485265225933203,0.8503937007874016,0.9654195935493678,1.0,2/2,55.90%,RBMX;PRKCA
2788,prerank,lymphocyte proliferation (GO:0046651),0.44836190748630905,0.7479011913480313,0.8503184713375797,1.0,1.0,1/2,29.80%,BCL2
2789,prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.26797294057104515,0.7476358347925675,0.7933333333333333,1.0,1.0,9/11,62.20%,HECW2;CDH2;BMPER;FLT4;ADGRA2;ETS1;NF1;EPHA2;LRRC4C
2790,prerank,peptidyl-lysine hydroxylation (GO:0017185),-0.5605605605605606,-0.7475710640929825,0.8803088803088803,0.9656617943610509,1.0,1/1,44.10%,PLOD3
2791,prerank,protein hydroxylation (GO:0018126),-0.5605605605605606,-0.7475710640929825,0.8803088803088803,0.9656617943610509,1.0,1/1,44.10%,PLOD3
2792,prerank,positive regulation of DNA repair (GO:0045739),0.317645484240605,0.7475693983205328,0.8062575210589651,1.0,1.0,2/6,24.70%,FMN2;EYA2
2793,prerank,neurotransmitter-gated ion channel clustering (GO:0072578),0.5535535535535536,0.7473962355744828,0.8836734693877552,1.0,1.0,1/1,44.70%,GPHN
2794,prerank,postsynaptic membrane organization (GO:0001941),0.5535535535535536,0.7473962355744828,0.8836734693877552,1.0,1.0,1/1,44.70%,GPHN
2795,prerank,heterocycle biosynthetic process (GO:0018130),0.5535535535535536,0.7473962355744828,0.8836734693877552,1.0,1.0,1/1,44.70%,GPHN
2796,prerank,molybdopterin cofactor biosynthetic process (GO:0032324),0.5535535535535536,0.7473962355744828,0.8836734693877552,1.0,1.0,1/1,44.70%,GPHN
2797,prerank,organic cyclic compound biosynthetic process (GO:1901362),0.5535535535535536,0.7473962355744828,0.8836734693877552,1.0,1.0,1/1,44.70%,GPHN
2798,prerank,regulation of cholesterol efflux (GO:0010874),0.4027178823113864,0.7473436172998986,0.8479776847977685,1.0,1.0,1/3,25.00%,ABCA5
2799,prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.36071479273078527,0.7472223255683225,0.8243064729194187,1.0,1.0,1/4,11.20%,MAP2
2800,prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.38882070030839067,0.7468705096767148,0.8302158273381295,1.0,1.0,2/3,43.50%,RORA;FLT4
2801,prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.38882070030839067,0.7468705096767148,0.8302158273381295,1.0,1.0,2/3,43.50%,RORA;FLT4
2802,prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5575575575575575,0.7466742943014736,0.8598726114649682,1.0,1.0,1/1,44.30%,PRKCA
2803,prerank,regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070),0.5575575575575575,0.7466742943014736,0.8598726114649682,1.0,1.0,1/1,44.30%,PRKCA
2804,prerank,desmosome organization (GO:0002934),0.5575575575575575,0.7466742943014736,0.8598726114649682,1.0,1.0,1/1,44.30%,PRKCA
2805,prerank,regulation of platelet aggregation (GO:0090330),0.5575575575575575,0.7466742943014736,0.8598726114649682,1.0,1.0,1/1,44.30%,PRKCA
2806,prerank,positive regulation of bone resorption (GO:0045780),0.5575575575575575,0.7466742943014736,0.8598726114649682,1.0,1.0,1/1,44.30%,PRKCA
2807,prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.5575575575575575,0.7466742943014736,0.8598726114649682,1.0,1.0,1/1,44.30%,PRKCA
2808,prerank,regulation of glial cell apoptotic process (GO:0034350),0.5575575575575575,0.7466742943014736,0.8598726114649682,1.0,1.0,1/1,44.30%,PRKCA
2809,prerank,gluconeogenesis (GO:0006094),0.36526694051279285,0.74613729741453,0.7926509186351706,1.0,1.0,3/4,50.10%,PPARGC1A;GOT1;SLC25A12
2810,prerank,hexose biosynthetic process (GO:0019319),0.36526694051279285,0.74613729741453,0.7926509186351706,1.0,1.0,3/4,50.10%,PPARGC1A;GOT1;SLC25A12
2811,prerank,glucose metabolic process (GO:0006006),0.36526694051279285,0.74613729741453,0.7926509186351706,1.0,1.0,3/4,50.10%,PPARGC1A;GOT1;SLC25A12
2812,prerank,regulated exocytosis (GO:0045055),0.36504458557368624,0.7457870302132148,0.8308321964529332,1.0,1.0,1/4,14.00%,PCLO
2813,prerank,isoleucine metabolic process (GO:0006549),-0.5545545545545546,-0.7455645616954834,0.8740458015267175,0.9681977094504316,1.0,1/1,44.70%,ACADSB
2814,prerank,response to cholesterol (GO:0070723),-0.4338677354709419,-0.7436759329685698,0.8142857142857143,0.9698408028550944,1.0,2/2,56.80%,CES1;GRAMD1B
2815,prerank,cellular response to cholesterol (GO:0071397),-0.4338677354709419,-0.7436759329685698,0.8142857142857143,0.9698408028550944,1.0,2/2,56.80%,CES1;GRAMD1B
2816,prerank,regulation of macroautophagy (GO:0016241),0.31881855478610965,0.7433472552980149,0.8081180811808119,1.0,1.0,1/6,9.10%,SNX32
2817,prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.39518555667001,0.7429506755994074,0.8352112676056338,1.0,1.0,3/3,60.60%,BCL2;CASP9;EPHA2
2818,prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2896819474532689,0.7426673949044905,0.7942857142857143,1.0,1.0,3/8,35.00%,POLE;CDK14;CDK6
2819,prerank,Rho protein signal transduction (GO:0007266),-0.31224899598393574,-0.7425525025760319,0.7872340425531915,0.9711138773564802,1.0,4/4,69.00%,ARHGEF3;CTNNAL1;RHOJ;EPS8L2
2820,prerank,import into nucleus (GO:0051170),0.33939047317767446,0.7412449814039108,0.8177215189873418,1.0,1.0,3/5,47.80%,BACH2;NUP93;IPO8
2821,prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.5555555555555556,-0.7411396174340114,0.8939096267190569,0.9684030481053174,1.0,1/1,44.60%,ETS1
2822,prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.5555555555555556,-0.7411396174340114,0.8939096267190569,0.9684030481053174,1.0,1/1,44.60%,ETS1
2823,prerank,PML body organization (GO:0030578),-0.5555555555555556,-0.7411396174340114,0.8939096267190569,0.9684030481053174,1.0,1/1,44.60%,ETS1
2824,prerank,nuclear body organization (GO:0030575),-0.5555555555555556,-0.7411396174340114,0.8939096267190569,0.9684030481053174,1.0,1/1,44.60%,ETS1
2825,prerank,positive regulation of inflammatory response (GO:0050729),-0.5555555555555556,-0.7411396174340114,0.8939096267190569,0.9684030481053174,1.0,1/1,44.60%,ETS1
2826,prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.5555555555555556,-0.7411396174340114,0.8939096267190569,0.9684030481053174,1.0,1/1,44.60%,ETS1
2827,prerank,positive regulation of cellular component movement (GO:0051272),-0.5555555555555556,-0.7411396174340114,0.8939096267190569,0.9684030481053174,1.0,1/1,44.60%,ETS1
2828,prerank,central nervous system neuron axonogenesis (GO:0021955),0.39323192211055275,0.7403722278960051,0.8345323741007195,1.0,1.0,2/3,41.00%,SPTBN4;MYCBP2
2829,prerank,regulation of endothelial cell migration (GO:0010594),0.24022558053541207,0.7395878812628436,0.8048523206751055,1.0,1.0,16/17,73.90%,SLIT2;SASH1;BMPER;ADGRB1;SMOC2;RHOJ;FLT4;PRKCA;PTK2;ETS1;NF1;EPHA2;FOXP1;FOXC2;ITGB1BP1;ADAMTS9
2830,prerank,regulation of water loss via skin (GO:0033561),-0.5585585585585585,-0.7389039087562759,0.8928571428571429,0.9696257891851835,1.0,1/1,44.30%,CLDN1
2831,prerank,establishment of skin barrier (GO:0061436),-0.5585585585585585,-0.7389039087562759,0.8928571428571429,0.9696257891851835,1.0,1/1,44.30%,CLDN1
2832,prerank,positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),-0.5585585585585585,-0.7389039087562759,0.8928571428571429,0.9696257891851835,1.0,1/1,44.30%,CLDN1
2833,prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.4318637274549098,-0.7386120348569071,0.8328611898016998,0.9686798177366825,1.0,2/2,57.00%,POU2F1;ZC3H8
2834,prerank,snRNA transcription (GO:0009301),-0.4318637274549098,-0.7386120348569071,0.8328611898016998,0.9686798177366825,1.0,2/2,57.00%,POU2F1;ZC3H8
2835,prerank,smoothened signaling pathway (GO:0007224),0.4002006018054163,0.7384306608742733,0.8498583569405099,1.0,1.0,3/3,60.10%,GLI3;ARL13B;TTBK2
2836,prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.44488977955911835,0.7381578320484042,0.8552845528455284,1.0,1.0,2/2,55.60%,WT1;ETS1
2837,prerank,extracellular matrix assembly (GO:0085029),-0.3132530120481927,-0.7378499078263999,0.8326693227091634,0.9691350792695002,1.0,4/4,68.90%,GAS6;EMILIN1;NTN4;PXDN
2838,prerank,positive regulation of transport (GO:0051050),0.3601765181885077,0.7373642643619632,0.8183041722745625,1.0,1.0,1/4,14.40%,CAMK1D
2839,prerank,anterior/posterior pattern specification (GO:0009952),0.3595212854316433,0.7366652750238802,0.8221024258760108,1.0,1.0,3/4,51.80%,WT1;HOXB3;WLS
2840,prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5505505505505505,0.7366225786436849,0.8877551020408163,1.0,1.0,1/1,45.00%,WRN
2841,prerank,t-circle formation (GO:0090656),0.5505505505505505,0.7366225786436849,0.8877551020408163,1.0,1.0,1/1,45.00%,WRN
2842,prerank,DNA unwinding involved in DNA replication (GO:0006268),0.5505505505505505,0.7366225786436849,0.8877551020408163,1.0,1.0,1/1,45.00%,WRN
2843,prerank,telomere organization (GO:0032200),0.5505505505505505,0.7366225786436849,0.8877551020408163,1.0,1.0,1/1,45.00%,WRN
2844,prerank,telomeric loop disassembly (GO:0090657),0.5505505505505505,0.7366225786436849,0.8877551020408163,1.0,1.0,1/1,45.00%,WRN
2845,prerank,protein localization to nucleolus (GO:1902570),0.5505505505505505,0.7366225786436849,0.8877551020408163,1.0,1.0,1/1,45.00%,WRN
2846,prerank,telomeric D-loop disassembly (GO:0061820),0.5505505505505505,0.7366225786436849,0.8877551020408163,1.0,1.0,1/1,45.00%,WRN
2847,prerank,telomere maintenance via telomere trimming (GO:0090737),0.5505505505505505,0.7366225786436849,0.8877551020408163,1.0,1.0,1/1,45.00%,WRN
2848,prerank,G-quadruplex DNA unwinding (GO:0044806),0.5505505505505505,0.7366225786436849,0.8877551020408163,1.0,1.0,1/1,45.00%,WRN
2849,prerank,response to UV-C (GO:0010225),0.5505505505505505,0.7366225786436849,0.8877551020408163,1.0,1.0,1/1,45.00%,WRN
2850,prerank,DNA recombination (GO:0006310),0.5505505505505505,0.7366225786436849,0.8877551020408163,1.0,1.0,1/1,45.00%,WRN
2851,prerank,supramolecular fiber organization (GO:0097435),0.21068669514208932,0.7363984993540189,0.8499496475327291,1.0,1.0,13/35,38.00%,COL25A1;SHROOM3;COL22A1;HIP1;COL8A1;LAMA3;ADAMTS3;TRPV4;PXDN;KATNAL2;COL5A3;CD2AP;DDR2
2852,prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.14387755102040817,-0.7359983106018121,0.8064516129032258,0.9712919324391592,1.0,20/20,86.00%,UBE2D3;ANKIB1;ANAPC16;BTRC;ATE1;FAF1;MDM2;FBXO22;MIB1;UBXN2A;FBXW4;HACE1;USP33;PRAME;TBL1X;ZNRF3;TOM1L1;TRIM2;USP44;HECW2
2853,prerank,alpha-amino acid catabolic process (GO:1901606),0.44589178356713427,0.7359726016379743,0.8644338118022329,1.0,1.0,2/2,55.50%,HAAO;ACADSB
2854,prerank,glycerophospholipid catabolic process (GO:0046475),-0.42985971943887774,-0.7358621025897876,0.8217054263565892,0.9708837733595078,1.0,2/2,57.20%,PLA2G4A;INPP5F
2855,prerank,positive regulation of ligase activity (GO:0051351),-0.5475475475475475,-0.73581004089653,0.89738430583501,0.9702253321113355,1.0,1/1,45.40%,GCLM
2856,prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.4428857715430863,0.735744393479963,0.871499176276771,1.0,1.0,2/2,55.80%,ACSF2;ACBD6
2857,prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.4428857715430863,0.735744393479963,0.871499176276771,1.0,1.0,2/2,55.80%,ACSF2;ACBD6
2858,prerank,cellular amide metabolic process (GO:0043603),0.4428857715430863,0.735744393479963,0.871499176276771,1.0,1.0,2/2,55.80%,ACSF2;ACBD6
2859,prerank,cerebral cortex neuron differentiation (GO:0021895),0.5555555555555556,0.7355235221195447,0.8958333333333334,1.0,1.0,1/1,44.50%,TOX
2860,prerank,regulation of neural precursor cell proliferation (GO:2000177),0.5555555555555556,0.7355235221195447,0.8958333333333334,1.0,1.0,1/1,44.50%,TOX
2861,prerank,regulation of DNA demethylation (GO:1901535),0.5555555555555556,0.7355235221195447,0.8958333333333334,1.0,1.0,1/1,44.50%,TOX
2862,prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.5555555555555556,0.7355235221195447,0.8958333333333334,1.0,1.0,1/1,44.50%,TOX
2863,prerank,positive regulation of DNA demethylation (GO:1901537),0.5555555555555556,0.7355235221195447,0.8958333333333334,1.0,1.0,1/1,44.50%,TOX
2864,prerank,organic cation transport (GO:0015695),-0.5505505505505506,-0.7351926464499965,0.8785425101214575,0.9697613274981131,1.0,1/1,45.10%,SLC44A2
2865,prerank,choline transport (GO:0015871),-0.5505505505505506,-0.7351926464499965,0.8785425101214575,0.9697613274981131,1.0,1/1,45.10%,SLC44A2
2866,prerank,nucleosome organization (GO:0034728),-0.43587174348697394,-0.7346832929202478,0.847769028871391,0.9690440777509264,1.0,2/2,56.60%,NAP1L4;KAT6B
2867,prerank,nucleosome assembly (GO:0006334),-0.43587174348697394,-0.7346832929202478,0.847769028871391,0.9690440777509264,1.0,2/2,56.60%,NAP1L4;KAT6B
2868,prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.27893114955381054,0.7340846686884093,0.8168028004667445,1.0,1.0,5/9,47.70%,HECW2;PRKAR2B;NINL;CDC14B;CEP70
2869,prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3150152173206506,0.7337577930042434,0.823086574654956,1.0,1.0,2/6,24.10%,FLRT2;SPRED2
2870,prerank,protein stabilization (GO:0050821),0.30259370387930107,0.7337006658755725,0.8259833134684148,1.0,1.0,5/7,52.80%,PPARGC1A;HIP1;COG7;TBL1X;USP33
2871,prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3357057611684928,0.7326321638940148,0.8152866242038217,1.0,1.0,2/5,29.80%,EYA2;BCL2
2872,prerank,maintenance of synapse structure (GO:0099558),-0.5485485485485485,-0.7325946509766293,0.907258064516129,0.9716532021388892,1.0,1/1,45.30%,CBLN2
2873,prerank,embryonic skeletal system development (GO:0048706),0.5585585585585586,0.7324017319479802,0.908203125,1.0,1.0,1/1,44.20%,HOXB3
2874,prerank,embryonic skeletal system morphogenesis (GO:0048704),0.5585585585585586,0.7324017319479802,0.908203125,1.0,1.0,1/1,44.20%,HOXB3
2875,prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.34939759036144585,0.7322197359879512,0.8245614035087719,1.0,1.0,4/4,65.20%,PRKAR2B;PRKAR1B;NF1;PTEN
2876,prerank,cellular response to growth factor stimulus (GO:0071363),0.29354736531415215,0.7304663300738512,0.8353221957040573,1.0,1.0,4/7,46.40%,MAGI2;SEMA6A;FLT4;EGFR
2877,prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3940286519713351,0.730431153269761,0.8396501457725948,1.0,1.0,1/3,20.80%,LIMCH1
2878,prerank,positive regulation of stress fiber assembly (GO:0051496),0.3940286519713351,0.730431153269761,0.8396501457725948,1.0,1.0,1/3,20.80%,LIMCH1
2879,prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3927083009128306,0.7287707095371392,0.8533145275035261,1.0,1.0,2/3,47.10%,MYO10;PTK2
2880,prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3927083009128306,0.7287707095371392,0.8533145275035261,1.0,1.0,2/3,47.10%,MYO10;PTK2
2881,prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3927083009128306,0.7287707095371392,0.8533145275035261,1.0,1.0,2/3,47.10%,MYO10;PTK2
2882,prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.25443696201541965,0.7286283178323237,0.8251900108577633,1.0,1.0,8/13,51.80%,WNK2;KANK1;TBL1X;CAPRIN2;GPC3;ADGRA2;EGFR;WLS
2883,prerank,inhibitory synapse assembly (GO:1904862),-0.5425425425425425,-0.7284187277311277,0.9050387596899225,0.975502929419468,1.0,1/1,45.90%,FGF13
2884,prerank,regulation of voltage-gated sodium channel activity (GO:1905150),-0.5425425425425425,-0.7284187277311277,0.9050387596899225,0.975502929419468,1.0,1/1,45.90%,FGF13
2885,prerank,cerebral cortex cell migration (GO:0021795),-0.5425425425425425,-0.7284187277311277,0.9050387596899225,0.975502929419468,1.0,1/1,45.90%,FGF13
2886,prerank,telencephalon cell migration (GO:0022029),-0.5425425425425425,-0.7284187277311277,0.9050387596899225,0.975502929419468,1.0,1/1,45.90%,FGF13
2887,prerank,regulation of muscle contraction (GO:0006937),0.5395395395395395,0.7269332960048679,0.9181636726546906,1.0,1.0,1/1,46.10%,TNNT3
2888,prerank,positive regulation of ATPase activity (GO:0032781),0.5395395395395395,0.7269332960048679,0.9181636726546906,1.0,1.0,1/1,46.10%,TNNT3
2889,prerank,skeletal muscle contraction (GO:0003009),0.5395395395395395,0.7269332960048679,0.9181636726546906,1.0,1.0,1/1,46.10%,TNNT3
2890,prerank,regulation of striated muscle contraction (GO:0006942),0.5395395395395395,0.7269332960048679,0.9181636726546906,1.0,1.0,1/1,46.10%,TNNT3
2891,prerank,muscle filament sliding (GO:0030049),0.5395395395395395,0.7269332960048679,0.9181636726546906,1.0,1.0,1/1,46.10%,TNNT3
2892,prerank,actin-myosin filament sliding (GO:0033275),0.5395395395395395,0.7269332960048679,0.9181636726546906,1.0,1.0,1/1,46.10%,TNNT3
2893,prerank,JNK cascade (GO:0007254),-0.4188376753507014,-0.7268087796946976,0.8545454545454545,0.9773257049010998,1.0,2/2,58.30%,MAP2K4;MAP3K13
2894,prerank,regulation of cell communication (GO:0010646),-0.3510531594784353,-0.7267875383889816,0.8745762711864407,0.9766287439162218,1.0,3/3,65.10%,CAMK2D;MGLL;GRK5
2895,prerank,purine ribonucleoside monophosphate catabolic process (GO:0009169),0.5445445445445445,0.7266511500400459,0.9154929577464789,1.0,1.0,1/1,45.60%,PRTFDC1
2896,prerank,purine ribonucleotide catabolic process (GO:0009154),0.5445445445445445,0.7266511500400459,0.9154929577464789,1.0,1.0,1/1,45.60%,PRTFDC1
2897,prerank,signal transduction by p53 class mediator (GO:0072331),0.44303903399865674,0.7257730496077457,0.8675496688741722,1.0,1.0,1/2,28.20%,ACER2
2898,prerank,RNA transport (GO:0050658),0.3929549180231773,0.7255612209793848,0.8463687150837989,1.0,1.0,1/3,20.20%,KIF5C
2899,prerank,calcium ion homeostasis (GO:0055074),0.3296238985097657,0.7252512177475601,0.8268229166666666,1.0,1.0,2/5,30.10%,SLC24A2;TRPV4
2900,prerank,regulation of intracellular protein transport (GO:0033157),-0.4258517034068136,-0.7250958061792276,0.8197969543147208,0.978659401824874,1.0,2/2,57.60%,BCAS3;UHMK1
2901,prerank,transferrin transport (GO:0033572),0.5425425425425425,0.7249984829576785,0.9230769230769231,1.0,1.0,1/1,45.80%,ATP6V0A4
2902,prerank,regulation of pH (GO:0006885),0.5425425425425425,0.7249984829576785,0.9230769230769231,1.0,1.0,1/1,45.80%,ATP6V0A4
2903,prerank,phagosome acidification (GO:0090383),0.5425425425425425,0.7249984829576785,0.9230769230769231,1.0,1.0,1/1,45.80%,ATP6V0A4
2904,prerank,phagosome maturation (GO:0090382),0.5425425425425425,0.7249984829576785,0.9230769230769231,1.0,1.0,1/1,45.80%,ATP6V0A4
2905,prerank,vacuolar acidification (GO:0007035),0.5425425425425425,0.7249984829576785,0.9230769230769231,1.0,1.0,1/1,45.80%,ATP6V0A4
2906,prerank,intracellular pH reduction (GO:0051452),0.5425425425425425,0.7249984829576785,0.9230769230769231,1.0,1.0,1/1,45.80%,ATP6V0A4
2907,prerank,triglyceride catabolic process (GO:0019433),0.5465465465465466,0.7245126789718823,0.892,1.0,1.0,1/1,45.40%,LIPG
2908,prerank,positive regulation of sterol transport (GO:0032373),0.5465465465465466,0.7245126789718823,0.892,1.0,1.0,1/1,45.40%,LIPG
2909,prerank,positive regulation of lipoprotein particle clearance (GO:0010986),0.5465465465465466,0.7245126789718823,0.892,1.0,1.0,1/1,45.40%,LIPG
2910,prerank,organophosphate catabolic process (GO:0046434),0.5465465465465466,0.7245126789718823,0.892,1.0,1.0,1/1,45.40%,LIPG
2911,prerank,phospholipid homeostasis (GO:0055091),0.5465465465465466,0.7245126789718823,0.892,1.0,1.0,1/1,45.40%,LIPG
2912,prerank,positive regulation of viral process (GO:0048524),-0.4288577154308617,-0.7242348740223572,0.8398950131233596,0.9785604918486658,1.0,2/2,57.30%,PKN2;SRPK1
2913,prerank,positive regulation of viral genome replication (GO:0045070),-0.4288577154308617,-0.7242348740223572,0.8398950131233596,0.9785604918486658,1.0,2/2,57.30%,PKN2;SRPK1
2914,prerank,nephric duct morphogenesis (GO:0072178),0.5415415415415415,0.7240634727975653,0.937246963562753,1.0,1.0,1/1,45.90%,GPC3
2915,prerank,gastrulation (GO:0007369),0.5415415415415415,0.7240634727975653,0.937246963562753,1.0,1.0,1/1,45.90%,GPC3
2916,prerank,coronary vasculature development (GO:0060976),0.5415415415415415,0.7240634727975653,0.937246963562753,1.0,1.0,1/1,45.90%,GPC3
2917,prerank,cell migration involved in gastrulation (GO:0042074),0.5415415415415415,0.7240634727975653,0.937246963562753,1.0,1.0,1/1,45.90%,GPC3
2918,prerank,mesonephric duct development (GO:0072177),0.5415415415415415,0.7240634727975653,0.937246963562753,1.0,1.0,1/1,45.90%,GPC3
2919,prerank,lipid homeostasis (GO:0055088),-0.35807422266800404,-0.7212779269532574,0.8064516129032258,0.9824613590541413,1.0,3/3,64.40%,ZBTB20;LIPG;ACOX3
2920,prerank,regulation of neurotransmitter secretion (GO:0046928),0.5475475475475475,0.7207989909621132,0.9122055674518201,1.0,1.0,1/1,45.30%,CPLX1
2921,prerank,regulation of neurotransmitter transport (GO:0051588),0.5475475475475475,0.7207989909621132,0.9122055674518201,1.0,1.0,1/1,45.30%,CPLX1
2922,prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5385385385385385,-0.7205357142857152,0.9036144578313253,0.98080847122673,1.0,1/1,46.30%,CAMTA1
2923,prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5385385385385385,-0.7205357142857152,0.9036144578313253,0.98080847122673,1.0,1/1,46.30%,CAMTA1
2924,prerank,positive regulation of dephosphorylation (GO:0035306),-0.5385385385385385,-0.7205357142857152,0.9036144578313253,0.98080847122673,1.0,1/1,46.30%,CAMTA1
2925,prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.5385385385385385,-0.7205357142857152,0.9036144578313253,0.98080847122673,1.0,1/1,46.30%,CAMTA1
2926,prerank,muscle contraction (GO:0006936),0.38272741928397036,0.7205112251304692,0.8421052631578947,1.0,1.0,2/3,46.10%,GNAO1;TNNT3
2927,prerank,regulation of protein modification process (GO:0031399),-0.2416918429003021,-0.7200644315468355,0.8727272727272727,0.9807395662829972,1.0,7/7,76.10%,SPRED1;PUM3;PARG;KAT2B;PTK2;SPRED3;SPRED2
2928,prerank,microtubule depolymerization (GO:0007019),-0.5345345345345345,-0.7183712162724935,0.9287169042769857,0.9826339348676543,1.0,1/1,46.70%,NCKAP5
2929,prerank,negative regulation of protein secretion (GO:0050709),-0.4168336673346693,-0.7180861106366148,0.8619791666666666,0.9824130346854495,1.0,2/2,58.50%,CD200;IRS1
2930,prerank,hippo signaling (GO:0035329),0.5305305305305306,0.7180187341384385,0.9259259259259259,1.0,1.0,1/1,47.00%,AMOT
2931,prerank,regulation of protein localization (GO:0032880),0.32556043581556077,0.7172384321608937,0.8339622641509434,1.0,1.0,2/5,31.40%,MAP2;DZIP1L
2932,prerank,phospholipid transport (GO:0015914),0.43705404277439347,0.7157194443357295,0.8820678513731826,1.0,1.0,1/2,29.40%,PITPNC1
2933,prerank,GDP-mannose metabolic process (GO:0019673),-0.5355355355355356,-0.7155315354774123,0.9337231968810916,0.9855668487295356,1.0,1/1,46.60%,GMDS
2934,prerank,aspartate metabolic process (GO:0006531),0.5335335335335336,0.7153185054037109,0.9302325581395349,1.0,1.0,1/1,46.70%,GOT1
2935,prerank,aspartate family amino acid catabolic process (GO:0009068),0.5335335335335336,0.7153185054037109,0.9302325581395349,1.0,1.0,1/1,46.70%,GOT1
2936,prerank,glycerol biosynthetic process (GO:0006114),0.5335335335335336,0.7153185054037109,0.9302325581395349,1.0,1.0,1/1,46.70%,GOT1
2937,prerank,aspartate family amino acid biosynthetic process (GO:0009067),0.5335335335335336,0.7153185054037109,0.9302325581395349,1.0,1.0,1/1,46.70%,GOT1
2938,prerank,dicarboxylic acid catabolic process (GO:0043649),0.5335335335335336,0.7153185054037109,0.9302325581395349,1.0,1.0,1/1,46.70%,GOT1
2939,prerank,2-oxoglutarate metabolic process (GO:0006103),0.5335335335335336,0.7153185054037109,0.9302325581395349,1.0,1.0,1/1,46.70%,GOT1
2940,prerank,endothelial cell migration (GO:0043542),0.5405405405405405,0.7150499475630034,0.924,1.0,1.0,1/1,46.00%,ADGRA2
2941,prerank,release of cytochrome c from mitochondria (GO:0001836),0.42730537686147424,0.7146866200367098,0.8752025931928687,1.0,1.0,1/2,29.80%,BCL2
2942,prerank,apoptotic mitochondrial changes (GO:0008637),0.42730537686147424,0.7146866200367098,0.8752025931928687,1.0,1.0,1/2,29.80%,BCL2
2943,prerank,mitochondrion organization (GO:0007005),0.32654737171457576,0.714441049574197,0.8413705583756346,1.0,1.0,2/5,34.30%,PPARGC1A;AKT3
2944,prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.4168336673346693,-0.7142792593328934,0.8789473684210526,0.9867959236282668,1.0,2/2,58.50%,CES1;IRS1
2945,prerank,mitochondrial translational termination (GO:0070126),-0.34804413239719156,-0.7135121338973247,0.8562091503267973,0.9844670130363145,1.0,3/3,65.40%,DAP3;MRPS21;MRPS25
2946,prerank,translational termination (GO:0006415),-0.34804413239719156,-0.7135121338973247,0.8562091503267973,0.9844670130363145,1.0,3/3,65.40%,DAP3;MRPS21;MRPS25
2947,prerank,mitochondrial translation (GO:0032543),-0.34804413239719156,-0.7135121338973247,0.8562091503267973,0.9844670130363145,1.0,3/3,65.40%,DAP3;MRPS21;MRPS25
2948,prerank,mitochondrial translational elongation (GO:0070125),-0.34804413239719156,-0.7135121338973247,0.8562091503267973,0.9844670130363145,1.0,3/3,65.40%,DAP3;MRPS21;MRPS25
2949,prerank,translational elongation (GO:0006414),-0.34804413239719156,-0.7135121338973247,0.8562091503267973,0.9844670130363145,1.0,3/3,65.40%,DAP3;MRPS21;MRPS25
2950,prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.4218436873747495,-0.7132917117077358,0.8619791666666666,0.9833395679489907,1.0,2/2,58.00%,INSR;IGF1R
2951,prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.4218436873747495,-0.7132917117077358,0.8619791666666666,0.9833395679489907,1.0,2/2,58.00%,INSR;IGF1R
2952,prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.35005015045135407,-0.7131427054999,0.8571428571428571,0.9815439288251224,1.0,3/3,65.20%,DLG1;PTEN;CDK6
2953,prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.35005015045135407,-0.7131427054999,0.8571428571428571,0.9815439288251224,1.0,3/3,65.20%,DLG1;PTEN;CDK6
2954,prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.35005015045135407,-0.7131427054999,0.8571428571428571,0.9815439288251224,1.0,3/3,65.20%,DLG1;PTEN;CDK6
2955,prerank,regulation of protein export from nucleus (GO:0046825),-0.4258517034068136,-0.7131148598939046,0.841025641025641,0.9808594736746626,1.0,2/2,57.60%,GAS6;UHMK1
2956,prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.4168336673346693,-0.7123449444275382,0.8620689655172413,0.980548842089509,1.0,2/2,58.50%,BRWD1;IRS1
2957,prerank,cellular response to interleukin-7 (GO:0098761),-0.4168336673346693,-0.7123449444275382,0.8620689655172413,0.980548842089509,1.0,2/2,58.50%,BRWD1;IRS1
2958,prerank,DNA catabolic process (GO:0006308),0.5325325325325325,0.7122884242519523,0.9432485322896281,1.0,1.0,1/1,46.80%,DNASE1
2959,prerank,regulation of leukocyte mediated cytotoxicity (GO:0001910),0.5325325325325325,0.7122884242519523,0.9432485322896281,1.0,1.0,1/1,46.80%,DNASE1
2960,prerank,regulation of myeloid leukocyte mediated immunity (GO:0002886),0.5325325325325325,0.7122884242519523,0.9432485322896281,1.0,1.0,1/1,46.80%,DNASE1
2961,prerank,neutrophil activation (GO:0042119),0.5325325325325325,0.7122884242519523,0.9432485322896281,1.0,1.0,1/1,46.80%,DNASE1
2962,prerank,myeloid cell activation involved in immune response (GO:0002275),0.5325325325325325,0.7122884242519523,0.9432485322896281,1.0,1.0,1/1,46.80%,DNASE1
2963,prerank,nucleobase-containing compound catabolic process (GO:0034655),0.5325325325325325,0.7122884242519523,0.9432485322896281,1.0,1.0,1/1,46.80%,DNASE1
2964,prerank,regulation of acute inflammatory response (GO:0002673),0.5325325325325325,0.7122884242519523,0.9432485322896281,1.0,1.0,1/1,46.80%,DNASE1
2965,prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.5325325325325325,-0.7112033770766512,0.9321357285429142,0.9765402345584593,1.0,1/1,46.90%,AK3
2966,prerank,nucleoside triphosphate biosynthetic process (GO:0009142),-0.5325325325325325,-0.7112033770766512,0.9321357285429142,0.9765402345584593,1.0,1/1,46.90%,AK3
2967,prerank,GTP metabolic process (GO:0046039),-0.5325325325325325,-0.7112033770766512,0.9321357285429142,0.9765402345584593,1.0,1/1,46.90%,AK3
2968,prerank,pyrimidine ribonucleotide metabolic process (GO:0009218),-0.5325325325325325,-0.7112033770766512,0.9321357285429142,0.9765402345584593,1.0,1/1,46.90%,AK3
2969,prerank,AMP metabolic process (GO:0046033),-0.5325325325325325,-0.7112033770766512,0.9321357285429142,0.9765402345584593,1.0,1/1,46.90%,AK3
2970,prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.5325325325325325,-0.7112033770766512,0.9321357285429142,0.9765402345584593,1.0,1/1,46.90%,AK3
2971,prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.5325325325325325,-0.7112033770766512,0.9321357285429142,0.9765402345584593,1.0,1/1,46.90%,AK3
2972,prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.5325325325325325,-0.7112033770766512,0.9321357285429142,0.9765402345584593,1.0,1/1,46.90%,AK3
2973,prerank,regulation of erythrocyte differentiation (GO:0045646),-0.35005015045135407,-0.7108386340204009,0.8422818791946308,0.9764219345175731,1.0,3/3,65.20%,ARNT;ETS1;CDK6
2974,prerank,regulation of translational initiation (GO:0006446),-0.4258517034068136,-0.7107397750915168,0.8372703412073491,0.9758379282890247,1.0,2/2,57.60%,AGO2;UHMK1
2975,prerank,mitochondrial transport (GO:0006839),0.3679046893188841,0.7094886056199756,0.8589928057553957,1.0,1.0,2/3,45.50%,BCL2;SLC25A16
2976,prerank,nucleic acid-templated transcription (GO:0097659),0.43086172344689383,0.7094879911283846,0.8809523809523809,1.0,1.0,2/2,57.00%,DTX1;PPP5C
2977,prerank,cellular response to cadmium ion (GO:0071276),0.5365365365365365,0.7094436014715042,0.9402061855670103,1.0,1.0,1/1,46.40%,EGFR
2978,prerank,positive regulation of phosphate metabolic process (GO:0045937),0.5365365365365365,0.7094436014715042,0.9402061855670103,1.0,1.0,1/1,46.40%,EGFR
2979,prerank,positive regulation of RNA metabolic process (GO:0051254),0.5365365365365365,0.7094436014715042,0.9402061855670103,1.0,1.0,1/1,46.40%,EGFR
2980,prerank,regulation of ERBB signaling pathway (GO:1901184),0.5365365365365365,0.7094436014715042,0.9402061855670103,1.0,1.0,1/1,46.40%,EGFR
2981,prerank,response to reactive oxygen species (GO:0000302),0.5365365365365365,0.7094436014715042,0.9402061855670103,1.0,1.0,1/1,46.40%,EGFR
2982,prerank,activation of phospholipase C activity (GO:0007202),0.5365365365365365,0.7094436014715042,0.9402061855670103,1.0,1.0,1/1,46.40%,EGFR
2983,prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5365365365365365,0.7094436014715042,0.9402061855670103,1.0,1.0,1/1,46.40%,EGFR
2984,prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5365365365365365,0.7094436014715042,0.9402061855670103,1.0,1.0,1/1,46.40%,EGFR
2985,prerank,protein insertion into membrane (GO:0051205),0.5365365365365365,0.7094436014715042,0.9402061855670103,1.0,1.0,1/1,46.40%,EGFR
2986,prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5365365365365365,0.7094436014715042,0.9402061855670103,1.0,1.0,1/1,46.40%,EGFR
2987,prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.5365365365365365,0.7094436014715042,0.9402061855670103,1.0,1.0,1/1,46.40%,EGFR
2988,prerank,cellular response to reactive oxygen species (GO:0034614),0.5365365365365365,0.7094436014715042,0.9402061855670103,1.0,1.0,1/1,46.40%,EGFR
2989,prerank,regulation of protein kinase C activity (GO:1900019),0.5365365365365365,0.7094436014715042,0.9402061855670103,1.0,1.0,1/1,46.40%,EGFR
2990,prerank,negative regulation of cardiocyte differentiation (GO:1905208),0.5365365365365365,0.7094436014715042,0.9402061855670103,1.0,1.0,1/1,46.40%,EGFR
2991,prerank,positive regulation of protein kinase C activity (GO:1900020),0.5365365365365365,0.7094436014715042,0.9402061855670103,1.0,1.0,1/1,46.40%,EGFR
2992,prerank,negative regulation of retinoic acid receptor signaling pathway (GO:0048387),0.5355355355355355,0.7088430600360303,0.9367588932806324,1.0,1.0,1/1,46.50%,PRAME
2993,prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.30044389164842733,0.7074157129007322,0.8718274111675127,1.0,1.0,3/6,41.70%,KANK1;PTPRE;IRS1
2994,prerank,regulation of wound healing (GO:0061041),0.3435047112243938,0.7047678211709886,0.8772845953002611,1.0,1.0,3/4,55.90%,KANK1;PTK2;CLDN1
2995,prerank,positive regulation of response to wounding (GO:1903036),0.3435047112243938,0.7047678211709886,0.8772845953002611,1.0,1.0,3/4,55.90%,KANK1;PTK2;CLDN1
2996,prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.41182364729458915,-0.7046977203406267,0.8740359897172236,0.9838400039805651,1.0,2/2,59.00%,BMPR1A;NUP93
2997,prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.41182364729458915,-0.7046977203406267,0.8740359897172236,0.9838400039805651,1.0,2/2,59.00%,BMPR1A;NUP93
2998,prerank,negative regulation of protein kinase B signaling (GO:0051898),0.3443775100401607,0.7037441374079736,0.8552631578947368,1.0,1.0,4/4,65.70%,MAGI2;EPHA2;PTEN;PHLPP1
2999,prerank,placenta development (GO:0001890),0.5295295295295295,0.7033499403979576,0.9406130268199234,1.0,1.0,1/1,47.10%,PTK2
3000,prerank,cellular response to growth hormone stimulus (GO:0071378),0.5295295295295295,0.7033499403979576,0.9406130268199234,1.0,1.0,1/1,47.10%,PTK2
3001,prerank,growth hormone receptor signaling pathway (GO:0060396),0.5295295295295295,0.7033499403979576,0.9406130268199234,1.0,1.0,1/1,47.10%,PTK2
3002,prerank,lipid modification (GO:0030258),0.4318637274549098,0.7025444088889478,0.900163666121113,1.0,1.0,2/2,56.90%,MBOAT1;MBOAT2
3003,prerank,response to fatty acid (GO:0070542),0.43086172344689383,0.7021217208487253,0.9156050955414012,1.0,1.0,2/2,57.00%,IRS1;PPP5C
3004,prerank,positive regulation of endothelial cell migration (GO:0010595),0.25318320161876884,0.7015324646430515,0.8653846153846154,1.0,1.0,10/11,70.70%,SASH1;SMOC2;AKT3;FLT4;PRKCA;ETS1;FOXP1;FGFR1;FOXC2;ITGB1BP1
3005,prerank,astrocyte development (GO:0014002),0.4188376753507015,0.700805745459926,0.9046849757673667,1.0,1.0,2/2,58.20%,CDK6;NF1
3006,prerank,glial cell development (GO:0021782),0.4188376753507015,0.700805745459926,0.9046849757673667,1.0,1.0,2/2,58.20%,CDK6;NF1
3007,prerank,regulation of microtubule depolymerization (GO:0031114),-0.3012048192771084,-0.698946518031273,0.8806584362139918,0.9916249660823552,1.0,4/4,70.10%,CAMSAP2;TTBK2;FGF13;TRPV4
3008,prerank,galactose catabolic process (GO:0019388),-0.5255255255255256,-0.6988790924700484,0.9440993788819876,0.9867819664345595,1.0,1/1,47.60%,PGM2L1
3009,prerank,galactose metabolic process (GO:0006012),-0.5255255255255256,-0.6988790924700484,0.9440993788819876,0.9867819664345595,1.0,1/1,47.60%,PGM2L1
3010,prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.5255255255255256,-0.6988790924700484,0.9440993788819876,0.9867819664345595,1.0,1/1,47.60%,PGM2L1
3011,prerank,glycogen catabolic process (GO:0005980),-0.5255255255255256,-0.6988790924700484,0.9440993788819876,0.9867819664345595,1.0,1/1,47.60%,PGM2L1
3012,prerank,glucan catabolic process (GO:0009251),-0.5255255255255256,-0.6988790924700484,0.9440993788819876,0.9867819664345595,1.0,1/1,47.60%,PGM2L1
3013,prerank,cellular polysaccharide catabolic process (GO:0044247),-0.5255255255255256,-0.6988790924700484,0.9440993788819876,0.9867819664345595,1.0,1/1,47.60%,PGM2L1
3014,prerank,hexose catabolic process (GO:0019320),-0.5255255255255256,-0.6988790924700484,0.9440993788819876,0.9867819664345595,1.0,1/1,47.60%,PGM2L1
3015,prerank,positive regulation of gene expression (GO:0010628),0.2121797060547294,0.6987319478265767,0.878323108384458,1.0,1.0,5/26,17.50%,HMGA2;PPARGC1A;NOS1AP;CADM1;CALCR
3016,prerank,cellular protein localization (GO:0034613),0.22878282024823055,0.6983835407551461,0.8590956887486856,1.0,1.0,10/18,51.80%,GRID2;CNTNAP2;GRTP1;COG7;SGSM3;TBC1D16;EGFR;AMOT;SEC23IP;WLS
3017,prerank,protein K48-linked deubiquitination (GO:0071108),-0.5275275275275275,-0.698099814493763,0.9601593625498008,0.9864609172803083,1.0,1/1,47.40%,USP33
3018,prerank,protein K63-linked deubiquitination (GO:0070536),-0.5275275275275275,-0.698099814493763,0.9601593625498008,0.9864609172803083,1.0,1/1,47.40%,USP33
3019,prerank,positive regulation of glucose import (GO:0046326),-0.4168336673346693,-0.697956626588742,0.8644501278772379,0.9825450875976663,1.0,2/2,58.50%,INSR;IRS1
3020,prerank,regulation of glucose import (GO:0046324),-0.4168336673346693,-0.697956626588742,0.8644501278772379,0.9825450875976663,1.0,2/2,58.50%,INSR;IRS1
3021,prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4168336673346693,-0.697956626588742,0.8644501278772379,0.9825450875976663,1.0,2/2,58.50%,INSR;IRS1
3022,prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4168336673346693,-0.697956626588742,0.8644501278772379,0.9825450875976663,1.0,2/2,58.50%,INSR;IRS1
3023,prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4168336673346693,-0.697956626588742,0.8644501278772379,0.9825450875976663,1.0,2/2,58.50%,INSR;IRS1
3024,prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.4168336673346693,-0.697956626588742,0.8644501278772379,0.9825450875976663,1.0,2/2,58.50%,INSR;IRS1
3025,prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.5245245245245245,0.6973677258993329,0.9527410207939508,1.0,1.0,1/1,47.60%,GCNT2
3026,prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5245245245245245,0.6973677258993329,0.9527410207939508,1.0,1.0,1/1,47.60%,GCNT2
3027,prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3776768954975322,0.69696359501927,0.8837209302325582,1.0,1.0,2/3,42.80%,UBASH3B;TRPC1
3028,prerank,metal ion homeostasis (GO:0055065),0.313633749473327,0.6968324168355046,0.8668373879641486,1.0,1.0,2/5,28.10%,CLDN16;SCNN1B
3029,prerank,positive regulation of response to external stimulus (GO:0032103),0.33835341365461863,0.6966863752226395,0.8688741721854305,1.0,1.0,4/4,66.30%,SASH1;PRKCA;ETS1;OPTN
3030,prerank,Notch signaling pathway (GO:0007219),0.2809667673716013,0.696161570817198,0.865315852205006,1.0,1.0,7/7,72.10%,ZNF423;DTX1;PBX1;GMDS;KAT2B;MIB1;NOTCH2
3031,prerank,cellular response to UV (GO:0034644),0.4248496993987977,0.6959708162598824,0.8953488372093024,1.0,1.0,2/2,57.60%,CASP9;DDB2
3032,prerank,monocarboxylic acid catabolic process (GO:0072329),0.5255255255255256,0.695668986852282,0.9571984435797666,1.0,1.0,1/1,47.50%,LPIN1
3033,prerank,cytokine-mediated signaling pathway (GO:0019221),0.2228965224941939,0.6956492246987913,0.8562434417628542,1.0,1.0,7/17,41.70%,GREM2;LRP8;RORA;BCL2;IL34;MID1;IRS1
3034,prerank,positive regulation of lyase activity (GO:0051349),0.4188376753507015,0.6954138088201554,0.8954248366013072,1.0,1.0,2/2,58.20%,CACNA1C;NF1
3035,prerank,positive regulation of adenylate cyclase activity (GO:0045762),0.4188376753507015,0.6954138088201554,0.8954248366013072,1.0,1.0,2/2,58.20%,CACNA1C;NF1
3036,prerank,positive regulation of cyclase activity (GO:0031281),0.4188376753507015,0.6954138088201554,0.8954248366013072,1.0,1.0,2/2,58.20%,CACNA1C;NF1
3037,prerank,pore complex assembly (GO:0046931),-0.41182364729458915,-0.6950540084691017,0.8620689655172413,0.9846912418109292,1.0,2/2,59.00%,AHCTF1;NUP93
3038,prerank,nuclear pore organization (GO:0006999),-0.41182364729458915,-0.6950540084691017,0.8620689655172413,0.9846912418109292,1.0,2/2,59.00%,AHCTF1;NUP93
3039,prerank,nuclear pore complex assembly (GO:0051292),-0.41182364729458915,-0.6950540084691017,0.8620689655172413,0.9846912418109292,1.0,2/2,59.00%,AHCTF1;NUP93
3040,prerank,endocrine system development (GO:0035270),0.4188376753507014,0.6944922785443117,0.9081967213114754,1.0,1.0,2/2,58.20%,WT1;NF1
3041,prerank,adrenal gland development (GO:0030325),0.4188376753507014,0.6944922785443117,0.9081967213114754,1.0,1.0,2/2,58.20%,WT1;NF1
3042,prerank,unsaturated fatty acid metabolic process (GO:0033559),0.37174740998417155,0.6938666592669683,0.8969957081545065,1.0,1.0,1/3,18.40%,ELOVL2
3043,prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.41182364729458915,-0.6924473155112071,0.861878453038674,0.9877917315998287,1.0,2/2,59.00%,THOC2;NUP93
3044,prerank,histone H3-K9 methylation (GO:0051567),0.5125125125125125,0.6918990021477974,0.967680608365019,1.0,1.0,1/1,48.80%,PRDM5
3045,prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.36571396186127814,0.6918470821514112,0.8973214285714286,1.0,1.0,2/3,43.50%,SEMA6A;FLT4
3046,prerank,RNA metabolic process (GO:0016070),0.28364603536567884,0.6911425200291127,0.8642857142857143,1.0,1.0,3/7,34.70%,DHX8;NOVA1;ATXN1
3047,prerank,ncRNA export from nucleus (GO:0097064),-0.41182364729458915,-0.6909468209459007,0.8880208333333334,0.9844800056706557,1.0,2/2,59.00%,NUP58;NUP93
3048,prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.41182364729458915,-0.6909468209459007,0.8880208333333334,0.9844800056706557,1.0,2/2,59.00%,NUP58;NUP93
3049,prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.41182364729458915,-0.6909468209459007,0.8880208333333334,0.9844800056706557,1.0,2/2,59.00%,NUP58;NUP93
3050,prerank,tRNA export from nucleus (GO:0006409),-0.41182364729458915,-0.6909468209459007,0.8880208333333334,0.9844800056706557,1.0,2/2,59.00%,NUP58;NUP93
3051,prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.41182364729458915,-0.6909468209459007,0.8880208333333334,0.9844800056706557,1.0,2/2,59.00%,NUP58;NUP93
3052,prerank,tRNA transport (GO:0051031),-0.41182364729458915,-0.6909468209459007,0.8880208333333334,0.9844800056706557,1.0,2/2,59.00%,NUP58;NUP93
3053,prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.41182364729458915,-0.6909468209459007,0.8880208333333334,0.9844800056706557,1.0,2/2,59.00%,NUP58;NUP93
3054,prerank,regulation of ATP metabolic process (GO:1903578),-0.41182364729458915,-0.6909468209459007,0.8880208333333334,0.9844800056706557,1.0,2/2,59.00%,NUP58;NUP93
3055,prerank,response to unfolded protein (GO:0006986),-0.34002006018054165,-0.6909034553439388,0.8906752411575563,0.9838183017904258,1.0,3/3,66.20%,TM7SF3;OPTN;HSPA4L
3056,prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5085085085085085,-0.6906228495661368,0.9794238683127572,0.9793352295321993,1.0,1/1,49.30%,DDAH1
3057,prerank,arginine metabolic process (GO:0006525),-0.5085085085085085,-0.6906228495661368,0.9794238683127572,0.9793352295321993,1.0,1/1,49.30%,DDAH1
3058,prerank,negative regulation of cellular response to hypoxia (GO:1900038),-0.5085085085085085,-0.6906228495661368,0.9794238683127572,0.9793352295321993,1.0,1/1,49.30%,DDAH1
3059,prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5085085085085085,-0.6906228495661368,0.9794238683127572,0.9793352295321993,1.0,1/1,49.30%,DDAH1
3060,prerank,glutamine family amino acid catabolic process (GO:0009065),-0.5085085085085085,-0.6906228495661368,0.9794238683127572,0.9793352295321993,1.0,1/1,49.30%,DDAH1
3061,prerank,regulation of cellular response to hypoxia (GO:1900037),-0.5085085085085085,-0.6906228495661368,0.9794238683127572,0.9793352295321993,1.0,1/1,49.30%,DDAH1
3062,prerank,citrulline metabolic process (GO:0000052),-0.5085085085085085,-0.6906228495661368,0.9794238683127572,0.9793352295321993,1.0,1/1,49.30%,DDAH1
3063,prerank,establishment of protein localization to extracellular region (GO:0035592),-0.5165165165165165,-0.6902329737329674,0.9567779960707269,0.9778230180542825,1.0,1/1,48.50%,OLFM2
3064,prerank,positive regulation of smooth muscle cell differentiation (GO:0051152),-0.5165165165165165,-0.6902329737329674,0.9567779960707269,0.9778230180542825,1.0,1/1,48.50%,OLFM2
3065,prerank,regulation of smooth muscle cell differentiation (GO:0051150),-0.5165165165165165,-0.6902329737329674,0.9567779960707269,0.9778230180542825,1.0,1/1,48.50%,OLFM2
3066,prerank,serine transport (GO:0032329),0.5155155155155153,0.6889763244263286,0.943089430894309,1.0,1.0,1/1,48.50%,SFXN1
3067,prerank,outflow tract septum morphogenesis (GO:0003148),-0.28913945174640304,-0.6887120583478352,0.9063829787234042,0.9794821107112366,1.0,3/4,25.70%,ROBO1;SEMA3C;BMPR1A
3068,prerank,purine-containing compound salvage (GO:0043101),0.5175175175175175,0.6886700705081442,0.9592233009708738,1.0,1.0,1/1,48.30%,GMPR
3069,prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.5175175175175175,0.6886700705081442,0.9592233009708738,1.0,1.0,1/1,48.30%,GMPR
3070,prerank,purine-containing compound biosynthetic process (GO:0072522),0.5175175175175175,0.6886700705081442,0.9592233009708738,1.0,1.0,1/1,48.30%,GMPR
3071,prerank,regulation of digestive system process (GO:0044058),0.5145145145145145,0.6882183446340391,0.984,1.0,1.0,1/1,48.60%,EPB41
3072,prerank,positive regulation of protein localization to cell cortex (GO:1904778),0.5145145145145145,0.6882183446340391,0.984,1.0,1.0,1/1,48.60%,EPB41
3073,prerank,regulation of protein localization to cell cortex (GO:1904776),0.5145145145145145,0.6882183446340391,0.984,1.0,1.0,1/1,48.60%,EPB41
3074,prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.31261386409299374,0.6880110884863668,0.8836915297092288,1.0,1.0,4/5,61.80%,IGF2BP2;CPEB3;SAMD4A;ILF3
3075,prerank,positive regulation of catabolic process (GO:0009896),0.336544727683455,0.6877916913912367,0.885752688172043,1.0,1.0,3/4,55.00%,HECW2;GPC3;HACE1
3076,prerank,membrane lipid metabolic process (GO:0006643),-0.5215215215215215,-0.6866639948572155,0.9591836734693877,0.9816824711232267,1.0,1/1,48.00%,TEX2
3077,prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.414883660579855,0.686366339273629,0.9180064308681672,1.0,1.0,1/2,29.80%,BCL2
3078,prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.4098196392785571,-0.6863106396598234,0.8937329700272479,0.9807910484922544,1.0,2/2,59.20%,PRICKLE1;MYCBP2
3079,prerank,positive regulation of protein ubiquitination (GO:0031398),-0.4098196392785571,-0.6863106396598234,0.8937329700272479,0.9807910484922544,1.0,2/2,59.20%,PRICKLE1;MYCBP2
3080,prerank,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.5145145145145145,-0.6850612905854602,0.9783037475345168,0.9811152424838655,1.0,1/1,48.70%,DPY19L3
3081,prerank,protein C-linked glycosylation via tryptophan (GO:0018317),-0.5145145145145145,-0.6850612905854602,0.9783037475345168,0.9811152424838655,1.0,1/1,48.70%,DPY19L3
3082,prerank,B cell activation (GO:0042113),0.3640922768304914,0.6850353894007101,0.9090909090909091,1.0,1.0,3/3,63.70%,BCL2;TPD52;HDAC5
3083,prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.2941425406187048,0.6847081859042194,0.8795031055900621,1.0,1.0,2/6,28.20%,SEMA3E;ACER2
3084,prerank,defense response to symbiont (GO:0140546),0.4095570022622386,0.683460975376071,0.9059011164274322,1.0,1.0,1/2,29.80%,BCL2
3085,prerank,neuron apoptotic process (GO:0051402),0.4095570022622386,0.683460975376071,0.9059011164274322,1.0,1.0,1/2,29.80%,BCL2
3086,prerank,defense response to virus (GO:0051607),0.4095570022622386,0.683460975376071,0.9059011164274322,1.0,1.0,1/2,29.80%,BCL2
3087,prerank,organonitrogen compound biosynthetic process (GO:1901566),0.23117835484175212,0.6822475135759795,0.8656554712892741,1.0,1.0,13/14,73.70%,ELOVL2;ELOVL7;ACER2;ELOVL6;CHKA;GPHN;LPIN1;SLC44A2;LPCAT1;CERS6;PLA2G4A;CSNK1G2;SGMS1
3088,prerank,epithelial cell migration (GO:0010631),0.36969974278905426,0.682055680474577,0.8934659090909091,1.0,1.0,2/3,46.00%,KANK1;ADGRA2
3089,prerank,regulation of cellular protein localization (GO:1903827),0.2886034666210101,0.680832598530614,0.8765432098765432,1.0,1.0,3/6,45.90%,MAP2;GPC4;GPC3
3090,prerank,nuclear envelope organization (GO:0006998),-0.41182364729458915,-0.6806971475646173,0.8911917098445595,0.9864199916452921,1.0,2/2,59.00%,REEP3;NUP93
3091,prerank,nucleus organization (GO:0006997),-0.41182364729458915,-0.6806971475646173,0.8911917098445595,0.9864199916452921,1.0,2/2,59.00%,REEP3;NUP93
3092,prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.1953693656241457,0.6804800684320278,0.893037336024218,1.0,1.0,7/36,20.60%,ESRRG;HMGA2;PPARGC1A;ZNF423;MECOM;GLI3;RORA
3093,prerank,sodium ion homeostasis (GO:0055078),0.4178110812051448,0.6801681952391607,0.9155844155844156,1.0,1.0,1/2,28.10%,SCNN1B
3094,prerank,myelination in peripheral nervous system (GO:0022011),0.4188376753507014,0.67941577521994,0.9006514657980456,1.0,1.0,2/2,58.20%,PARD3;NF1
3095,prerank,peripheral nervous system axon ensheathment (GO:0032292),0.4188376753507014,0.67941577521994,0.9006514657980456,1.0,1.0,2/2,58.20%,PARD3;NF1
3096,prerank,Schwann cell development (GO:0014044),0.4188376753507014,0.67941577521994,0.9006514657980456,1.0,1.0,2/2,58.20%,PARD3;NF1
3097,prerank,myelination (GO:0042552),0.4188376753507014,0.67941577521994,0.9006514657980456,1.0,1.0,2/2,58.20%,PARD3;NF1
3098,prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.3079037391951174,0.6792823037973955,0.8770806658130602,1.0,1.0,2/5,29.80%,EYA2;BCL2
3099,prerank,regulation of gene expression (GO:0010468),0.1856530660639071,0.6791042561984191,0.9179179179179179,1.0,1.0,31/54,58.10%,ESRRG;HMGA2;ZNF536;IGF2BP2;PPARGC1A;SH3GL2;NOS1AP;ZNF423;CALCR;RORA;WT1;TCF7L1;NOVA1;NCOA2;BNC2;ATXN1;CDK6;ZNF462;KAT6B;GCNT2;PRDM5;NR2C2;ZNF37A;TNRC6B;ZNF219;ZNF678;GCFC2;ETS1;FOXN3;HAND2;MAGED1
3100,prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.3596140599977187,0.6778136132148179,0.9065693430656935,1.0,1.0,1/3,20.30%,SEMA6A
3101,prerank,organic substance transport (GO:0071702),-0.25025125628140704,-0.6776746570699518,0.8863636363636364,0.990040492602069,1.0,5/5,75.20%,ATP8A1;ABCD3;ABCA10;CHKA;ABCA5
3102,prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.40577743619647516,0.6775555759426491,0.9158576051779935,1.0,1.0,1/2,29.80%,BCL2
3103,prerank,protein targeting (GO:0006605),-0.2831325301204819,-0.6771740080881478,0.8917748917748918,0.989950548128845,1.0,4/4,71.90%,MFF;CHM;AP1M2;PARD3
3104,prerank,proteolysis (GO:0006508),0.22827313503551566,0.6769411946727161,0.8619201725997843,1.0,1.0,4/14,25.90%,MMP16;MMP17;LRP8;ADAMTS3
3105,prerank,negative regulation of cellular catabolic process (GO:0031330),0.40827959557042065,0.6766782465448039,0.9345335515548282,1.0,1.0,1/2,29.80%,BCL2
3106,prerank,protein heterooligomerization (GO:0051291),0.5135135135135136,0.6764713797464942,0.9693877551020408,1.0,1.0,1/1,48.70%,TMEM120B
3107,prerank,valine metabolic process (GO:0006573),-0.5075075075075075,-0.6762197387158685,0.9922630560928434,0.9905745904907955,1.0,1/1,49.40%,HIBCH
3108,prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.2066532258064516,-0.6755474674197699,0.8843537414965986,0.9907063400840667,1.0,8/8,79.60%,PELI2;TLE1;OPTN;PPP5C;SLC44A2;WLS;PIDD1;RORA
3109,prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.29393234114407374,0.675488316443579,0.9095354523227384,1.0,1.0,5/6,60.60%,WNK3;EGFR;EPB41;PTPN9;EPHA2
3110,prerank,dephosphorylation (GO:0016311),0.22717440843447273,0.6754288642572487,0.8569915254237288,1.0,1.0,2/14,10.10%,PTPRN2;PTPRD
3111,prerank,regulation of cytoplasmic translational elongation (GO:1900247),0.40981963927855725,0.6751404882923399,0.9208074534161491,1.0,1.0,2/2,59.10%,CPEB3;DPH6
3112,prerank,regulation of T cell proliferation (GO:0042129),-0.39979959919839675,-0.6747483067109443,0.9015544041450777,0.9912139427668333,1.0,2/2,60.20%,SLC7A1;DLG5
3113,prerank,organonitrogen compound catabolic process (GO:1901565),-0.3887775551102204,-0.6746287375652023,0.9234972677595629,0.9906593433707479,1.0,2/2,61.30%,PLA2G4A;NPEPPS
3114,prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.39078156312625245,-0.6743808099850481,0.9147869674185464,0.9881826533334649,1.0,2/2,61.10%,CAMK2D;CACNA1C
3115,prerank,cardiac muscle cell contraction (GO:0086003),-0.39078156312625245,-0.6743808099850481,0.9147869674185464,0.9881826533334649,1.0,2/2,61.10%,CAMK2D;CACNA1C
3116,prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.39078156312625245,-0.6743808099850481,0.9147869674185464,0.9881826533334649,1.0,2/2,61.10%,CAMK2D;CACNA1C
3117,prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.39078156312625245,-0.6743808099850481,0.9147869674185464,0.9881826533334649,1.0,2/2,61.10%,CAMK2D;CACNA1C
3118,prerank,embryonic digit morphogenesis (GO:0042733),0.36108324974924777,0.6737401914437634,0.9109195402298851,1.0,1.0,3/3,64.00%,GLI3;ECE1;TBX3
3119,prerank,cytosolic calcium ion transport (GO:0060401),-0.39078156312625245,-0.6733584084832559,0.9238845144356955,0.9889215668711682,1.0,2/2,61.10%,MICU1;CACNA1C
3120,prerank,pattern recognition receptor signaling pathway (GO:0002221),0.5035035035035035,0.6729096989966549,0.9940944881889764,1.0,1.0,1/1,49.70%,TLR5
3121,prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5035035035035035,0.6729096989966549,0.9940944881889764,1.0,1.0,1/1,49.70%,TLR5
3122,prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5035035035035035,0.6729096989966549,0.9940944881889764,1.0,1.0,1/1,49.70%,TLR5
3123,prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.5035035035035035,0.6729096989966549,0.9940944881889764,1.0,1.0,1/1,49.70%,TLR5
3124,prerank,positive regulation of interleukin-8 production (GO:0032757),0.5035035035035035,0.6729096989966549,0.9940944881889764,1.0,1.0,1/1,49.70%,TLR5
3125,prerank,establishment of protein localization to membrane (GO:0090150),-0.2831325301204819,-0.6718409135276749,0.8879668049792531,0.9900353611025521,1.0,4/4,71.90%,RAB3GAP2;CHM;EGFR;PARD3
3126,prerank,hemostasis (GO:0007599),0.5115115115115115,0.6715281630548694,0.9850746268656716,1.0,1.0,1/1,48.90%,FLI1
3127,prerank,bicellular tight junction assembly (GO:0070830),0.30916892776169247,0.6714063576861787,0.8915510718789408,1.0,1.0,2/5,28.30%,CLDN16;PARD3
3128,prerank,tight junction assembly (GO:0120192),0.30916892776169247,0.6714063576861787,0.8915510718789408,1.0,1.0,2/5,28.30%,CLDN16;PARD3
3129,prerank,regulation of protein secretion (GO:0050708),0.24436466610830795,0.6711804038710587,0.8671875,1.0,1.0,7/11,57.30%,CACNA1A;STXBP5;CD2AP;CACNA1C;PRKCA;FRMD4A;ENSA
3130,prerank,genitalia development (GO:0048806),0.36108324974924777,0.6710632523086102,0.9186046511627907,1.0,1.0,3/3,64.00%,WT1;CHD7;TBX3
3131,prerank,aspartate transmembrane transport (GO:0015810),-0.5005005005005005,-0.6704266427547836,1.0,0.9903508299420426,1.0,1/1,50.10%,SLC25A12
3132,prerank,C4-dicarboxylate transport (GO:0015740),-0.5005005005005005,-0.6704266427547836,1.0,0.9903508299420426,1.0,1/1,50.10%,SLC25A12
3133,prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.18806423812359996,0.6702882929213939,0.921765295887663,1.0,1.0,29/42,65.80%,HMGA2;ZNF536;ZNF20;KCTD1;TENM2;GLI3;FOXP2;ETV5;ZNF248;BCL11A;WT1;ATXN1;NR6A1;MEIS2;CPEB3;TBL1X;PRDM5;NR2C2;MXI1;ZNF219;ZNF25;ZNF529;TRPS1;MTA3;NFIX;HDAC5;TBX3;GATAD2B;FOXP1
3134,prerank,forelimb morphogenesis (GO:0035136),-0.39078156312625245,-0.6693382990225942,0.91,0.9902922265858529,1.0,2/2,61.10%,TBX3;CACNA1C
3135,prerank,embryonic forelimb morphogenesis (GO:0035115),-0.39078156312625245,-0.6693382990225942,0.91,0.9902922265858529,1.0,2/2,61.10%,TBX3;CACNA1C
3136,prerank,positive regulation of intracellular transport (GO:0032388),0.4077985075559322,0.6685944733167053,0.9112903225806451,1.0,1.0,1/2,33.50%,PGAP1
3137,prerank,response to organophosphorus (GO:0046683),-0.38777555110220435,-0.6685245541785774,0.93646408839779,0.9903560171991694,1.0,2/2,61.40%,VGF;RFC3
3138,prerank,limb morphogenesis (GO:0035108),0.36108324974924777,0.6680393725712531,0.9005763688760807,1.0,1.0,3/3,64.00%,GLI3;FBXW4;TBX3
3139,prerank,endothelial cell proliferation (GO:0001935),0.3534429767729953,0.6676273490134306,0.9125188536953243,1.0,1.0,1/3,20.50%,BMPER
3140,prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.40109786426212685,0.6668208451538421,0.925686591276252,1.0,1.0,1/2,29.80%,BCL2
3141,prerank,negative regulation of cellular process (GO:0048523),0.195006633920066,0.6658240821261967,0.8915906788247214,1.0,1.0,24/27,75.50%,WNK2;SLIT2;BRINP1;MAGI2;ADGRB1;WT1;BCL2;CDK6;DLG5;CAPRIN2;PRAME;ROR2;DDAH1;WFDC1;ETS1;KAT2B;PTEN;TNS2;CDK10;CD200;ITGB1BP1;TESC;CXCL1;CRLF3
3142,prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.2867203219315895,0.6648934952651131,0.8786764705882353,1.0,1.0,6/6,71.50%,ACER2;PTK2;EPHA2;FOXC2;ITGB1BP1;TESC
3143,prerank,positive regulation of signal transduction (GO:0009967),0.20834323284202128,0.6642863594909542,0.8842975206611571,1.0,1.0,9/20,44.30%,SASH1;KANK1;LMO3;ADAMTS3;SMOC2;EVC;DLG5;IRS1;PRKCA
3144,prerank,positive regulation of lipid storage (GO:0010884),-0.3957915831663326,-0.6639158619336772,0.9098143236074271,0.9937509002674125,1.0,2/2,60.60%,SREBF2;OSBPL11
3145,prerank,nucleotide-excision repair (GO:0006289),0.27016060976618334,0.6635279466397098,0.8960573476702509,1.0,1.0,1/7,6.00%,POLE
3146,prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.2026868672536204,0.6623069029738596,0.8791878172588833,1.0,1.0,13/24,51.80%,WNK2;MCC;GLI3;KANK1;CDK14;ZNRF3;TBL1X;CAPRIN2;GPC3;ADGRA2;EGFR;BICC1;WLS
3147,prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3259779338014042,-0.6622765942950232,0.9018987341772152,0.9941615729155985,1.0,3/3,67.60%,PIAS2;FOXP1;NCOA2
3148,prerank,positive regulation of hydrolase activity (GO:0051345),0.26180338091659383,0.6620476331733428,0.8997668997668997,1.0,1.0,4/8,45.00%,RGS7;DOCK10;SGSM3;WRN
3149,prerank,regulation of biomineral tissue development (GO:0070167),0.40696820860750593,0.6598614071452836,0.9369817578772802,1.0,1.0,1/2,38.00%,DDR2
3150,prerank,negative regulation of translation (GO:0017148),0.30094369288911804,0.659162850162541,0.9083870967741936,1.0,1.0,4/5,61.80%,IGF2BP2;CPEB3;SAMD4A;ILF3
3151,prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.3973368373934991,0.6585087418560219,0.9461172741679873,1.0,1.0,1/2,35.00%,CDK6
3152,prerank,long-term memory (GO:0007616),0.404809619238477,0.6581289068092401,0.9189627228525121,1.0,1.0,2/2,59.60%,CPEB3;KAT2A
3153,prerank,lipid transport (GO:0006869),0.2601567239988618,0.6577052506570743,0.8658959537572254,1.0,1.0,5/8,51.20%,ABCA5;PITPNC1;NCOA2;CHKA;ABCA10
3154,prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.5055055055055055,-0.6573340082637426,0.9885057471264368,0.9949798174067292,1.0,1/1,49.60%,ECE1
3155,prerank,regulation of systemic arterial blood pressure by endothelin (GO:0003100),-0.5055055055055055,-0.6573340082637426,0.9885057471264368,0.9949798174067292,1.0,1/1,49.60%,ECE1
3156,prerank,ear development (GO:0043583),-0.5055055055055055,-0.6573340082637426,0.9885057471264368,0.9949798174067292,1.0,1/1,49.60%,ECE1
3157,prerank,epithelial cell differentiation (GO:0030855),-0.27811244979919675,-0.6572281038609765,0.876984126984127,0.9943705902779243,1.0,4/4,72.40%,CES1;BASP1;PTER;WT1
3158,prerank,postreplication repair (GO:0006301),-0.38777555110220435,-0.6554814108674928,0.9345549738219895,0.993865226379903,1.0,2/2,61.40%,RFC1;RFC3
3159,prerank,error-free translesion synthesis (GO:0070987),-0.38777555110220435,-0.6554814108674928,0.9345549738219895,0.993865226379903,1.0,2/2,61.40%,RFC1;RFC3
3160,prerank,mitochondrial membrane organization (GO:0007006),0.39754485159027225,0.6547301037826591,0.9382911392405063,1.0,1.0,1/2,29.80%,BCL2
3161,prerank,positive regulation of transferase activity (GO:0051347),0.2235814027445433,0.6538473530217701,0.8823529411764706,1.0,1.0,12/13,75.00%,ALK;DDR2;RFC3;IGF1R;FLT4;EGFR;ROR2;EPHA2;FGFR1;CD200;NVL;NEK7
3162,prerank,positive regulation of B cell activation (GO:0050871),0.39688177587606405,0.6530669638511633,0.9524564183835182,1.0,1.0,1/2,29.80%,BCL2
3163,prerank,chromatin organization (GO:0006325),0.2274113290188513,0.6502739357520986,0.8945615982241953,1.0,1.0,2/12,16.30%,HMGA2;MECOM
3164,prerank,positive regulation of cellular metabolic process (GO:0031325),-0.1975806451612903,-0.6498784887253285,0.9375,0.9956415278311533,1.0,8/8,80.50%,INSR;ACACA;ATAD1;TBC1D5;ACACB;ECE1;INPP5F;MAGI2
3165,prerank,regulation of insulin secretion (GO:0050796),0.24784687692972346,0.6493663037407144,0.896,1.0,1.0,1/9,3.50%,CACNA1A
3166,prerank,epithelium development (GO:0060429),0.34300828092136193,0.6488877297521174,0.9217638691322901,1.0,1.0,2/3,52.50%,WT1;PTER
3167,prerank,regulation of macromolecule metabolic process (GO:0060255),0.23085579075594165,0.6484535859629587,0.8802197802197802,1.0,1.0,6/11,48.80%,IGF2BP2;NOVA1;CDK6;ZNF462;TBC1D16;PRDM5
3168,prerank,positive regulation of osteoblast differentiation (GO:0045669),0.28886158615952867,0.6478615490003155,0.9031847133757962,1.0,1.0,1/5,10.20%,FBN2
3169,prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.37975951903807614,-0.6476859867411843,0.9396325459317585,0.995974772075485,1.0,2/2,62.20%,EMILIN1;DDR2
3170,prerank,replication fork processing (GO:0031297),-0.2710843373493976,-0.6469218172666428,0.9325396825396826,0.9956230218192729,1.0,4/4,73.10%,NUCKS1;ZRANB3;WRN;EME2
3171,prerank,activation of GTPase activity (GO:0090630),0.2585372923748064,0.6459839876289691,0.8895417156286721,1.0,1.0,4/8,43.30%,TIAM1;GRTP1;SGSM3;TBC1D16
3172,prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3488713107286586,0.6453544979702361,0.9229691876750701,1.0,1.0,2/3,46.40%,SASH1;EGFR
3173,prerank,regulation of DNA metabolic process (GO:0051052),-0.24924623115577893,-0.6451560160010988,0.933649289099526,0.9956867889484764,1.0,5/5,75.30%,NUCKS1;SMARCAD1;SMG6;PARG;TOM1L1
3174,prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.31329908096004533,0.6451510882790984,0.9163346613545816,1.0,1.0,2/4,39.90%,USP44;CDC14B
3175,prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.25636138002882936,0.6448024358965473,0.9085714285714286,1.0,1.0,2/8,18.20%,MCC;GLI3
3176,prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.25636138002882936,0.6448024358965473,0.9085714285714286,1.0,1.0,2/8,18.20%,MCC;GLI3
3177,prerank,response to endoplasmic reticulum stress (GO:0034976),0.3847057361275113,0.6445041890515903,0.941747572815534,1.0,1.0,1/2,29.80%,BCL2
3178,prerank,leukotriene metabolic process (GO:0006691),0.39378778434355244,0.6437643654900879,0.9414634146341463,1.0,1.0,1/2,28.00%,DPEP1
3179,prerank,regulation of cellular component organization (GO:0051128),0.2549414039457244,0.6419091145590488,0.9198167239404352,1.0,1.0,2/8,21.20%,RIT2;HIP1
3180,prerank,positive regulation of MAP kinase activity (GO:0043406),0.29563368513513144,0.6413093857804546,0.926860025220681,1.0,1.0,3/5,46.40%,SASH1;IL34;EGFR
3181,prerank,cellular response to chemokine (GO:1990869),0.33923947535052007,0.6408492590929491,0.943884892086331,1.0,1.0,1/3,22.10%,STK39
3182,prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.33797955608385705,0.6407526391394617,0.9322766570605188,1.0,1.0,2/3,44.30%,IL34;PRKCA
3183,prerank,substrate-dependent cell migration (GO:0006929),-0.3787575150300601,-0.6400672096252538,0.9511568123393316,0.9971660664263273,1.0,2/2,62.30%,ITGB1BP1;CD2AP
3184,prerank,monovalent inorganic cation homeostasis (GO:0055067),0.34272584286572116,0.6388707461598756,0.9251798561151079,1.0,1.0,2/3,45.80%,SCNN1B;ATP6V0A4
3185,prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.38912847070054446,0.6386743874388346,0.9494097807757167,1.0,1.0,1/2,29.50%,SMOC2
3186,prerank,positive regulation of binding (GO:0051099),0.2738281513365343,0.6382204629044578,0.9200492004920049,1.0,1.0,4/6,52.80%,TIAM1;CAPRIN2;EPB41;USP33
3187,prerank,positive regulation of protein binding (GO:0032092),0.2738281513365343,0.6382204629044578,0.9200492004920049,1.0,1.0,4/6,52.80%,TIAM1;CAPRIN2;EPB41;USP33
3188,prerank,regulation of focal adhesion assembly (GO:0051893),-0.2084592145015106,-0.6373040980980638,0.9444444444444444,0.9975973139594722,1.0,7/7,79.40%,MAP4K4;BCAS3;ITGB1BP1;EFNA5;PTEN;PTK2;LIMCH1
3189,prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3827016728690336,0.6365773907838052,0.9654036243822076,1.0,1.0,1/2,29.80%,BCL2
3190,prerank,negative regulation of signaling (GO:0023057),-0.3687374749498998,-0.6362981077507484,0.9616368286445013,0.9973395546822286,1.0,2/2,63.30%,OPTN;UBASH3B
3191,prerank,regulation of inflammatory response (GO:0050727),-0.20644511581067473,-0.635378540575598,0.9503105590062112,0.9970608745808067,1.0,7/7,79.60%,NLRP1;MGLL;CD200;FOXP1;ETS1;DNASE1;RORA
3192,prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.3887172523389544,0.6351576754860392,0.9489953632148377,1.0,1.0,1/2,31.10%,CAP2
3193,prerank,cAMP-mediated signaling (GO:0019933),0.3887172523389544,0.6351576754860392,0.9489953632148377,1.0,1.0,1/2,31.10%,CAP2
3194,prerank,negative regulation of protein binding (GO:0032091),0.2862732597516167,0.6349515670077801,0.9098984771573604,1.0,1.0,1/5,11.20%,MAP2
3195,prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.34102767668927103,0.634778512544469,0.930298719772404,1.0,1.0,1/3,18.70%,CLDN16
3196,prerank,positive regulation of biosynthetic process (GO:0009891),-0.26798065371984625,-0.63377780066812,0.928030303030303,0.9970294475973203,1.0,3/4,25.90%,SUCO;ZBTB20;CREB3L1
3197,prerank,cellular response to interferon-gamma (GO:0071346),-0.36472945891783565,-0.6319530158557926,0.9713541666666666,0.9963332147891012,1.0,2/2,63.70%,CAMK2D;MID1
3198,prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.36472945891783565,-0.6319530158557926,0.9713541666666666,0.9963332147891012,1.0,2/2,63.70%,CAMK2D;MID1
3199,prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3869036367542506,0.6316463935061993,0.9652448657187994,1.0,1.0,1/2,29.20%,CDK14
3200,prerank,defense response to Gram-negative bacterium (GO:0050829),0.33801404212637914,0.630738726161818,0.9601139601139601,1.0,1.0,3/3,66.30%,ADGRB1;BPI;OPTN
3201,prerank,negative regulation of growth (GO:0045926),0.2652225112958992,0.6284769185339989,0.9202988792029888,1.0,1.0,4/6,54.20%,SLIT2;WT1;CAPRIN2;WFDC1
3202,prerank,regulation of myeloid leukocyte differentiation (GO:0002761),-0.3687374749498998,-0.6284487500221789,0.9766233766233766,0.9969745799882581,1.0,2/2,63.30%,FOXP1;UBASH3B
3203,prerank,microtubule polymerization (GO:0046785),0.3340020060180541,0.6281796916215581,0.9269340974212035,1.0,1.0,3/3,66.70%,TRPV4;FGF13;CCDC57
3204,prerank,mRNA transport (GO:0051028),-0.20241691842900303,-0.6278064113553236,0.958041958041958,0.9965446258735323,1.0,7/7,80.00%,THOC2;NUP58;UPF2;SMG6;SRSF1;NUP93;KIF5C
3205,prerank,regulation of anoikis (GO:2000209),0.3360616865847906,0.6276611013415258,0.9457142857142857,1.0,1.0,2/3,47.10%,BCL2;PTK2
3206,prerank,negative regulation of anoikis (GO:2000811),0.3360616865847906,0.6276611013415258,0.9457142857142857,1.0,1.0,2/3,47.10%,BCL2;PTK2
3207,prerank,DNA replication (GO:0006260),0.2463998304704844,0.6270958158810441,0.9141176470588235,1.0,1.0,1/8,6.00%,POLE
3208,prerank,response to cAMP (GO:0051591),0.38056435302993885,0.6263867009890779,0.9662379421221865,1.0,1.0,1/2,27.80%,WT1
3209,prerank,positive regulation of receptor internalization (GO:0002092),0.30950408061985524,0.6258637503733746,0.9322493224932249,1.0,1.0,1/4,19.70%,MAGI2
3210,prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.17803003365372855,0.624563965197226,0.9366197183098591,1.0,1.0,33/40,74.30%,NRG1;HMGA2;IGF2BP2;KCTD1;ZNF423;MECOM;GLI3;FOXP2;WT1;ATXN1;CPEB3;ZC3H8;KAT6B;PRAME;PRDM5;SCMH1;SAMD4A;ZNF219;GCFC2;FOXN3;MTA3;RBFOX2;ZHX3;ILF3;HDAC5;TBX3;FOXP1;BTAF1;RCOR3;PLCB1;POU2F1;TFDP2;CREB3L1
3211,prerank,transcription by RNA polymerase II (GO:0006366),0.19578760277813473,0.6239430903678742,0.8996865203761756,1.0,1.0,9/20,45.10%,ESRRG;PPARGC1A;RORA;DTX1;NR6A1;TAF1C;ZC3H8;TBL1X;TAF4B
3212,prerank,actin filament bundle assembly (GO:0051017),0.34009749481442275,0.6233405291817158,0.941944847605225,1.0,1.0,1/3,23.50%,BAIAP2L1
3213,prerank,actin filament bundle organization (GO:0061572),0.34009749481442275,0.6233405291817158,0.941944847605225,1.0,1.0,1/3,23.50%,BAIAP2L1
3214,prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.16485087379753613,0.6221213260473482,0.973,1.0,1.0,36/77,51.10%,ESRRG;HMGA2;SHOX;AUTS2;TET1;PPARGC1A;ZNF423;MECOM;GLI3;RORA;ETV5;WT1;ETV4;ETV1;MEIS1;NCOA2;ZIC1;TCF20;BCL9;CREB5;MEIS2;ZNF462;CSRNP3;ZC3H8;KAT6B;TBL1X;HOXB3;CAPRIN2;EGFR;MLLT10;LPIN1;FLI1;WBP2NL;HIVEP3;NR2C2;PBX1
3215,prerank,protein localization to Golgi apparatus (GO:0034067),-0.30190571715145437,-0.6215158306697899,0.937888198757764,0.9982278382269708,1.0,3/3,70.00%,GBF1;OPTN;COG7
3216,prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3306030626448906,0.619277277703314,0.9521739130434783,1.0,1.0,2/3,46.40%,LRP8;EGFR
3217,prerank,proteasomal protein catabolic process (GO:0010498),0.21946181723216446,0.618763998671525,0.9126637554585153,1.0,1.0,3/12,24.30%,HECW2;USP44;TRIM2
3218,prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.37815500542775876,0.6172575879735491,0.9517684887459807,1.0,1.0,1/2,29.80%,BCL2
3219,prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.37815500542775876,0.6172575879735491,0.9517684887459807,1.0,1.0,1/2,29.80%,BCL2
3220,prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.37815500542775876,0.6172575879735491,0.9517684887459807,1.0,1.0,1/2,29.80%,BCL2
3221,prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.24762989535811525,0.6165815122936109,0.9287383177570093,1.0,1.0,2/8,17.90%,CALCR;RGS11
3222,prerank,cortical cytoskeleton organization (GO:0030865),-0.30090270812437314,-0.6157773201844705,0.967948717948718,0.9995977728049938,1.0,3/3,70.10%,DLG1;RHOBTB1;TRPV4
3223,prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.2978936810431294,-0.6154996028630937,0.9451219512195121,0.99902697879481,1.0,3/3,70.40%,MDM2;CREB3L1;BCL2
3224,prerank,regulation of cellular catabolic process (GO:0031329),0.3295512110077232,0.614550548526668,0.9453471196454948,1.0,1.0,2/3,52.80%,ACER2;USP33
3225,prerank,positive regulation of JNK cascade (GO:0046330),0.2958516322083883,0.6143780377215547,0.9509283819628647,1.0,1.0,1/4,15.30%,SEMA3A
3226,prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.2977880292667876,0.6137802154660194,0.9479305740987984,1.0,1.0,2/4,45.90%,GLI3;GPC3
3227,prerank,marginal zone B cell differentiation (GO:0002315),0.3752360593617189,0.6137092213485837,0.9701492537313433,1.0,1.0,1/2,29.90%,DOCK10
3228,prerank,mature B cell differentiation involved in immune response (GO:0002313),0.3752360593617189,0.6137092213485837,0.9701492537313433,1.0,1.0,1/2,29.90%,DOCK10
3229,prerank,cholesterol metabolic process (GO:0008203),0.32889629708484647,0.6128824295274816,0.9452247191011236,1.0,1.0,1/3,25.00%,ABCA5
3230,prerank,protein polyubiquitination (GO:0000209),0.1929536585283489,0.6126150366387799,0.920997920997921,1.0,1.0,13/21,61.00%,MKRN3;HECW2;SASH1;TRIM2;BCL2;NPEPPS;PRAME;HECTD2;HACE1;DDB2;FBXW8;PPIL2;FBXW4
3231,prerank,ear morphogenesis (GO:0042471),0.37474949899799603,0.612515412215032,0.9754901960784313,1.0,1.0,2/2,62.60%,ZIC1;CHD7
3232,prerank,inner ear morphogenesis (GO:0042472),0.37474949899799603,0.612515412215032,0.9754901960784313,1.0,1.0,2/2,62.60%,ZIC1;CHD7
3233,prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.30532541432363214,-0.6103895396233314,0.9559322033898305,0.9999993788909025,1.0,2/3,11.40%,CSNK2A1;SH3RF1
3234,prerank,fatty acid beta-oxidation (GO:0006635),-0.3577154308617234,-0.6072559952983669,0.9803370786516854,1.0,1.0,2/2,64.40%,ABCD3;ACOX3
3235,prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.252008032128514,-0.6030951925625467,0.9558232931726908,1.0,1.0,4/4,75.00%,ROBO1;ITGB1BP1;KAT2B;ROBO2
3236,prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3632990178607225,0.6024731917458419,0.988599348534202,1.0,1.0,1/2,29.10%,MBOAT1
3237,prerank,positive regulation of wound healing (GO:0090303),0.2602458704014025,0.6013796940857669,0.9296116504854369,1.0,1.0,4/6,55.90%,KANK1;SMOC2;PTK2;CLDN1
3238,prerank,regulation of cell growth (GO:0001558),0.22125862003920943,0.6013687569241337,0.9249720044792833,1.0,1.0,6/10,54.20%,SLIT2;WT1;BCL2;CAPRIN2;EGFR;WFDC1
3239,prerank,regulation of cell-substrate junction assembly (GO:0090109),0.32139955537762066,0.6007612562520703,0.9565217391304348,1.0,1.0,2/3,47.10%,LIMCH1;PTK2
3240,prerank,regulation of vascular wound healing (GO:0061043),-0.2948846539618857,-0.5996559319162251,0.952076677316294,1.0,1.0,3/3,70.70%,SLC12A2;FOXC2;SMOC2
3241,prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.2941767068273094,0.5991134168260897,0.9429347826086957,1.0,1.0,4/4,70.70%,KANK1;PTK2;EFNA5;ITGB1BP1
3242,prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.2743338488080089,0.5985958614625344,0.9326683291770573,1.0,1.0,4/5,60.60%,WNK3;EGFR;PTPN9;EPHA2
3243,prerank,regulation of protein localization to plasma membrane (GO:1903076),0.2743338488080089,0.5985958614625344,0.9326683291770573,1.0,1.0,4/5,60.60%,WNK3;EGFR;PTPN9;EPHA2
3244,prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3647294589178357,0.5975220553120344,0.9763779527559056,1.0,1.0,2/2,63.60%,BCL9;LTBP4
3245,prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3647294589178357,0.5975220553120344,0.9763779527559056,1.0,1.0,2/2,63.60%,BCL9;LTBP4
3246,prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3426853707414829,-0.596682930208194,0.9900744416873449,1.0,1.0,2/2,65.90%,FGFR1;AKT3
3247,prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.3426853707414829,-0.596682930208194,0.9900744416873449,1.0,1.0,2/2,65.90%,FGFR1;AKT3
3248,prerank,regulation of response to external stimulus (GO:0032101),-0.2012072434607646,-0.5966091982831836,0.9591836734693877,1.0,1.0,6/6,80.10%,METAP2;NLRP1;MGLL;FOXP1;ADGRA2;LRP8
3249,prerank,peptidyl-lysine modification (GO:0018205),0.2444060962522011,0.5964563790798252,0.9375764993880049,1.0,1.0,5/7,60.20%,RNF212;BCL11A;NUP93;PLOD3;KAT2B
3250,prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.2978936810431294,-0.5963578739140721,0.9589905362776026,0.999462759628182,1.0,3/3,70.40%,CSNK2A1;SGMS1;BCL2
3251,prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.36666309896777194,0.5962929667641897,0.9861351819757366,1.0,1.0,1/2,29.50%,SMOC2
3252,prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.20102236407710375,0.5962759162715432,0.92497320471597,1.0,1.0,8/15,51.80%,WNK2;KANK1;TBL1X;CAPRIN2;GPC3;ADGRA2;EGFR;WLS
3253,prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.32045421978427246,0.5954208254803167,0.96759941089838,1.0,1.0,1/3,21.70%,KANK1
3254,prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.32045421978427246,0.5954208254803167,0.96759941089838,1.0,1.0,1/3,21.70%,KANK1
3255,prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.34969939879759515,-0.5946993290740513,0.9869451697127938,0.9992456710132707,1.0,2/2,65.20%,BAMBI;CDK6
3256,prerank,positive regulation of developmental process (GO:0051094),0.197928044070809,0.5904091721197515,0.9315960912052117,1.0,1.0,6/15,41.90%,ALK;LRP8;WT1;DLG5;CPEB3;MAP3K13
3257,prerank,DNA-dependent DNA replication (GO:0006261),0.22407588575539317,0.5897039963480069,0.9250288350634371,1.0,1.0,1/9,6.00%,POLE
3258,prerank,regulation of DNA repair (GO:0006282),-0.2469879518072289,-0.5879895528537658,0.9710743801652892,1.0,1.0,4/4,75.50%,NPAS2;PARG;EGFR;EYA2
3259,prerank,regulation of autophagy (GO:0010506),0.21151489565748977,0.5861590870269272,0.9267480577136515,1.0,1.0,3/11,29.80%,SNX32;ACER2;BCL2
3260,prerank,anion transmembrane transport (GO:0098656),0.25618303760913735,0.5857236069656705,0.9517923362175525,1.0,1.0,5/6,64.10%,SLC16A12;SFXN1;SLC25A12;SLC13A4;SLC1A3
3261,prerank,organic acid transport (GO:0015849),0.36346798938253694,0.5853180422106614,0.9903691813804173,1.0,1.0,1/2,32.60%,NCOA2
3262,prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.16820576087142214,0.5852126427879554,0.9537223340040242,1.0,1.0,30/37,74.30%,NRG1;HMGA2;KCTD1;ZNF423;MECOM;GLI3;FOXP2;WT1;ATXN1;ZC3H8;KAT6B;PRAME;PRDM5;SCMH1;ZNF219;GCFC2;FOXN3;MTA3;RBFOX2;ZHX3;ILF3;HDAC5;TBX3;FOXP1;BTAF1;RCOR3;PLCB1;POU2F1;TFDP2;CREB3L1
3263,prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.28043887543516727,0.5820338436273736,0.9691275167785235,1.0,1.0,1/4,20.50%,BMPER
3264,prerank,apical junction assembly (GO:0043297),0.25397736968039647,0.5808094368803427,0.956949569495695,1.0,1.0,2/6,28.30%,CLDN16;PARD3
3265,prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.1579524062803757,0.5796148903561991,0.978,1.0,1.0,25/58,47.50%,HMGA2;SHOX;AUTS2;TET1;PPARGC1A;GLI3;RORA;ETV5;WT1;ETV4;ETV1;MEIS1;NCOA2;TCF20;BCL9;MEIS2;ZNF462;CSRNP3;KAT6B;TBL1X;HOXB3;CAPRIN2;EGFR;MLLT10;LPIN1
3266,prerank,negative regulation of cell cycle process (GO:0010948),0.3085387726769444,0.5790115551824884,0.9713876967095851,1.0,1.0,1/3,24.90%,TOM1L1
3267,prerank,negative regulation of cell junction assembly (GO:1901889),-0.252008032128514,-0.5789374503200139,0.9679715302491103,1.0,1.0,4/4,75.00%,BCAS3;ITGB1BP1;PTEN;ROBO2
3268,prerank,dendritic spine morphogenesis (GO:0060997),0.3520578399245289,0.5787508995594887,0.9839743589743589,1.0,1.0,1/2,29.90%,DOCK10
3269,prerank,regulation of metal ion transport (GO:0010959),0.30470747286527794,0.5785977187766207,0.9728958630527818,1.0,1.0,2/3,48.60%,BCL2;EPB41
3270,prerank,fatty acid metabolic process (GO:0006631),-0.14842303130448742,-0.5784045978408412,1.0,1.0,1.0,10/11,65.00%,CES1;ACACA;ADIPOR2;PER2;ABCD3;AASDH;ACADSB;LPIN1;LIPG;ACSF2
3271,prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.3069207622868605,0.5775099540350247,0.9799713876967096,1.0,1.0,3/3,69.40%,MBOAT1;MBOAT2;PLA2G4A
3272,prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.3069207622868605,0.5775099540350247,0.9799713876967096,1.0,1.0,3/3,69.40%,MBOAT1;MBOAT2;PLA2G4A
3273,prerank,phosphatidylserine metabolic process (GO:0006658),0.3069207622868605,0.5775099540350247,0.9799713876967096,1.0,1.0,3/3,69.40%,MBOAT1;MBOAT2;PLA2G4A
3274,prerank,ceramide metabolic process (GO:0006672),-0.2818455366098295,-0.5766139609150751,0.9935483870967742,1.0,1.0,3/3,72.00%,SGMS1;CERS6;ACER2
3275,prerank,positive regulation of protein metabolic process (GO:0051247),0.25819046568793996,0.5712640401675699,0.9586466165413534,1.0,1.0,1/5,14.20%,HECW2
3276,prerank,establishment of centrosome localization (GO:0051660),-0.28284854563691075,-0.5708087318377943,0.9933993399339934,1.0,1.0,3/3,71.90%,PARD3B;DLG1;PARD3
3277,prerank,response to lipid (GO:0033993),-0.2818455366098295,-0.5702727796389381,0.9903225806451613,1.0,1.0,3/3,72.00%,ASXL1;FOXP1;ACER2
3278,prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.2778335005015045,-0.5670007791556068,0.9935483870967742,1.0,1.0,3/3,72.40%,NFIB;ETS1;WT1
3279,prerank,glutathione metabolic process (GO:0006749),0.30090270812437314,0.5655072339858314,0.9727011494252874,1.0,1.0,3/3,70.00%,DPEP1;GCLM;HAGH
3280,prerank,embryonic organ development (GO:0048568),0.2744894236496353,0.5650087407302445,0.9716216216216216,1.0,1.0,1/4,18.20%,GLI3
3281,prerank,respiratory system development (GO:0060541),-0.2778335005015045,-0.5643637710687165,0.9968652037617555,0.9998844334596336,1.0,3/3,72.40%,BASP1;CHD7;WT1
3282,prerank,aorta development (GO:0035904),0.3021492203032746,0.5634208299726519,0.9807956104252401,1.0,1.0,1/3,25.20%,ROBO2
3283,prerank,regulation of mitotic cell cycle (GO:0007346),-0.1416225847381063,-0.5629318672463559,0.9680851063829787,0.9994175371284484,1.0,9/13,33.50%,GBF1;ANAPC16;BTRC;USP22;PKN2;MDM2;NEK7;CDK10;CCDC57
3284,prerank,regulation of lipid metabolic process (GO:0019216),0.20827173455505033,0.5599760800594161,0.9633333333333334,1.0,1.0,7/10,64.20%,RORA;ELOVL6;NCOA2;TBL1X;ACACB;IDI1;CHD9
3285,prerank,blood circulation (GO:0008015),0.29388164493480445,0.5590593406697908,0.986764705882353,1.0,1.0,3/3,70.70%,HTR7;GCLM;ITGB1BP1
3286,prerank,protein glycosylation (GO:0006486),0.23875963300782477,0.5583977289807573,0.9619047619047619,1.0,1.0,4/6,56.10%,TET1;COG7;GCNT2;PLOD3
3287,prerank,regulation of intracellular signal transduction (GO:1902531),0.16176514162428163,0.5532452102897385,0.9634888438133874,1.0,1.0,13/31,46.40%,TIAM1;RIT2;OBSCN;MAP2K6;MOB3B;PRKAR2B;PRKAR1B;RHOJ;RFC3;PIDD1;WRN;TAF4B;EGFR
3288,prerank,positive regulation of protein catabolic process (GO:0045732),0.250423126219599,0.552530212611392,0.9774718397997497,1.0,1.0,1/5,14.20%,HECW2
3289,prerank,icosanoid metabolic process (GO:0006690),0.29689067201604824,0.5509488273480163,0.9855491329479769,1.0,1.0,3/3,70.40%,DPEP1;PLA2G4A;MGLL
3290,prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.1483598242592284,0.5500347450945855,0.979,1.0,1.0,49/64,74.30%,NRG1;HMGA2;ZNF536;ZNF20;KCTD1;TENM2;ZNF423;MECOM;GLI3;FOXP2;ETV5;ZNF248;BCL11A;WT1;ATXN1;NR6A1;MEIS2;CPEB3;ZC3H8;KAT6B;TBL1X;PRAME;PRDM5;NR2C2;SCMH1;MXI1;ZNF219;GCFC2;ZNF25;ZNF529;FOXN3;TRPS1;MTA3;RBFOX2;ZHX3;ILF3;NFIX;HDAC5;TBX3;GATAD2B;FOXP1;BTAF1;FOXC2;RCOR3;PLCB1;POU2F1;TFDP2;MXD4;CREB3L1
3291,prerank,integrin-mediated signaling pathway (GO:0007229),-0.2369477911646586,-0.5479963596646706,0.996078431372549,1.0,1.0,4/4,76.50%,DST;ITGB1BP1;PTK2;LAMA3
3292,prerank,regulation of osteoblast differentiation (GO:0045667),0.2109918051373679,0.5466398295220969,0.9702857142857143,1.0,1.0,4/8,47.10%,FBN2;CDK6;DDR2;PTK2
3293,prerank,regulation of translation (GO:0006417),0.2240337737362198,0.5444017318058035,0.9655172413793104,1.0,1.0,1/7,9.40%,IGF2BP2
3294,prerank,positive regulation of protein modification process (GO:0031401),0.18007438438606604,0.5435235879797735,0.9573105656350054,1.0,1.0,8/15,55.20%,NOS1AP;LIMCH1;IL34;FLT4;EGFR;PTK2;CAMTA1;CCND2
3295,prerank,cellular response to DNA damage stimulus (GO:0006974),0.16935583192535636,0.5414648865390942,0.9677083333333333,1.0,1.0,9/21,45.00%,STK33;FMN2;MAP2K6;ACER2;BCL2;CASP9;RFC3;PIDD1;WRN
3296,prerank,regulation of protein binding (GO:0043393),0.20484359233097882,0.5404614610125316,0.967816091954023,1.0,1.0,9/9,79.70%,TIAM1;CAPRIN2;EPB41;USP33;HDAC5;ITGB1BP1;NVL;CSNK1E;BAMBI
3297,prerank,positive regulation of cytoskeleton organization (GO:0051495),0.26399322180661894,0.5386592348319713,0.9852744310575636,1.0,1.0,1/4,23.50%,BAIAP2L1
3298,prerank,regulation of mRNA stability (GO:0043488),0.21090346623814477,0.538051887115452,0.9695906432748538,1.0,1.0,5/8,59.90%,IGF2BP2;CSDC2;PRKCA;SAMD4A;XPO1
3299,prerank,defense response to bacterium (GO:0042742),-0.2133439786248974,-0.5363266605146614,0.9813953488372092,1.0,1.0,4/5,41.60%,NLRP1;COLEC12;OPTN;BPI
3300,prerank,positive regulation of epithelial cell migration (GO:0010634),0.19741760103201847,0.532962088709642,0.9717194570135747,1.0,1.0,8/10,70.70%,SASH1;SMOC2;FLT4;PRKCA;ETS1;FOXP1;FOXC2;ITGB1BP1
3301,prerank,regulation of defense response (GO:0031347),0.25396317650152567,0.5306215321752217,0.988950276243094,1.0,1.0,1/4,20.10%,LRP8
3302,prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.25702811244979923,0.5299354845578949,0.9819694868238558,1.0,1.0,4/4,74.40%,LRP8;CAPRIN2;PTEN;TANC2
3303,prerank,regulation of immune response (GO:0050776),0.2504477922452514,0.523722122501561,0.9903314917127072,1.0,1.0,1/4,20.10%,LRP8
3304,prerank,regulation of organelle organization (GO:0033043),-0.2040201005025126,-0.5236038626996434,0.9812206572769953,1.0,1.0,5/5,79.80%,MFF;CAMSAP2;CAPN2;PTK2;RBSN
3305,prerank,mRNA processing (GO:0006397),-0.1225937183383992,-0.5193209584348581,1.0,0.9994684096629172,1.0,13/13,88.00%,THOC2;CCAR1;RBMX;PNN;CWC27;MNAT1;CSTF3;SRSF1;GCFC2;PRPF40B;NOVA1;DHX8;PPARGC1A
3306,prerank,regulation of mRNA catabolic process (GO:0061013),0.20217864772798272,0.5182395134885396,0.9895470383275261,1.0,1.0,5/8,59.90%,IGF2BP2;CSDC2;PRKCA;SAMD4A;XPO1
3307,prerank,sulfur compound biosynthetic process (GO:0044272),0.2173038229376258,0.5122215383170186,0.9730061349693252,1.0,1.0,6/6,78.40%,CHST9;GCLM;SLC10A7;HAGH;ST3GAL3;PAPSS1
3308,prerank,artery development (GO:0060840),0.26845696938159924,0.5058431246030228,0.997229916897507,1.0,1.0,1/3,25.20%,ROBO2
3309,prerank,positive regulation of protein localization to membrane (GO:1905477),0.18548719757546833,0.5044832518201307,0.9832026875699889,1.0,1.0,9/10,75.90%,WNK3;BCL2;EGFR;PTPN9;EPHA2;TCAF1;ITGB1BP1;TFDP2;DLG1
3310,prerank,cellular protein modification process (GO:0006464),0.13496328306357447,0.5030182829240565,0.991991991991992,1.0,1.0,25/67,45.90%,HS3ST5;WNK2;CHRM3;HIF3A;PTPRN2;PTPRD;WNK3;CDC42BPA;CDH2;STK39;CDK14;COG7;PGAP1;AKT3;CDK6;GRK5;PRKAR1B;PTPRE;MAST2;CDC14B;MAP3K13;SRPK1;PRKCA;VRK1;GPC3
3311,prerank,protein ubiquitination (GO:0016567),0.14614718280482453,0.49857866218095936,0.9848178137651822,1.0,1.0,17/31,61.00%,HIF3A;MKRN3;HECW2;SASH1;TRIM2;DTX1;BCL2;NPEPPS;MYCBP2;ZNRF3;PRAME;HECTD2;HACE1;DDB2;FBXW8;PPIL2;FBXW4
3312,prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.21218756221011828,0.49564633287943866,0.9890510948905109,1.0,1.0,4/6,58.20%,MCC;CDK6;MAGED1;NF1
3313,prerank,regulation of p38MAPK cascade (GO:1900744),0.24353777473980112,0.4945272702498789,0.9961340206185567,1.0,1.0,1/4,19.20%,SASH1
3314,prerank,cellular macromolecule biosynthetic process (GO:0034645),0.18138101693926126,0.4881082002785301,0.9920814479638009,1.0,1.0,1/10,6.00%,POLE
3315,prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.12324669881753764,0.48571782347007597,0.998,1.0,1.0,73/136,60.20%,ESRRG;HMGA2;ZNF536;HIF3A;PKNOX2;SHOX;AUTS2;TFCP2L1;EBF2;ZNF20;TET1;PPARGC1A;KCTD1;BACH2;TENM2;MECOM;TARBP1;GLI3;MAMLD1;RORA;FOXP2;ETV5;ZNF248;BCL11A;WT1;ETV4;ETV1;TCF7L1;MEIS1;NCOA2;ZIC1;TCF20;ATXN1;NR6A1;BCL9;CREB5;MEIS2;ZNF462;CPEB3;BRD9;CSRNP3;KAT6B;TBL1X;TSHZ2;HOXB3;TOX;CAPRIN2;EGFR;MLLT10;LPIN1;PRDM5;FLI1;HIVEP3;NR2C2;ZNF37A;PBX1;MXI1;TNRC6B;ZNF219;CAMTA1;ZFP14;ZNF25;ZNF529;ETS1;ZNF518A;RFX7;HAND2;ERG;TRPS1;MTA3;KAT2A;ZHX3;KAT2B
3316,prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.12188949667467525,0.48253467069110206,1.0,1.0,1.0,75/141,59.80%,ESRRG;NRG1;HMGA2;ZNF536;HIF3A;PKNOX2;SHOX;TFCP2L1;EBF2;ZNF20;PPARGC1A;KCTD1;BACH2;ZNF423;MECOM;TARBP1;GLI3;MAMLD1;RORA;FOXP2;ETV5;ZNF248;BCL11A;WT1;ETV4;ETV1;CDK14;TCF7L1;MEIS1;NCOA2;ZIC1;TCF20;BNC2;ATXN1;NR6A1;CREB5;MEIS2;BRD9;CSRNP3;ZC3H8;KAT6B;TBL1X;TSHZ2;HOXB3;TOX;EGFR;PRAME;PRDM5;FLI1;WBP2NL;HIVEP3;NR2C2;ZNF37A;SCMH1;PBX1;MXI1;ZNF219;ZNF678;GCFC2;CAMTA1;ZFP14;ZNF25;ZNF529;ETS1;FOXN3;ZNF518A;RFX7;HAND2;ERG;MAGED1;TRPS1;MTA3;RBFOX2;KAT2A;ZHX3
3317,prerank,post-translational protein modification (GO:0043687),0.1649713173956328,0.4824475425769812,0.9786096256684492,1.0,1.0,2/14,18.10%,HIF3A;CDH2
3318,prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.16023602549986155,0.47725241555065284,0.9817792068595927,1.0,1.0,3/15,24.30%,HECW2;USP44;TRIM2
3319,prerank,membrane organization (GO:0061024),0.16850076422070964,0.47453360921400334,0.9837662337662337,0.9999282256159702,1.0,8/12,67.20%,SH3GL2;HIP1;FNBP1L;NUP93;EGFR;HACE1;SPAST;UBXN2A
3320,prerank,protein dephosphorylation (GO:0006470),0.14908383623409818,0.4652667223261836,0.9770833333333333,0.9998978508318325,1.0,2/18,10.10%,PTPRN2;PTPRD
3321,prerank,positive regulation of phosphorylation (GO:0042327),0.14483482566267947,0.46351809161661234,0.9844398340248963,0.9994374976353205,1.0,9/20,49.30%,ALK;LIMCH1;IL34;DDR2;IGF1R;FLT4;EGFR;PTK2;ROR2
3322,prerank,heart morphogenesis (GO:0003007),0.19324691485054665,0.4484753763217425,0.9949685534591195,0.9995534158004683,1.0,1/6,14.90%,FLRT2
3323,prerank,non-canonical Wnt signaling pathway (GO:0035567),0.1412060380324821,0.39599074276344265,0.9967391304347826,1.0,1.0,2/12,22.60%,TIAM1;GNAO1
3324,prerank,regulation of GTPase activity (GO:0043087),0.11607059184768194,0.32996118865008905,1.0,0.999961016440955,1.0,1/13,8.00%,RGS7
